Sentence,class,file
Curr Biol 2003; 13:790-5;  PMID:12725740; http://dx.doi.org/10.1016/S0960- 9822(03)00250-1 10.,OADS,/arxiv_data1/oa_pdf/43/10/rna-10-1042.PMC3904584.pdf
Curr Biol  1999; 9:1019-29; PMID:10508611; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/10/rna-10-1042.PMC3904584.pdf
Curr Biol 2001; 11:213-21;  PMID:11250149; http://dx.doi.org/10.1016/S0960-9822(01)00068-9 12.,OADS,/arxiv_data1/oa_pdf/43/10/rna-10-1042.PMC3904584.pdf
Curr Biol 2005; 15:1796-807; PMID:16182527; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/10/rna-10-1042.PMC3904584.pdf
Exp Gerontol 2011; 46:382-90; PMID:21130151;  http://dx.doi.org/10.1016/j.exger.2010.11.036 15.,OADS,/arxiv_data1/oa_pdf/43/10/rna-10-1042.PMC3904584.pdf
Curr Biol 2002; 12:712-23;  PMID:12007414; http://dx.doi.org/10.1016/S0960- 9822(02)00808-4 16.,OADS,/arxiv_data1/oa_pdf/43/10/rna-10-1042.PMC3904584.pdf
Cell Metab 2011; 13:340-50; PMID:21356523;  http://dx.doi.org/10.1016/j.cmet.2011.02.003 18.,OADS,/arxiv_data1/oa_pdf/43/10/rna-10-1042.PMC3904584.pdf
Exp Gerontol 2004; 39:1137- 43; PMID:15288688; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/43/10/rna-10-1042.PMC3904584.pdf
FEBS Lett  2006; 580:2821-9; PMID:16684541; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/10/rna-10-1042.PMC3904584.pdf
Cell  2009; 136:521-34; PMID:19203585; http://dx.doi.org/10.1016/j.cell.2008.11.044 21.,OADS,/arxiv_data1/oa_pdf/43/10/rna-10-1042.PMC3904584.pdf
Nat  Rev Mol Cell Biol 2011; 12:21-35; PMID:21157483; http://dx.doi.org/10.1038/nrm3025 22.,OADS,/arxiv_data1/oa_pdf/43/10/rna-10-1042.PMC3904584.pdf
J Clin Invest 1998; 101:1519-29;  PMID:9525995; http://dx.doi.org/10.1172/JCI1326 24.,Non-OADS,/arxiv_data1/oa_pdf/43/10/rna-10-1042.PMC3904584.pdf
Diabetes 2001; 50:353-60; PMID:11272147;  http://dx.doi.org/10.2337/diabetes.50.2.353 25.,Non-OADS,/arxiv_data1/oa_pdf/43/10/rna-10-1042.PMC3904584.pdf
Diabetologia 1988; 31:435-42; PMID:2851470;  http://dx.doi.org/10.1007/BF00271588 26.,Non-OADS,/arxiv_data1/oa_pdf/43/10/rna-10-1042.PMC3904584.pdf
Cell Metab 2010; 12:362-72; PMID:20889128;  http://dx.doi.org/10.1016/j.cmet.2010.08.01627.,OADS,/arxiv_data1/oa_pdf/43/10/rna-10-1042.PMC3904584.pdf
Cell  Metab 2009; 9:311-26; PMID:19356713; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/10/rna-10-1042.PMC3904584.pdf
Diabetologia 2010; 53:757-67; PMID:20076942; http://dx.doi.org/10.1007/s00125- 009-1637-8 29.,Non-OADS,/arxiv_data1/oa_pdf/43/10/rna-10-1042.PMC3904584.pdf
Nat Med 2011; 17:448-53;  PMID:21423183; http://dx.doi.org/10.1038/nm.2307 30.,Non-OADS,/arxiv_data1/oa_pdf/43/10/rna-10-1042.PMC3904584.pdf
Science 2012; 338:394-7; PMID:22956686;  http://dx.doi.org/10.1126/science.1224631 32.,Non-OADS,/arxiv_data1/oa_pdf/43/10/rna-10-1042.PMC3904584.pdf
J Gerontol A Biol Sci Med Sci 2004; 59:B896- 901; PMID:15472152; http://dx.doi.org/10.1093/ gerona/59.9.B896 34.,Non-OADS,/arxiv_data1/oa_pdf/43/10/rna-10-1042.PMC3904584.pdf
Cell  2006; 125:887-901; PMID:16751099; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/10/rna-10-1042.PMC3904584.pdf
Nature 2010; 466:835- 40; PMID:20703300; http://dx.doi.org/10.1038/ nature09267 37.,Non-OADS,/arxiv_data1/oa_pdf/43/10/rna-10-1042.PMC3904584.pdf
Nature 2008; 455:58- 63; PMID:18668040; http://dx.doi.org/10.1038/nature07228 38.,Non-OADS,/arxiv_data1/oa_pdf/43/10/rna-10-1042.PMC3904584.pdf
Nature 2008; 455:64-71; PMID:18668037; http://dx.doi.org/10.1038/nature07242 39.,Non-OADS,/arxiv_data1/oa_pdf/43/10/rna-10-1042.PMC3904584.pdf
Nucleic Acids Res 2011; 39(Web Server issue):W307-15; PMID:21646343; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/10/rna-10-1042.PMC3904584.pdf
PLoS Biol 2003; 1:E60; PMID:14691535; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/10/rna-10-1042.PMC3904584.pdf
Development 2012; 139:2821-31; PMID:22745315;  http://dx.doi.org/10.1242/dev.079939 74.,OADS,/arxiv_data1/oa_pdf/43/10/rna-10-1042.PMC3904584.pdf
Ann N Y Acad Sci 1989; 573:230-9; PMID:2634347; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/10/rna-10-1042.PMC3904584.pdf
J Inherit Metab Dis  2000; 23:805-18; PMID:11196106; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/10/rna-10-1042.PMC3904584.pdf
Biochem Biophys Res Commun  2006; 343:1244-50; PMID:16581023; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/10/rna-10-1042.PMC3904584.pdf
Biochem  J 2006; 400:153-62; PMID:16875466; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/10/rna-10-1042.PMC3904584.pdf
Life Sci 2006; 79:737-43; PMID:16616211;  http://dx.doi.org/10.1016/j.lfs.2006.02.037 81.,OADS,/arxiv_data1/oa_pdf/43/10/rna-10-1042.PMC3904584.pdf
Hum Mol Genet 2005; 14:3371-7; PMID:16203741;  http://dx.doi.org/10.1093/hmg/ddi368 83.,OADS,/arxiv_data1/oa_pdf/43/10/rna-10-1042.PMC3904584.pdf
PLoS Biol 2005; 3:e223; PMID:16000018;  http://dx.doi.org/10.1371/journal.pbio.0030223 84.,OADS,/arxiv_data1/oa_pdf/43/10/rna-10-1042.PMC3904584.pdf
PLoS  Biol 2005; 3:e236; PMID:15918770; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/10/rna-10-1042.PMC3904584.pdf
Nucleic Acids Res 2011; 39:3836- 51; PMID:21245036; http://dx.doi.org/10.1093/nar/ gkq1324 86.,OADS,/arxiv_data1/oa_pdf/43/10/rna-10-1042.PMC3904584.pdf
Genome Biol 2009; 10:R25;  PMID:19261174; http://dx.doi.org/10.1186/gb-2009- 10-3-r25 87.,OADS,/arxiv_data1/oa_pdf/43/10/rna-10-1042.PMC3904584.pdf
Curr  Biol 2004; 14:885-90; PMID:15186745; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/10/rna-10-1042.PMC3904584.pdf
Cell 2005; 120:15- 20; PMID:15652477; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/43/10/rna-10-1042.PMC3904584.pdf
Cell 2009; 136:215-33; PMID:19167326;  http://dx.doi.org/10.1016/j.cell.2009.01.002 59.,OADS,/arxiv_data1/oa_pdf/43/10/rna-10-1042.PMC3904584.pdf
Genome Res 2009; 19:92-105; PMID:18955434;  http://dx.doi.org/10.1101/gr.082701.108 60.,OADS,/arxiv_data1/oa_pdf/43/10/rna-10-1042.PMC3904584.pdf
Nat Genet 2006; 38(Suppl):S8-13; PMID:16736023;  http://dx.doi.org/10.1038/ng1798 62.,OADS,/arxiv_data1/oa_pdf/43/10/rna-10-1042.PMC3904584.pdf
PLoS Biol 2005;  3:e85; PMID:15723116; http://dx.doi.org/10.1371/ journal.pbio.0030085 63.,OADS,/arxiv_data1/oa_pdf/43/10/rna-10-1042.PMC3904584.pdf
Nature 2007; 450:219-32; PMID:17994088;  http://dx.doi.org/10.1038/nature06340 64.,OADS,/arxiv_data1/oa_pdf/43/10/rna-10-1042.PMC3904584.pdf
Curr Biol 2009; 19:870-3; PMID:19375315; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/10/rna-10-1042.PMC3904584.pdf
Angew Chem Int Ed Engl 2009;  48:853-5; PMID:19115352; http://dx.doi.org/10.1002/ anie.200805127 66.,OADS,/arxiv_data1/oa_pdf/43/10/rna-10-1042.PMC3904584.pdf
RNA Biol 2007;  4:76-84; PMID:17637574; http://dx.doi.org/10.4161/ rna.4.2.4640 67.,OADS,/arxiv_data1/oa_pdf/43/10/rna-10-1042.PMC3904584.pdf
Cell 2010; 141:129- 41; PMID:20371350; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/43/10/rna-10-1042.PMC3904584.pdf
Nat Biotechnol 2011; 29:607-14;  PMID:21633356; http://dx.doi.org/10.1038/nbt.1873 71.,Non-OADS,/arxiv_data1/oa_pdf/43/10/rna-10-1042.PMC3904584.pdf
Nat Struct Mol Biol 2011; 18:1139- 46; PMID:21909094; http://dx.doi.org/10.1038/nsmb.2115 72.,OADS,/arxiv_data1/oa_pdf/43/10/rna-10-1042.PMC3904584.pdf
Genetics 2012; 192:1543-52; PMID:23051640; http://dx.doi.org/10.1534/genet- ics.112.14538341.,OADS,/arxiv_data1/oa_pdf/43/10/rna-10-1042.PMC3904584.pdf
RNA 2008; 14:1959- 72; PMID:18658122; http://dx.doi.org/10.1261/ rna.1136108 42.,OADS,/arxiv_data1/oa_pdf/43/10/rna-10-1042.PMC3904584.pdf
Mol  Syst Biol 2011; 7:458; PMID:21206491; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/10/rna-10-1042.PMC3904584.pdf
Nat Biotechnol 2011; 29:436-42; PMID:21516085; http://dx.doi.org/10.1038/ nbt.1861 45.,Non-OADS,/arxiv_data1/oa_pdf/43/10/rna-10-1042.PMC3904584.pdf
J Nutr  2010; 140:1418-24; PMID:20534881; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/10/rna-10-1042.PMC3904584.pdf
Brain Res 2010; 1324:75-84;  PMID:20153737; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/43/10/rna-10-1042.PMC3904584.pdf
J Biol Chem  2002; 277:9952-7; PMID:11788584; http://dx.doi.org/10.1074/jbc.M107694200 49.,OADS,/arxiv_data1/oa_pdf/43/10/rna-10-1042.PMC3904584.pdf
Neuron 1996; 17:641-54; PMID:8893022; http://dx.doi.org/10.1016/S0896- 6273(00)80197-X 52.,OADS,/arxiv_data1/oa_pdf/43/10/rna-10-1042.PMC3904584.pdf
Nat Methods 2009; 6:897- 903; PMID:19915559; http://dx.doi.org/10.1038/ nmeth.1402 53.,OADS,/arxiv_data1/oa_pdf/43/10/rna-10-1042.PMC3904584.pdf
Nat Methods 2007; 4:721-6; PMID:17694064;  http://dx.doi.org/10.1038/nmeth1079 54.,OADS,/arxiv_data1/oa_pdf/43/10/rna-10-1042.PMC3904584.pdf
Cell  Metab 2010; 11:35-46; PMID:20074526; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/10/rna-10-1042.PMC3904584.pdf
"http://www.landesbioscience.com/ journals/10/article/23604/    Reference hu J, et al.",OADS,/arxiv_data1/oa_pdf/32/2e/rna-10-907.PMC3904587.pdf
Plant Signal Behav 2013; 8:e23604; PMid:  23333975; http://dx.doi.org/10.4161/psb.23604 it has previously been shown that about  10% of all eukaryotic mRNAs contain potential  programmed -1 ribosomal frameshifting (-1  PRF) signals.,Non-OADS,/arxiv_data1/oa_pdf/32/2e/rna-10-907.PMC3904587.pdf
"http://www.landesbioscience.com/journals/translation/article/24418/ Reference Advani VM, et al.",Non-OADS,/arxiv_data1/oa_pdf/32/2e/rna-10-907.PMC3904587.pdf
translation 2013; 1:e24418;   http://dx.doi.org/10.4161/trla.24418,Non-OADS,/arxiv_data1/oa_pdf/32/2e/rna-10-907.PMC3904587.pdf
"http://www.landesbioscience.com/journals/epigenetics/article/24519/   Reference Sousa E, et al.",Non-OADS,/arxiv_data1/oa_pdf/32/2e/rna-10-907.PMC3904587.pdf
Epigenetics 2013; 8:548-58; PMid:23644875;  http://dx.doi.org/10.4161/epi.24519 there is evidence to suggest that the pro - cess of gene transcription is tightly connected  with the spatial organization of chromosomes.,Non-OADS,/arxiv_data1/oa_pdf/32/2e/rna-10-907.PMC3904587.pdf
"g enome structure could be topo - logically constrained by gene expression and  gene expression could be reciprocally facili- tated by genome structure.http://www.landesbioscience.com/journals/ nucleus/article/24875/ Reference Li S, et al.",OADS,/arxiv_data1/oa_pdf/32/2e/rna-10-907.PMC3904587.pdf
Nucleus 2013; 4:216-28; PMid:23674068;   http://dx.doi.org/10.4161/nucl.24875,OADS,/arxiv_data1/oa_pdf/32/2e/rna-10-907.PMC3904587.pdf
J Oral Maxillofac Res 2013;4(4):e1 URL: http://www.ejomr.org/JOMR/archives/2013/4/e1/v4n4e1ht.pdf doi: 10.5037/jomr.2013.4401 http://www.ejomr.org/JOMR/archives/2013/4/e1/v4n4e1ht.htm J Oral Maxillofac Res 2013 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/e4/1a/jomr-04-e1.PMC3904727.pdf
http://www.ejomr.org/JOMR/archives/2013/4/e1/v4n4e1ht.htm J Oral Maxillofac Res 2013 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/e4/1a/jomr-04-e1.PMC3904727.pdf
MATERIAL AND METHODS   The study was registered with Prospero - The   International Prospective Register of Systematic  Reviews: http://www.crd.york.ac.uk/NIHR_ PROSPERO/ .,Non-OADS,/arxiv_data1/oa_pdf/e4/1a/jomr-04-e1.PMC3904727.pdf
http://www.ejomr.org/JOMR/archives/2013/4/e1/v4n4e1ht.htm J Oral Maxillofac Res 2013 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/e4/1a/jomr-04-e1.PMC3904727.pdf
http://www.ejomr.org/JOMR/archives/2013/4/e1/v4n4e1ht.htm J Oral Maxillofac Res 2013 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/e4/1a/jomr-04-e1.PMC3904727.pdf
http://www.ejomr.org/JOMR/archives/2013/4/e1/v4n4e1ht.htm J Oral Maxillofac Res 2013 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/e4/1a/jomr-04-e1.PMC3904727.pdf
http://www.ejomr.org/JOMR/archives/2013/4/e1/v4n4e1ht.htm J Oral Maxillofac Res 2013 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/e4/1a/jomr-04-e1.PMC3904727.pdf
http://www.ejomr.org/JOMR/archives/2013/4/e1/v4n4e1ht.htm J Oral Maxillofac Res 2013 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/e4/1a/jomr-04-e1.PMC3904727.pdf
http://www.ejomr.org/JOMR/archives/2013/4/e1/v4n4e1ht.htm J Oral Maxillofac Res 2013 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/e4/1a/jomr-04-e1.PMC3904727.pdf
http://www.ejomr.org/JOMR/archives/2013/4/e1/v4n4e1ht.htm J Oral Maxillofac Res 2013 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/e4/1a/jomr-04-e1.PMC3904727.pdf
Avialable at: http://www.sdcep.org.uk/?o=3120 12.,Non-OADS,/arxiv_data1/oa_pdf/e4/1a/jomr-04-e1.PMC3904727.pdf
http://www.ejomr.org/JOMR/archives/2013/4/e1/v4n4e1ht.htm J Oral Maxillofac Res 2013 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/e4/1a/jomr-04-e1.PMC3904727.pdf
"J Oral Maxillofac Res 2013;4(4):e1 URL: http://www.ejomr.org/JOMR/archives/2013/4/e1/v4n4e1ht.pdf doi: 10.5037/jomr.2013.4401 Copyright ©  Hennedige AA, Jayasinghe J, Khajeh J, Macfarlane TV .",Non-OADS,/arxiv_data1/oa_pdf/e4/1a/jomr-04-e1.PMC3904727.pdf
"Published in the JOURNAL OF ORAL &  MAXILLOFACIAL RESEARCH ( http://www.ejomr.org ), 1 January 2014.",Non-OADS,/arxiv_data1/oa_pdf/e4/1a/jomr-04-e1.PMC3904727.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.30.",Non-OADS,/arxiv_data1/oa_pdf/e4/1a/jomr-04-e1.PMC3904727.pdf
URL: http://www.ejomr.org/JOMR/archives/2010/2/e3/e3ht.htm,OADS,/arxiv_data1/oa_pdf/e4/1a/jomr-04-e1.PMC3904727.pdf
J Oral Maxillofac Res 2013;4(4):e2 URL: http://www.ejomr.org/JOMR/archives/2013/4/e2/v4n4e2ht.pdf doi: 10.5037/jomr.2013.4402 http://www.ejomr.org/JOMR/archives/2013/4/e2/v4n4e2ht.htm J Oral Maxillofac Res 2013 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/38/8b/jomr-04-e2.PMC3904728.pdf
http://www.ejomr.org/JOMR/archives/2013/4/e2/v4n4e2ht.htm J Oral Maxillofac Res 2013 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/38/8b/jomr-04-e2.PMC3904728.pdf
http://www.ejomr.org/JOMR/archives/2013/4/e2/v4n4e2ht.htm J Oral Maxillofac Res 2013 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/38/8b/jomr-04-e2.PMC3904728.pdf
http://www.ejomr.org/JOMR/archives/2013/4/e2/v4n4e2ht.htm J Oral Maxillofac Res 2013 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/38/8b/jomr-04-e2.PMC3904728.pdf
http://www.ejomr.org/JOMR/archives/2013/4/e2/v4n4e2ht.htm J Oral Maxillofac Res 2013 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/38/8b/jomr-04-e2.PMC3904728.pdf
http://www.ejomr.org/JOMR/archives/2013/4/e2/v4n4e2ht.htm J Oral Maxillofac Res 2013 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/38/8b/jomr-04-e2.PMC3904728.pdf
URL:  http://www.ejomr.org/JOMR/archives/2013/2/e1/v4n2e1ht.htm   [doi: 10.5037/jomr.2013.4201 ] 4.,OADS,/arxiv_data1/oa_pdf/38/8b/jomr-04-e2.PMC3904728.pdf
"J Oral Maxillofac Res 2013;4(4):e2 URL: http://www.ejomr.org/JOMR/archives/2013/4/e2/v4n4e2ht.pdf doi: 10.5037/jomr.2013.4402 Copyright ©  Mendes MBM, de Carvalho Leite Leal Nunes CM, de Almeida Lopes MC.",Non-OADS,/arxiv_data1/oa_pdf/38/8b/jomr-04-e2.PMC3904728.pdf
"Published in the JOURNAL OF  ORAL & MAXILLOFACIAL RESEARCH ( http://www.ejomr.org ), 1 January 2014.",Non-OADS,/arxiv_data1/oa_pdf/38/8b/jomr-04-e2.PMC3904728.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/38/8b/jomr-04-e2.PMC3904728.pdf
http://www.ejomr.org/JOMR/archives/2013/4/e2/v4n4e2ht.htm J Oral Maxillofac Res 2013 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/38/8b/jomr-04-e2.PMC3904728.pdf
J Oral Maxillofac Res 2013;4(4):e3 URL: http://www.ejomr.org/JOMR/archives/2013/4/e3/v4n4e3ht.pdf doi: 10.5037/jomr.2013.4403 http://www.ejomr.org/JOMR/archives/2013/4/e3/v4n4e3ht.htm J Oral Maxillofac Res 2013 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/f6/e8/jomr-04-e3.PMC3904729.pdf
http://www.ejomr.org/JOMR/archives/2013/4/e3/v4n4e3ht.htm J Oral Maxillofac Res 2013 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/f6/e8/jomr-04-e3.PMC3904729.pdf
http://www.ejomr.org/JOMR/archives/2013/4/e3/v4n4e3ht.htm J Oral Maxillofac Res 2013 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/f6/e8/jomr-04-e3.PMC3904729.pdf
http://www.ejomr.org/JOMR/archives/2013/4/e3/v4n4e3ht.htm J Oral Maxillofac Res 2013 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/f6/e8/jomr-04-e3.PMC3904729.pdf
http://www.ejomr.org/JOMR/archives/2013/4/e3/v4n4e3ht.htm J Oral Maxillofac Res 2013 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/f6/e8/jomr-04-e3.PMC3904729.pdf
http://www.ejomr.org/JOMR/archives/2013/4/e3/v4n4e3ht.htm J Oral Maxillofac Res 2013 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/f6/e8/jomr-04-e3.PMC3904729.pdf
"J Oral Maxillofac Res 2013;4(4):e3 URL: http://www.ejomr.org/JOMR/archives/2013/4/e3/v4n4e3ht.pdf doi: 10.5037/jomr.2013.4403 Copyright ©  Williams CL, Khalaf K. Published in the JOURNAL OF ORAL & MAXILLOFACIAL RESEARCH   (http://www.ejomr.org ), 1 January 2014.",Non-OADS,/arxiv_data1/oa_pdf/f6/e8/jomr-04-e3.PMC3904729.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/f6/e8/jomr-04-e3.PMC3904729.pdf
http://www.ejomr.org/JOMR/archives/2013/4/e3/v4n4e3ht.htm J Oral Maxillofac Res 2013 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/f6/e8/jomr-04-e3.PMC3904729.pdf
J Oral Maxillofac Res 2013;4(4):e4 URL: http://www.ejomr.org/JOMR/archives/2013/4/e4/v4n4e4ht.pdf doi: 10.5037/jomr.2013.4404 http://www.ejomr.org/JOMR/archives/2013/4/e4/v4n4e4ht.htm J Oral Maxillofac Res 2013 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/20/52/jomr-04-e4.PMC3904730.pdf
http://www.ejomr.org/JOMR/archives/2013/4/e4/v4n4e4ht.htm J Oral Maxillofac Res 2013 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/20/52/jomr-04-e4.PMC3904730.pdf
http://www.ejomr.org/JOMR/archives/2013/4/e4/v4n4e4ht.htm J Oral Maxillofac Res 2013 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/20/52/jomr-04-e4.PMC3904730.pdf
http://www.ejomr.org/JOMR/archives/2013/4/e4/v4n4e4ht.htm J Oral Maxillofac Res 2013 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/20/52/jomr-04-e4.PMC3904730.pdf
http://www.ejomr.org/JOMR/archives/2013/4/e4/v4n4e4ht.htm J Oral Maxillofac Res 2013 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/20/52/jomr-04-e4.PMC3904730.pdf
"URL:   http://www.ejomr.org/JOMR/archives/2011/3/e5/v2n3e5ht.htm   [doi: 10.5037/jomr.2011.2305 ] To cite this article: Köse TE, Köse OD, Karabas HC, Erdem TL, Özcan İ.",Non-OADS,/arxiv_data1/oa_pdf/20/52/jomr-04-e4.PMC3904730.pdf
J Oral Maxillofac Res 2013;4(4):e4 URL: http://www.ejomr.org/JOMR/archives/2013/4/e4/v4n4e4ht.pdf doi: 10.5037/jomr.2013.4404,Non-OADS,/arxiv_data1/oa_pdf/20/52/jomr-04-e4.PMC3904730.pdf
http://www.ejomr.org/JOMR/archives/2013/4/e5/v4n4e5ht.htm J Oral Maxillofac Res 2013 (Oct-Dec) | vol.,Non-OADS,/arxiv_data1/oa_pdf/20/52/jomr-04-e4.PMC3904730.pdf
"Published in the JOURNAL OF ORAL &   MAXILLOFACIAL RESEARCH ( http://www.ejomr.org ), 1 January 2014.",Non-OADS,/arxiv_data1/oa_pdf/20/52/jomr-04-e4.PMC3904730.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/20/52/jomr-04-e4.PMC3904730.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/07/93/ccid-7-035.PMC3904776.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical, Cosmetic and Investigational Dermatology 2014:7 35–42Clinical, Cosmetic and Investigational Dermatology Dove press submit your manuscript | www.dovepress.co m Dove press  35Case serIesopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CCID.S5665 5Treatment of elderly patients with advanced  lipedema: a combination of laser-assisted  liposuction, medial thigh lift, and lower partial  abdominoplasty Uwe Wollina1 Birgit Heinig2 andreas Nowak3 1Department of Dermatology and  allergology, 2Centre of Physical  Therapy and rehabilitative Medicine,   3Department of anaesthesiology and  Intensive Medical Care, emergency  Medicine and Pain Management,   academic T eaching Hospital Dresden- Friedrichstadt, Dresden, Germany Correspondence: Uwe Wollina   Department of Dermatology and  allergology, academic Teaching Hospital  Dresden-Friedrichstadt, Friedrichstrasse  41, 01067 Dresden, Germany   email wollina-uw@khdf.d eBackground:  Lipedema is a rare female disorder with a characteristic distribution of adipose  tissue hypertrophy on the extremities, with pain and bruising.",Non-OADS,/arxiv_data1/oa_pdf/07/93/ccid-7-035.PMC3904776.pdf
"Clinical, Cosmetic and Investigational Dermatology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-cosmetic-and-investigational-dermatology-journa lClinical, Cosmetic and Investigational Dermatology is an interna - tional, peer-reviewed, open access, online journal that focuses on  the latest clinical and experimental research in all aspects of skin  disease and cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/07/93/ccid-7-035.PMC3904776.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/07/93/ccid-7-035.PMC3904776.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/7c/d0/cia-9-227.PMC3904777.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2014:9 227–232Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  227OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/CIA.S5764 4The utility of rebound tonometer in late   elderly subjects rei sakata1,2 Jiro numaga1 1T okyo Metropolitan geriatric  hospital, T okyo, Japan; 2Department   of Ophthalmology, University of  Tokyo, graduate school of   Medicine, T okyo, Japan Correspondence: rei sakata   Department of Ophthalmology,   Tokyo Metropolitan geriatric   hospital, 35-2 sakaecho Iabashi,   Tokyo 173-0015, Japan   Tel +81 3 3964 1141   Fax +81 3 3964 1392   email reisakata-tky@umin.ac.j pBackground:  To compare intraocular pressure (IOP) readings using the Icare rebound tonometer  (RBT) versus the Goldmann applanation tonometer (GAT) in late elderly (aged 75 years or  older) subjects with or without glaucoma, and to evaluate the influence of central corneal thick - ness (CCT) on IOP readings.",Non-OADS,/arxiv_data1/oa_pdf/7c/d0/cia-9-227.PMC3904777.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treat - ments intended to prevent or delay the onset of maladaptive correlates  of aging in human beings.",Non-OADS,/arxiv_data1/oa_pdf/7c/d0/cia-9-227.PMC3904777.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/7c/d0/cia-9-227.PMC3904777.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/73/9e/cia-9-201.PMC3904778.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2014:9 201–207Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  201OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S5235 6The use of potentially inappropriate medications  and changes in quality of life among older nursing  home residents sana’ M h Al Aqqad li li Chen Asrul Akmal shafie Mohamed Azmi hassali Balamurugan Tangiisuran Pharmacy Practice research group,   school of Pharmaceutical sciences,   Universiti sains Malaysia, Penang,   Malaysia Correspondence: Balamurugan  Tangiisuran   Discipline of Clinical Pharmacy,   school of Pharmaceutical sciences,  Universiti sains Malaysia, Minden   11800, Pulau Pinang, Malaysia   Tel +60 4653 2579   Fax +60 4657 0017   email bala@usm.m yBackground:  Nursing home residents are mainly older people with multiple diseases and  taking multiple medications.",Non-OADS,/arxiv_data1/oa_pdf/73/9e/cia-9-201.PMC3904778.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treat - ments intended to prevent or delay the onset of maladaptive correlates  of aging in human beings.",Non-OADS,/arxiv_data1/oa_pdf/73/9e/cia-9-201.PMC3904778.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/73/9e/cia-9-201.PMC3904778.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f1/ba/cia-9-233.PMC3904779.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2014:9 233–242Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  233OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S5608 6Additional measures do not improve the   diagnostic accuracy of the hospital Admission   Risk Profile for detecting downstream quality   of life in community-dwelling older people   presenting to a hospital emergency department K grimmer s Milanese K Beaton A Atlas International Centre for Allied  health evidence, University of south  Australia, Adelaide, sA, Australia Correspondence: Karen grimmer   International Centre for Allied   health evidence, University of south   Australia, City east Campus, school   of health sciences, gPO Box 2471,   Adelaide, sA 5001, Australia   email k aren.grimmer@unisa.edu.a uIntroduction:  The Hospital Admission Risk Profile (HARP) instrument is commonly used to  assess risk of functional decline when older people are admitted to hospital.",Non-OADS,/arxiv_data1/oa_pdf/f1/ba/cia-9-233.PMC3904779.pdf
"Available from: http://docs.health.vic.gov.au/docs/doc/611584D DA451964DCA25785200107D95/$FILE/assessing-older-people.pd f.  Accessed November 27, 2013.",Non-OADS,/arxiv_data1/oa_pdf/f1/ba/cia-9-233.PMC3904779.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treat - ments intended to prevent or delay the onset of maladaptive correlates  of aging in human beings.",Non-OADS,/arxiv_data1/oa_pdf/f1/ba/cia-9-233.PMC3904779.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/f1/ba/cia-9-233.PMC3904779.pdf
"Available from: http://health.adelaide.edu.au/pros/docs/reports/ general/qol_quality_of_life_sf_12.pd f. Accessed November 27, 2013.",Non-OADS,/arxiv_data1/oa_pdf/f1/ba/cia-9-233.PMC3904779.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/af/5b/imcrj-7-011.PMC3904807.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Medical Case Reports Journal 2014:7 11–13International Medical Case Reports Journal Dove press submit your manuscript | www.dovepress.co m Dove press  11Case Repo Rtopen access to scientific and medical research open access Full text article http: //dx.doi.org/10.2147/IMCRJ.S5419 2Chemotherapy-induced enterocutaneous fistula   after perineal hernia repair using a biological   mesh: a case report MH eriksen o Bulut Department of surgical  Gastroenterology, Hvidovre  University Hospital, University of  Copenhagen, Copenhagen, Denmark Correspondence: MH eriksen   Department of surgical   Gastroenterology, Hvidovre University   Hospital, University of Copenhagen,   Kettegaards allé 30, DK-2650   Hvidovre, Copenhagen, Denmark   tel +45 2744 9151   Fax +45 3862 3760   email mhyrupe@hotmail.co mAbstract:  This is the first reported case of an enterocutaneous fistula as a late complication to  reconstruction of the pelvic floor with a Permacol™ mesh after a perineal hernia.",Non-OADS,/arxiv_data1/oa_pdf/af/5b/imcrj-7-011.PMC3904807.pdf
"International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-medical-case-reports-journal-journa lThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports  from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/af/5b/imcrj-7-011.PMC3904807.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/af/5b/imcrj-7-011.PMC3904807.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a1/4e/copd-9-107.PMC3904808.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2014:9 107–114International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  107OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S5677 7Efficacy of indacaterol on quality of life   and pulmonary function in patients with COPD   and inhaler device preferences Takeshi Ohno1 Shota Wada1 Souichirou Hanada1 Hirochiyo Sawaguchi1 Masato Muraki1 Yuji T ohda2 1Department of Respiratory Medicine  and Allergology, Nara Hospital, Kinki  University Faculty of Medicine, Ikoma,   Japan; 2Department of Respiratory  Medicine and Allergology, Kinki  University School of Medicine,   Osakasayama, Japan Correspondence: Masato Muraki   Department of Respiratory Medicine and   Allergology, Nara Hospital, Kinki University   Faculty of Medicine, 1248-1 Otoda-cho,   Ikoma, Nara 630-0298, Japan   Tel +81 743 77 0880   Fax +81 743 77 0890   email muraki@nara.med.kindai.ac.j pBackground:  Indacaterol is a novel, once-daily, inhaled, long-acting b2-agonist for patients  with chronic obstructive pulmonary disease (COPD).",Non-OADS,/arxiv_data1/oa_pdf/a1/4e/copd-9-107.PMC3904808.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-copd-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/a1/4e/copd-9-107.PMC3904808.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a1/4e/copd-9-107.PMC3904808.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/fe/f6/dddt-8-175.PMC3904809.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2014:8 175–182Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  175Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S5244 6Significant roadblocks exist in developing   sputum sample libraries for clinical validation   of novel in vitro diagnostics Joshua M Dollow Justin A Green GlaxoSmithKline, Uxbridge, UK Correspondence: Justin A Green   GlaxoSmithKline, Stockley Park West,  B11G, 1-3 Ironbridge Road, Uxbridge,  UB11 1BT, UK   email j ustin.a.green@gsk.co mAbstract:  With the continuing rise of multiresistant pathogens, reliable, cost-effective, and  novel diagnostics are urgently required by clinicians and clinical trialists to diagnose conditions  such as respiratory tract infections to enable rational antimicrobial choice and enhance clinical  outcomes.",Non-OADS,/arxiv_data1/oa_pdf/fe/f6/dddt-8-175.PMC3904809.pdf
Available from: http://www.ua.ac.be/main.aspx?c =RAPP-ID&n =9390 5.,Non-OADS,/arxiv_data1/oa_pdf/fe/f6/dddt-8-175.PMC3904809.pdf
"Available at:  http://www.imi.europa.eu/content/hom e. Accessed October 25, 2013.",Non-OADS,/arxiv_data1/oa_pdf/fe/f6/dddt-8-175.PMC3904809.pdf
"Available from: http://www.imdrf.org/docs/ghtf/final/sg5/ technical-docs/ghtf-sg5-n8-2012-clinical-performance-studies-ivd- medical-devices-121102.pd f. Accessed August 29, 2013.",Non-OADS,/arxiv_data1/oa_pdf/fe/f6/dddt-8-175.PMC3904809.pdf
Available from: http://apps.who.int/bookorders/anglais/detart1.jsp?cod lan=1&codcol =93&codcch =3167.,OADS,/arxiv_data1/oa_pdf/fe/f6/dddt-8-175.PMC3904809.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/fe/f6/dddt-8-175.PMC3904809.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/fe/f6/dddt-8-175.PMC3904809.pdf
Available from:  http://www.nature.com/protocolexchange/protocols/199 9.,Non-OADS,/arxiv_data1/oa_pdf/fe/f6/dddt-8-175.PMC3904809.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/11/81/ijn-9-669.PMC3904810.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 669–678International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  669OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5731 4evaluation of psoralen ethosomes for topical  delivery in rats by using in vivo microdialysis Y ong-Tai Zhang li-Na shen Ji-hui Zhao Nian-Ping Feng Department of Pharmaceutical  sciences, shanghai University of  Traditional chinese Medicine,   shanghai, People’s republic of china correspondence: Nian-Ping Feng   Department of Pharmaceutics, school  of Pharmacy, shanghai University of  Traditional chinese Medicine, 1200  cailun road, Zhangjiang hi-Tech Park,  Pudong New District, shanghai 201203,  People’s republic of china   Tel + 86 21 5132 2198   Fax + 86 21 5132 2198   email npfeng@hotmail.co mAbstract:  This study aimed to improve skin permeation and deposition of psoralen by using  ethosomes and to investigate real-time drug release in the deep skin in rats.",Non-OADS,/arxiv_data1/oa_pdf/11/81/ijn-9-669.PMC3904810.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/11/81/ijn-9-669.PMC3904810.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/11/81/ijn-9-669.PMC3904810.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/33/ac/ijn-9-615.PMC3904811.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 615–626International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  615OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5268 9Injectable thermosensitive hydrogel composite   with surface-functionalized calcium phosphate   as raw materials rang rang Fan1 Xiaohui Deng2 liangXue Zhou1 Xiang gao1 Min Fan1 Yuelong Wang1 gang guo1 1state Key laboratory of Biotherapy  and cancer center, Department of  Neurosurgery, West china hospital,   West china Medical school, sichuan  University, chengdu, 2Department of  human anatomy, Xinxiang Medical  University, Xinxiang, People’s republic  of china correspondence: gang guo   state Key laboratory of Biotherapy   and cancer center, Department of   Neurosurgery, West china hospital,   West china Medical school, sichuan   University, chengdu 610041,   People’s republic of china   Tel +86 28 8516 4063   Fax +86 28 8516 4060   email guogang@scu.edu.c nAbstract:  In this study, L-lactide was used to modify the tricalcium phosphate ( β-TCP) and  tetracalcium phosphate (TTCP) surface which can form functionalized poly(l-lactic acid)  (PLLA)-grafted β-TCP (g- β-TCP) and PLLA-grafted TTCP (g-TTCP) particles.",Non-OADS,/arxiv_data1/oa_pdf/33/ac/ijn-9-615.PMC3904811.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical ﬁeld.",Non-OADS,/arxiv_data1/oa_pdf/33/ac/ijn-9-615.PMC3904811.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/33/ac/ijn-9-615.PMC3904811.pdf
Available from: https://archive.org/details/is.en.,Non-OADS,/arxiv_data1/oa_pdf/33/ac/ijn-9-615.PMC3904811.pdf
"Available from http://www.sciencedirect.com/science/article/pii/ S016943321300295 X.  Accessed December 11, 2103.",Non-OADS,/arxiv_data1/oa_pdf/33/ac/ijn-9-615.PMC3904811.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/cb/1e/jmdh-7-055.PMC3904812.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpJournal of Multidisciplinary Healthcare 2014:7 55–63Journal of Multidisciplinary Healthcare Dove press submit your manuscript | www.dovepress.co m Dove press  55Original researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JMDH.S5582 8Physical functioning after occupational   rehabilitation and returning to work among   employees with chronic musculoskeletal pain   and comorbid depressive symptoms linda ernstsen1 Monica lillefjell2 1Faculty of nursing, sør-Trøndelag  University college, Trondheim,  norway; 2Department of  Occupational Therapy, Faculty of  Health education and social Work,  sør-Trøndelag University college,  Trondheim, norway correspondence: linda ernstsen   Faculty of nursing education,   sør-Trøndelag University college,  nO-7004 Trondheim, norway   Tel +47 72 57 56 25   email linda.ernstsen@hist.n oBackground:  The aim of this investigation was to assess whether measures of physical   functioning after multidisciplinary rehabilitation are associated with return to work among indi - viduals with chronic musculoskeletal pain conditions and comorbid depressive symptoms.",Non-OADS,/arxiv_data1/oa_pdf/cb/1e/jmdh-7-055.PMC3904812.pdf
Available from: http://www.who.int/ mediacentre/factsheets/fs369/en /.,Non-OADS,/arxiv_data1/oa_pdf/cb/1e/jmdh-7-055.PMC3904812.pdf
Available from: http://www.irsst.,Non-OADS,/arxiv_data1/oa_pdf/cb/1e/jmdh-7-055.PMC3904812.pdf
"Available from: http://allpsych.com/ disorders/dsm.htm l. Accessed November 26, 2013.",Non-OADS,/arxiv_data1/oa_pdf/cb/1e/jmdh-7-055.PMC3904812.pdf
"Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-multidisciplinary-healthcare-journa lThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research  in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/cb/1e/jmdh-7-055.PMC3904812.pdf
Visit http://www.dove - press.com/testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/cb/1e/jmdh-7-055.PMC3904812.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/50/ae/ndt-10-141.PMC3904813.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 141–146Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  141Shor T repor Topen access to scientific and medical research open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S5551 8Pediatric neurofibromatosis 1 and parental   stress: a multicenter study Maria esposito1 rosa Marotta2 Michele roccella3 Beatrice Gallai4 Lucia p arisi3 Serena Marianna Lavano2 Marco Carotenuto1 1Clinic of Child and Adolescent  Neuropsychiatry, Department of  Mental health, physical and preventive  Medicine, Second University of  Naples, Naples, Italy; 2Department of  psychiatry, “Magna Graecia” University  of Catanzaro, Catanzaro, Italy; 3Child  Neuropsychiatry, Department of  psychology, University of palermo,   palermo, Italy; 4Unit of Child and  Adolescent Neuropsychiatry,   University of perugia, perugia, Italy Correspondence: Marco Carotenuto   Clinic of Child and Adolescent  Neuropsychiatry, Department   of Mental health, physical and   preventive Medicine, Via Sergio   pansini 5 pAD XI, 80131 Naples, Italy   Tel +39 8 1566 6988   Fax +39 8 1566 6694   email marco.carotenuto@unina2.i tBackground:  Neurofibromatosis 1 (NF1) is a complex and multifaceted neurocutaneous  syndrome with many and varied comorbidities.",Non-OADS,/arxiv_data1/oa_pdf/50/ae/ndt-10-141.PMC3904813.pdf
Available from: http://www.omim.org/ entry/162200.,Non-OADS,/arxiv_data1/oa_pdf/50/ae/ndt-10-141.PMC3904813.pdf
Available  from: http://www.wma.net/en/30publications/10policies/b3/.,Non-OADS,/arxiv_data1/oa_pdf/50/ae/ndt-10-141.PMC3904813.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/50/ae/ndt-10-141.PMC3904813.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/50/ae/ndt-10-141.PMC3904813.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/05/11/clep-6-059.PMC3904814.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Epidemiology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-epidemiology-journa lClinical Epidemiology is an international, peer-reviewed, open access  journal focusing on disease and drug epidemiology, identification of  risk factors and screening procedures to develop optimal preventative  initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/05/11/clep-6-059.PMC3904814.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/35/49/ijwh-6-115.PMC3904822.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Women’s Health 2014:6 115–122International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  115RevIeWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/IJWH.S5574 8A life course perspective on polycystic   ovary syndrome Ninive Sanchez School of Social Work, University   of Michigan, Ann Arbor, MI, USA Correspondence: Ninive Sanchez   School of Social Work, University of  Michigan, 1080 South University Avenue,   Ann Arbor, MI 48109-1106, USA   Tel +1 734 757 0436   Fax +1 734 615 3192   email ninive@umich.ed uAbstract:  Polycystic ovary syndrome (PCOS) is a major public health problem in the US.",Non-OADS,/arxiv_data1/oa_pdf/35/49/ijwh-6-115.PMC3904822.pdf
One of the recommendations was to “establish multidisci - plinary programs to improve public and health care provider  awareness and management for women who currently have  the syndrome”.1 The workshop report and panel recom - mendations are available online ( http://prevention.nih.gov/ workshops/2012/pcos/docs/PCOS_Final_Statement.pd f).,Non-OADS,/arxiv_data1/oa_pdf/35/49/ijwh-6-115.PMC3904822.pdf
"Available from: http://prevention.nih.gov/workshops/2012/pcos/docs/ PCOS_Final_Statement.pd f. Accessed December 6, 2013.",Non-OADS,/arxiv_data1/oa_pdf/35/49/ijwh-6-115.PMC3904822.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’ s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/35/49/ijwh-6-115.PMC3904822.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/35/49/ijwh-6-115.PMC3904822.pdf
"Available from: http://www.ruralhealth.org.au/papers/6_D_6_2.pd f.  Accessed November 4, 2012.",Non-OADS,/arxiv_data1/oa_pdf/35/49/ijwh-6-115.PMC3904822.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/40/bc/jmdh-7-051.PMC3904828.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpJournal of Multidisciplinary Healthcare 2014:7 51–54Journal of Multidisciplinary Healthcare Dove press submit your manuscript | www.dovepress.co m Dove press  51PersPectivesopen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/JMDH.S5694 8transitioning from physician to nurse practitioner Monica Flowers Maria Olenick college of Nursing and Health  sciences, N icole Wertheim college of  Nursing and Health sciences, Florida  international University, Miami,    FL, UsA correspondence: Monica Flowers   college of Nursing and Health sciences,  Nicole Wertheim college of Nursing  and Health sciences, Foreign Physician  Program, Florida international University,  3000 Ne 151st street, Acii-204,   North Miami, FL 33181, UsA   tel +1 305 919 4419   Fax +1 305 919 5209   email mflower@fiu.ed uAbstract:  Foreign-educated physicians (FEPs), also known as “international medical graduates”,  represent a rich source of potential primary-care providers.",Non-OADS,/arxiv_data1/oa_pdf/40/bc/jmdh-7-051.PMC3904828.pdf
Available from: https://www.aamc.org/ download/150584/data /.,OADS,/arxiv_data1/oa_pdf/40/bc/jmdh-7-051.PMC3904828.pdf
Available from: http://www.uscis.,Non-OADS,/arxiv_data1/oa_pdf/40/bc/jmdh-7-051.PMC3904828.pdf
Available from: http://www.forbes.com/ sites/stuartanderson/2012/12/02/doctor-doctor-why-wont-america-let- in-more-doctors /.,Non-OADS,/arxiv_data1/oa_pdf/40/bc/jmdh-7-051.PMC3904828.pdf
"Available  from: https://www.cms.gov/nationalhealthexpenddata/03_national   healthaccountsprojected.as p. Accessed May 13, 2013.",Non-OADS,/arxiv_data1/oa_pdf/40/bc/jmdh-7-051.PMC3904828.pdf
"Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-multidisciplinary-healthcare-journa lThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research  in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/40/bc/jmdh-7-051.PMC3904828.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/40/bc/jmdh-7-051.PMC3904828.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/93/31/copd-9-129.PMC3904829.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2014:9 129–137International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  129RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/COPD.S5687 9Regadenoson use in patients with chronic   obstructive pulmonary disease: the state   of current knowledge Yasmeen Golzar1,2 Rami Doukky1,2 1Division of Adult Cardiology,    John H Stroger Jr, Hospital of   Cook County, 2Division of   Cardiology, Rush University   Medical Center, Chicago, IL, USA Correspondence: Rami Doukky   Rush University Medical Center,   Section of Cardiology, 1653 w Congress   Parkway, Chicago, IL 60612, USA   Tel +1 312 942 4655   Fax +1 312 563 3213   email rami_doukky@rush.ed uAbstract:  Stress testing is challenging in patients with chronic obstructive pulmonary disease  (COPD).",Non-OADS,/arxiv_data1/oa_pdf/93/31/copd-9-129.PMC3904829.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-copd-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/93/31/copd-9-129.PMC3904829.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/93/31/copd-9-129.PMC3904829.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ae/d2/copd-9-115.PMC3904833.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2014:9 115–128International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  115OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S5445 7Barriers to and enablers of physical activity  in patients with COPD following a hospital  admission: a qualitative study Olivia Thorpe saravana Kumar Kylie Johnston International Centre for allied   health evidence, The samson Institute  for health research, school of  health sciences, University of south  australia, adelaide, sa, australia Correspondence: Olivia Thorpe   University of south australia, school  of health sciences, north Terrace,  Centenary Building, adelaide, sa,  australia 5000   Tel +8 8302 2099   Fax +8 8302 2853   email olivia.thorpe@unisa.edu.a u Background:  Chronic obstructive pulmonary disease (COPD) is characterized by a persistent  blockage of airflow, prompting episodes of shortness of breath, commonly leading to  hospitalization.",Non-OADS,/arxiv_data1/oa_pdf/ae/d2/copd-9-115.PMC3904833.pdf
2013; Available from: http://www.who.int/mediacentre/ factsheets /fs315/en /.,Non-OADS,/arxiv_data1/oa_pdf/ae/d2/copd-9-115.PMC3904833.pdf
Available from: http://www.goldcopd.,Non-OADS,/arxiv_data1/oa_pdf/ae/d2/copd-9-115.PMC3904833.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-copd-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/ae/d2/copd-9-115.PMC3904833.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ae/d2/copd-9-115.PMC3904833.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/0b/f6/ijn-9-589.PMC3904834.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 589–613International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  589RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJN.S5094 1Overview of the role of nanotechnological   innovations in the detection and treatment   of solid tumors Derusha Frank1 Charu Tyagi1 Lomas T omar1 Yahya e Choonara1 Lisa C du T oit1 Pradeep Kumar1 Clement Penny2 viness Pillay1 1Department of Pharmacy and  Pharmacology, 2Department of  Medical Oncology, Faculty of   Health Sciences, University of   the witwatersrand, Johannesburg,    South Africa Correspondence: viness Pillay   Department of Pharmacy and   Pharmacology, Faculty of Health   Sciences, University of the   witwatersrand, 7 York Road, Parktown,   Johannesburg 2193, South Africa   Tel +27 11 717 2274   Fax +27 11 642 4355   email viness.pillay@wits.ac.z aAbstract:  Nanotechnology, although still in its infantile stages, has the potential to revolutionize  the diagnosis, treatment, and monitoring of disease progression and success of therapy for numer - ous diseases and conditions, not least of which is cancer.",Non-OADS,/arxiv_data1/oa_pdf/0b/f6/ijn-9-589.PMC3904834.pdf
Available from: http://www.who.int/media - centre/factsheets/fs297/en/index.html .,Non-OADS,/arxiv_data1/oa_pdf/0b/f6/ijn-9-589.PMC3904834.pdf
Available from:  http://www.nih.gov/science/colorectalcancer/nanotech.htm .,OADS,/arxiv_data1/oa_pdf/0b/f6/ijn-9-589.PMC3904834.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/0b/f6/ijn-9-589.PMC3904834.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/0b/f6/ijn-9-589.PMC3904834.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ff/08/ijn-9-653.PMC3904835.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 653–668International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  653OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5491 1anacardic acid enhances the anticancer   activity of liposomal mitoxantrone towards   melanoma cell lines – in vitro studies Mateusz legut Dominik lipka Nina Filipczak adriana Piwoni arkadiusz Kozubek Jerzy gubernator Department of lipids and liposomes,   Faculty of Biotechnology, University  of Wrocław, Wrocław, Poland correspondence: Dominik lipka   Department of lipids and liposomes,   Faculty of Biotechnology, University   of Wrocław, 63/77 Przybyszewskiego   Street, Wrocław 51-148, Poland   Tel +48 71 3756 338   Fax +48 71 3756 234   email dlipka@ibmb.uni.wroc.p lAbstract:  This paper describes a novel formulation of antineoplastic drug: mitoxantrone loaded  into liposomal carriers enriched with encapsulated anacardic acid in the liposomal bilayer using  a vitamin C gradient.",Non-OADS,/arxiv_data1/oa_pdf/ff/08/ijn-9-653.PMC3904835.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/ff/08/ijn-9-653.PMC3904835.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ff/08/ijn-9-653.PMC3904835.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6e/ec/jpr-7-081.PMC3904836.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpJournal of Pain Research 2014:7 81–87Journal of Pain Research Dove press submit your manuscript | www.dovepress.co m Dove press  81ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JPR.S4923 6Pain-related mood influences pain perception  differently in fibromyalgia and multiple sclerosis Céline Borg1–3 catherine Padovan4,5 catherine Thomas- antérion1,2 céline chanial1 anaïs sanchez1,5 Marion godot6 Roland Peyron1,6,7 Odile De Parisot5 Bernard laurent1,6,7 1Neurology/Neuropsychology, Center  Memory of Resources and Research  Unit, north saint-etienne University  Hospital Center, Avenue Albert  Raimond, saint-Priest-en-Jarez, France;   2Study of Cognitive Mechansims  Laboratory, 3Psychology Unit,   University lumière of lyon 2,    Bron, France; 4Brain Dynamics and  Cognition, Lyon Neuroscience  Research center and Vinatier hospital  center, Bron, France; 5germaine Revel  Center, Dargoire, France; 6Pain center,   north saint-etienne University  hospital center, saint-Priest-en-Jarez,   France; 7Central Integration of Pain,   lyon neuroscience Research center,   Bron, France Correspondence: Céline Borg   Neurology/Neuropsychology-CMRR  Unit, chU nord saint-etienne,   42270 saint-Priest-en-Jarez, France   Tel +33 4 77 12 78 05   Fax +33 4 77 12 05 43   email celine.borg@chu-st-etienne.f rAbstract:  In patients, the perception of pain intensity may be influenced by the subjective  representation of their disease.",Non-OADS,/arxiv_data1/oa_pdf/6e/ec/jpr-7-081.PMC3904836.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/6e/ec/jpr-7-081.PMC3904836.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/6e/ec/jpr-7-081.PMC3904836.pdf
"It is not clear whether and how a miRNA’s binding location and timing may alter its effectiveness on regulation  *Correspondence to: Bolin Liu; Email: bolin.liu@ucdenver.edu Submitted: 08/16/2013; Accepted: 08/18/2013 http://dx.doi.org/10.4161/cc.26875Comment on: Wang S, et al.",Non-OADS,/arxiv_data1/oa_pdf/11/7c/cc-12-3703.PMC3905054.pdf
"Cell Death Dis 2013; 4:e556; PMID:23519125; http://dx.doi.org/10.1038/cddis.2013.79“Sister” miRNAs in cancers reema Wahdan- alaswad and Bolin liu* department of Pathology; s chool of Medicine; u niversity of Colorado a nschutz Medical Campus; aurora, C o usa",Non-OADS,/arxiv_data1/oa_pdf/11/7c/cc-12-3703.PMC3905054.pdf
Cell 2013; 153:516-9;  PMID:23622238 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/11/7c/cc-12-3703.PMC3905054.pdf
EMBO Rep 2009; 10:400- 5; PMID:19247375 ; http://dx.doi.org/10.1038/ embor.2009.9 3.,Non-OADS,/arxiv_data1/oa_pdf/11/7c/cc-12-3703.PMC3905054.pdf
J Biol Chem 2010; 285:21496-507; PMID:20460378 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/11/7c/cc-12-3703.PMC3905054.pdf
Cancer Res 2013; 73:473-7;  PMID:23316035 ; http://dx.doi.org/10.1158/0008- 5472.CAN-12-3731 5.,Non-OADS,/arxiv_data1/oa_pdf/11/7c/cc-12-3703.PMC3905054.pdf
Cell 2012; 151:278-88; PMID:23063121 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/11/7c/cc-12-3703.PMC3905054.pdf
Cell Death Dis 2013; 4:e556;  PMID:23519125 ; http://dx.doi.org/10.1038/ cddis.2013.79 7.,Non-OADS,/arxiv_data1/oa_pdf/11/7c/cc-12-3703.PMC3905054.pdf
Oncogene 2010; 29:2302-8;  PMID:20190813 ; http://dx.doi.org/10.1038/ onc.2010.34 8.,Non-OADS,/arxiv_data1/oa_pdf/11/7c/cc-12-3703.PMC3905054.pdf
PLoS One 2013; 8:e62589; PMID:23667495 ; http://dx.doi.org/10.1371/jour - nal.pone.0062589,Non-OADS,/arxiv_data1/oa_pdf/11/7c/cc-12-3703.PMC3905054.pdf
"Verhaak; Email: rverhaak@mdanderson.org Submitted: 08/28/2013; Accepted: 09/02/2013http://dx.doi.org/10.4161/cc.26874Comment on: Zheng S, et al.",Non-OADS,/arxiv_data1/oa_pdf/cf/39/cc-12-3705.PMC3905055.pdf
"Genes Dev 2013; 27:1462-72; PMID:23796897; http://dx.doi.org/10.1101/gad.213686.113Intragenic breakpoint A marker of genome instability in glioblastoma siyuan Zheng1 and Roel GW Verhaak1,2,* 1Department of Bioinformatics and Computational Biology; t he u niversity of t exas MD a nderson Cancer Center; Houston t X usa ; 2Department of Genomic Medicine;   the u niversity of t exas MD a nderson Cancer Center; Houston t X usa Figure 1. a double minute model to explain the 12q14–15 breakpoint enriched region (B eR).",Non-OADS,/arxiv_data1/oa_pdf/cf/39/cc-12-3705.PMC3905055.pdf
Genes Dev 2011; 25:534-55;  PMID:21406553 ; http://dx.doi.org/10.1101/ gad.2017311 2.,OADS,/arxiv_data1/oa_pdf/cf/39/cc-12-3705.PMC3905055.pdf
Genes Dev 2013; 27:1462-72;  PMID:23796897 ; http://dx.doi.org/10.1101/ gad.213686.113 3.,OADS,/arxiv_data1/oa_pdf/cf/39/cc-12-3705.PMC3905055.pdf
Cell 2013; 155:462-77;  PMID:24120142 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cf/39/cc-12-3705.PMC3905055.pdf
Genome Res 2010; 20:1198- 206; PMID:20631050 ; http://dx.doi.org/10.1101/ gr.106252.110 5.,OADS,/arxiv_data1/oa_pdf/cf/39/cc-12-3705.PMC3905055.pdf
Proc Natl Acad Sci U S A 2004; 101:11368-73;  PMID:15269346 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cf/39/cc-12-3705.PMC3905055.pdf
"6 Our study and a very recent  *Correspondence to: Hai-Kun Liu; Email: l.haikun@dkfz.de Submitted: 08/30/2013; Accepted: 09/02/2013http://dx.doi.org/10.4161/cc.26876Comment on: Feng W, et al.",Non-OADS,/arxiv_data1/oa_pdf/e1/56/cc-12-3707.PMC3905056.pdf
"Cell Stem Cell 2013; 13:62-72; PMID:23827709; http://dx.doi.org/10.1016/j.stem.2013.05.002Epigenetic regulation of neuronal   fate determination The role of CHD7 Weijun Feng and Hai-Kun Liu* Helmholtz Young Investigator Group-Normal and Neoplastic CNS Stem Cells; German Cancer Research Center (DKFZ); DKFZ-ZMBH Alliance; Heidelberg, Germany",OADS,/arxiv_data1/oa_pdf/e1/56/cc-12-3707.PMC3905056.pdf
Science 2000; 287:1433-8;  PMID:10688783 ; http://dx.doi.org/10.1126/ science.287.5457.1433 2.,OADS,/arxiv_data1/oa_pdf/e1/56/cc-12-3707.PMC3905056.pdf
Cell Stem Cell 2013; 13:62-72;  PMID:23827709 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e1/56/cc-12-3707.PMC3905056.pdf
Cell Stem Cell 2010; 7:744-58;  PMID:21112568 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e1/56/cc-12-3707.PMC3905056.pdf
Nat Genet 2004; 36:955-7;  PMID :15300250 ; http://dx.doi.org/10.1038/ng1407 5.,OADS,/arxiv_data1/oa_pdf/e1/56/cc-12-3707.PMC3905056.pdf
J Med Genet 2011; 48:334- 42; PMID:21378379 ; http://dx.doi.org/10.1136/ jmg.2010.087106 6.,Non-OADS,/arxiv_data1/oa_pdf/e1/56/cc-12-3707.PMC3905056.pdf
Nat Neurosci 2010; 13:1338-44;  PMID:20975758 ; http://dx.doi.org/10.1038/ nn.2672 7.,Non-OADS,/arxiv_data1/oa_pdf/e1/56/cc-12-3707.PMC3905056.pdf
Cell Stem Cell 2013; 13:403-18; PMID:23933087 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e1/56/cc-12-3707.PMC3905056.pdf
Testa G. Bioessays 2011; 33:519-28; PMID:21633963 ;  http://dx.doi.org/10.1002/bies.201100021Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/e1/56/cc-12-3707.PMC3905056.pdf
"It will also be of interest to determine whether, in addition to the  *Correspondence to: Ann Marie Pendergast; Email: ann.pendergast@duke.edu Submitted: 08/13/2013; Accepted: 09/02/2013http://dx.doi.org/10.4161/cc.26877Comment on: Chislock EM, et al.",Non-OADS,/arxiv_data1/oa_pdf/86/77/cc-12-3709.PMC3905057.pdf
Angiogenesis 2009; 12:125- 37; PMID:19449109 ; http://dx.doi.org/10.1007/ s10456-009-9147-3 3.,Non-OADS,/arxiv_data1/oa_pdf/86/77/cc-12-3709.PMC3905057.pdf
Proc Natl Acad Sci U S A 2013;  110:12432-7;  PMID:23840065 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/86/77/cc-12-3709.PMC3905057.pdf
Nat Rev Cancer 2013; 13:559-71; PMID:23842646 ; http://dx.doi.org/10.1038/ nrc3563 6.,Non-OADS,/arxiv_data1/oa_pdf/86/77/cc-12-3709.PMC3905057.pdf
Neuron 1998; 21:1259-72; PMID:9883720 ; http://dx.doi.org/10.1016/ S0896-6273(00)80646-7 7.,OADS,/arxiv_data1/oa_pdf/86/77/cc-12-3709.PMC3905057.pdf
Colicelli J. Sci Signal 2010; 3:re6; PMID:20841568 ;  http://dx.doi.org/10.1126/scisignal.3139re6Figure  1.,OADS,/arxiv_data1/oa_pdf/86/77/cc-12-3709.PMC3905057.pdf
"To add further complexity, while  Drosophila  encode only one known  decapper, in mammals there are at least two decappers (DCP2 and NUDT16)  *Correspondence to: Sara Cherry; Email: cherrys@mail.med.upenn.edu Submitted: 09/01/2013; Accepted: 09/04/2013http://dx.doi.org/10.4161/cc.26878Comment on: Hopkins KC, et al.",Non-OADS,/arxiv_data1/oa_pdf/82/b1/cc-12-3711.PMC3905058.pdf
"Genes Dev 2013; 27:1511-25; PMID:23824541; http://dx.doi.org/10.1101/gad.215384.113Bunyaviral cap-snatching vs. decapping Recycling cell cycle mRNAs Kaycie Hopkins1 and sara Cherry1,2,* 1Department of Microbiology; u niversity of p ennsylvania s chool of Medicine; p hiladelphia, pa usa ;   2penn Genome Frontiers i nstitute; u niversity of p ennsylvania s chool of Medicine; p hiladelphia, pa usa",Non-OADS,/arxiv_data1/oa_pdf/82/b1/cc-12-3711.PMC3905058.pdf
Genes Dev 2013; 27:1511- 25; PMID:23824541 ; http://dx.doi.org/10.1101/ gad.215384.113 2.,OADS,/arxiv_data1/oa_pdf/82/b1/cc-12-3711.PMC3905058.pdf
Proc Natl Acad Sci U S A 2008;  105:19294-9;  PMID:19047634 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/b1/cc-12-3711.PMC3905058.pdf
J Cell Sci 2004; 117:5567-78; PMID :15494374 ; http://dx.doi.org/10.1242/ jcs.01477 5.,OADS,/arxiv_data1/oa_pdf/82/b1/cc-12-3711.PMC3905058.pdf
J Biol Chem 2012; 287:7399-410;  PMID:22223653 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/82/b1/cc-12-3711.PMC3905058.pdf
Nat Cell Biol 2012; 14:1305-13;  PMID:23178881 ; http://dx.doi.org/10.1038/ ncb2627 7.,OADS,/arxiv_data1/oa_pdf/82/b1/cc-12-3711.PMC3905058.pdf
Nat Cell Biol 2005; 7:633-6;  PMID :15908945 ; http://dx.doi.org/10.1038/ ncb1265 8.,OADS,/arxiv_data1/oa_pdf/82/b1/cc-12-3711.PMC3905058.pdf
RNA 2011; 17:419-28; PMID:21224379 ;  http://dx.doi.org/10.1261/rna.2439811Figure 1.,OADS,/arxiv_data1/oa_pdf/82/b1/cc-12-3711.PMC3905058.pdf
"7,8 Correspondence to: Domenico Maiorano; Email: Domenico.Maiorano@igh.cnrs.fr; Jean-Sébastien Hoffmann; Email: jseb@ipbs.fr Submitted: 08/22/2013; Accepted: 09/25/2013http://dx.doi.org/10.4161/cc.26976Comment on: Bétous R, et al.",Non-OADS,/arxiv_data1/oa_pdf/f7/be/cc-12-3713.PMC3905059.pdf
"EMBO J 2013; 32:2172-85; PMID:23799366; http://dx.doi.org/10.1038/emboj.2013.148Pol κ in replication checkpoint domenico Maiorano1 and Jean- sébastien Hoffmann2,3 1institut de Génétique Humaine ( iGH); CN rs - u Pr 1142; Montpellier, France; 2iNsErM u Mr 1037; CN rs E rl 505294; C rCt (Cancer r esearch Center of t oulouse);   toulouse, France; 3university of t oulouse; u niversité t oulouse iii  Paul s abatier ( uPs); toulouse, France",Non-OADS,/arxiv_data1/oa_pdf/f7/be/cc-12-3713.PMC3905059.pdf
Nat Rev Mol Cell Biol  2008; 9:616-27;  PMID:18594563 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f7/be/cc-12-3713.PMC3905059.pdf
Nat Rev Mol Cell Biol 2005; 6:943- 53; PMID:16341080 ; http://dx.doi.org/10.1038/ nrm1781 3.,OADS,/arxiv_data1/oa_pdf/f7/be/cc-12-3713.PMC3905059.pdf
Microbiol Mol Biol Rev 2009; 73:134-54;  PMID:19258535 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f7/be/cc-12-3713.PMC3905059.pdf
EMBO J 2013; 32:2172-85;  PMID:23799366 ; http://dx.doi.org/10.1038/ emboj.2013.148 5.,Non-OADS,/arxiv_data1/oa_pdf/f7/be/cc-12-3713.PMC3905059.pdf
J Cell Biol 2010; 189:233-46; PMID:20385778 ; http://dx.doi.org/10.1083/ jcb.200909105 6.,OADS,/arxiv_data1/oa_pdf/f7/be/cc-12-3713.PMC3905059.pdf
Nucleic Acids Res 2012; 40:1636-47;  PMID:22021378 ; http://dx.doi.org/10.1093/nar/ gkr889 7.,Non-OADS,/arxiv_data1/oa_pdf/f7/be/cc-12-3713.PMC3905059.pdf
J Cell Biol 2013; 201:395-408;  PMID:23609533 ; http://dx.doi.org/10.1083/ jcb.201207066 8.,Non-OADS,/arxiv_data1/oa_pdf/f7/be/cc-12-3713.PMC3905059.pdf
Mol Cell Biol 2009; 29:3344-54;  PMID:19380493 ; http://dx.doi.org/10.1128/ MCB.00115-09 9.,Non-OADS,/arxiv_data1/oa_pdf/f7/be/cc-12-3713.PMC3905059.pdf
Mol Cell 2013; In press; http://dx.doi.org/10.1016/j.molcel.2013.09.025  10.,OADS,/arxiv_data1/oa_pdf/f7/be/cc-12-3713.PMC3905059.pdf
EMBO Rep 2013; In press; PMID:24126761; http://dx.doi.org/10.1038/embor.2013.159 Figure 1.  speculative model of Pol κ function in replication checkpoint.,OADS,/arxiv_data1/oa_pdf/f7/be/cc-12-3713.PMC3905059.pdf
"Cell Cycle 2013; 12:3781–90;   PMID:24107628; http://dx.doi.org/10.4161/cc.26674 Marco Crescenzi;Department of Cell Biology and Neurosciences; Italian National Institute of Health; Rome, Italy;   Email: marco.crescenzi@iss.it; http://dx.doi.org/10.4161/cc.26962 The complexities of cellular regulations  seem to never end.",Non-OADS,/arxiv_data1/oa_pdf/0e/ac/cc-12-3715.PMC3905060.pdf
J Cell s ci 2008 ; 121:3853 -7;  PMiD:19020303 ; http://dx.doi.org/10.1242/ jcs.039131 3.,OADS,/arxiv_data1/oa_pdf/0e/ac/cc-12-3715.PMC3905060.pdf
J Cell Physiol 2009 ; 220:292-6;  PMiD:19415697 ; http://dx.doi.org/10.1002/ jcp.21791 4.,Non-OADS,/arxiv_data1/oa_pdf/0e/ac/cc-12-3715.PMC3905060.pdf
Mol Cell Biol  2001 ; 21:5631 -43;  PMiD:114 638 4 4 ; http://dx.doi.org/10.1128/ MCB.21.16.5631-5643.2001 5.,Non-OADS,/arxiv_data1/oa_pdf/0e/ac/cc-12-3715.PMC3905060.pdf
Circ Res  2003 ; 92:e12- 9; PM iD:12522130 ; http://dx.doi.org/10.1161/01.,Non-OADS,/arxiv_data1/oa_pdf/0e/ac/cc-12-3715.PMC3905060.pdf
"Cell Cycle 2013; 12:3749-58;   PMID:24107634; http://dx.doi.org/10.4161/cc.26640 Christopher J  Bakkenist1 and Cyrus  Vaziri2; 1Departments of Radiation Oncology and Pharmacology and Chemical Biology; University of Pittsburgh School  of Medicine; Hillman Cancer Center; Pittsburgh, PA USA; 2Department of Pathology; University of North Carolina Chapel Hill; Chapel Hill, NC USA;   Email: bakkenistcj@upmc.edu and cyrus_vaziri@med.unc.edu ; http://dx.doi.org/10.4161/cc.26963 DNA damage is an ever-present chal - lenge to genome stability and cell viability.",Non-OADS,/arxiv_data1/oa_pdf/5b/54/cc-12-3716.PMC3905061.pdf
Nat Cell Biol 2011 ; 13:1161 -9;  PMiD:21968989 ; http://dx.doi.org/10.1038/ ncb2344 3.,OADS,/arxiv_data1/oa_pdf/5b/54/cc-12-3716.PMC3905061.pdf
Mol Cell  2013 ; 49:795-807;  PMi D:23416108 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/5b/54/cc-12-3716.PMC3905061.pdf
Cell 2010 ; 141:243-54;  PMiD:20362325 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/5b/54/cc-12-3716.PMC3905061.pdf
J exp Med 2010 ; 207:855-65;  PMiD:20368578 ; http://dx.doi.org/10.1084/ jem.20100244 6.,Non-OADS,/arxiv_data1/oa_pdf/5b/54/cc-12-3716.PMC3905061.pdf
Mol Cell  2012 ; 47:383-95;  PMiD:22742833 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/5b/54/cc-12-3716.PMC3905061.pdf
J Cell Biol 2012 ; 197:189-99;  PMiD:22492721 ; http://dx.doi.org/10.1083/ jcb.201109100,Non-OADS,/arxiv_data1/oa_pdf/5b/54/cc-12-3716.PMC3905061.pdf
"Cell Cycle 2013; 12:3650 –62;  PMID:24091729; http://dx.doi.org/10.4161/cc.26585 Leonidas Benetatos; Blood Bank; General Hospital of Preveza; Preveza, Greece; Correspondence to: Leonidas Benetatos;  Email: benetatosleon@yahoo.com, me01532@cc.uoi.gr ; http://dx.doi.org/10.4161/cc.26975 Multiple myeloma (MM) is a heteroge - neous disease originating from the transfor - mation of a post-germinal center B cell.",Non-OADS,/arxiv_data1/oa_pdf/ee/59/cc-12-3718.PMC3905062.pdf
N e ngl J Med 2011; 364:1046- 60; PM iD:21410373; http://dx.doi.org/10.1056/ NeJMra1011442 2.,OADS,/arxiv_data1/oa_pdf/ee/59/cc-12-3718.PMC3905062.pdf
Crit Rev Oncol Hematol 2010; 74:149- 55; PM iD:19520590; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ee/59/cc-12-3718.PMC3905062.pdf
Cancer 2012; 118:878-87; PMiD:21837684; http://dx.doi.org/10.1002/ cncr.26297 4.,Non-OADS,/arxiv_data1/oa_pdf/ee/59/cc-12-3718.PMC3905062.pdf
Curr Cancer Drug Targets  2012; 12:838-46; PM iD:22671926; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ee/59/cc-12-3718.PMC3905062.pdf
e ur J Cell Biol 2013; 92:123-8;  PMiD:23357522; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ee/59/cc-12-3718.PMC3905062.pdf
"Cell Cycle 2013; 12:3650-62;  PMiD:24091729; http://dx.doi.org/10.4161/ cc.26585 8. s hen L, et al.",OADS,/arxiv_data1/oa_pdf/ee/59/cc-12-3718.PMC3905062.pdf
"68-72 In yeast, “oncogenic” pathways such as Ras  and TOR accelerate chronological senescence.73-75 Inhibitors of  the TOR pathway, including rapamycin, decelerate chronological Correspondence to: Mikhail V Blagosklonny; Email:   Mikhail.blagosklonny@roswellpark.org, blagosklonny@oncotarget.comSubmit te d: 11/11/2013; Accepte d: 11/13/2013http://dx.doi.org/10.4161/cc.27188Aging is not programmed Genetic pseudo-program is a shadow  of developmental growth Mikhail v  Blagosklonny Cell s tress Biology; Roswell Park Cancer i nstitute; Buffalo, NY U sA Keywords:  senescence, geroconversion, gerosuppression, rapamycin, rapalogs, evolution, selection Aging is not and cannot be programmed.",Non-OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Nature 1993; 366:461-4; PMID :8247153 ;  http://dx.doi.org/10.1038/366461a0 2.,Non-OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Nature 2000;  408:255-62;  PMID:11089983 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Nat Rev Genet 2002; 3:165-75;  PMID:11972154 ; http://dx.doi.org/10.1038/nrg753 4.,OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Science 2003; 299:1351- 4; PMID:12610295 ; http://dx.doi.org/10.1126/ science.1082358 5.,Non-OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
"Sci Am 2006; 294:48-51, 54-7;  PMID:16502611 ; http://dx.doi.org/10.1038/ scientificamerican0306-48 6.",OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Nature 2010;  464:504-12;  PMID:20336132 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
F1000Prime Rep 2013; 5:5; PMID:23513177 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Cell Cycle 2008; 7:3338-43; PMID:18948730 ; http://dx.doi.org/10.4161/ cc.7.21.7012 12.,Non-OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Aging Cell  2008; 7:13-22;  PMID:17996009 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Science 2009; 326:140-4;  PMID:19797661 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Cell Rep  2013; 4:913-20;  PMID:23994476 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
EMBO Rep 2003; 4:358-62; PMID:12671679 ; http://dx.doi.org/10.1038/ sj.embor.embor806 20.,Non-OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Cell Cycle 2008; 7:3355- 61; PMID:18948731 ; http://dx.doi.org/10.4161/ cc.7.21.6919 21.,Non-OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Cell Cycle 2009;  8:1888-95;  PMID:19471117 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Cell Cycle 2009; 8:1896-900;  PMID:19478560 ; http://dx.doi.org/10.4161/ cc.8.12.8809 23.,OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Proc Natl Acad Sci U S A  2010; 107:9660-4;  PMID:20457898 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Proc Natl Acad Sci U S A  2012; 109:13314-8;  PMID:22847439 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Cell Death Differ 2013; 20:1241- 9; PMID:23852369 ; http://dx.doi.org/10.1038/ cdd.2013.86 30.,Non-OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Cell Cycle 2013; 12:3063- 9; PMID:23974099 ; http://dx.doi.org/10.4161/ cc.2613031.,OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Cell Cycle 2012; 11:2391-401;  PMID:22627671 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Cell Cycle 2009; 8:1820- 1; PMID:19471126 ; http://dx.doi.org/10.4161/ cc.8.12.8967 33.,Non-OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Cell Cycle 2010; 9:3945-55; PMID:20935470 ;  http://dx.doi.org/10.4161/cc.9.19.13160 34.,OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Cell Cycle 2009; 8:1158-60; PMID:19270502 ; http://dx.doi.org/10.4161/ cc.8.8.8139 37.,Non-OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Cell Cycle  2009; 8:1003-6;  PMID:19270523 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Science  2011; 332:966-70;  PMID :21512002 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Autophagy 2011; 7:1387-8; PMID:21799306 ; http://dx.doi.org/10.4161/ auto.7.11.17348 40.,Non-OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Oncoimmunology 2012; 1:630-41; PMID:22934255 ; http://dx.doi.org/10.4161/ onci.20297 41.,Non-OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Cell Cycle 2006; 5:2087-102; PMID:17012837 ;  http://dx.doi.org/10.4161/cc.5.18.3288 43.,OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Cell Cycle 2009; 8:4055- 9; PMID:19923900 ; http://dx.doi.org/10.4161/ cc.8.24.10310 45.,OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Cell Cycle  2010; 9:1673-4;  PMID:20404510 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Cell Cycle 2013; 12:3353-4;   PMID:24091532 ; http://dx.doi.org/10.4161/cc.26578 49.,OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Cell Cycle 2010; 9:3151-6;  PMID:20724817 ; http://dx.doi.org/10.4161/ cc.9.16.13120 50.,Non-OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Cell Cycle 2013; 12:1842- 7; PMID:23708516 ; http://dx.doi.org/10.4161/ cc.25062 53.,OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Nat Rev Genet 2005; 6:866- 72; PMID:16304601 ; http://dx.doi.org/10.1038/ nrg1706 54.,OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Aging Cell 2004;  3:255-9;  PMID :15379848 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
EMBO Rep 2005; 6:S14-9; PMID :15995655 ;  http://dx.doi.org/10.1038/sj.embor.7400425 56. de Magalhães JP.,OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
"FASEB J 2012; 26:4821- 6; PMID:22964300 ; http://dx.doi.org/10.1096/ fj.12-210872 57. de Magalhães JP, Church GM.",Non-OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Exp Gerontol 2006; 41:1-10;  PMID:16226003 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
J Gerontol A Biol Sci Med Sci 2004; 59:B573-8; PMID :15215267 ;  http://dx.doi.org/10.1093/gerona/59.6.B573 60.,Non-OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Ann N Y Acad Sci 2005; 1057:145- 64; PMID:16399892 ; http://dx.doi.org/10.1196/ annals.1356.009 61.,Non-OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Biochim Biophys Acta 2009; 1787:437- 61; PMID :19159610 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Ann N Y Acad Sci 2002; 959:214-37;  PMID:11976198 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
J Cell Biol 2004; 164:501-7; PMID:14970189 ;  http://dx.doi.org/10.1083/jcb.200310014 66.,OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
J Cell Biol  2004; 166:1055-67;  PMID :15452146 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Biochim Biophys Acta 2008;  1783:1280-5;  PMID:18445486 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Cell Cycle 2009; 8:1256-70; PMID:19305133 ;  http://dx.doi.org/10.4161/cc.8.8.8287 70.,Non-OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Nature 2010; 464:513-9; PMID:20336133 ;  http://dx.doi.org/10.1038/nature08981 72.,Non-OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Sci Aging Knowledge Environ 2004; 2004:pe36;  PMID:15456908 ; http://dx.doi.org/10.1126/ sageke.2004.39.pe36 74.,OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Cell Metab 2007; 5:265-77;  PMID:17403371 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Genes Dev 2006; 20:174-84; PMID:16418483 ;  http://dx.doi.org/10.1101/gad.1381406 76.,OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
PLoS Genet 2005; 1:e69; PMID:16311627 ;  http://dx.doi.org/10.1371/journal.pgen.0010069 80.,OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Cell Metab 2007; 6:1-2; PMID:17618850 ;  http://dx.doi.org/10.1016/j.cmet.2007.06.009 81.,OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Cell Mol Life Sci  2007; 64:1323-8;  PMID:17396225 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Bioessays 2001;  23:282-7;  PMID:11223885 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Nature 2000; 408:233-8;  PMID:11089980 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Aging Cell 2004; 3:249-51;  PMID :15379846 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Cell Cycle  2007; 6:2997-3003;  PMID :18156807 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
J  Cell Biochem 2007; 102:1389-99; PMID:17975792 ;  http://dx.doi.org/10.1002/jcb.21602 87.,Non-OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Cell Cycle 2010;  9:1859-62;  PMID:20436272 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Cell 2006; 124:471-84; PMID:16469695 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Cell Cycle 2010; 9:2473- 4; PMID:20543582 ; http://dx.doi.org/10.4161/ cc.9.13.12124 94.,OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Mol Cell 2010; 40:310-22; PMID:20965424 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Curr Opin Genet Dev  2013; 23:53-62;  PMID:23317514 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Genetics  2011; 189:1177-201;  PMID:22174183 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Nat  Rev Mol Cell Biol 2011; 12:21-35; PMID :21157483 ;  http://dx.doi.org/10.1038/nrm3025 99.,OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Cell Cycle  2009; 8:1014-8;  PMID:19270521 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Cell 2013;  153:1194-217;  PMID:23746838 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Cell Cycle 2013; 12:1922-7; PMID:23673343 ;  http://dx.doi.org/10.4161/cc.24944 102.,OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Cell Cycle 2013; 12: In  press; PMID:24131922; http://dx.doi.org/10.4161/cc.26822.,OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Environ Health Perspect 1989; 80:199-207; PMID:2647480 ; http://dx.doi.org/10.1289/ ehp.8980199 104.,Non-OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Cancer 2000;  89:551-60;  PMID:10931454 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Stem Cells 1994;  12(Suppl 1):259-75;  PMID:7696965 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Am J Hematol 2001; 68:99-105;  PMID:11559949 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Am J Pathol  2012; 181:1142-6;  PMID:22841821 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Cell Cycle 2009; 8:1883-7;  PMID:19448395 ; http://dx.doi.org/10.4161/ cc.8.12.8815 109.,Non-OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Cell Cycle 2010; 9:683-8;  PMID:20139716 ; http://dx.doi.org/10.4161/ cc.9.4.10766 110.,OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Cell Cycle 2010; 9:4788-94; PMID :21150328 ;  http://dx.doi.org/10.4161/cc.9.24.14360 112.,OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
BMC Immunol  2009; 10:28;  PMID:19457267 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Mol Cell Biol 2004; 24:3112- 24; PMID :15060135 ; http://dx.doi.org/10.1128/ MCB.24.8.3112-3124.2004 117.,Non-OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Genes Dev 2000;  14:2712-24;  PMID:11069888 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Cell Cycle 2010; 9:4262- 3; PMID:21057199 ; http://dx.doi.org/10.4161/ cc.9.21.13853 119.,Non-OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Genome Biol 2013; 14:R32; PMID:23594524 ; http://dx.doi.org/10.1186/ gb-2013-14-4-r32 120.,OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Cell Cycle 2010; 9:4256-7;  PMID:20980826 ; http://dx.doi.org/10.4161/ cc.9.21.13785 121.,OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Cell Cycle  2008; 7:842-7;  PMID:18414039 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Cell Cycle 2010; 9:3438- 41; PMID:20814241 ; http://dx.doi.org/10.4161/ cc.9.17.13001 123.,Non-OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Cell Cycle 2009; 8:1821; PMID:19471127 ;  http://dx.doi.org/10.4161/cc.8.12.9010 124.,OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Cell Cycle 2013; 12:20- 5; PMID:23255104 ; http://dx.doi.org/10.4161/ cc.22912 125.,OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Nature 2007; 448:375- 9; PMID:17637672 ; http://dx.doi.org/10.1038/ nature05949 126.,Non-OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Cell Metab 2013; 18:617-33; PMID:23954639 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Cell Cycle  2010; 9:3840-1;  PMID:20935483 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Cell Cycle 2009; 8:2324; PMID:19633411 ;  http://dx.doi.org/10.4161/cc.8.15.9126 129.,OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Drug  Discov Today 2007; 12:218-24; PMID:17331886 ;  http://dx.doi.org/10.1016/j.drudis.2007.01.004130.,OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
J Gerontol A Biol Sci Med Sci  2011; 66:191-201;  PMID:20974732 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Aging Cell  2012; 11:326-35;  PMID:22212527 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Neuroscience  2012; 223:102-13;  PMID:22750207 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Aging Cell 2012; 11:675-82; PMID:22587563 ;  http://dx.doi.org/10.1111/j.1474-9726.2012.00832.x 138.,OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Aging Cell 2013; 12:652-60; PMID:23601176 ; http://dx.doi.org/10.1111/ acel.12090 142.,OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Cell Cycle 2010; 9:2713-8; PMID:20581466 ; http://dx.doi.org/10.4161/ cc.9.14.12180 143.,OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Aging Cell 2013; 12:851-62; PMID:23734717 ;  http://dx.doi.org/10.1111/acel.12109 144.,OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Gene 2013; 523:82-7; PMID:23566837 ;  http://dx.doi.org/10.1016/j.gene.2013.03.039,OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Cell Cycle 2009; 8:1738-46; PMID:19395857 ;  http://dx.doi.org/10.4161/cc.8.11.8619 146.,OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Exp Gerontol 2012; 47:958- 65; PMID:22981852 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Sci Transl Med 2011; 3:89ra58; PMID :21715679 ;  http://dx.doi.org/10.1126/scitranslmed.3002346 149.,Non-OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Aging Cell 2012; 11:668-74; PMID:22577861 ;  http://dx.doi.org/10.1111/j.1474-9726.2012.00833.x 150.,Non-OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Am J Pathol  2012; 181:472-7;  PMID:22683466 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Antioxid Redox Signal  2013; 19:321-9;  PMID:22870907 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Rejuvenation Res 2010; 13:246-7; PMID:20017609 ;  http://dx.doi.org/10.1089/rej.2009.0903 154.,Non-OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Cell Metab 2010; 11:35-46; PMID:20074526 ;  http://dx.doi.org/10.1016/j.cmet.2009.11.010 155.,OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Cell Cycle 2013;  12:2493-504;  PMID:23839034 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
J Gerontol A Biol Sci Med Sci 2013;  PMID:23682161 ; http://dx.doi.org/10.1093/gerona/ glt056157.,OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Aging Cell 2013; 12:24-31; PMID:23061800 ; http://dx.doi.org/10.1111/ acel.12015 159.,OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Cell Stem Cell 2012; 11:401-14; PMID:22958932 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
J Clin Invest 2013; 123:1821-32; PMID:23549082 ; http://dx.doi.org/10.1172/ JCI64398 162.,Non-OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Nature 2013; 497:211-6; PMID:23636330 ;  http://dx.doi.org/10.1038/nature12143 165.,Non-OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Cell Cycle 2013;  12:2711-2;  PMID :23966154 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
J Immunol 2013; 191:4648- 55; PMID:24078700 ; http://dx.doi.org/10.4049/ jimmunol.1300750 167.,Non-OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Am J Pathol 2013; 182:2005- 14; PMID:23567640 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Autophagy 2013; 9:939-41;  PMID :23529215 ; http://dx.doi.org/10.4161/ auto.24398169.,Non-OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Cell Cycle 2010; 9:2996-3001;  PMID:20699660 ; http://dx.doi.org/10.4161/ cc.9.15.12359 170.,OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Nature  2009; 460:108-12;  PMID:19543266 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Clin  Exp Immunol 2009; 155:28-34; PMID:19076826 ;  http://dx.doi.org/10.1111/j.1365-2249.2008.03780.x 172.,Non-OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
J Immunol 2010; 185:2004-8; PMID:20631309 ;  http://dx.doi.org/10.4049/jimmunol.1001176 173.,Non-OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Transplantation 2007; 84:1436-42;  PMID :18091519 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Transpl Infect Dis 2013 ; 15:150-62 ;  PMID:23013440 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
Br J Cancer 2011; 104:643-52; PMID:21285988 ;  http://dx.doi.org/10.1038/bjc.2011.15,Non-OADS,/arxiv_data1/oa_pdf/58/fc/cc-12-3736.PMC3905065.pdf
"The fundamental results of such studies in our knowledge of the biology of cancer and on  *Correspondence to: Jacques E Dumont; Email: jedumont@ulb.ac.be Submitted: 09/17/2013; Revised: 11/21/2013; Accepted: 11/21/2013http://dx.doi.org/10.4161/cc.27305Cancer stem cells, a fuzzy evolving concept A cell population or a cell property?",Non-OADS,/arxiv_data1/oa_pdf/69/b6/cc-12-3743.PMC3905066.pdf
Annu Rev Med 2007; 58:267- 84; PMID:17002552 ; http://dx.doi.org/10.1146/ annurev.med.58.062105.204854 2.,Non-OADS,/arxiv_data1/oa_pdf/69/b6/cc-12-3743.PMC3905066.pdf
Cell 2006; 124:1111-5; PMID:16564000 ;  http://dx.doi.org/10.1016/j.cell.2006.03.011 4.,OADS,/arxiv_data1/oa_pdf/69/b6/cc-12-3743.PMC3905066.pdf
J Clin Oncol 2008; 26:2795- 9; PMID:18539956 ; http://dx.doi.org/10.1200/ JCO.2008.17.74366.,Non-OADS,/arxiv_data1/oa_pdf/69/b6/cc-12-3743.PMC3905066.pdf
Cell 2009; 138:645-59; PMID:19682730 ;  http://dx.doi.org/10.1016/j.cell.2009.06.034 7.,OADS,/arxiv_data1/oa_pdf/69/b6/cc-12-3743.PMC3905066.pdf
Carcinogenesis 2010; 31:149-58;  PMID:19858069 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/69/b6/cc-12-3743.PMC3905066.pdf
Nat Rev Mol Cell Biol  2013; 14:489-502;  PMID:23860235 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/69/b6/cc-12-3743.PMC3905066.pdf
N Engl J Med 2009; 360:790- 800;  PMID:19228622 ; http://dx.doi.org/10.1056/ NEJMra0801289 10.,OADS,/arxiv_data1/oa_pdf/69/b6/cc-12-3743.PMC3905066.pdf
Oncogene 2012; 31:4490-8; PMID:22266856 ;  http://dx.doi.org/10.1038/onc.2011.62611.,Non-OADS,/arxiv_data1/oa_pdf/69/b6/cc-12-3743.PMC3905066.pdf
Semin Cancer Biol 2012;  22:250-60;  PMID:22459768 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/69/b6/cc-12-3743.PMC3905066.pdf
Nat Rev Clin Oncol 2012; 9:48-57; PMID:22143140 ;  http://dx.doi.org/10.1038/nrclinonc.2011.178 13.,Non-OADS,/arxiv_data1/oa_pdf/69/b6/cc-12-3743.PMC3905066.pdf
Nature 2008; 456:593-8;  PMID:19052619 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/69/b6/cc-12-3743.PMC3905066.pdf
Oncogene 2013; 32:135-40;  PMID:22349821 ; http://dx.doi.org/10.1038/ onc.2012.48 15.,Non-OADS,/arxiv_data1/oa_pdf/69/b6/cc-12-3743.PMC3905066.pdf
Trends Mol Med 2012; 18:509-15; PMID:22795735 ;  http://dx.doi.org/10.1016/j.molmed.2012.06.005,OADS,/arxiv_data1/oa_pdf/69/b6/cc-12-3743.PMC3905066.pdf
N Engl J Med 2013; 368:842-51;  PMID:23445095 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/69/b6/cc-12-3743.PMC3905066.pdf
Science 2013;  339:1543-5;  PMID:23539593 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/69/b6/cc-12-3743.PMC3905066.pdf
"Cancer Metastasis Rev 2013;  PMID :23615877 ; http://dx.doi.org/10.1007/ s10555-013-9431-y 21. van Es JH, Sato T, van de Wetering M, Lyubimova A,  Nee AN, Gregorieff A, Sasaki N, Zeinstra L, van den Born M, Korving J, et al.",Non-OADS,/arxiv_data1/oa_pdf/69/b6/cc-12-3743.PMC3905066.pdf
Nature  2010; 465:704-12;  PMID:20535199 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/69/b6/cc-12-3743.PMC3905066.pdf
Cancer Cell 2010; 18:510-23;  PMID:21075313 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/69/b6/cc-12-3743.PMC3905066.pdf
Cell 2011; 146:633- 44; PMID:21854987 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/69/b6/cc-12-3743.PMC3905066.pdf
Proc Natl Acad Sci U S A 2011; 108:7950- 5; PMID:21498687 ; http://dx.doi.org/10.1073/ pnas.1102454108 26.,OADS,/arxiv_data1/oa_pdf/69/b6/cc-12-3743.PMC3905066.pdf
Proc Natl Acad Sci U S A 2013; 110:3937-42; PMID :23431158 ; http://dx.doi.org/10.1073/ pnas.1219592110 27.,OADS,/arxiv_data1/oa_pdf/69/b6/cc-12-3743.PMC3905066.pdf
Nat Cell Biol 2008; 10:1021-3; PMID:18758491 ; http://dx.doi.org/10.1038/ ncb0908-1021 29.,OADS,/arxiv_data1/oa_pdf/69/b6/cc-12-3743.PMC3905066.pdf
Cancer Res 2013; 73:3051-61; PMID:23542356 ; http://dx.doi.org/10.1158/0008- 5472.CAN-12-4136 30.,Non-OADS,/arxiv_data1/oa_pdf/69/b6/cc-12-3743.PMC3905066.pdf
Oncogene 2011; 30:4609-21; PMID:21643013 ;  http://dx.doi.org/10.1038/onc.2011.18431.,Non-OADS,/arxiv_data1/oa_pdf/69/b6/cc-12-3743.PMC3905066.pdf
Science 2010; 327:542- 5; PMID:20110496 ; http://dx.doi.org/10.1126/ science.1180794 32.,Non-OADS,/arxiv_data1/oa_pdf/69/b6/cc-12-3743.PMC3905066.pdf
Cancer Metastasis Rev 2012;  PMID:22302111 ; http://dx.doi.org/10.1007/ s10555-012-9345-0 33.,Non-OADS,/arxiv_data1/oa_pdf/69/b6/cc-12-3743.PMC3905066.pdf
J Natl Cancer Inst 2008; 100:672-9; PMID:18445819 ;  http://dx.doi.org/10.1093/jnci/djn123 34.,Non-OADS,/arxiv_data1/oa_pdf/69/b6/cc-12-3743.PMC3905066.pdf
Nat Cell Biol 2013; 15:338-44; PMID:23548926 ;  http://dx.doi.org/10.1038/ncb2717 35.,OADS,/arxiv_data1/oa_pdf/69/b6/cc-12-3743.PMC3905066.pdf
Nature 2011; 478:399-403;  PMID:22012397 ; http://dx.doi.org/10.1038/ nature10525 36.,Non-OADS,/arxiv_data1/oa_pdf/69/b6/cc-12-3743.PMC3905066.pdf
J Cell Mol Med 2009; 13(8B):2236-52;  PMID:18681906 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/69/b6/cc-12-3743.PMC3905066.pdf
Breast Cancer Res 2013; 15:R77; PMID:24008095 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/69/b6/cc-12-3743.PMC3905066.pdf
Annu Rev Cell Dev Biol 2006; 22:339-73;  PMID:16824012 ; http://dx.doi.org/10.1146/ annurev.cellbio.22.010305.104357 39.,OADS,/arxiv_data1/oa_pdf/69/b6/cc-12-3743.PMC3905066.pdf
Cancer Biol Ther  2007; 6:1684-90;  PMID:18344680 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/69/b6/cc-12-3743.PMC3905066.pdf
Leukemia 2006; 20:385- 91; PMID:16357832 ; http://dx.doi.org/10.1038/ sj.leu.2404075 41.,Non-OADS,/arxiv_data1/oa_pdf/69/b6/cc-12-3743.PMC3905066.pdf
Br J Cancer 2010; 102:1276- 83; PMID:20354527 ; http://dx.doi.org/10.1038/ sj.bjc.6605626 42.,Non-OADS,/arxiv_data1/oa_pdf/69/b6/cc-12-3743.PMC3905066.pdf
Nat Methods  2010; 7:224-8;  PMID:20173750 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/69/b6/cc-12-3743.PMC3905066.pdf
Eur J Cancer  1973; 9:305-12;  PMID:4360278 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/69/b6/cc-12-3743.PMC3905066.pdf
Nature 2012; 488:527-30;  PMID:22854777 ; http://dx.doi.org/10.1038/ nature1134446.,Non-OADS,/arxiv_data1/oa_pdf/69/b6/cc-12-3743.PMC3905066.pdf
Science 2012; 337:730- 5; PMID:22855427 ; http://dx.doi.org/10.1126/ science.1224676 47.,Non-OADS,/arxiv_data1/oa_pdf/69/b6/cc-12-3743.PMC3905066.pdf
Dev Cell 2008; 14:818-29;  PMID:18539112 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/69/b6/cc-12-3743.PMC3905066.pdf
Nature  1997; 390:395-8;  PMID:9389477 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/69/b6/cc-12-3743.PMC3905066.pdf
Nat Rev Genet  2007; 8:610-8;  PMID:17637733 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/69/b6/cc-12-3743.PMC3905066.pdf
Nat Rev Cancer 2012; 12:425-36;  PMID:22576165 ; http://dx.doi.org/10.1038/ nrc3265 53.,Non-OADS,/arxiv_data1/oa_pdf/69/b6/cc-12-3743.PMC3905066.pdf
Int J Cancer 2013; 132:1249-59; PMID:23180591 ;  http://dx.doi.org/10.1002/ijc.27961 54.,Non-OADS,/arxiv_data1/oa_pdf/69/b6/cc-12-3743.PMC3905066.pdf
Nature 2011; 474:318-26; PMID:21677748 ;  http://dx.doi.org/10.1038/nature10212 55.,Non-OADS,/arxiv_data1/oa_pdf/69/b6/cc-12-3743.PMC3905066.pdf
Cell 2011; 144:646-74; PMID:21376230 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/69/b6/cc-12-3743.PMC3905066.pdf
Bioessays 2013; 35:253-60;  PMID:23027425 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/69/b6/cc-12-3743.PMC3905066.pdf
Cancer Res 2006; 66:9339-44; PMID:16990346 ; http://dx.doi.org/10.1158/0008- 5472.CAN-06-3126 59.,Non-OADS,/arxiv_data1/oa_pdf/69/b6/cc-12-3743.PMC3905066.pdf
Oncogene 2013; 32:2247- 8; PMID:22869153 ; http://dx.doi.org/10.1038/ onc.2012.349 60.,Non-OADS,/arxiv_data1/oa_pdf/69/b6/cc-12-3743.PMC3905066.pdf
Acta Neuropathol 2013; PMID :24154962 ;  http://dx.doi.org/10.1007/s00401-013-1196-4 62.,Non-OADS,/arxiv_data1/oa_pdf/69/b6/cc-12-3743.PMC3905066.pdf
Nature 2011; 469:314-22;  PMID:21248838 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/69/b6/cc-12-3743.PMC3905066.pdf
Nature 2011; 479:189-93;  PMID:21983963 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/69/b6/cc-12-3743.PMC3905066.pdf
Science  2008; 319:336-9;  PMID:18202291 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/69/b6/cc-12-3743.PMC3905066.pdf
Nat Cell Biol 2013; 15:721- 3; PMID:23817234 ; http://dx.doi.org/10.1038/ ncb2794 66.,OADS,/arxiv_data1/oa_pdf/69/b6/cc-12-3743.PMC3905066.pdf
Nat Cell Biol 2013; 15:807- 17; PMID:23728425 ; http://dx.doi.org/10.1038/ ncb276767.,OADS,/arxiv_data1/oa_pdf/69/b6/cc-12-3743.PMC3905066.pdf
Cell 2008; 133:704-15;  PMID:18485877 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/69/b6/cc-12-3743.PMC3905066.pdf
"37 In the setting of metabolic syndrome and/or poorly con - trolled type 2 diabetes, host cells including occult or known  *Correspondence to: Ann D Thor; ann.thor@ucdenver.edu Submitted: 09/13/2013; Accepted: 09/26/2013http://dx.doi.org/10.4161/cc.26641Glucose promotes breast cancer aggression   and reduces metformin efficacy Reema Wahdan-Alaswad1, Zeying Fan1, Susan M e dgerton1, Bolin Liu1, Xin-Sheng Deng2, Sigrid Salling Arnadottir1,3,   Jennifer K Richer1, Steven M Anderson1, and Ann D t hor1,* 1Department of p athology; University of Colorado; Anschutz Medical Campus; Aurora, C o USA; 2Department of Surgery; University of Colorado; Anschutz Medical Campus;  Aurora, C o USA; 3Department of Molecular Medicine; Aarhus University; Aarhus, Denmark Keywords:  breast cancer, glucose, metformin, metabolism, therapy Metformin treatment has been associated with a decrease in breast cancer risk and improved survival.",Non-OADS,/arxiv_data1/oa_pdf/28/44/cc-12-3759.PMC3905068.pdf
JAMA 2008; 300:2754-64;  PMID:19088353 ;  http://dx.doi.org/10.1001/jama.2008.824 2.,Non-OADS,/arxiv_data1/oa_pdf/28/44/cc-12-3759.PMC3905068.pdf
Nat Rev Cancer 2004; 4:579-91; PMID :15286738 ;  http://dx.doi.org/10.1038/nrc1408 3.,Non-OADS,/arxiv_data1/oa_pdf/28/44/cc-12-3759.PMC3905068.pdf
J Clin Oncol  2008; 26:3299-300;  PMID:18612145 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/28/44/cc-12-3759.PMC3905068.pdf
BMC Public  Health 2009; 9:88; PMID:19320986 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/28/44/cc-12-3759.PMC3905068.pdf
Obes Rev  2003; 4:1 57-73;  PMID:12916817 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/28/44/cc-12-3759.PMC3905068.pdf
Endocr Rev  2007; 28:763-77;  PMID:17981890 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/28/44/cc-12-3759.PMC3905068.pdf
Curr Opin Cell Biol 2006; 18:598-608; PMID:17046224 ;  http://dx.doi.org/10.1016/j.ceb.2006.10.005 11.,OADS,/arxiv_data1/oa_pdf/28/44/cc-12-3759.PMC3905068.pdf
J Clin Oncol 2008; 26:3310-6; PMID:18612147 ;  http://dx.doi.org/10.1200/JCO.2006.10.3168 13.,Non-OADS,/arxiv_data1/oa_pdf/28/44/cc-12-3759.PMC3905068.pdf
J Clin Oncol  2008; 26:833-4;  PMID:18281653 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/28/44/cc-12-3759.PMC3905068.pdf
J Natl Cancer Inst 2008; 100:530-2;  PMID:18398091 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/28/44/cc-12-3759.PMC3905068.pdf
Breast Cancer Res Treat 2008; 109:389-95;  PMID:17659440 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/28/44/cc-12-3759.PMC3905068.pdf
J Clin Oncol 2011; 29:40- 6; PMID:21115865 ; http://dx.doi.org/10.1200/ JCO.2009.27.3011 18.,Non-OADS,/arxiv_data1/oa_pdf/28/44/cc-12-3759.PMC3905068.pdf
Breast Cancer Res Treat  2010; 123:627-35;  PMID:20571870 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/28/44/cc-12-3759.PMC3905068.pdf
Lancet Oncol  2005; 6:103-11;  PMID :15683819 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/28/44/cc-12-3759.PMC3905068.pdf
J Clin Oncol 2009; 27:3271-3;  PMID:19487373 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/28/44/cc-12-3759.PMC3905068.pdf
Int J Breast Cancer 2012; 2012:809291; PMID:22295251 ;  http://dx.doi.org/10.1155/2012/809291 22.,Non-OADS,/arxiv_data1/oa_pdf/28/44/cc-12-3759.PMC3905068.pdf
Curr Drug Targets Immune Endocr Metabol Disord 2004; 4:59-66; PMID:15032627 ;  http://dx.doi.org/10.2174/1568008043339965 23.,Non-OADS,/arxiv_data1/oa_pdf/28/44/cc-12-3759.PMC3905068.pdf
Breast Cancer  Res 2008; 10:202;  PMID:18304378 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/28/44/cc-12-3759.PMC3905068.pdf
Breast Cancer Res Treat 2009; 114:517-25; PMID:18437560 ;  http://dx.doi.org/10.1007/s10549-008-0019-0 25.,Non-OADS,/arxiv_data1/oa_pdf/28/44/cc-12-3759.PMC3905068.pdf
Cancer Res  2008; 68:10238-46;  PMID:19074892 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/28/44/cc-12-3759.PMC3905068.pdf
Cancer Discov 2012; 2:778-90; PMID:22926251 ;  http://dx.doi.org/10.1158/2159-8290.CD-12-0263 28.,Non-OADS,/arxiv_data1/oa_pdf/28/44/cc-12-3759.PMC3905068.pdf
Cancer 2012; 118:1202-11; PMID:21800293 ;  http://dx.doi.org/10.1002/cncr.2643931.,Non-OADS,/arxiv_data1/oa_pdf/28/44/cc-12-3759.PMC3905068.pdf
BMJ 2005; 330:1304-5; PMID :15849206 ; http://dx.doi.org/10.1136/ bmj.38415.708634.F7 33.,Non-OADS,/arxiv_data1/oa_pdf/28/44/cc-12-3759.PMC3905068.pdf
Diabetes Care  2009; 32:1620-5;  PMID:19564453 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/28/44/cc-12-3759.PMC3905068.pdf
Cancer Res  2006; 66:10269-73;  PMID:17062558 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/28/44/cc-12-3759.PMC3905068.pdf
J Clin Oncol 2009; 27:3297- 302; PMID:19487376 ; http://dx.doi.org/10.1200/ JCO.2009.19.6410 36.,Non-OADS,/arxiv_data1/oa_pdf/28/44/cc-12-3759.PMC3905068.pdf
Cell Cycle 2010; 9:1057- 64; PMID:20305377 ; http://dx.doi.org/10.4161/ cc.9.6.10994 37.,Non-OADS,/arxiv_data1/oa_pdf/28/44/cc-12-3759.PMC3905068.pdf
Diabetes Care  2006; 29:1990-1;  PMID:16873829 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/28/44/cc-12-3759.PMC3905068.pdf
Curr Opin Genet Dev 2008; 18:54-61;  PMID:18387799 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/28/44/cc-12-3759.PMC3905068.pdf
Science 2009;  324:1029-33;  PMID:19460998 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/28/44/cc-12-3759.PMC3905068.pdf
Cancer Cell 2008; 13:472-82; PMID:18538731 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/28/44/cc-12-3759.PMC3905068.pdf
Science 1956; 123:309-14;  PMID:13298683 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/28/44/cc-12-3759.PMC3905068.pdf
Semin Cancer Biol  2009; 19:1-3;  PMID:19162190 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/28/44/cc-12-3759.PMC3905068.pdf
J Clin Oncol  2005; 23:1664-73;  PMID:15755974 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/28/44/cc-12-3759.PMC3905068.pdf
J Exp Med 2012;  209:211-5;  PMID:22330683 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/28/44/cc-12-3759.PMC3905068.pdf
Cancer Res 2012; 72:6490-501; PMID:23222299 ;  http://dx.doi.org/10.1158/0008-5472.CAN-12-165346.,Non-OADS,/arxiv_data1/oa_pdf/28/44/cc-12-3759.PMC3905068.pdf
Cell Cycle 2009; 8:909- 15; PMID:19221498 ; http://dx.doi.org/10.4161/ cc.8.6.7933 47.,Non-OADS,/arxiv_data1/oa_pdf/28/44/cc-12-3759.PMC3905068.pdf
Cell Cycle 2012; 11:367-76;  PMID:22189713 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/28/44/cc-12-3759.PMC3905068.pdf
Cell Cycle 2009; 8:2031- 40; PMID:19440038 ; http://dx.doi.org/10.4161/ cc.8.13.8814 49.,Non-OADS,/arxiv_data1/oa_pdf/28/44/cc-12-3759.PMC3905068.pdf
Cell Cycle  2012; 11:2782-92;  PMID:22809961 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/28/44/cc-12-3759.PMC3905068.pdf
J Mol  Endocrinol 2012; 48:R31-43;  PMID:22355097 ;  http://dx.doi.org/10.1530/JME-12-0007 51.,Non-OADS,/arxiv_data1/oa_pdf/28/44/cc-12-3759.PMC3905068.pdf
Med Oncol  2012; 29:1314-27;  PMID:21301998 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/28/44/cc-12-3759.PMC3905068.pdf
N Engl J Med  1996; 334:574-9;  PMID:8569826 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/28/44/cc-12-3759.PMC3905068.pdf
Breast Cancer Res Treat 2012; 135:821- 30; PMID:22933030 ; http://dx.doi.org/10.1007/ s10549-012-2223-1 54.,Non-OADS,/arxiv_data1/oa_pdf/28/44/cc-12-3759.PMC3905068.pdf
Proc Natl Acad Sci U S A 2013; 110:972- 7; PMID:23277563 ; http://dx.doi.org/10.1073/ pnas.1221055110 56.,OADS,/arxiv_data1/oa_pdf/28/44/cc-12-3759.PMC3905068.pdf
Cell Cycle  2010; 9:3807-14;  PMID:20890129 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/28/44/cc-12-3759.PMC3905068.pdf
Cancer Res 2009; 69:7507-11;  PMID:19752085 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/28/44/cc-12-3759.PMC3905068.pdf
J Nucl Med 2008; 49(Suppl 2):24S-42S;  PMID:18523064 ; http://dx.doi.org/10.2967/ jnumed.107.047258 59.,OADS,/arxiv_data1/oa_pdf/28/44/cc-12-3759.PMC3905068.pdf
Mol Cancer Ther 2006; 5:1864-72;  PMID:16891473 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/28/44/cc-12-3759.PMC3905068.pdf
"Apparently, CRS dominance over NLS can be overpowered under certain conditions, as YB-1 could also be observed in  *Correspondence to: Lev P Ovchinnikov; Email: ovchinn@vega.protres.ru; Alexey V Sorokin; Email: alexey.v.sorokin@gmail.com Submitted: 06/26/2013; Revised: 10/01/2013; Accepted: 10/01/2013http://dx.doi.org/10.4161/cc.26670The proteolytic YB-1 fragment interacts   with DNA repair machinery and enhances   survival during DNA damaging stress ekaterina R Kim1, Anastasia A Selyutina1,2, Ilya A Buldakov1, Valentina e vdokimova1,3, Lev p  ovchinnikov1,*,   and Alexey V Sorokin1,* 1Institute of p rotein Research; Russian Academy of Sciences; p ushchino, Moscow Region, Russian Federation; 2University of t artu; Institute of t echnology; t artu, e stonia;  3Department of Molecular o ncology; British Columbia Cancer Research Centre; Vancouver, British Columbia, Canada Keywords:  YB-1, proteasome, cleavage, PEST, truncation, nuclear localization, DNA reparation, DNA damage, drug resistance the Y-box binding protein 1 (YB-1) is a DNA/RNA-binding nucleocytoplasmic shuttling protein whose regulatory  effect on many DNA and RNA-dependent events is determined by its localization in the cell.",Non-OADS,/arxiv_data1/oa_pdf/8c/b7/cc-12-3791.PMC3905071.pdf
"32 Using the  PESTFind algorithm (http://emboss.bioinformatics.nl/cgi-bin/emboss/epestfind), we found the highly conserved PEST regions within YB-1, including residues 1–26, 26–52, 118–137, 170–185, 205–231, 264–279, and 304–324.",Non-OADS,/arxiv_data1/oa_pdf/8c/b7/cc-12-3791.PMC3905071.pdf
"Using DAVID Bioinformatics Database  (http://david.abcc.ncifcrf.gov), we established that WT YB-1 mostly affects genes associated with cytoskeleton  Figure  3.  expression, stability, and pro-survival effects of proteasome-resistant  YB-1 mutants in cells treated with doxorubicin.",OADS,/arxiv_data1/oa_pdf/8c/b7/cc-12-3791.PMC3905071.pdf
Analysis was done using DAVID Bioinformatics Resources (http://david.abcc.ncifcrf.gov).,OADS,/arxiv_data1/oa_pdf/8c/b7/cc-12-3791.PMC3905071.pdf
Functional categorization of affected genes was made using DAVID Bioinformatics Resources   (http://david.abcc.ncifcrf.gov).In vitro transport assay In vitro transport assay was assembled as described previously.,OADS,/arxiv_data1/oa_pdf/8c/b7/cc-12-3791.PMC3905071.pdf
Biochemistry (Mosc) 2011; 76:1402- 33; PMID:22339596 ; http://dx.doi.org/10.1134/ S0006297911130049 2.,Non-OADS,/arxiv_data1/oa_pdf/8c/b7/cc-12-3791.PMC3905071.pdf
Proc Natl Acad Sci U S A 1988; 85:7322-6; PMID:3174636 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8c/b7/cc-12-3791.PMC3905071.pdf
J Biol Chem 2003; 278:5156-62; PMID:12446674 ;  http://dx.doi.org/10.1074/jbc.M208724200 5.,OADS,/arxiv_data1/oa_pdf/8c/b7/cc-12-3791.PMC3905071.pdf
Oncogene 2007; 26:2736-46;  PMID:17072343 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8c/b7/cc-12-3791.PMC3905071.pdf
EMBO J 2001;  20:5491-502;  PMID :11574481 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8c/b7/cc-12-3791.PMC3905071.pdf
Oncogene 2013;  32:4189-90;  PMID:23160378 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8c/b7/cc-12-3791.PMC3905071.pdf
Nucleic Acids Res 1991; 19:4915-20; PMID:1923758 ; http://dx.doi.org/10.1093/ nar/19.18.4915 14.,Non-OADS,/arxiv_data1/oa_pdf/8c/b7/cc-12-3791.PMC3905071.pdf
Nucleic Acids Res  2004; 32:316-27;  PMID:14718551 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8c/b7/cc-12-3791.PMC3905071.pdf
J Biol Chem 2007; 282:28474-84; PMID:17686777 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/8c/b7/cc-12-3791.PMC3905071.pdf
Nat Med 1997; 3:447-50;  PMID:9095180 ; http://dx.doi.org/10.1038/ nm0497-447 19.,Non-OADS,/arxiv_data1/oa_pdf/8c/b7/cc-12-3791.PMC3905071.pdf
J Biol Chem 2001; 276:28562-9;  PMID:11369762 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/8c/b7/cc-12-3791.PMC3905071.pdf
J Biol Chem 2003; 278:27988-96; PMID:12695516 ;  http://dx.doi.org/10.1074/jbc.M212966200 21.,OADS,/arxiv_data1/oa_pdf/8c/b7/cc-12-3791.PMC3905071.pdf
Mol Cell Biol 2005; 25:2095- 106; PMID :15743808 ; http://dx.doi.org/10.1128/ MCB.25.6.2095-2106.2005 22.,Non-OADS,/arxiv_data1/oa_pdf/8c/b7/cc-12-3791.PMC3905071.pdf
Oncogene 2005; 24:4281-92; PMID:15806160 ;  http://dx.doi.org/10.1038/sj.onc.1208590 23.,Non-OADS,/arxiv_data1/oa_pdf/8c/b7/cc-12-3791.PMC3905071.pdf
EMBO J  2005; 24:3602-12;  PMID:16193061 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8c/b7/cc-12-3791.PMC3905071.pdf
Int J Cancer 1999; 83:732- 7; PMID:10597187 ; http://dx.doi.org/10.1002/ (SICI)1097-0215(19991210)83:6<732::AID- IJC6>3.0.CO;2-# 25.,Non-OADS,/arxiv_data1/oa_pdf/8c/b7/cc-12-3791.PMC3905071.pdf
Cancer Res 2005; 65:4078-87; PMID:15899797 ; http://dx.doi.org/10.1158/0008- 5472.CAN-04-4056 26.,Non-OADS,/arxiv_data1/oa_pdf/8c/b7/cc-12-3791.PMC3905071.pdf
Cancer Cell 2009; 15:402-15; PMID:19411069 ;  http://dx.doi.org/10.1016/j.ccr.2009.03.01727.,Non-OADS,/arxiv_data1/oa_pdf/8c/b7/cc-12-3791.PMC3905071.pdf
J Biol Chem  1998; 273:5858-68;  PMID:9488723 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8c/b7/cc-12-3791.PMC3905071.pdf
Curr Opin Genet Dev 2002; 12:162-9; PMID:11893489 ; http://dx.doi.org/10.1016/ S0959-437X(02)00282-4 29.,OADS,/arxiv_data1/oa_pdf/8c/b7/cc-12-3791.PMC3905071.pdf
Biochemistry (Mosc) 2009; 74:1411-42; PMID:20210701 ; http://dx.doi.org/10.1134/ S000629790913001X 30.,Non-OADS,/arxiv_data1/oa_pdf/8c/b7/cc-12-3791.PMC3905071.pdf
Cell 1991;  66 : 615-8 ;  PMID:1652366 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8c/b7/cc-12-3791.PMC3905071.pdf
Science 1989; 243:1493-5; PMID:2928784 ; http://dx.doi.org/10.1126/ science.2928784 33.,Non-OADS,/arxiv_data1/oa_pdf/8c/b7/cc-12-3791.PMC3905071.pdf
Mol Carcinog  2006; 45:403-8;  PMID:16691596 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8c/b7/cc-12-3791.PMC3905071.pdf
Curr Biol 2000; 10:886- 95; PMID:10959836 ; http://dx.doi.org/10.1016/ S0960-9822(00)00610-2 35.,OADS,/arxiv_data1/oa_pdf/8c/b7/cc-12-3791.PMC3905071.pdf
Int J Cancer  2002; 97:278-82;  PMID:11774277 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8c/b7/cc-12-3791.PMC3905071.pdf
J Cancer Res Clin Oncol 2002; 128:621- 6; PMID:12458343 ; http://dx.doi.org/10.1007/ s00432-002-0386-6 39.,Non-OADS,/arxiv_data1/oa_pdf/8c/b7/cc-12-3791.PMC3905071.pdf
Cancer Lett 2003; 190:191-7; PMID:12565174 ;  http://dx.doi.org/10.1016/S0304-3835(02)00590-640.,Non-OADS,/arxiv_data1/oa_pdf/8c/b7/cc-12-3791.PMC3905071.pdf
Prostate 2004; 59:337-49; PMID:15042610 ;  http://dx.doi.org/10.1002/pros.20023 41.,Non-OADS,/arxiv_data1/oa_pdf/8c/b7/cc-12-3791.PMC3905071.pdf
Clin Cancer Res 2005; 11:7354-61;  PMID:16243807 ; http://dx.doi.org/10.1158/1078- 0432.CCR-05-1027 42.,Non-OADS,/arxiv_data1/oa_pdf/8c/b7/cc-12-3791.PMC3905071.pdf
Int J Cancer 2007; 120:2110- 8; PMID:17266041 ; http://dx.doi.org/10.1002/ ijc.22512 43.,Non-OADS,/arxiv_data1/oa_pdf/8c/b7/cc-12-3791.PMC3905071.pdf
Eur J Haematol 2009; 83:313-9; PMID:19500133 ;  http://dx.doi.org/10.1111/j.1600-0609.2009.01285.x 44.,Non-OADS,/arxiv_data1/oa_pdf/8c/b7/cc-12-3791.PMC3905071.pdf
"Shibahara K, Uchiumi T, Fukuda T, Kura S,  Tominaga Y, Maehara Y, Kohno K, Nakabeppu Y,  Tsuzuki T, Kuwano M. Targeted disruption of one allele of the Y-box binding protein-1 (YB-1) gene  in mouse embryonic stem cells and increased sen - sitivity to cisplatin and mitomycin C. Cancer Sci  2004; 95:348-53;  PMID:15072594 ; http://dx.doi.",OADS,/arxiv_data1/oa_pdf/8c/b7/cc-12-3791.PMC3905071.pdf
Blood  2008; 111:3714-22;  PMID:18006704 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8c/b7/cc-12-3791.PMC3905071.pdf
Cancer Res  2009; 69:3148-56;  PMID:19318582 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8c/b7/cc-12-3791.PMC3905071.pdf
Mol Cancer Ther 2009;  8:3276-84;  PMID:19996271 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8c/b7/cc-12-3791.PMC3905071.pdf
Proc Natl Acad Sci U S A 2001; 98:7277- 82; PMID:11390977 ; http://dx.doi.org/10.1073/ pnas.121592298,OADS,/arxiv_data1/oa_pdf/8c/b7/cc-12-3791.PMC3905071.pdf
Int J Biochem Cell Biol 2008; 40:2492-507; PMID:18571458 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/8c/b7/cc-12-3791.PMC3905071.pdf
J Biol Chem 1998; 273:5997- 6000;  PMID:9497311 ; http://dx.doi.org/10.1074/ jbc.273.11.5997 52.,OADS,/arxiv_data1/oa_pdf/8c/b7/cc-12-3791.PMC3905071.pdf
Biochem Biophys Res Commun  2007; 357:295-301;  PMID:17418094 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8c/b7/cc-12-3791.PMC3905071.pdf
J Biol Chem 1995; 270:3186-92; PMID:7852402 ;  http://dx.doi.org/10.1074/jbc.270.7.3186 54.,OADS,/arxiv_data1/oa_pdf/8c/b7/cc-12-3791.PMC3905071.pdf
Nucleic Acids Res  1997; 25:2911-6;  PMID:9207042 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8c/b7/cc-12-3791.PMC3905071.pdf
Oncogene 2013; 32:3130- 8; PMID:22824790 ; http://dx.doi.org/10.1038/ onc.2012.327 56.,Non-OADS,/arxiv_data1/oa_pdf/8c/b7/cc-12-3791.PMC3905071.pdf
J Cell Biol 1990; 111:807- 16; PMID:2391365 ; http://dx.doi.org/10.1083/ jcb.111.3.807,OADS,/arxiv_data1/oa_pdf/8c/b7/cc-12-3791.PMC3905071.pdf
"In humans, Nup62 mutations cause autoso - mal recessive infantile bilateral striatal necrosis.24 *Correspondence to: Richard W Wong; Email: rwong@staff.kanazawa-u.ac.jp Submitted: 07/30/2013; Revised: 09/29/2013; Accepted: 10/01/2013http://dx.doi.org/10.4161/cc.26671Nucleoporin Nup62 maintains centrosome  homeostasis Chieko Hashizume1,†, Akane Moyori1,2,†, Akiko Kobayashi1, Nana Yamakoshi1,2, Aoi e ndo1, and Richard W Wong1,3,* 1Laboratory of Molecular and Cellular Biology; Department of Biology; Faculty of Natural Systems; Institute of Science and e ngineering; Kanazawa University; Kakuma-machi,  Kanazawa, Japan; 2Division of Natural System; Graduate School of Natural Science and t echnology; Kanazawa University; Kakuma-machi, Kanazawa, Japan; 3Bio-AFM Frontier  Research Center; Kanazawa University; Kakuma-machi, Kanazawa, Japan †these authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/75/b9/cc-12-3804.PMC3905072.pdf
Nature 2007; 450:695-701;  PMID:18046406 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/75/b9/cc-12-3804.PMC3905072.pdf
Cell 2013; 152:1218- 21; PMID:23498931 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/75/b9/cc-12-3804.PMC3905072.pdf
Trends Cell Biol  2008; 18:456-66;  PMID:18786826 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/75/b9/cc-12-3804.PMC3905072.pdf
Cell Cycle  2011; 10:425-33;  PMID:21270521 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/75/b9/cc-12-3804.PMC3905072.pdf
Curr Opin Cell Biol 2013; 25:378-86; PMID:23567027 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/75/b9/cc-12-3804.PMC3905072.pdf
Nat Rev Mol Cell Biol 2009; 10:178- 91; PMID:19234477 ; http://dx.doi.org/10.1038/ nrm2641 8.,OADS,/arxiv_data1/oa_pdf/75/b9/cc-12-3804.PMC3905072.pdf
Cell  Mol Life Sci 2010; 67:2215-30; PMID:20372967 ;  http://dx.doi.org/10.1007/s00018-010-0325-79.,OADS,/arxiv_data1/oa_pdf/75/b9/cc-12-3804.PMC3905072.pdf
Mol Cell Biol 2001; 21:7944-55; PMID:11689687 ; http://dx.doi.org/10.1128/ MCB.21.23.7944-7955.2001 10.,Non-OADS,/arxiv_data1/oa_pdf/75/b9/cc-12-3804.PMC3905072.pdf
Nature  2009; 457:1023-7;  PMID:19098896 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/75/b9/cc-12-3804.PMC3905072.pdf
Plant Signal Behav 2011; 6:330-4;  PMID:21673506 ;  http://dx.doi.org/10.4161/psb.6.3.13402,OADS,/arxiv_data1/oa_pdf/75/b9/cc-12-3804.PMC3905072.pdf
J Cell Biol  1996; 134:589-601;  PMID:8707840 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/75/b9/cc-12-3804.PMC3905072.pdf
Mol Biol Cell  1995; 6 :1591-603 ;  PMID:8589458 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/75/b9/cc-12-3804.PMC3905072.pdf
J Neuropathol Exp Neurol 2006; 65:45-54;  PMID:16410748 ; http://dx.doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/75/b9/cc-12-3804.PMC3905072.pdf
Proc Natl Acad Sci U S A  2006; 103:2172-7;  PMID:16461911 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/75/b9/cc-12-3804.PMC3905072.pdf
J Cell Biol 1991; 114:169- 83; PMID:2050741 ; http://dx.doi.org/10.1083/ jcb.114.1.169 18.,OADS,/arxiv_data1/oa_pdf/75/b9/cc-12-3804.PMC3905072.pdf
Cell 2011; 147:590- 602; PMID:22036567 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/75/b9/cc-12-3804.PMC3905072.pdf
J Biol Chem 2010; 285:28796-805; PMID:20622012 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/75/b9/cc-12-3804.PMC3905072.pdf
J Biol Chem 2007; 282:19321-30;  PMID:17500061 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/75/b9/cc-12-3804.PMC3905072.pdf
Mol Cell Biol 2009; 29:4788-97; PMID:19581287 ;  http://dx.doi.org/10.1128/MCB.00649-09 22.,Non-OADS,/arxiv_data1/oa_pdf/75/b9/cc-12-3804.PMC3905072.pdf
Traffic 2009;  10:1257-71;  PMID:19552648 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/75/b9/cc-12-3804.PMC3905072.pdf
J Cell Biol 2011; 193:619- 31; PMID :21576391 ; http://dx.doi.org/10.1083/ jcb.201008064 24.,OADS,/arxiv_data1/oa_pdf/75/b9/cc-12-3804.PMC3905072.pdf
Ann Neurol 2006; 60:214-22; PMID:16786527 ; http://dx.doi.org/10.1002/ ana.20902 25.,OADS,/arxiv_data1/oa_pdf/75/b9/cc-12-3804.PMC3905072.pdf
Cell Cycle 2010; 9:198-200; PMID:20016259 ;  http://dx.doi.org/10.4161/cc.9.1.1043126.,OADS,/arxiv_data1/oa_pdf/75/b9/cc-12-3804.PMC3905072.pdf
Proc Natl Acad Sci U S A 2008; 105:15441- 5; PMID :18832153 ; http://dx.doi.org/10.1073/ pnas.0807660105 28.,OADS,/arxiv_data1/oa_pdf/75/b9/cc-12-3804.PMC3905072.pdf
Proc Natl Acad Sci U S A 2006; 103:19783-7; PMID:17172455 ; http://dx.doi.org/10.1073/ pnas.0609582104 29.,OADS,/arxiv_data1/oa_pdf/75/b9/cc-12-3804.PMC3905072.pdf
J Biol Chem  2010; 285:10841-9;  PMID:20133940 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/75/b9/cc-12-3804.PMC3905072.pdf
Mol Cancer 2010;  9:119;  PMID:20497554 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/75/b9/cc-12-3804.PMC3905072.pdf
Cell Death Dis 2013; 4:e854; PMID:24113188; http://dx.doi.org/10.1038/ cddis.2013.370 33.,Non-OADS,/arxiv_data1/oa_pdf/75/b9/cc-12-3804.PMC3905072.pdf
Cell 2009; 139:663- 78; PMID:19914163 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/75/b9/cc-12-3804.PMC3905072.pdf
Dev Cell 2002; 3:339-50; PMID :12361598 ;  http://dx.doi.org/10.1016/S1534-5807(02)00258-7 36.,OADS,/arxiv_data1/oa_pdf/75/b9/cc-12-3804.PMC3905072.pdf
Sci Rep 2012;  2:878;  PMID:23170199 ; http://dx.doi.org/10.1038/ srep00878 37.,OADS,/arxiv_data1/oa_pdf/75/b9/cc-12-3804.PMC3905072.pdf
PLoS One 2012; 7:e36137;  PMID:22558357 ; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/75/b9/cc-12-3804.PMC3905072.pdf
J Cell Sci 2012; 125:5096- 109; PMID:22899712 ; http://dx.doi.org/10.1242/ jcs.107326 39.,OADS,/arxiv_data1/oa_pdf/75/b9/cc-12-3804.PMC3905072.pdf
Nat Rev Mol Cell Biol  2012; 13:687-99;  PMID:23090414 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/75/b9/cc-12-3804.PMC3905072.pdf
Cancer Metastasis Rev 2011; 30:239-51;  PMID:21298575 ; http://dx.doi.org/10.1007/ s10555-011-9287-y41.,Non-OADS,/arxiv_data1/oa_pdf/75/b9/cc-12-3804.PMC3905072.pdf
Am J Pathol 2012; 180:375-89;  PMID:22074739 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/75/b9/cc-12-3804.PMC3905072.pdf
Nat Cell Biol  2012; 14:431-7;  PMID:22388888 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/75/b9/cc-12-3804.PMC3905072.pdf
Dev Cell 2012; 22:693-4;  PMID:22516195 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/75/b9/cc-12-3804.PMC3905072.pdf
FEBS Lett 2010; 584:3013- 20; PMID:20561986 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/75/b9/cc-12-3804.PMC3905072.pdf
J Cell Sci 2007; 120:1717-22;  PMID:17502482 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/75/b9/cc-12-3804.PMC3905072.pdf
Mol Biol Cell  2006; 17:3806-18;  PMID:16807356 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/75/b9/cc-12-3804.PMC3905072.pdf
Curr Biol 2006; 16:1748- 56; PMID:16950114 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/75/b9/cc-12-3804.PMC3905072.pdf
J Cell Biol  2001; 154:1147-60;  PMID :11564755 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/75/b9/cc-12-3804.PMC3905072.pdf
Mol Cell  2003; 11:853-64;  PMID:12718872 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/75/b9/cc-12-3804.PMC3905072.pdf
Mol Biol Cell 2004; 15:3333-44;  PMID :15146057 ;  http://dx.doi.org/10.1091/mbc.E03-12-0878 57.,Non-OADS,/arxiv_data1/oa_pdf/75/b9/cc-12-3804.PMC3905072.pdf
J Cell Biol 2003; 162:991-1001;  PMID:12963708 ; http://dx.doi.org/10.1083/ jcb.20030408058.,OADS,/arxiv_data1/oa_pdf/75/b9/cc-12-3804.PMC3905072.pdf
Curr  Biol 2004; 14:611-7; PMID:15062103 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/75/b9/cc-12-3804.PMC3905072.pdf
Cancer Sci 2013; 104:871- 9; PMID:23551833 ; http://dx.doi.org/10.1111/ cas.12159 62.,Non-OADS,/arxiv_data1/oa_pdf/75/b9/cc-12-3804.PMC3905072.pdf
http://www.fda.gov/downloads/Drugs/Gu idanceComplianceRegulatorylnformation/Guidances/UCM193282.pdf.,Non-OADS,/arxiv_data1/oa_pdf/93/86/cjc-33-01-040.PMC3905089.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4a/98/vhrm-10-049.PMC3905091.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpVascular Health and Risk Management 2014:10 49–54Vascular Health and Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  49ORiginal ReseaRcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/VHRM.S5542 3Is higher body temperature beneficial in ischemic  stroke patients with normal admission   cT angiography of the cerebral arteries?,Non-OADS,/arxiv_data1/oa_pdf/4a/98/vhrm-10-049.PMC3905091.pdf
"Vascular Health and Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/vascular-health-and-risk-management-journa lVascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on  concise rapid reporting of clinical studies on the processes involved  in the maintenance of vascular health; the monitoring, prevention and  treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/4a/98/vhrm-10-049.PMC3905091.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/4a/98/vhrm-10-049.PMC3905091.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/20/27/ott-7-135.PMC3905092.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/20/27/ott-7-135.PMC3905092.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/20/27/ott-7-135.PMC3905092.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/78/86/opth-8-283.PMC3905093.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 283–287Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  283Case seriesopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S5425 5Clinical experiences in fungal keratitis   caused by Acremonium seong-Jae Kim1,2 Y ong-Wun Cho1 seong-Wook seo1,2 sun-Joo Kim2,3 Ji-Myong Y oo1,2 1Department of Ophthalmology,   2Gyeongsang institute of Health  science, 3Department of Laboratory  Medicine, Gyeongsang National  University, College of Medicine,    Jinju, Korea Correspondence: seong-Jae Kim   Department of Ophthalmology, school  of Medicine, institute of Health science,  Gyeongsang National University, Jinju,  Gyeongnam 660-751, s Korea   Tel + 82 55 750 8170   Fax + 82 55 758 4158   email maya12kim@naver.co mPurpose:  To report the predisposing risk factors, clinical presentation, management, and  therapeutic outcomes of fungal keratitis caused by Acremonium .",Non-OADS,/arxiv_data1/oa_pdf/78/86/opth-8-283.PMC3905093.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/78/86/opth-8-283.PMC3905093.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/78/86/opth-8-283.PMC3905093.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/90/5b/rmhp-7-025.PMC3905094.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpRisk Management and Healthcare Policy 2014:7 25–28Risk Management and Healthcare Policy Dove press submit your manuscript | www.dovepress.co m Dove press  25ORiginal ReseaRcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/RMHP .S5708 2implementation of innovative pulsed xenon   ultraviolet (PX-UV) environmental cleaning   in an acute care hospital lori Fornwalt1 Brad Riddell1,2 1Departments of infection Prevention  and environmental services, Trinity  Medical centre, Birmingham, al,   2environmental services, Medical  University of south carolina,   charleston, sc, Usa correspondence: lori Fornwalt   Departments of infection Prevention   and environmental services, Trinity   Medical centre, 800 Montclair Road,   Birmingham, al 35213, Usa   Tel +1 205 592 5415   Fax +1 205 592 1163   email l ori.fornwalt@trinitymedicalonline.",Non-OADS,/arxiv_data1/oa_pdf/90/5b/rmhp-7-025.PMC3905094.pdf
"Survey data for 2011 reported that 25,826 patients visited  the hospital’ s emergency room and that there were 14,273  admissions ( http://health.usnews.com/best-hospitals/area/al/ trinity-medical-center-653016 1).",Non-OADS,/arxiv_data1/oa_pdf/90/5b/rmhp-7-025.PMC3905094.pdf
"At-risk reimbursement  is a part of the Centers for Medicare and Medicaid Services’  value-based purchasing program, which rewards health care  facilities for providing high-quality care using a formula con - sisting of outcome measures and patient satisfaction.3 Discussion Prior to the introduction of the PX-UV program, published  results from the HCAHPA survey in August 2012 reported  levels of patient satisfaction with the cleanliness of rooms and  bedrooms as average (69%) ( http://health.usnews.com/best- hospitals/area/al/trinity-medical-center-653016 1/patient- satisfaction ).",Non-OADS,/arxiv_data1/oa_pdf/90/5b/rmhp-7-025.PMC3905094.pdf
"Risk Management and Healthcare Policy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/risk-management-and-healthcare-policy-journa lRisk Management and Healthcare Policy is an international, peer- reviewed, open access journal focusing on all aspects of public health,  policy, and preventative measures to promote good health and improve  morbidity and mortality in the population.",Non-OADS,/arxiv_data1/oa_pdf/90/5b/rmhp-7-025.PMC3905094.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/90/5b/rmhp-7-025.PMC3905094.pdf
"Available from: http://www.cms.gov/Medicare/ Quality-Initiatives-Patient-Assessment-Instruments/hospital-value- based-purchasing/index.htm l. Accessed August 20, 2013.",Non-OADS,/arxiv_data1/oa_pdf/90/5b/rmhp-7-025.PMC3905094.pdf
"Available from: http://www.gpo.gov/ fdsys/pkg/PLAW-111publ148/pdf/PLAW-111publ148.pd f. Accessed  October 9, 2013.",Non-OADS,/arxiv_data1/oa_pdf/90/5b/rmhp-7-025.PMC3905094.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e4/55/ott-7-147.PMC3905095.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2014:7 147–164OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  147Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S5260 0Triple-negative breast cancer risk in women  is defined by the defect of estrogen signaling:  preventive and therapeutic implications Zsuzsanna Suba National Institute of Oncology,   Surgical and Molecular T umor  Pathology Centre, Budapest, Hungary Correspondence: Zsuzsanna Suba   National Institute of Oncology,   Surgical and Molecular Tumor   Pathology Centre, H-1122 Ráth   György Str 7-9, Budapest, Hungary   Tel +36 1 224 86 00   Fax +36 1 224 86 20   email subazdr@gmail.co mAbstract:  Epidemiologic studies strongly support that triple-negative breast cancers (TNBCs)  may be distinct entities as compared with estrogen receptor (ER) + tumors, suggesting that the etio - logic factors, clinical characteristics, and therapeutic possibilities may vary by molecular subtypes.",Non-OADS,/arxiv_data1/oa_pdf/e4/55/ott-7-147.PMC3905095.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/e4/55/ott-7-147.PMC3905095.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e4/55/ott-7-147.PMC3905095.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/26/5b/opth-8-271.PMC3905096.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 271–282Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  271Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S5205 5Critical analysis of the classification of glaucomas  issued by the european glaucoma society in 2008 Constantin-Dan Bordeianu emergency hospital Ploiesti, Prahova,   romania Correspondence: Constantin-Dan  Bordeianu   15, Cameliei st, Bl 26, sc B, et i, ap 26,  Ploiesti, 100091, Prahova, romania   email bordmail3@yahoo.co m and  oftamedica.ro@gmail.co mPurpose:  To critically analyze the 2008 European Glaucoma Society classification of   glaucomas, in order to reveal its advantages and shortcomings.",Non-OADS,/arxiv_data1/oa_pdf/26/5b/opth-8-271.PMC3905096.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/26/5b/opth-8-271.PMC3905096.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/26/5b/opth-8-271.PMC3905096.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/67/be/opth-8-263.PMC3905097.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 263–269Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  263MethO dOlOgyopen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/OPTH.S5280 3A novel technique for inferior rectus recession Birsen gokyigit Serpil Akar Omer Faruk yilmaz department of Strabismus, Istanbul  Beyoglu educational and Research  eye hospital, Istanbul, turkey Correspondence: Birsen gokyigit   tekfen Sitesi, yagmur Apt d5,   Ulus 34340, Istanbul, turkey   tel :+90-532-246 37 99   Fax:+90-212-613 51 62   email bgokyigit@hotmail.co m;  bgokyigit@dr.co mPurpose:  To introduce a novel technique of inferior rectus recession operation to allow larger  amounts of recession without causing lower lid retraction and to compare this method with the  results obtained in standard inferior rectus recession.",Non-OADS,/arxiv_data1/oa_pdf/67/be/opth-8-263.PMC3905097.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/67/be/opth-8-263.PMC3905097.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/67/be/opth-8-263.PMC3905097.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1b/88/ndt-10-111.PMC3905098.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 111–122Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  111Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S5391 3epidemiological, humanistic, and economic   burden of illness of lower limb spasticity   in adults: a systematic review Alison Martin1 Seye Abogunrin1 Hannah Kurth2 Jerome Dinet2 1evidera, London, UK; 2ipsen, Boulogne  Billancourt Cedex, France Correspondence: Alison Martin   evidera, 26–28 Hammersmith Grove,  London w6 7HA, UK   Tel +44 020 8834 9586   Fax +44 020 8834 0101   email alison.martin@evidera.co mBackground:  The purpose of this study was to investigate the epidemiological, humanistic,  and economic burden of illness associated with adult lower limb spasticity (LLS) and its  complications.",Non-OADS,/arxiv_data1/oa_pdf/1b/88/ndt-10-111.PMC3905098.pdf
co.uk) •	World Stroke Congress ( http://www1.kenes.com/ wsc) •	World Federation of Neurology ( http://www.,Non-OADS,/arxiv_data1/oa_pdf/1b/88/ndt-10-111.PMC3905098.pdf
"org) •	American Neurological Association/Association of  British Neurologists ( http://www.aneuroa.or g) inclusion and exclusion criteria inclusion criteria Patient population •	Patients older than 18 years of age with LLS, that could  have resulted from any of the following underlying  diseases: o	Stroke Table  S1 Search string for MeDLiNe-indexed publications Search algorithm Hits 1.",Non-OADS,/arxiv_data1/oa_pdf/1b/88/ndt-10-111.PMC3905098.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/1b/88/ndt-10-111.PMC3905098.pdf
Visit  http://www.dovepress.com/testimonials.php to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/1b/88/ndt-10-111.PMC3905098.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/89/2e/ppa-8-107.PMC3905099.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2014:8 107–117Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  107ORIGINAL RESEARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S5206 0A critical analysis of user satisfaction surveys   in addiction services: opioid maintenance   treatment as a representative case study Joan Trujols1,2 Ioseba Iraurgi3 Eugenia Oviedo-Joekes4,5 Joan Guàrdia-Olmos6 1Unitat de Conductes Addictives,   Servei de Psiquiatria, Hospital de  la Santa Creu i Sant Pau, Institut  d’Investigació Biomèdica Sant Pau  (IIB Sant Pau), Barcelona, 2Centro  de Investigación Biomédica en  Red de Salud Mental (CIBERSAM),   Madrid, 3DeustoPsych – Unidad de  Investigación, Desarrollo e Innovación  en Psicología y Salud, Universidad  de Deusto, Bilbao, Spain; 4School  of Population and Public Health,   University of British Columbia,   5Centre for Health Evaluation and  Outcome Sciences, Providence  Health Care Research Institute,   Vancouver, Canada; 6Departament  de Metodologia de les Ciències del  Comportament, Facultat de   Psicologia, Institut de Recerca   en Cervell, Cognició i Conducta   (IR3C), Universitat de Barcelona,   Barcelona, Spain Correspondence: Joan Trujols   Unitat de Conductes Addictives, Servei  de Psiquiatria, Hospital de la Santa Creu i  Sant Pau, Institut d’Investigació Biomèdica  Sant Pau (IIB Sant Pau), Sant Antoni Maria  Claret 167, 08025 Barcelona, Spain   Tel +34 93 553 7665   Fax +34 93 553 7666   Email jtrujols@santpau.ca tBackground:  Satisfaction with services represents a key component of the user’ s perspective,  and user satisfaction surveys are the most commonly used approach to evaluate the aforemen - tioned perspective.",Non-OADS,/arxiv_data1/oa_pdf/89/2e/ppa-8-107.PMC3905099.pdf
"Available from: http://www.dpt.samhsa.gov/pdf/ FederalGuidelinesfo rOpioidTreatment5 -6-2013revisiondraft_508.pd f. Accessed July 25,  2013.",Non-OADS,/arxiv_data1/oa_pdf/89/2e/ppa-8-107.PMC3905099.pdf
Available from: https://csrh.arts.,Non-OADS,/arxiv_data1/oa_pdf/89/2e/ppa-8-107.PMC3905099.pdf
"Available  from: http://www.emcdda.europa.eu/attachements.cfm/att_5868_EN_6_ client_satisfaction_evaluations.pd f. Accessed November 7, 2013.",Non-OADS,/arxiv_data1/oa_pdf/89/2e/ppa-8-107.PMC3905099.pdf
Available from: http://www.groups.psychology.,Non-OADS,/arxiv_data1/oa_pdf/89/2e/ppa-8-107.PMC3905099.pdf
"Available from:  http://www.drugscope.org.uk/Resources/Drugscope/Documents/PDF/ Good%20Practice/Gettinginvolved.pd f. Accessed July 25, 2013.",Non-OADS,/arxiv_data1/oa_pdf/89/2e/ppa-8-107.PMC3905099.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal focusing on the growing importance of patient  preference and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/89/2e/ppa-8-107.PMC3905099.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/89/2e/ppa-8-107.PMC3905099.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f7/f5/vhrm-10-055.PMC3905100.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpVascular Health and Risk Management 2014:10 55–62Vascular Health and Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  55ORiginal ReseaRcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/VHRM.S5355 7increased prevalence of coronary artery   disease risk markers in patients with chronic  hepatitis c – a cross-sectional study T orsten Roed1 Ulrik sloth Kristoffersen2 andreas Knudsen1,2 niels Wiinberg3 anne-Mette lebech1 Thomas almdal4 Reimar W Thomsen5 andreas Kjær2 nina Weis1,6 1Department of infectious Diseases,   copenhagen University Hospital,   Hvidovre, Denmark; 2Department of  clinical Physiology, nuclear Medicine  and P eT and cluster for Molecular  imaging, Rigshospitalet, University of  copenhagen, copenhagen, Denmark;   3Department of clinical Physiology,   Frederiksberg Hospital, copenhagen,   Denmark; 4steno Diabetes center,   copenhagen, Denmark; 5Department  of clinical epidemiology, aarhus  University Hospital, aarhus, Denmark;   6Faculty of Health sciences, University  of copenhagen, copenhagen,   Denmark correspondence: T orsten Roed   Department of infectious Diseases,  copenhagen University Hospital,  Hvidovre, Kettegårds allé 30, 2650  Hvidovre, Denmark   T el +45 61650344   Fax +45 38623405   email torstenroed@gmail.co mObjective:  Chronic hepatitis C is a global health problem and has been associated with coronary  artery disease.",Non-OADS,/arxiv_data1/oa_pdf/f7/f5/vhrm-10-055.PMC3905100.pdf
"Available from: http://www.niaid.nih.gov/topics/hepatitis/hepatitisc/ Pages/Default.asp x. Accessed December 12, 2013.",Non-OADS,/arxiv_data1/oa_pdf/f7/f5/vhrm-10-055.PMC3905100.pdf
"Vascular Health and Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/vascular-health-and-risk-management-journa lVascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on  concise rapid reporting of clinical studies on the processes involved  in the maintenance of vascular health; the monitoring, prevention and  treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/f7/f5/vhrm-10-055.PMC3905100.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f7/f5/vhrm-10-055.PMC3905100.pdf
"For the diverse array of imaging technologies, there are Review http://dx.doi.org/10.4070/kcj.2014.44.1.1 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Cardiovascular Molecular Imaging with Contrast Ultrasound:  Principles and Applications Chi Young Shim, MD and Jonathan R. Lindner, MD From the Knight Cardiovascular Institute, Oregon Health & Science University, Portland, OR, USA Methods for imaging the molecular or cellular profile of tissue are being developed for all forms of non-invasive cardiovascular imaging.",Non-OADS,/arxiv_data1/oa_pdf/bd/c8/kcj-44-1.PMC3905109.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.major differences between the detectors with regards to resolution,  sensitivity, speed and cost.",Non-OADS,/arxiv_data1/oa_pdf/bd/c8/kcj-44-1.PMC3905109.pdf
"2 Ultrasound Molecular Imaging http://dx.doi.org/10.4070/kcj.2014.44.1.1 www.e-kcj.org of CEU molecular imaging are that it provides real-time informa- tion, represents a good balance between spatial resolution and sensitivity, is portable is rapid, is widely available, and does not in-volve non-ionizing radiation.",Non-OADS,/arxiv_data1/oa_pdf/bd/c8/kcj-44-1.PMC3905109.pdf
http://dx.doi.org/10.4070/kcj.2014.44.1.1 www.e-kcj.org been developed.,OADS,/arxiv_data1/oa_pdf/bd/c8/kcj-44-1.PMC3905109.pdf
4 Ultrasound Molecular Imaging http://dx.doi.org/10.4070/kcj.2014.44.1.1 www.e-kcj.org which permits their intravenous injection and free passage through  the microcirculation of the pulmonary and peripheral circulation.,Non-OADS,/arxiv_data1/oa_pdf/bd/c8/kcj-44-1.PMC3905109.pdf
"http://dx.doi.org/10.4070/kcj.2014.44.1.1 www.e-kcj.org Cardiovascular Applications for Ultrasound  Molecular Imaging   Atherosclerosis The pathophysiology of atherosclerosis is diverse, complex, and  changes over the decades between disease inception and clinical  events.",Non-OADS,/arxiv_data1/oa_pdf/bd/c8/kcj-44-1.PMC3905109.pdf
6 Ultrasound Molecular Imaging http://dx.doi.org/10.4070/kcj.2014.44.1.1 www.e-kcj.org oxidized lipids or ECAM expression.,Non-OADS,/arxiv_data1/oa_pdf/bd/c8/kcj-44-1.PMC3905109.pdf
"http://dx.doi.org/10.4070/kcj.2014.44.1.1 www.e-kcj.org peripheral arterial disease.43) Vascular remodeling is a complex pro- cess involving multiple different biologic triggers, signaling path- ways, and cellular responses.44)45) Perfusion imaging alone is an  attractive method for ultimately determining the end-result of adaptive vascular remodeling in ischemic disease.",Non-OADS,/arxiv_data1/oa_pdf/bd/c8/kcj-44-1.PMC3905109.pdf
8 Ultrasound Molecular Imaging http://dx.doi.org/10.4070/kcj.2014.44.1.1 www.e-kcj.org 4.,Non-OADS,/arxiv_data1/oa_pdf/bd/c8/kcj-44-1.PMC3905109.pdf
http://dx.doi.org/10.4070/kcj.2014.44.1.1 www.e-kcj.org tissue transfection with ultrasound destruction of plasmid-bearing  cationic microbubbles.,Non-OADS,/arxiv_data1/oa_pdf/bd/c8/kcj-44-1.PMC3905109.pdf
"10 Copyright © 2014 The Korean Society of CardiologyKorean Circulation Journal Introduction Myeloperoxidase (MPO) is a leukocyte enzyme and a part of the  innate host defence.1) By generating a highly reactive oxygen spe-Original Article http://dx.doi.org/10.4070/kcj.2014.44.1.10 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Myeloperoxidase Is Not Useful for Detecting Stress Inducible  Myocardial Ischemia but May Be Indicative of the Severity  of Coronary Artery Disease Christoph G. Schuhmann, MD1, Marcus Hacker, MD2, Philip Jung, MD1, Florian Krötz, MD1, and Hae-Young Sohn, MD1 1Department of Cardiology, Medizinische Klinik I and  2Department of Nuclear Medicine, University Hospital of the Ludwig Maximilian University of Munich, Munich, Germany Background and Objectives: Elevated levels of myeloperoxidase (MPO) have been found in patients in different stages of coronary ar- tery disease (CAD).",Non-OADS,/arxiv_data1/oa_pdf/78/87/kcj-44-10.PMC3905110.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.cies, it contributes to the pathogenesis of atherosclerosis, e.g., by  lipoprotein oxidation, matrix metalloprotease degradation and ni-tric oxide consumption.",Non-OADS,/arxiv_data1/oa_pdf/78/87/kcj-44-10.PMC3905110.pdf
http://dx.doi.org/10.4070/kcj.2014.44.1.10 www.e-kcj.org myocardial perfusion scintigraphy (MPS) in patients with suspect- ed CAD.,Non-OADS,/arxiv_data1/oa_pdf/78/87/kcj-44-10.PMC3905110.pdf
"12 Myeloperoxidase Is Not Useful for Detecting Stress Inducible Myocardial Ischemia http://dx.doi.org/10.4070/kcj.2014.44.1.10 www.e-kcj.org higher in the ACS patients, while high density lipoprotein-cholesterol  levels were higher in the MPS group.",Non-OADS,/arxiv_data1/oa_pdf/78/87/kcj-44-10.PMC3905110.pdf
"http://dx.doi.org/10.4070/kcj.2014.44.1.10 www.e-kcj.org p=0.03) and after the stress testing (36 ±5 ng/mL vs. 25 ±2 ng/mL,  p=0.03) (Fig.",Non-OADS,/arxiv_data1/oa_pdf/78/87/kcj-44-10.PMC3905110.pdf
"14 Myeloperoxidase Is Not Useful for Detecting Stress Inducible Myocardial Ischemia http://dx.doi.org/10.4070/kcj.2014.44.1.10 www.e-kcj.org Nevertheless, we believe our results may contribute to the under - standing of the circulation of MPO in the patients with CAD.",Non-OADS,/arxiv_data1/oa_pdf/78/87/kcj-44-10.PMC3905110.pdf
http://dx.doi.org/10.4070/kcj.2014.44.1.10 www.e-kcj.org 18.,Non-OADS,/arxiv_data1/oa_pdf/78/87/kcj-44-10.PMC3905110.pdf
"3) Therefore, loss of calcium homeostasis, such as an Original Article http://dx.doi.org/10.4070/kcj.2014.44.1.16 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Effect of Hypoxic Paracrine Media on Calcium-Regulatory Proteins  in Infarcted Rat Myocardium Byeong-Wook Song, PhD1, Hye Jin Hwang, MD2, Minji Seung, BS2, and Moon-Hyoung Lee, MD2 1Institute of Catholic Integrative Medicine, Incheon St. Mary’s Hospital, The Catholic University of Korea College of Medicine, Incheon,  2Division of Cardiology, Severance Cardiovascular Research Center, Yonsei University College of Medicine, Seoul, Korea Background and Objectives: An increase in intracellular calcium concentration due to loss of Ca2+ homeostasis triggers arrhythmia or  cardiac cell death in the heart.",Non-OADS,/arxiv_data1/oa_pdf/cb/f6/kcj-44-16.PMC3905111.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.increase in intracellular calcium, is important to trigger the process  leading to cardiac cell death.4)  Stem cell therapy can potentially provide beneficial paracrine fac- tors for cellular repair to protect damaged myocardium and to re-store or regenerate injured myocardium.",Non-OADS,/arxiv_data1/oa_pdf/cb/f6/kcj-44-16.PMC3905111.pdf
http://dx.doi.org/10.4070/kcj.2014.44.1.16 www.e-kcj.org calcium cycling.,OADS,/arxiv_data1/oa_pdf/cb/f6/kcj-44-16.PMC3905111.pdf
"18 Calcium Regulatory Effect of Paracrine Media http://dx.doi.org/10.4070/kcj.2014.44.1.16 www.e-kcj.org we observed previously by optical mapping.14) Levels of intracellular  Ca2+ and Na+ play a key role in maintenance of physiological cycling  of action potentials and excitation-contraction coupling.15) We ob- served a decrease in the expression of LTCC, SERCA2a, and Na+/K+  ATPase in the sham group, whereas marked increases in these were  observed in the border zone of the hypoxic PM group.",OADS,/arxiv_data1/oa_pdf/cb/f6/kcj-44-16.PMC3905111.pdf
"http://dx.doi.org/10.4070/kcj.2014.44.1.16 www.e-kcj.org been clearly defined, and low viability of stem cells transplanted  into the myocardium may limit cardiac regeneration.18) Furthermore,  a heterogeneous feature of stem cells coupled to naive cardiomyo-cytes may lead to increased arrhythmogeneity.",Non-OADS,/arxiv_data1/oa_pdf/cb/f6/kcj-44-16.PMC3905111.pdf
"20 Calcium Regulatory Effect of Paracrine Media http://dx.doi.org/10.4070/kcj.2014.44.1.16 www.e-kcj.org regulator of ion homeostasis.25) Our results show that the hypoxic  PM treatment restored calmodulin expression, as supported by the  previous results; calmodulin expression decreases in human isch-emic heart disease, and calmodulin decreased in hypoxic myocy-tes.",Non-OADS,/arxiv_data1/oa_pdf/cb/f6/kcj-44-16.PMC3905111.pdf
http://dx.doi.org/10.4070/kcj.2014.44.1.16 www.e-kcj.org 21.,Non-OADS,/arxiv_data1/oa_pdf/cb/f6/kcj-44-16.PMC3905111.pdf
"QRS duration is a pre- dictor of poor prognosis in HF.2)3) Wide QRS duration was found in Original Article http://dx.doi.org/10.4070/kcj.2014.44.1.22 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Prognostic Implication of QRS Variability during Hospitalization  in Patients with Acute Decompensated Heart Failure So-Ryoung Lee, MD1, Eue-Keun Choi, MD1, Do-Yoon Kang, MD1, Myung-Jin Cha, MD1,   Youngjin Cho, MD1, Il-Young Oh, MD2, and Seil Oh, MD1 1Department of Internal Medicine, Seoul National University Hospital, Seoul,  2Cardiovascular Center, Seoul National University Bundang Hospital, Seongnam, Korea Background and Objectives: Heart failure (HF) patients display more varied QRS duration.",Non-OADS,/arxiv_data1/oa_pdf/5e/7f/kcj-44-22.PMC3905112.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.20-30% of HF patients, especially in those with severe left ventric- ular (LV) dysfunction.2)4)5) Patients with wide QRS duration display in - creased prevalence of sudden cardiac death and all-caused death.3)6-8)  One of the possible explanations for poor outcomes in those with wide QRS duration is LV dyssynchrony.",Non-OADS,/arxiv_data1/oa_pdf/5e/7f/kcj-44-22.PMC3905112.pdf
"http://dx.doi.org/10.4070/kcj.2014.44.1.22 www.e-kcj.org BBB in HF patients shows poor clinical outcomes, few studies have  addressed QRS variability and BBB in HF patients.13-16) This study was undertaken to investigate whether QRS variation  during hospitalization for acute decompensated HF is prognostically influential for clinical outcomes after discharge.",Non-OADS,/arxiv_data1/oa_pdf/5e/7f/kcj-44-22.PMC3905112.pdf
"24 QRS Variability in Acute Decompensated Heart Failure http://dx.doi.org/10.4070/kcj.2014.44.1.22 www.e-kcj.org (n=61) was not different from those without (16.4 ±21.9 vs. 15.6 ±  13.4, p=0.766).",OADS,/arxiv_data1/oa_pdf/5e/7f/kcj-44-22.PMC3905112.pdf
http://dx.doi.org/10.4070/kcj.2014.44.1.22 www.e-kcj.org Table 1.,OADS,/arxiv_data1/oa_pdf/5e/7f/kcj-44-22.PMC3905112.pdf
"26 QRS Variability in Acute Decompensated Heart Failure http://dx.doi.org/10.4070/kcj.2014.44.1.22 www.e-kcj.org 0.021), more frequent ECG evaluation (10 ±5 times vs. 6 ±4 times,  p<0.001), and higher prevalence of AMI on admission (33.3% vs.  16.8%, p=0.028).",Non-OADS,/arxiv_data1/oa_pdf/5e/7f/kcj-44-22.PMC3905112.pdf
http://dx.doi.org/10.4070/kcj.2014.44.1.22 www.e-kcj.org severe LV dysfunction.,Non-OADS,/arxiv_data1/oa_pdf/5e/7f/kcj-44-22.PMC3905112.pdf
"28 QRS Variability in Acute Decompensated Heart Failure http://dx.doi.org/10.4070/kcj.2014.44.1.22 www.e-kcj.org be associated with fatal arrhythmia among patients with known  cause of death (n=18, 42.9% of deceased patients).",Non-OADS,/arxiv_data1/oa_pdf/5e/7f/kcj-44-22.PMC3905112.pdf
http://dx.doi.org/10.4070/kcj.2014.44.1.22 www.e-kcj.org survival in non-ST elevation acute myocardial infarction.,Non-OADS,/arxiv_data1/oa_pdf/5e/7f/kcj-44-22.PMC3905112.pdf
"30 Copyright © 2014 The Korean Society of CardiologyKorean Circulation Journal Introduction High sodium intake increases blood pressure (BP),1) and eventual - ly leads to a high incidence of cardiovascular events.2)3) Conversely,  reductions in sodium intake lowers BP.4)5) In the Dietary Approaches Original Article http://dx.doi.org/10.4070/kcj.2014.44.1.30 Print ISSN 1738-5520 • On-line ISSN 1738-5555 High Sodium Intake in Women with Metabolic Syndrome Moo-Yong Rhee, MD1, Ji-Hyun Kim, MD1, Yong-Seok Kim, MD1, Jin-Wook Chung, MD2, Jun-Ho Bae, MD2,   Deuk-Young Nah, MD2, Young-Kwon Kim, MD1, Myoung-Mook Lee, MD1, Chi-Yeon Lim, PhD3, Jae-Eon Byun, PhD4,  Hye-Kyung Park, PhD4, Baeg-Won Kang, PhD4, Jong-Wook Kim, PhD4, and Sun-Woong Kim, PhD5 1Cardiovascular Center and 3Clinical Trial Center, Dongguk University Ilsan Hospital, Goyang,   2Division of Cardiology, Department of Internal Medicine, College of Medicine, Dongguk University, Gyeongju,   4Nutrition Safety Policy Division, Food Nutrition and Dietary Safety Bureau, Ministry of Food and Drug Safety, Osong,  5Department of Statistics, Survey Research Center, Dongguk University, Seoul, Korea Background and Objectives: Metabolic syndrome and high sodium intake are associated with frequent cardiovascular events.",Non-OADS,/arxiv_data1/oa_pdf/7d/02/kcj-44-30.PMC3905113.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.to Stop Hypertension (DASH)-sodium trial, the BP lowering effect  of low sodium diet was additive to the effects of DASH diet.",Non-OADS,/arxiv_data1/oa_pdf/7d/02/kcj-44-30.PMC3905113.pdf
"http://dx.doi.org/10.4070/kcj.2014.44.1.30 www.e-kcj.org Furthermore, few studies have estimated sodium intake in subjects  with metabolic syndrome by using 24-hour urine sodium excretion.",Non-OADS,/arxiv_data1/oa_pdf/7d/02/kcj-44-30.PMC3905113.pdf
"32 Sodium Intake and Metabolic Syndrome http://dx.doi.org/10.4070/kcj.2014.44.1.30 www.e-kcj.org device (WatchBP Office; Microlife, Widnau, Switzerland).",Non-OADS,/arxiv_data1/oa_pdf/7d/02/kcj-44-30.PMC3905113.pdf
http://dx.doi.org/10.4070/kcj.2014.44.1.30 www.e-kcj.org Analysis of variance test were used for evaluation of differences  between mean values of groups.,OADS,/arxiv_data1/oa_pdf/7d/02/kcj-44-30.PMC3905113.pdf
"34 Sodium Intake and Metabolic Syndrome http://dx.doi.org/10.4070/kcj.2014.44.1.30 www.e-kcj.org been based on the dietary survey data from the Korean Health and  Nutrition Examination Survey.10)19) When evaluating the relationship  between sodium intake and disease, it is recommended that the data should be obtained using the 24-hour urine collection meth-od.",Non-OADS,/arxiv_data1/oa_pdf/7d/02/kcj-44-30.PMC3905113.pdf
http://dx.doi.org/10.4070/kcj.2014.44.1.30 www.e-kcj.org diet patterns among subjects with metabolic syndrome.22) The col- lective findings from previous and the present studies provide indi- rect evidence that reduction of sodium consumption is an important preventive goal in reducing cardiovascular event in individuals with metabolic syndrome.,Non-OADS,/arxiv_data1/oa_pdf/7d/02/kcj-44-30.PMC3905113.pdf
"36 Sodium Intake and Metabolic Syndrome http://dx.doi.org/10.4070/kcj.2014.44.1.30 www.e-kcj.org of a WHO forum and technical meeting 5-7 October 2006, Paris, France.",Non-OADS,/arxiv_data1/oa_pdf/7d/02/kcj-44-30.PMC3905113.pdf
"37 Copyright © 2014 The Korean Society of CardiologyKorean Circulation Journal Introduction Infective endocarditis (IE) is a disease that can cause serious com - plications, and the risk of IE is higher in patients with underlying  heart disease.1) Over the past several decades, IE was commonly Original Article http://dx.doi.org/10.4070/kcj.2014.44.1.37 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Changes in Patient Characteristics of Infective Endocarditis with  Congenital Heart Disease: 25 Years Experience in a Single Institution Jae Eun Baek, MD1, Su Jin Park, MD2, Saet Byul Woo, MD1,   Jae Young Choi, MD1, Jo Won Jung, MD1, and Nam Kyun Kim, MD1 1Division of Pediatric Cardiology, Congenital Heart Disease Center, Severance Cardiovascular Hospital, Department of Pediatrics, Yonsei University College of Medicine, Seoul,  2Department of Pediatric Cardiology, Sejong General Hospital, Bucheon, Korea Background and Objectives: The profile of infective endocarditis (IE) has changed and is now showing an increasing prevalence of IE  among congenital heart disease (CHD) patients.",Non-OADS,/arxiv_data1/oa_pdf/41/8f/kcj-44-37.PMC3905114.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.associated with rheumatic heart disease and degenerative valvular  heart disease.",Non-OADS,/arxiv_data1/oa_pdf/41/8f/kcj-44-37.PMC3905114.pdf
"38 Changes in Patient Characteristics of Infective Endocarditis with Congenital Heart Disease http://dx.doi.org/10.4070/kcj.2014.44.1.37 www.e-kcj.org 31, 2012.",Non-OADS,/arxiv_data1/oa_pdf/41/8f/kcj-44-37.PMC3905114.pdf
http://dx.doi.org/10.4070/kcj.2014.44.1.37 www.e-kcj.org cardiac surgery upon the diagnosis of IE.,Non-OADS,/arxiv_data1/oa_pdf/41/8f/kcj-44-37.PMC3905114.pdf
"40 Changes in Patient Characteristics of Infective Endocarditis with Congenital Heart Disease http://dx.doi.org/10.4070/kcj.2014.44.1.37 www.e-kcj.org with vegetation removal), and 10 cases in group B (nine cases re- quired valvuloplasty, and one case had vegetation removal only).",Non-OADS,/arxiv_data1/oa_pdf/41/8f/kcj-44-37.PMC3905114.pdf
"http://dx.doi.org/10.4070/kcj.2014.44.1.37 www.e-kcj.org survival rate of patients with complex CHD and an improvement in  surgical techniques, such as the use of prosthetic materials.",Non-OADS,/arxiv_data1/oa_pdf/41/8f/kcj-44-37.PMC3905114.pdf
"Ini-tial 12-lead electrocardiography (ECG) revealed ST-segment elevation Case Report http://dx.doi.org/10.4070/kcj.2014.44.1.42 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Myocardial Infarction Type 4b in Human Immunodeficiency  Virus-Infected Patient Aneta Cybula-Walczak, MD1, Filip M. Szymanski, MD2, Anna E. Platek, MD2, and Grzegorz Karpinski, MD2 1Departments of Hepatology and Acquired Immunodeficiencies and 2Cardiology, Medical University of Warsaw, Warsaw, Poland We report a case of a 52-year-old human immunodeficiency virus (HIV)-infected male patient receiving combined antiretroviral therapy  (cART), who presented with acute ST-elevation myocardial infarction (STEMI).",Non-OADS,/arxiv_data1/oa_pdf/5e/b1/kcj-44-42.PMC3905115.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.in V 2-5 leads, and ST-segment depression in II, III and aVF.",Non-OADS,/arxiv_data1/oa_pdf/5e/b1/kcj-44-42.PMC3905115.pdf
http://dx.doi.org/10.4070/kcj.2014.44.1.42 www.e-kcj.org medications.,Non-OADS,/arxiv_data1/oa_pdf/5e/b1/kcj-44-42.PMC3905115.pdf
44 Myocardial Infarction Type 4b in HIV-Infected Patient http://dx.doi.org/10.4070/kcj.2014.44.1.42 www.e-kcj.org prasugrel instead of clopidogrel.,Non-OADS,/arxiv_data1/oa_pdf/5e/b1/kcj-44-42.PMC3905115.pdf
"3) Although it is known that Case Report http://dx.doi.org/10.4070/kcj.2014.44.1.45 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Percutaneous Closure of an Iatrogenic Ventricular Septal Defect  Following Concomitant Septal Myectomy  at the Time of Aortic Valve Replacement Il Hwan Ryu, MD1, Won Ho Kim, MD1, Ah Jeong Ryu, MD1, Min Gyu Kim, MD1,   Jae Woong Jeon, MD1, Joo Seok Kim, MD1, Jae Joon Lee, MD1, and Jin Ho Choi, MD2 1Department of Internal Medicine, Eulji University Hospital, Eulji University School of Medicine, Daejeon,   2Division of Thoracic and Cardiovascular Surgery, Eulji University Hospital, Eulji University School of Medicine, Daejeon, Korea A 77-year-old female patient underwent aortic valve replacement (AVR) with concomitant septal myectomy and tricuspid annuloplasty.",Non-OADS,/arxiv_data1/oa_pdf/6c/30/kcj-44-45.PMC3905116.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.concomitant myectomy with AVR is relatively safe and effective,  complications beyond surgeons’ control, such as iatrogenic ventric - ular septal defect (VSD) and atrioventricular block, may be devel-oped.",Non-OADS,/arxiv_data1/oa_pdf/6c/30/kcj-44-45.PMC3905116.pdf
"46 Percutaneous Closure of an Iatrogenic VSD Following Septal Myectomy http://dx.doi.org/10.4070/kcj.2014.44.1.45 www.e-kcj.org a 28-mm Edwards MC3 (Edwards Lifesciences LLC, Irvine, CA, USA).",Non-OADS,/arxiv_data1/oa_pdf/6c/30/kcj-44-45.PMC3905116.pdf
"http://dx.doi.org/10.4070/kcj.2014.44.1.45 www.e-kcj.org mm Hg, suggesting the presence of a possible iatrogenic VSD (Fig.",Non-OADS,/arxiv_data1/oa_pdf/6c/30/kcj-44-45.PMC3905116.pdf
"48 Percutaneous Closure of an Iatrogenic VSD Following Septal Myectomy http://dx.doi.org/10.4070/kcj.2014.44.1.45 www.e-kcj.org In summary, percutaneous VSD closure may appear to amelio- rate the pathologic changes that flow from hemodynamically-sig- nificant left to right shunting, easily, safely and effectively.",Non-OADS,/arxiv_data1/oa_pdf/6c/30/kcj-44-45.PMC3905116.pdf
"1)2)5) Here we  describe successful staged transcatheter closures for the fistula tract Case Report http://dx.doi.org/10.4070/kcj.2014.44.1.49 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Transcatheter Closures for Fistula Tract and Paravalvular Leak  after Mitral Valve Replacement and Tricuspid Annuloplasty Sang Yong Om, MD1, Gyung Min Park, MD3, Jin Yong Kim, MD1, Yong Hoon Yoon, MD1,   Sinwon Lee, MD1, Young-Hak Kim, MD2, and Jae-Kwan Song, MD2 1Department of Internal Medicine and 2Division of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul,  3Division of Cardiology, Daejeon St. Mary’s Hospital, The Catholic University of Korea College of Medicine, Seoul, Korea Paravalvular leaks (PVLs) often occur after surgical valve replacement.",Non-OADS,/arxiv_data1/oa_pdf/0f/ce/kcj-44-49.PMC3905117.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.between the aorta and right atrium, and mitral PVL after mitral valve  replacement and tricuspid annuloplasty.",Non-OADS,/arxiv_data1/oa_pdf/0f/ce/kcj-44-49.PMC3905117.pdf
"50 Percutaneous Closures for Fistula Tract and Paravalvular Leak http://dx.doi.org/10.4070/kcj.2014.44.1.49 www.e-kcj.org teams, we decided to perform staged transcatheter closures for  both the fistula tract and mitral PVL.",Non-OADS,/arxiv_data1/oa_pdf/0f/ce/kcj-44-49.PMC3905117.pdf
http://dx.doi.org/10.4070/kcj.2014.44.1.49 www.e-kcj.org atrium (Fig.,Non-OADS,/arxiv_data1/oa_pdf/0f/ce/kcj-44-49.PMC3905117.pdf
"52 Percutaneous Closures for Fistula Tract and Paravalvular Leak http://dx.doi.org/10.4070/kcj.2014.44.1.49 www.e-kcj.org Using a 6 Fr multipurpose catheter, the stainless steel wire was ex- changed for a 0.035 inch stiff wire (Fig.",Non-OADS,/arxiv_data1/oa_pdf/0f/ce/kcj-44-49.PMC3905117.pdf
http://dx.doi.org/10.4070/kcj.2014.44.1.49 www.e-kcj.org the shape of the PVL was cylindrical.,Non-OADS,/arxiv_data1/oa_pdf/0f/ce/kcj-44-49.PMC3905117.pdf
"Here, we report 2 cases of successful management of super-giant CAA in the acute setting.Case Report http://dx.doi.org/10.4070/kcj.2014.44.1.54 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Two Cases of Super-Giant Coronary Aneurysms after Kawasaki Disease Joowon Lee, MD, Gi Beom Kim, MD, Bo Sang Kwon, MD, Eun Jung Bae, MD, and Chung Il Noh, MD Department of Pediatrics, Seoul National University Children’s Hospital, Seoul, Korea Acute giant coronary aneurysm after Kawasaki disease (KD) is a catastrophic complication that can be fatal and very difficult to manage.",Non-OADS,/arxiv_data1/oa_pdf/71/95/kcj-44-54.PMC3905118.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Cases Case 1 A 31-month-old girl presenting with a fever was admitted to a  nearby hospital.",Non-OADS,/arxiv_data1/oa_pdf/71/95/kcj-44-54.PMC3905118.pdf
http://dx.doi.org/10.4070/kcj.2014.44.1.54 www.e-kcj.org at a high risk of aneurysmal rupture or myocardial infarction.,Non-OADS,/arxiv_data1/oa_pdf/71/95/kcj-44-54.PMC3905118.pdf
56 Giant Coronary Aneurysm after Kawasaki Disease http://dx.doi.org/10.4070/kcj.2014.44.1.54 www.e-kcj.org fever.,Non-OADS,/arxiv_data1/oa_pdf/71/95/kcj-44-54.PMC3905118.pdf
"http://dx.doi.org/10.4070/kcj.2014.44.1.54 www.e-kcj.org 109 beats/min; respiratory rate, 24 breaths/min; temperature, 36.7°C.",OADS,/arxiv_data1/oa_pdf/71/95/kcj-44-54.PMC3905118.pdf
58 Giant Coronary Aneurysm after Kawasaki Disease http://dx.doi.org/10.4070/kcj.2014.44.1.54 www.e-kcj.org manage 2 cases of super-giant CAA in the acute phase through sta - bilizing the hemodynamic status and maintaining anticoagulation.,Non-OADS,/arxiv_data1/oa_pdf/71/95/kcj-44-54.PMC3905118.pdf
"The structures of these compounds wereMini-review Mycobiology 2013 December, 41(4): 171-176 http://dx.doi.org/10.5941/MYCO.2013.41.4.171 pISSN 1229-8093  eISSN 2092-9323 © The Korean Society of Mycology *Corresponding author E-mail: bsyun@jbnu.ac.kr †These authors contributed equally to this paper.",Non-OADS,/arxiv_data1/oa_pdf/e3/f6/mb-41-171.PMC3905119.pdf
"The species of Arthonia excipienda , A. radiata , Arthothelium ruanum , Enterographa leucolyta , Fissurina elaiocarpa , Rinodina oleae , and Thelotrema porinaceum  have been recorded from the north-east and southern regions of South Korea and are described here as new records for the country.çs çsResearch Article Mycobiology 2013 December, 41(4): 177-182 http://dx.doi.org/10.5941/MYCO.2013.41.4.177 pISSN 1229-8093  eISSN 2092-9323 © The Korean Society of Mycology *Corresponding author E-mail: jshur1@sunchon.ac.kr Received  May 20, 2013 Revised  July 26, 2013 Accepted  October 11, 2013 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/) which permits unrestrictednon-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/82/a6/mb-41-177.PMC3905120.pdf
"Quél., characterized by a pileus that is usually distinctly colored, a margin that is notappendiculate and does not exceed the gill margin, and abasal bulb that is usually small (studies in the Amanitaceae:http://www.amanitaceae.org/) [8, 9].",Non-OADS,/arxiv_data1/oa_pdf/08/bd/mb-41-183.PMC3905121.pdf
"Therefore, the application ofResearch Article Mycobiology 2013 December, 41(4): 183-190 http://dx.doi.org/10.5941/MYCO.2013.41.4.183 pISSN 1229-8093  eISSN 2092-9323© The Korean Society of Mycology *Corresponding author E-mail: hansk75@forest.go.kr (S.-K. Han)       sung97330@gmail.com (G.-H.",Non-OADS,/arxiv_data1/oa_pdf/08/bd/mb-41-183.PMC3905121.pdf
"Amanita citrina  possesses a fleshy pale yellow to white basidiocarp, a 3~12 cm pileus, a large volva at the base of the 6~8 cm tall stem, and a smell ofrapeseed or potato (studies in the Amanitaceae: http://www.amanitaceae.org/) [25].",Non-OADS,/arxiv_data1/oa_pdf/08/bd/mb-41-183.PMC3905121.pdf
This species consists of severalvarieties and formae (three varieties and five formae arerecorded in Index Fungorum: http://www.indexfungorum.org/Names/Names.asp).,Non-OADS,/arxiv_data1/oa_pdf/08/bd/mb-41-183.PMC3905121.pdf
"pileus, a nonstriate and nonappendiculate margin, which is covered with a volva at the pileus, which is white topale gray and striate above the annulus, with broadlyellipsoid to ellipsoid and amyloid spores, and no clamps atthe bases of basidia (studies in the Amanitaceae: http://www.amanitaceae.org/) [9].",Non-OADS,/arxiv_data1/oa_pdf/08/bd/mb-41-183.PMC3905121.pdf
"Amanita flavipes  is characterized by a olive to yellow pileus and is paler toward the margin, decorated with yellowfloccose to patch-like volval remnants, and has basidiosporesmeasuring 7~8 × 5.5~8 µm in size, with Q = 1.06~1.47 (studies in the Amanitaceae: http://www.amanitaceae.org/)[25].",Non-OADS,/arxiv_data1/oa_pdf/08/bd/mb-41-183.PMC3905121.pdf
"Atk., however, they have different distributions: A. flavipes  is distributed in Asia, while A. flavoconia  is one of the most common and widespread species found in eastern North America(studies in the Amanitaceae: http://www.amanitaceae.org/).Our two specimens (KA12-0685 and KA12-1517) weregrouped with Chinese A. flavipes  HKAS:32505, A. flavoconia RV5Aug96, and A. flavorubescens  R V96/102 (R V : collections of Moncalvo et al .",Non-OADS,/arxiv_data1/oa_pdf/08/bd/mb-41-183.PMC3905121.pdf
"They are characterized by a brownishpileus, flesh that is slowly stained a dingy reddish colorwhen bruised or cut, adnate to narrowly adnate gills,usually absent volval remnants, and smooth, elliptical, andamyloid spores, and were phylogenetically matched withthe sequences deposited in GenBank (studies in theAmanitaceae: http://www.amanitaceae.org/) (Figs.",Non-OADS,/arxiv_data1/oa_pdf/08/bd/mb-41-183.PMC3905121.pdf
"However, they can be distinguishedbased on the size of spores, the morphologies of thebasidia and basidiomata, and the fact that A. subjunquillea are normally smaller than A. phalloides (studies in the Amanitaceae: http://www.amanitaceae.org/) [8, 9].",Non-OADS,/arxiv_data1/oa_pdf/08/bd/mb-41-183.PMC3905121.pdf
"Amidella and has worldwide distribution (studies in the Amanitaceae: http://www.amanitaceae.org/)[8, 9].",Non-OADS,/arxiv_data1/oa_pdf/08/bd/mb-41-183.PMC3905121.pdf
"Morphologically this species is similar to species suchas A. avellaneosquamosa  (S. Imai) S. Imai, A. clarisquamosa (S. Imai) S. Imai, and A. duplex  Corner & Bas (studies in the Amanitaceae: http://www.amanitaceae.org/).",Non-OADS,/arxiv_data1/oa_pdf/08/bd/mb-41-183.PMC3905121.pdf
"The LSU marker is normally moreco n serv ed a nd ea sier to align tha n ITS, while RPB2 is alsohighly conserved among eukaryotes and has proven to beuseful for systematics and identification of fungal species [11].Research Article Mycobiology 2013 December, 41(4): 191-201 http://dx.doi.org/10.5941/MYCO.2013.41.4.191 pISSN 1229-8093  eISSN 2092-9323 © The Korean Society of Mycology *Corresponding author E-mail: ywlim@snu.ac.kr Received  October 20, 2013 Revised  November 12, 2013 Accepted  November 14, 2013 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/) which permits unrestrictednon-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c4/e6/mb-41-191.PMC3905122.pdf
"1 and 2); dried specimenswere deposited in the Herbarium Conservation Center of the National Academy of Agricultural Sciences (HCCN)or Seoul National University Fungus Collection (SFC).These specimens were identified using field guides [14],a photographic illustration website (http://www.mtsn.tn.it/russulales-news/), and a light microscope (Nikon 80i; Nikon,Tokyo, Japan).",Non-OADS,/arxiv_data1/oa_pdf/c4/e6/mb-41-191.PMC3905122.pdf
Available from: http://tree.bio.ed.ac.uk/ software/tracer/.2009.,OADS,/arxiv_data1/oa_pdf/c4/e6/mb-41-191.PMC3905122.pdf
"There are three main vegetation types:evergreen broadleaved forest (up to 600 m), deciduousbroadleaved forest (600~1,400 m), and coniferous forest(1,400~1,950 m) with scattered scrubs and grasslands [8-10].Research Article Mycobiology 2013 December, 41(4): 202-209 http://dx.doi.org/10.5941/MYCO.2013.41.4.202 pISSN 1229-8093  eISSN 2092-9323© The Korean Society of Mycology *Corresponding author E-mail: jshur1@sunchon.ac.kr †These authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/72/33/mb-41-202.PMC3905123.pdf
Available from: http://en.wikipedia.org/wiki/ gotjawal_Forests.,Non-OADS,/arxiv_data1/oa_pdf/72/33/mb-41-202.PMC3905123.pdf
"Thus, theobjectives of this study were to evaluate the applicability ofFWC as a substrate for cultivation of mushrooms, toestimate the FWC content at which mushroom productionis greatest, and to determine the mineral element contentsResearch Article Mycobiology 2013 December, 41(4): 210-213 http://dx.doi.org/10.5941/MYCO.2013.41.4.210 pISSN 1229-8093  eISSN 2092-9323 © The Korean Society of Mycology *Corresponding author E-mail: johnghwa@kangwon.ac.kr Received  July 5, 2013 Revised  September 12, 2013 Accepted  September 16, 2013 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/) which permits unrestrictednon-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0f/77/mb-41-210.PMC3905124.pdf
"These soluble compounds are then absorbed byfungal hyphae through a process called nutritive absorption.Three major groups of enzymes involved in breaking downResearch Article Mycobiology 2013 December, 41(4): 214-220 http://dx.doi.org/10.5941/MYCO.2013.41.4.214 pISSN 1229-8093  eISSN 2092-9323 © The Korean Society of Mycology *Corresponding author E-mail: kanghw2@hknu.ac.kr Received  August 23, 2013 Revised  October 10, 2013 Accepted  October 14, 2013 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/) which permits unrestrictednon-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b9/45/mb-41-214.PMC3905125.pdf
"Because both spores and compoundsare killing factors, whole fungal cultures that include sporesResearch Article Mycobiology 2013 December, 41(4): 221-224 http://dx.doi.org/10.5941/MYCO.2013.41.4.221 pISSN 1229-8093  eISSN 2092-9323 © The Korean Society of Mycology *Corresponding author E-mail: jjkim66@korea.kr Received  November 5, 2013 Revised  November 18, 2013 Accepted  November 22, 2013 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/) which permits unrestrictednon-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e3/48/mb-41-221.PMC3905126.pdf
"A  r e c e n t  s t u d y  a l s oResearch Article Mycobiology 2013 December, 41(4): 225-233 http://dx.doi.org/10.5941/MYCO.2013.41.4.225 pISSN 1229-8093  eISSN 2092-9323 © The Korean Society of Mycology *Corresponding author E-mail: hosun83@korea.kr Received  August 26, 2013 Revised  October 1, 2013 Accepted  October 10, 2013 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/) which permits unrestrictednon-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f6/f1/mb-41-225.PMC3905127.pdf
Sequenceswere then compared with other sequences found inNCBI database (http://blast.ncbi.nih.gov) and Fusarium-ID(http://isolate.fusariumdb.org) [15] using Clustal W with agap opening penalty of 3.0 and a gap extension penalty of 1.8.The neighbor-joining (NJ) method was used for phylogenetic,OADS,/arxiv_data1/oa_pdf/f6/f1/mb-41-225.PMC3905127.pdf
Available from: http://www.R-project.org/.,Non-OADS,/arxiv_data1/oa_pdf/f6/f1/mb-41-225.PMC3905127.pdf
"[5] of Heriot-WattResearch Article Mycobiology 2013 December, 41(4): 234-242 http://dx.doi.org/10.5941/MYCO.2013.41.4.234 pISSN 1229-8093  eISSN 2092-9323 © The Korean Society of Mycology *Corresponding author E-mail: shunyu@cnu.ac.kr Received  August 13, 2013 Revised  October 21, 2013 Accepted  October 28, 2013 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/) which permits unrestrictednon-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f2/fb/mb-41-234.PMC3905128.pdf
"Upper cortex (22~) 25~37.5 (~50) µm thick, hyaline, euparaplectenchymatous.Research Note Mycobiology 2013 December, 41(4): 243-244 http://dx.doi.org/10.5941/MYCO.2013.41.4.243 pISSN 1229-8093  eISSN 2092-9323 © The Korean Society of Mycology *Corresponding author E-mail: jshur1@sunchon.ac.kr Received  June 24, 2013 Revised  August 26, 2013 Accepted  September 3, 2013 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/) which permits unrestrictednon-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/45/3a/mb-41-243.PMC3905129.pdf
"Y eastgenomic DNA was prepared from cells of the four isolatesResearch Note Mycobiology 2013 December, 41(4): 245-247 http://dx.doi.org/10.5941/MYCO.2013.41.4.245pISSN 1229-8093  eISSN 2092-9323 © The Korean Society of Mycology *Corresponding author E-mail: piceae@naver.com Received  September 13, 2013 Accepted  October 14, 2013 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium,provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ac/ad/mb-41-245.PMC3905130.pdf
Thedetermined nucleotide sequences were searched throughBLASTN in the GenBank database (http://www.ncbi.nlm.gov/BLAST).,OADS,/arxiv_data1/oa_pdf/ac/ad/mb-41-245.PMC3905130.pdf
"Literature survey indicated thatonly molecular evidence of Australian G. cupreum wasResearch Note Mycobiology 2013 December, 41(4): 248-251 http://dx.doi.org/10.5941/MYCO.2013.41.4.248 pISSN 1229-8093  eISSN 2092-9323 © The Korean Society of Mycology *Corresponding author E-mail: malar.kaliyaperumal@gmail.com Received  August 23, 2013 Revised  October 1, 2013 Accepted  November 1, 2013 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/) which permits unrestrictednon-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f0/a1/mb-41-248.PMC3905131.pdf
"Detection of the infected fungi wasResearch Note Mycobiology 2013 December, 41(4): 252-255 http://dx.doi.org/10.5941/MYCO.2013.41.4.252 pISSN 1229-8093  eISSN 2092-9323 © The Korean Society of Mycology *Corresponding author E-mail: rohyeon@gnu.ac.kr Received  September 16, 2013 Revised  November 1, 2013 Accepted  November 17, 2013 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/) which permits unrestrictednon-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/17/bf/mb-41-252.PMC3905132.pdf
"To confirm the morphological results, molecularResearch Note Mycobiology 2013 December, 41(4): 256-259 http://dx.doi.org/10.5941/MYCO.2013.41.4.256 pISSN 1229-8093  eISSN 2092-9323 © The Korean Society of Mycology *Corresponding author E-mail: Lfah@usm.my Received  September 26, 2013 Revised  November 22, 2013 Accepted  December 9, 2013 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/) which permits unrestrictednon-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/87/5d/mb-41-256.PMC3905133.pdf
"Adler LA, Kessler RC, Spencer T. Adult ADHD Self- Report Scale-v1.1 (ASRS-v1.1) Symptom Checklist.New York, NY: World Health Organization; 2003.Available at: http://www.med.nyu.edu/Psych/ training/adhd.html .",Non-OADS,/arxiv_data1/oa_pdf/70/10/12325_2013_Article_85.PMC3905180.pdf
Available from http://dsm.psychiatryonline.,Non-OADS,/arxiv_data1/oa_pdf/70/10/12325_2013_Article_85.PMC3905180.pdf
http://dx.doi.org/10.1016/j.neuropsychologia.2013.09.039 nCorresponding author.,OADS,/arxiv_data1/oa_pdf/bd/2c/main.PMC3905186.pdf
Supplementary material Supplementary data associated with this article can be found in the online version at http://dx.doi.org/10.1016/j.neuropsychologia.,Non-OADS,/arxiv_data1/oa_pdf/bd/2c/main.PMC3905186.pdf
"Timing and Time Perception , http://dx.doi.org/10.1163/22134468-00002009 , in press.",Non-OADS,/arxiv_data1/oa_pdf/bd/2c/main.PMC3905186.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)Ketamine rises 5-HT1B through the AMPA receptor H Yamanaka et al 7 © 2014 Macmillan Publishers Limited Translational Psychiatry (2014), 1 –7",Non-OADS,/arxiv_data1/oa_pdf/ee/42/tp2013112a.PMC3905222.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Emotional contagion for pain is intact in autism spectrum disorders N Hadjikhani et al 9 © 2014 Macmillan Publishers Limited Translational Psychiatry (2014), 1 –9",Non-OADS,/arxiv_data1/oa_pdf/d7/34/tp2013113a.PMC3905223.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ZNF804A effects on auditory P300 response in SZ TO ’Donoghue et al 6 Translational Psychiatry (2014), 1 –6 © 2014 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/88/32/tp2013115a.PMC3905225.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)Compromised pain anticipation and modulation in MTBI IA Strigo et al 8 Translational Psychiatry (2014), 1 –8 © 2014 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/38/05/tp2013116a.PMC3905226.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)ZNF804A is associated with novel P300b amplitude EC del Re et al 9 © 2014 Macmillan Publishers Limited Translational Psychiatry (2014), 1 –9",Non-OADS,/arxiv_data1/oa_pdf/73/c1/tp2013117a.PMC3905227.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)Inﬂammation and glucocorticoid receptors in depression LA Carvalho et al 8 Translational Psychiatry (2014), 1 –8 © 2014 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/18/e8/tp2013118a.PMC3905228.pdf
"Clinical Practice Guidelines 2005, http://www.psychiatry.org/ practice/clinical-practice-guidelines.",Non-OADS,/arxiv_data1/oa_pdf/1c/1a/tp2013119a.PMC3905229.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Microglia in bipolar disorder CC Watkins et al 10 Translational Psychiatry (2014), 1 –10 © 2014 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/1c/1a/tp2013119a.PMC3905229.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)Sleep loss changes DNA methylation and hydroxymethylation R Massart et al 8 Translational Psychiatry (2014), 1 –8 © 2014 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/e7/43/tp2013120a.PMC3905230.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)Novel implications of Lingo-1 in schizophrenia F Fernandez-Enright et al 8 Translational Psychiatry (2014), 1 –8 © 2014 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/d8/ba/tp2013121a.PMC3905231.pdf
Brain mRNA expression was analyzed with the help of the web site http://braincloud.jhmi.edu using genotype information fromdbGaP (phs000417.v1.p1).,OADS,/arxiv_data1/oa_pdf/bb/05/tp2013122a.PMC3905232.pdf
We used publically available array-based gene expression data (http://braincloud.jhmi.edu 15) to test for a similar effect in brain tissue.,OADS,/arxiv_data1/oa_pdf/bb/05/tp2013122a.PMC3905232.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)The endomannosidase gene and anxiety disorder risk KP Jensen et al 6 Translational Psychiatry (2014), 1 –6 © 2014 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/bb/05/tp2013122a.PMC3905232.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)MeCP2 binding to GAD1 and RELN promoters in ASD A Zhubi et al 7 © 2014 Macmillan Publishers Limited Translational Psychiatry (2014), 1 –7",Non-OADS,/arxiv_data1/oa_pdf/ce/ec/tp2013123a.PMC3905233.pdf
14 US_Census_Bureau http://www.Census.Gov/hhes/families/data/cps2012.html.,OADS,/arxiv_data1/oa_pdf/18/25/tp2013128a.PMC3905235.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/Post-stroke social interaction hastens recovery VR Venna et al 9 © 2014 Macmillan Publishers Limited Translational Psychiatry (2014), 1 –9",Non-OADS,/arxiv_data1/oa_pdf/18/25/tp2013128a.PMC3905235.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)Fibrinogen as an antidepressant response marker D Martins-de-Souza et al 4 Translational Psychiatry (2014), 1 –4 © 2014 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/7a/47/tp2013129a.PMC3905236.pdf
All authors reviewed the manuscript.Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/02/64/srep03923.PMC3905266.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3923 | DOI: 10.1038/srep03923 6",Non-OADS,/arxiv_data1/oa_pdf/02/64/srep03923.PMC3905266.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3922 | DOI: 10.1038/srep03922 3",Non-OADS,/arxiv_data1/oa_pdf/ce/ca/srep03922.PMC3905267.pdf
All the authors discussed the results and commented on the manuscript.Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/23/16/srep03928.PMC3905268.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3928 | DOI: 10.1038/srep03928 6",Non-OADS,/arxiv_data1/oa_pdf/23/16/srep03928.PMC3905268.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/35/17/srep03917.PMC3905270.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3917 | DOI: 10.1038/srep03917 7",Non-OADS,/arxiv_data1/oa_pdf/35/17/srep03917.PMC3905270.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/88/18/srep03919.PMC3905272.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3919 | DOI: 10.1038/srep03919 7",Non-OADS,/arxiv_data1/oa_pdf/88/18/srep03919.PMC3905272.pdf
"Molecular evolutionary analysis .We performed a positive selection analysis with PSP 59, which is a web tool designed for calculating the selection pressure across multiply closely related genomes (http://db-mml.sjtu.edu.cn/PSP/or http://202.120.",OADS,/arxiv_data1/oa_pdf/86/75/srep03926.PMC3905273.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/86/75/srep03926.PMC3905273.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3926 | DOI: 10.1038/srep03926 10",Non-OADS,/arxiv_data1/oa_pdf/86/75/srep03926.PMC3905273.pdf
"Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: J.W.T., P. L. and Y.S.",Non-OADS,/arxiv_data1/oa_pdf/d7/5b/srep03918.PMC3905274.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3918 | DOI: 10.1038/srep03918 5",Non-OADS,/arxiv_data1/oa_pdf/d7/5b/srep03918.PMC3905274.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/7d/99/srep03896.PMC3905276.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3896 | DOI: 10.1038/srep03896 9",Non-OADS,/arxiv_data1/oa_pdf/7d/99/srep03896.PMC3905276.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3900 | DOI: 10.1038/srep03900 9",Non-OADS,/arxiv_data1/oa_pdf/6d/1c/srep03900.PMC3905277.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/73/82/srep03920.PMC3905278.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3920 | DOI: 10.1038/srep03920 8",Non-OADS,/arxiv_data1/oa_pdf/73/82/srep03920.PMC3905278.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/bd/62/srep03925.PMC3905279.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3925 | DOI: 10.1038/srep03925 10",Non-OADS,/arxiv_data1/oa_pdf/bd/62/srep03925.PMC3905279.pdf
"Available from: http://www.seercancergov/ csr/1975_2008/(based on November 2010 SEER data submission, posted  to the SEER web site).",OADS,/arxiv_data1/oa_pdf/15/0a/ABR-2-51.PMC3905340.pdf
Available from: http://www.nccn.org/ professionals/physician_gls/pdf/aml.pdf.,Non-OADS,/arxiv_data1/oa_pdf/15/0a/ABR-2-51.PMC3905340.pdf
Available from: http://www.al-islam.org/ nahjul/commentaries.htm.,Non-OADS,/arxiv_data1/oa_pdf/21/bc/ABR-2-53.PMC3905344.pdf
Available form: http://www.the-hadith- software.en.softonic.com.,Non-OADS,/arxiv_data1/oa_pdf/21/bc/ABR-2-53.PMC3905344.pdf
http://www.who.int/cancer/modules/en/ 2005 [cited 2013 November 12].,Non-OADS,/arxiv_data1/oa_pdf/35/b4/TONURSJ-8-1.PMC3905349.pdf
http://www.wma.net/en/30publicati ons/10policies/b3/1964 [cited 2013 12 November].,Non-OADS,/arxiv_data1/oa_pdf/35/b4/TONURSJ-8-1.PMC3905349.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/35/b4/TONURSJ-8-1.PMC3905349.pdf
"This is an open access article licensed under the te rms of the Creative Commons Attribution Non -Commercial License (http://creativecommons.org/ - licenses/by -nc/3.0/) which permits unrestricted, non -commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d0/21/TOBEJ-7-147.PMC3905350.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/90/5c/TONIJ-7-53.PMC3905351.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/71/13/TONIJ-7-41.PMC3905352.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f2/92/TONIJ-7-36.PMC3905355.pdf
"Data Analysis    For each session, functional images were motion - corrected and registered to a single functional reference  volume using the 3dvolre g tool of AFNI package (available  at http://afni.nimh.nih.gov/afni).",OADS,/arxiv_data1/oa_pdf/7f/a4/TONIJ-7-58.PMC3905356.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non -Commercial License  (http://creativecommons.org/licenses/by - nc/3.0/), which permits unrestricted, non -commercial use, distribution and reproduction in any mediu m, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7f/a4/TONIJ-7-58.PMC3905356.pdf
The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/ licenses/by-nc-sa/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/b6/a5/S1751731113002127a.PMC3905469.pdf
"Microarray hybridisation and data acquisition were carried out by ARK-Genomics (Roslin Institute,University of Edinburgh) using 23 K Affymetrix GeneChipPorcine Genome Arrays based on established ARK-Genomics protocols ( http://www.ark-genomi cs.org/protocols).",OADS,/arxiv_data1/oa_pdf/b6/a5/S1751731113002127a.PMC3905469.pdf
"Supplementary material To view supplementary material for this article, please visit http://dx.doi.org/10.1017/S1751731113002127 References Anderson N, Strader R and Davidson C 2003.",Non-OADS,/arxiv_data1/oa_pdf/b6/a5/S1751731113002127a.PMC3905469.pdf
The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/ licenses/by-nc-sa/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/a1/15/S1751731113002061a.PMC3905470.pdf
"Retrieved April 22, 2013, from http://snp.toulouse.inra.fr/~alegarra.",Non-OADS,/arxiv_data1/oa_pdf/a1/15/S1751731113002061a.PMC3905470.pdf
To view these ﬁles please visit the journal online(http://dx.doi.org/10.1136/jnnp- 2012-303379).,Non-OADS,/arxiv_data1/oa_pdf/5e/d4/jnnp-2012-303379.PMC3905626.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.Derex L ,Nighoghossian N. Intracerebral haemorrhage after thrombolysis for acute ischaemic stroke: an update.",Non-OADS,/arxiv_data1/oa_pdf/5e/d4/jnnp-2012-303379.PMC3905626.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ jnnp-2012-304434).,OADS,/arxiv_data1/oa_pdf/3b/1b/jnnp-2012-304434.PMC3905629.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Qureshi AI, Mendelow AD, Hanley DF.",Non-OADS,/arxiv_data1/oa_pdf/3b/1b/jnnp-2012-304434.PMC3905629.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/3.0/), which permits non-commercial reproduction and distribution of the work, in any medium,provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/93/a8/hct190.PMC3905632.pdf
"http://www.cdc.gov/genomics/ gtesting/ACCE/ (26 September 2013, date last accessed).",OADS,/arxiv_data1/oa_pdf/93/a8/hct190.PMC3905632.pdf
"http://www.egappreviews.org/ (26 September 2013, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/93/a8/hct190.PMC3905632.pdf
Preprint at http://arxiv.org/abs/cond-mat/0204437 (2002).,Non-OADS,/arxiv_data1/oa_pdf/a4/68/ncomms3981.PMC3905696.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/a4/68/ncomms3981.PMC3905696.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Stavrinadis, A. et al.",Non-OADS,/arxiv_data1/oa_pdf/a4/68/ncomms3981.PMC3905696.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3981 ARTICLE NATURE COMMUNICATIONS | 4:2981 | DOI: 10.1038/ncomms3981 | www.nature.com/naturecommunications 7 &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/a4/68/ncomms3981.PMC3905696.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/nature communications.,Non-OADS,/arxiv_data1/oa_pdf/16/35/ncomms3946.PMC3905697.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Ho¨vener, J.-B.",Non-OADS,/arxiv_data1/oa_pdf/16/35/ncomms3946.PMC3905697.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3946 ARTICLE NATURE COMMUNICATIONS | 4:2946 | DOI: 10.1038/ncomms3946 | www.nature.com/naturecommunications 5 &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/16/35/ncomms3946.PMC3905697.pdf
"These putatively private alleles werethen intersected with publically available low coverage Y-chromosome sequence data from the 1,000 Genomes Project (http://www.1000genomes.org/data).",OADS,/arxiv_data1/oa_pdf/7a/9d/ncomms3928.PMC3905698.pdf
Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: Peter A. Underhill and Alice A. Lin are partially sup- ported by a grant from Ancestry.com.,Non-OADS,/arxiv_data1/oa_pdf/7a/9d/ncomms3928.PMC3905698.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article : Rootsi, S. et al.",Non-OADS,/arxiv_data1/oa_pdf/7a/9d/ncomms3928.PMC3905698.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3928 ARTICLE NATURE COMMUNICATIONS | 4:2928 | DOI: 10.1038/ncomms3928 | www.nature.com/naturecommunications 9 &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/7a/9d/ncomms3928.PMC3905698.pdf
"Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: X.B.W., Y.B.",Non-OADS,/arxiv_data1/oa_pdf/51/6e/ncomms3905.PMC3905699.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Wang, X. et al.",Non-OADS,/arxiv_data1/oa_pdf/51/6e/ncomms3905.PMC3905699.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3905 8 NATURE COMMUNICATIONS | 4:2905 | DOI: 10.1038/ncomms3905 | www.nature.com/naturecommunications &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/51/6e/ncomms3905.PMC3905699.pdf
Supplementary Information accompanies this paper at http://www.nature.com/nature communications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/77/e5/ncomms3980.PMC3905700.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Villarroya-Beltri, C. et al.",Non-OADS,/arxiv_data1/oa_pdf/77/e5/ncomms3980.PMC3905700.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3980 10 NATURE COMMUNICATIONS | 4:2980 | DOI: 10.1038/ncomms3980 | www.nature.com/naturecommunications &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/77/e5/ncomms3980.PMC3905700.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/14/69/ncomms4160.PMC3905701.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Blanco-Redondo, A. et al.",Non-OADS,/arxiv_data1/oa_pdf/14/69/ncomms4160.PMC3905701.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms4160 8 NATURE COMMUNICATIONS | 5:3160 | DOI: 10.1038/ncomms4160 | www.nature.com/naturecommunications &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/14/69/ncomms4160.PMC3905701.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/nature communications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/f5/2a/ncomms4024.PMC3905702.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Biermann, B. et al.",Non-OADS,/arxiv_data1/oa_pdf/f5/2a/ncomms4024.PMC3905702.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms4024 10 NATURE COMMUNICATIONS | 5:3024 | DOI: 10.1038/ncomms4024 | www.nature.com/naturecommunications &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/f5/2a/ncomms4024.PMC3905702.pdf
SUPPLEMENTARY MATERIAL Supplementary material is linked to the online version of the paper  at http://www.nature.com/gim ACKNOWLEDGMENTS We thank all the Delphi study experts.,Non-OADS,/arxiv_data1/oa_pdf/e9/48/gim201115a.PMC3905703.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/df/a8/eut244.PMC3905705.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/21/fa/eut293.PMC3905706.pdf
"conceived the project, designed the experiments and wrote the paper.Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.",Non-OADS,/arxiv_data1/oa_pdf/6b/32/ncomms3989.PMC3905707.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Liu, L. et al.",Non-OADS,/arxiv_data1/oa_pdf/6b/32/ncomms3989.PMC3905707.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3989 8 NATURE COMMUNICATIONS | 4:2989 | DOI: 10.1038/ncomms3989 | www.nature.com/naturecommunications &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/6b/32/ncomms3989.PMC3905707.pdf
All the authors contributed towriting the manuscript.Additional information Supplementary Information accompanies this paper at http://www.nature.com/nature communications.,Non-OADS,/arxiv_data1/oa_pdf/d6/e9/ncomms3970.PMC3905708.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Krasnov, V. M. et al.",Non-OADS,/arxiv_data1/oa_pdf/d6/e9/ncomms3970.PMC3905708.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3970 ARTICLE NATURE COMMUNICATIONS | 4:2970 | DOI: 10.1038/ncomms3970 | www.nature.com/naturecommunications 7 &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/d6/e9/ncomms3970.PMC3905708.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/30/e0/jht022.PMC3905710.pdf
[cited 02/09/2013] Available at: http://www.ema.europa.eu/docs/  en_GB/document_library/Scientific_guideline/2009/09/WC500003 964.pdf   [13] Hill RA.,Non-OADS,/arxiv_data1/oa_pdf/58/5b/CGT-13-385.PMC3905712.pdf
"Avail- able at: http://www.who.int/csr/resources/ publications/biosafety/  en/Biosafety7.pdf   [15] Fallaux FJ, Bout A, van der Velde I, et al.",OADS,/arxiv_data1/oa_pdf/58/5b/CGT-13-385.PMC3905712.pdf
"[online] 2008 [cited 02/09/2013] Available at: http://rivm.nl/bibliotheek/ rappor- ten/601850001.pdf   [22] Dorer DE, Nettelbeck DM.",Non-OADS,/arxiv_data1/oa_pdf/58/5b/CGT-13-385.PMC3905712.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/76/b9/ncomms3948.PMC3905713.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Schreiber, R. et al.",Non-OADS,/arxiv_data1/oa_pdf/76/b9/ncomms3948.PMC3905713.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3948 6 NATURE COMMUNICATIONS | 4:2948 | DOI: 10.1038/ncomms3948 | www.nature.com/naturecommunications &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/76/b9/ncomms3948.PMC3905713.pdf
Preprint at http://arxiv.org/abs/ 1210.6803 (2012).,Non-OADS,/arxiv_data1/oa_pdf/6d/1c/ncomms3953.PMC3905714.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Kolarczik, M. et al.",Non-OADS,/arxiv_data1/oa_pdf/6d/1c/ncomms3953.PMC3905714.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3953 ARTICLE NATURE COMMUNICATIONS | 4:2953 | DOI: 10.1038/ncomms3953 | www.nature.com/naturecommunications 7 &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/6d/1c/ncomms3953.PMC3905714.pdf
Preprint at http://arxiv.org/abs/1302.6732 (2013).,Non-OADS,/arxiv_data1/oa_pdf/e2/f6/ncomms4013.PMC3905717.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/e2/f6/ncomms4013.PMC3905717.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/How to cite this article: Shi, X.-q.",Non-OADS,/arxiv_data1/oa_pdf/e2/f6/ncomms4013.PMC3905717.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms4013 ARTICLE NATURE COMMUNICATIONS | 4:3013 | DOI: 10.1038/ncomms4013 | www.nature.com/naturecommunications 9 &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/e2/f6/ncomms4013.PMC3905717.pdf
Patch-clamp data were analysed with WinASCD software written by Dr Guy Droogmans (ftp://ftp.cc.kuleuven.ac.be/pub/droogmans/winascd.zip) and Origin 7.0 (OriginLab Corporation).,OADS,/arxiv_data1/oa_pdf/d5/36/ncomms4125.PMC3905718.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/nature communications.,Non-OADS,/arxiv_data1/oa_pdf/d5/36/ncomms4125.PMC3905718.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Meseguer, V. et al.",Non-OADS,/arxiv_data1/oa_pdf/d5/36/ncomms4125.PMC3905718.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms4125 14 NATURE COMMUNICATIONS | 5:3125 | DOI: 10.1038/ncomms4125 | www.nature.com/naturecommunications &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/d5/36/ncomms4125.PMC3905718.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/87/95/ncomms3976.PMC3905719.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article : Serrano, I. et al.",Non-OADS,/arxiv_data1/oa_pdf/87/95/ncomms3976.PMC3905719.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3976 12 NATURE COMMUNICATIONS | 4:2976 | DOI: 10.1038/ncomms3976 | www.nature.com/naturecommunications &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/87/95/ncomms3976.PMC3905719.pdf
The Base for checking plagiarism is set and available on the website of the Min - istry of Education and Science of R. Macedonia (http://plagijati.mon.gov.mk/plagiarism) and contains infor - mation about the author and title of the paper and of the high-educa-tional institution where the author/ student is enrolled.,Non-OADS,/arxiv_data1/oa_pdf/84/b9/AIM-21-4-228.PMC3905721.pdf
Available at: http://www.lkm.org.mk/VoxMedici/77.pdf.,Non-OADS,/arxiv_data1/oa_pdf/84/b9/AIM-21-4-228.PMC3905721.pdf
"Avail - able from: http://www.icmje.org/ Ac - cessed: June 12, 2013.",Non-OADS,/arxiv_data1/oa_pdf/84/b9/AIM-21-4-228.PMC3905721.pdf
"Avail - able from: http://www.academia.edu/2764566/Publication_Ethics_in_Biomedical_Journals_from_ Countries_in_Central_and_East - ern_Europe Accessed: Aug 14,2013.",Non-OADS,/arxiv_data1/oa_pdf/84/b9/AIM-21-4-228.PMC3905721.pdf
"Available from:  http://ori.hhs.gov/images/ddblock/ ori_annual_report_2010.pdf Ac - cessed: Jul 18, 2013.",OADS,/arxiv_data1/oa_pdf/84/b9/AIM-21-4-228.PMC3905721.pdf
Достапно на: http://www.mon.gov.mk/images/pdf/Zakon%20za%20 nauchno-istrazuvachkata%20dejnost.,Non-OADS,/arxiv_data1/oa_pdf/84/b9/AIM-21-4-228.PMC3905721.pdf
"Avail - able from: http://www.bioline.org.br/request?dv08146 Accessed: Jul  18,2013.",Non-OADS,/arxiv_data1/oa_pdf/84/b9/AIM-21-4-228.PMC3905721.pdf
"Available from:  http://www.plosone.org/article/ info%3Adoi%2F10.1371%2Fjournal.pone.0044118 Accessed: Jul 19, 2013.",Non-OADS,/arxiv_data1/oa_pdf/84/b9/AIM-21-4-228.PMC3905721.pdf
"Available from:  http://content.karger.com/produk - tedb/produkte.asp?typ=pdf&file= ORE2004036001001 Accessed: Jul  24, 2013.",Non-OADS,/arxiv_data1/oa_pdf/84/b9/AIM-21-4-228.PMC3905721.pdf
"Available  from: http://www.ncbi.nlm.nih.gov/ pubmed/16893357 Accessed: Jul 19, 2013.",OADS,/arxiv_data1/oa_pdf/84/b9/AIM-21-4-228.PMC3905721.pdf
co-wrotethe manuscript.Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/0f/c7/ncomms4092.PMC3905722.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Liu, B. et al.",Non-OADS,/arxiv_data1/oa_pdf/0f/c7/ncomms4092.PMC3905722.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms4092 8 NATURE COMMUNICATIONS | 5:3092 | DOI: 10.1038/ncomms4092 | www.nature.com/naturecommunications &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/0f/c7/ncomms4092.PMC3905722.pdf
Data from SNP array hybridization on the SNP6.0 platform have been deposited in EGA under the accession code EGAD00010000395.Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests : The authors declare no competing ﬁnancial interests.,OADS,/arxiv_data1/oa_pdf/b3/1a/ncomms3997.PMC3905727.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article : Bolli, N. et al.",Non-OADS,/arxiv_data1/oa_pdf/b3/1a/ncomms3997.PMC3905727.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3997 ARTICLE NATURE COMMUNICATIONS | 5:2997 | DOI: 10.1038/ncomms3997 | www.nature.com/naturecommunications 13 &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/b3/1a/ncomms3997.PMC3905727.pdf
"Supplementary Data S2 displays a systematic evaluation of effects in our discovery cohort for SNPs achieving genome-wide signiﬁcance in prior large-scale ( N410,000 in discovery þreplication cohorts) GWAS studies for schizophrenia or bipolar disorder (obtained from the NHGRI GWAS catalogue (http://www.genome.gov/gwastudies/, downloaded 10 January 2013).",OADS,/arxiv_data1/oa_pdf/b4/59/ncomms3739.PMC3905728.pdf
"Methods Discovery cohort description .Case ( n¼1,156) and control ( n¼2,279) samples were selected from an Ashkenazi Jewish repository (Hebrew University Genetic Resource, HUGR, http://hugr.huji.ac.il).",Non-OADS,/arxiv_data1/oa_pdf/b4/59/ncomms3739.PMC3905728.pdf
"For the analysis of differential expression across groups, analysis of covariance analysis including six factors (age, PMI, brain_pH, Affection status, sex and antipsychotics) was performed in SPSS16.0 software (http://www.spss.com).",OADS,/arxiv_data1/oa_pdf/b4/59/ncomms3739.PMC3905728.pdf
A full list of the investigators who contributed to the generation of these data sets is available from www.wtccc.org.uk as well as the followingstudies within dbGAP (http://www.ncbi.nlm.nih.gov/projects/gap):NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3739 ARTICLE NATURE COMMUNICATIONS | 4:2739 | DOI: 10.1038/ncomms3739 | www.nature.com/naturecommunications 9 &2013 Macmillan Publishers Limited.,Non-OADS,/arxiv_data1/oa_pdf/b4/59/ncomms3739.PMC3905728.pdf
All the authors con- tributed to the current version of the paper.Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/b4/59/ncomms3739.PMC3905728.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Lencz, T. et al.",Non-OADS,/arxiv_data1/oa_pdf/b4/59/ncomms3739.PMC3905728.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3739 10 NATURE COMMUNICATIONS | 4:2739 | DOI: 10.1038/ncomms3739 | www.nature.com/naturecommunications &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/b4/59/ncomms3739.PMC3905728.pdf
Phylogenetic analysis and sequence alignments were carried out using ClustalW provided by the DNA Data Bank of Japan (DDBJ; http://clustalw.ddbj.nig.ac.jp/index.php?lang=ja)50.,OADS,/arxiv_data1/oa_pdf/92/56/ncomms3792.PMC3905729.pdf
"The rice 44 K microarray (Agilent Technologies, Santa Clara, CA) used contains 43,144 unique 60-mer oligonucleotides synthesized based on sequence data from the Rice Full-length cDNA Project (http://cdna01.dna.affrc.go.jp/cDNA/ ).",OADS,/arxiv_data1/oa_pdf/92/56/ncomms3792.PMC3905729.pdf
Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/92/56/ncomms3792.PMC3905729.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Kobayashi, T. et al.",Non-OADS,/arxiv_data1/oa_pdf/92/56/ncomms3792.PMC3905729.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3792 12 NATURE COMMUNICATIONS | 4:2792 | DOI: 10.1038/ncomms3792 | www.nature.com/naturecommunications &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/92/56/ncomms3792.PMC3905729.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/da/eb/ncomms4109.PMC3905730.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Kuo, P. S. et al.",Non-OADS,/arxiv_data1/oa_pdf/da/eb/ncomms4109.PMC3905730.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms4109 ARTICLE NATURE COMMUNICATIONS | 5:3109 | DOI: 10.1038/ncomms4109 | www.nature.com/naturecommunications 7 &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/da/eb/ncomms4109.PMC3905730.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/02/8f/ncomms3917.PMC3905737.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Acun˜a, A.I.",Non-OADS,/arxiv_data1/oa_pdf/02/8f/ncomms3917.PMC3905737.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3917 ARTICLE NATURE COMMUNICATIONS | 4:2917 | DOI: 10.1038/ncomms3917 | www.nature.com/naturecommunications 13 &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/02/8f/ncomms3917.PMC3905737.pdf
"This is an Open Access article distributed underthe terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence(http://creativecommons.org/licenses/by-nc-nd/3.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work properly cited.",Non-OADS,/arxiv_data1/oa_pdf/49/72/cit763.PMC3905757.pdf
"DNA sequences were assembled with ChromasPro (Technelysium Pty Ltd, Tewantin, Australia), aligned with ClustalX ( http://www.clustal.",OADS,/arxiv_data1/oa_pdf/49/72/cit763.PMC3905757.pdf
Genotypes and GII.4 variants were identi ﬁed using NoroNet ( http://www.noronet.nl )[19].,Non-OADS,/arxiv_data1/oa_pdf/49/72/cit763.PMC3905757.pdf
Available at: https://research.tufts-nemc.org/ cear4/SearchingtheCEARegistry/SearchtheCEA Registry.aspx .,OADS,/arxiv_data1/oa_pdf/59/69/cit773.PMC3905758.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/3.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work properly cited.",Non-OADS,/arxiv_data1/oa_pdf/59/69/cit773.PMC3905758.pdf
Organ and tissue isolation and analysis.Histopathological assessments of two male and two female 6-week-old mice and clinical haematological analysis of one male and one female mouse were performed via the Australian Phenomics Net- work (http://www.australianphenomics.org.au/).,Non-OADS,/arxiv_data1/oa_pdf/9f/17/ncomms4164.PMC3905777.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/9f/17/ncomms4164.PMC3905777.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Teoh, S. S. Y. et al.",Non-OADS,/arxiv_data1/oa_pdf/9f/17/ncomms4164.PMC3905777.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms4164 ARTICLE NATURE COMMUNICATIONS | 5:3164 | DOI: 10.1038/ncomms4164 | www.nature.com/naturecommunications 9 &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/9f/17/ncomms4164.PMC3905777.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d9/f4/gkt823.PMC3905841.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5f/e0/gkt770.PMC3905846.pdf
"Manual segmentation of nu-cleus, nucleolus and dense ﬁbrillar component and meas- urement of their size were performed using ImageJ on 20 nuclei for each background (http://rsb.info.nih.gov/ij/).",OADS,/arxiv_data1/oa_pdf/5f/e0/gkt770.PMC3905846.pdf
"Exposure time was 200 ms. Confocal images were processed and analyzed with a Matlab script nucloc, available at http://www.nucloc.",OADS,/arxiv_data1/oa_pdf/5f/e0/gkt770.PMC3905846.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/14/c4/gkt832.PMC3905847.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/69/82/gkt774.PMC3905854.pdf
"The boundaries separatingthe domains are derived from functional analyses [reviewed in (2)], comparative amino acid sequence alignment of DnaA homologues (http://www.molgen.mpg.de/ /C24messer/) and from a homology model based on the X-ray crystal structure of domain 3 and 4 of Aquifex aeolicus DnaA (4).Nucleic Acids Research, 2013, Vol.",OADS,/arxiv_data1/oa_pdf/69/82/gkt774.PMC3905854.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fa/4e/gkt813.PMC3905856.pdf
ThemetaRNAmodules pipeline source for the internal loop modules is available at http://rth.dk/re sources/mrm.,OADS,/arxiv_data1/oa_pdf/f7/1e/gkt795.PMC3905863.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f7/1e/gkt795.PMC3905863.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d9/e0/gkt809.PMC3905865.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1b/57/gkt787.PMC3905868.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/af/da/gkt748.PMC3905869.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/83/5f/gkt801.PMC3905871.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b0/05/gkt814.PMC3905880.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ae/cf/gkt792.PMC3905882.pdf
(A) Secondary structures of the 16mer DLS derivatives (upper row) and the 27mer SL2 derivatives (lower row) were predicted with the Unafold Web Server program (http://mfold.rna.albany.edu/).,OADS,/arxiv_data1/oa_pdf/ae/cf/gkt792.PMC3905882.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3d/d2/gkt778.PMC3905886.pdf
The RNA-Seq data have been submitted to theSRA database (http://www.ncbi.nlm.nih.gov/sra) with identiﬁer PRJNA186590.,OADS,/arxiv_data1/oa_pdf/3d/d2/gkt778.PMC3905886.pdf
ACCESSION NUMBERS The RNA-Seq data have been submitted to the SRA database (http://www.ncbi.nlm.nih.gov/sra) with identiﬁerPRJNA186590.,OADS,/arxiv_data1/oa_pdf/3d/d2/gkt778.PMC3905886.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/53/35/gkt825.PMC3905887.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3c/f4/gkt820.PMC3905891.pdf
"Western blotting and antibodies Protein sample preparation , SDS–PAGE analysis and im- munoblotting and antibodies we re previously de scribed (16).Quantiﬁcation of protein levels was performed using ImageJ software (http://rsbweb.nih.gov/ij).",OADS,/arxiv_data1/oa_pdf/3c/f4/gkt820.PMC3905891.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/eb/cd/gkt819.PMC3905892.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/65/2f/gkt773.PMC3905896.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fe/25/gkt818.PMC3905897.pdf
"MATERIALS AND METHODS The model construction, graphs and statistical ana- lyses were done in R (http://www.r-project.org) andNucleic Acids Research, 2013, Vol.",OADS,/arxiv_data1/oa_pdf/fe/25/gkt818.PMC3905897.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/18/bf/gkt1070.PMC3905898.pdf
"EMIRGE comparison We used the EMIRGE amplicon software package for single-end reads (emirge_amplicon.py, emirge_rena- me_fasta.py) following the guidelines speciﬁed at theEMIRGE Web site (https://github.com/csmiller/EMIRGE).",OADS,/arxiv_data1/oa_pdf/18/bf/gkt1070.PMC3905898.pdf
Roche 454 data forDrosophila and saliva experiments can be downloaded from the MG-RAST Web site at http://metagenomics.anl.gov/linkin.cgi?project=4932.,OADS,/arxiv_data1/oa_pdf/18/bf/gkt1070.PMC3905898.pdf
Illumina data for Drosophila and saliva experi- ments can be downloaded from the MG-RAST Web sitehttp://metagenomics.anl.gov/linkin.cgi?project=5237.,OADS,/arxiv_data1/oa_pdf/18/bf/gkt1070.PMC3905898.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ce/e3/gkt796.PMC3905900.pdf
"For any reuse or distribution, you must make clear to others the license terms of this work, which can be found at http://creativecommons.org/licenses/by-nc-nd/3.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/6b/81/ima-4-2-161.PMC3905934.pdf
"This soil sample (LM28) formed part of  the Conservation and Sustainable Management of Below Ground Biodiversity project (CSM-BGBD) of the Los Tuxtlas Biosphere Reserve (http://www3.inecol.edu.mx/csmbgbd/ index.php/el-proyecto-bgbd-en-mexico ), and is also part of a  larger sampling programme of the Lopez-Mateos community  at Los Tuxtlas (Varela et al.",Non-OADS,/arxiv_data1/oa_pdf/6b/81/ima-4-2-161.PMC3905934.pdf
The sequences were queried  in a BLASTN search in the NCBI database (http://www.ncbi.,OADS,/arxiv_data1/oa_pdf/6b/81/ima-4-2-161.PMC3905934.pdf
"A similar phenomenon has been reported  at several sites (INVAM website: http://invam.caf.wvu.edu/),  in which AMF are not expressed in trap cultures at the  beginning of subculturing, and sometimes require up to two or  three subcultures to sporulate.",Non-OADS,/arxiv_data1/oa_pdf/6b/81/ima-4-2-161.PMC3905934.pdf
"For any reuse or distribution, you must make clear to others the license terms of this work, which can be found at http://creativecommons.org/licenses/by-nc-nd/3.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/79/5b/ima-4-2-169.PMC3905935.pdf
"For any reuse or distribution, you must make clear to others the license terms of this work, which can be found at http://creativecommons.org/licenses/by-nc-nd/3.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/f6/2b/ima-4-2-177.PMC3905936.pdf
Alignment was performed  using CLUSTAL W (http://www.ebi.ac.uk/clustalw/) and tree  construction with MEGA v.5 software (Tamura et al.,OADS,/arxiv_data1/oa_pdf/f6/2b/ima-4-2-177.PMC3905936.pdf
"For any reuse or distribution, you must make clear to others the license terms of this work, which can be found at http://creativecommons.org/licenses/by-nc-nd/3.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/6f/79/ima-4-2-187.PMC3905937.pdf
"1995, http://nt.ars-grin.",Non-OADS,/arxiv_data1/oa_pdf/6f/79/ima-4-2-187.PMC3905937.pdf
A basic alignment of the obtained sequence data was first done using  MAFFT v. 7 [(http://mafft.cbrc.jp/alignment /server/index.,OADS,/arxiv_data1/oa_pdf/6f/79/ima-4-2-187.PMC3905937.pdf
"Approximately 85 % of the world’s pistachio production presently comes  from Iran, the USA, and Turkey (http://faostat.fao.org/ site/339/default.aspx).",Non-OADS,/arxiv_data1/oa_pdf/6f/79/ima-4-2-187.PMC3905937.pdf
"For any reuse or distribution, you must make clear to others the license terms of this work, which can be found at http://creativecommons.org/licenses/by-nc-nd/3.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/65/64/ima-4-2-201.PMC3905938.pdf
The USDA  Fungal Database (http://nt.ars-grin.gov/fungaldatabases/)  listed 29 geographical records of 12 fungal taxa in association with this host.,OADS,/arxiv_data1/oa_pdf/65/64/ima-4-2-201.PMC3905938.pdf
"For any reuse or distribution, you must make clear to others the license terms of this work, which can be found at http://creativecommons.org/licenses/by-nc-nd/3.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/ad/a2/ima-4-2-205.PMC3905939.pdf
"For any reuse or distribution, you must make clear to others the license terms of this work, which can be found at http://creativecommons.org/licenses/by-nc-nd/3.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/6d/e9/ima-4-2-213.PMC3905940.pdf
"Version 2.75. http://mesquiteproject.org Mathur PN, Thirumalachar MJ (1960) A new Emericellopsis  species  with Stilbella -type of conidia.",Non-OADS,/arxiv_data1/oa_pdf/6d/e9/ima-4-2-213.PMC3905940.pdf
"Computer program  and documentation distributed by the authors: http://beast.bio.ed.ac.uk/Tracer Rossman AY, McKemy JM, Pardo-Schultheiss RA, Schroers HJ  (2001) Molecular studies of the Bionectriaceae  using large  subunit rDNA sequences.",OADS,/arxiv_data1/oa_pdf/6d/e9/ima-4-2-213.PMC3905940.pdf
"For any reuse or distribution, you must make clear to others the license terms of this work, which can be found at http://creativecommons.org/licenses/by-nc-nd/3.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/c5/58/ima-4-2-229.PMC3905941.pdf
Available from http://www.geneious.com.,Non-OADS,/arxiv_data1/oa_pdf/c5/58/ima-4-2-229.PMC3905941.pdf
"For any reuse or distribution, you must make clear to others the license terms of this work, which can be found at http://creativecommons.org/licenses/by-nc-nd/3.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/36/d7/ima-4-2-243.PMC3905942.pdf
"For any reuse or distribution, you must make clear to others the license terms of this work, which can be found at http://creativecommons.org/licenses/by-nc-nd/3.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/55/8a/ima-4-2-251.PMC3905943.pdf
"For any reuse or distribution, you must make clear to others the license terms of this work, which can be found at http://creativecommons.org/licenses/by-nc-nd/3.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/66/14/ima-4-2-259.PMC3905944.pdf
"The database, available at http://aftol.umn.edu, includes new and previously published subcellular data on Fungi, supplemented with images and literature links.",OADS,/arxiv_data1/oa_pdf/66/14/ima-4-2-259.PMC3905944.pdf
FSO in OBO-Edit format is hosted at: https://aftol.umn.edu/ontology .,Non-OADS,/arxiv_data1/oa_pdf/66/14/ima-4-2-259.PMC3905944.pdf
: The SBD is a phyloinformatics tool that includes published as well as new data on subcellular and biochemical characters (https://aftol.umn.edu) supplemented with images and literature links (Fig.,OADS,/arxiv_data1/oa_pdf/66/14/ima-4-2-259.PMC3905944.pdf
These lists can be downloaded from the  database as PDFs (https://aftol.umn.edu/glossary).,Non-OADS,/arxiv_data1/oa_pdf/66/14/ima-4-2-259.PMC3905944.pdf
"The Fungal Subcellular Ontology (FSO), also developed  as part of the AFTOL2 project (https://aftol.umn.edu/ontology), uses controlled vocabularies to describe subcellular  structures unique to fungi (Kumar et al.",OADS,/arxiv_data1/oa_pdf/66/14/ima-4-2-259.PMC3905944.pdf
"If the students have experience  using phylogenetics software, they  can download Mesquite software (http://mesquiteproject.org/mesquite/mesquite.html) to analyze comparative data about fungi on a phylogenetic tree.",Non-OADS,/arxiv_data1/oa_pdf/66/14/ima-4-2-259.PMC3905944.pdf
"For any reuse or distribution, you must make clear to others the license terms of this work, which can be found at http://creativecommons.org/licenses/by-nc-nd/3.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/1c/f1/ima-4-2-265.PMC3905945.pdf
"Taxonomy and nomenclature of plant families, genera and species are based  on the “Angiosperm Phylogeny Website” (http://www.mobot.",OADS,/arxiv_data1/oa_pdf/1c/f1/ima-4-2-265.PMC3905945.pdf
"Tropicos.org/), and The Plant List (http://www.theplantlist.org).",Non-OADS,/arxiv_data1/oa_pdf/1c/f1/ima-4-2-265.PMC3905945.pdf
"For any reuse or distribution, you must make clear to others the license terms of this work, which can be found at http://creativecommons.org/licenses/by-nc-nd/3.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/56/7a/ima-4-2-347.PMC3905946.pdf
"For any reuse or distribution, you must make clear to others the license terms of this work, which can be found at http://creativecommons.org/licenses/by-nc-nd/3.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/e0/6e/ima-4-2-357.PMC3905947.pdf
"For any reuse or distribution, you must make clear to others the license terms of this work, which can be found at http://creativecommons.org/licenses/by-nc-nd/3.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/6a/66/ima-4-2-359.PMC3905948.pdf
"Sequences for both datasets were  subsequently aligned, using the EMBL-EBI MAFFT server (http://www.ebi.ac.uk/Tools/msa/mafft/) in standard, default  setup.",OADS,/arxiv_data1/oa_pdf/6a/66/ima-4-2-359.PMC3905948.pdf
"For any reuse or distribution, you must make clear to others the license terms of this work, which can be found at http://creativecommons.org/licenses/by-nc-nd/3.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/83/18/ima-4-2-371.PMC3905949.pdf
"One year ago, one additional mycological taxon name  registration website was established (Fungal Names - FN in China at http://fungalinfo.im.ac.cn/fungalname/fungalname.",Non-OADS,/arxiv_data1/oa_pdf/83/18/ima-4-2-371.PMC3905949.pdf
"fungalbarcoding.org ), EUBOLD system (www.eubold.org ),  ISHAM ITS Database for Human and Animal Pathogenic Fungi (www.mycologylab.org ) or UNITE (http://unite.ut.ee).",OADS,/arxiv_data1/oa_pdf/83/18/ima-4-2-371.PMC3905949.pdf
The Darwin  Core standard (http://rs.tdwg.org/dwc/) has partly been  proposed and is one way to standardize the formulation of such data.,OADS,/arxiv_data1/oa_pdf/83/18/ima-4-2-371.PMC3905949.pdf
The	   Darwin	   Core	   standard 	   (http://rs.tdwg.org/dwc/ )	  has	  partly	  been	  proposed	   and	  is	  one	  way	  to	   standardize	   the	  formulation	  of	  such	   data.,OADS,/arxiv_data1/oa_pdf/83/18/ima-4-2-371.PMC3905949.pdf
"For any reuse or distribution, you must make clear to others the license terms of this work, which can be found at http://creativecommons.org/licenses/by-nc-nd/3.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/b0/db/ima-4-2-381.PMC3905950.pdf
"To address these shortcomings,  members of the algorithm development, FCM user, and software  and instrument vendor communities initiated the FlowCAP  project ( http://flowcap.flowsite.org /).",OADS,/arxiv_data1/oa_pdf/e3/03/41592_2013_Article_BFnmeth2365.PMC3906045.pdf
nature.com/doifinder /10.1038/nmeth.236 5.    reprints and permissions information is available online at http://www.nature.,Non-OADS,/arxiv_data1/oa_pdf/e3/03/41592_2013_Article_BFnmeth2365.PMC3906045.pdf
"www.landesbioscience.com Plant Signaling & Behavior e24012-1Plant Signaling & Behavior 8:5, e24012; May 2013; © 2013 Landes Bioscience ReSeaR ch P aPeR ReSeaR ch P aPeR *Correspondence to: Hemayet Ullah; Email: hullah@howard.edu Submitted: 11/28/12; Revised: 02/14/13; Accepted: 02/14/13http://dx.doi.org/10.4161/psb.24012Citation: Kundu N, Dozier U, Deslandes L, Somssich IE, Ullah H. Arabidopsis  scaffold protein RACK1A interacts with diverse environmental stress and  photosynthesis related proteins.",Non-OADS,/arxiv_data1/oa_pdf/26/94/psb-8-e24012.PMC3906143.pdf
Mol Pharmacol  2002; 62:1261-73; PMID:12435793; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/26/94/psb-8-e24012.PMC3906143.pdf
Prog Neurobiol 2006; 78:117-34; PMID:16457939;  http://dx.doi.org/10.1016/j.pneurobio.2005.12.002.,OADS,/arxiv_data1/oa_pdf/26/94/psb-8-e24012.PMC3906143.pdf
Mol Biol Cell 2008; 19:3909- 22; PMID:18596232; http://dx.doi.org/10.1091/mbc.,Non-OADS,/arxiv_data1/oa_pdf/26/94/psb-8-e24012.PMC3906143.pdf
Protein Sci 2008; 17:1771-80; PMID:18715992;  http://dx.doi.org/10.1110/ps.035121.108.,OADS,/arxiv_data1/oa_pdf/26/94/psb-8-e24012.PMC3906143.pdf
Cell  Commun Signal 2011; 9:22-46; PMID:21978545;  http://dx.doi.org/10.1186/1478-811X-9-22.,OADS,/arxiv_data1/oa_pdf/26/94/psb-8-e24012.PMC3906143.pdf
Plant Signal Behav 2012; 7:1771-80; PMID:22951405;  http://dx.doi.org/10.4161/psb.21995.,OADS,/arxiv_data1/oa_pdf/26/94/psb-8-e24012.PMC3906143.pdf
Nucleic Acids Res 2005; 33(Database issue):D418-24;  PMID:15608229; http://dx.doi.org/10.1093/nar/ gki051.,OADS,/arxiv_data1/oa_pdf/26/94/psb-8-e24012.PMC3906143.pdf
Nucleic Acids Res 2008; 36:e37;  PMID:18319286; http://dx.doi.org/10.1093/nar/ gkm1163.,OADS,/arxiv_data1/oa_pdf/26/94/psb-8-e24012.PMC3906143.pdf
J  Biol Chem 2003; 278:49119-28; PMID:12972434;  http://dx.doi.org/10.1074/jbc.M303968200.,OADS,/arxiv_data1/oa_pdf/26/94/psb-8-e24012.PMC3906143.pdf
Science  2011; 331:730-6; PMID:21205638; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/26/94/psb-8-e24012.PMC3906143.pdf
Plant Signal Behav 2011; 6:1741-5; PMID:22057331; http://dx.doi.org/10.4161/ psb.6.11.17729.15.,OADS,/arxiv_data1/oa_pdf/26/94/psb-8-e24012.PMC3906143.pdf
New Phytol  2006; 169:479-92; PMID:16411951; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/26/94/psb-8-e24012.PMC3906143.pdf
J  Plant Physiol 2004; 161:1189-202; PMID:15602811;  http://dx.doi.org/10.1016/j.jplph.2004.01.013.,OADS,/arxiv_data1/oa_pdf/26/94/psb-8-e24012.PMC3906143.pdf
J Plant Physiol 2012; 169:336- 44; PMID:22137606; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/26/94/psb-8-e24012.PMC3906143.pdf
Biochim  Biophys Acta 2009; 1787:753-72; PMID:19327340;  http://dx.doi.org/10.1016/j.bbabio.2009.03.012.,OADS,/arxiv_data1/oa_pdf/26/94/psb-8-e24012.PMC3906143.pdf
Bioinformatics  2005; 21:4411-3; PMID:16223790; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/26/94/psb-8-e24012.PMC3906143.pdf
Curr Opin Plant Biol 2003;  6:410-7; PMID:12972040; http://dx.doi.org/10.1016/ S1369-5266(03)00092-X.,OADS,/arxiv_data1/oa_pdf/26/94/psb-8-e24012.PMC3906143.pdf
Biochemistry 1988; 27:8931-8; PMID:3233213;  http://dx.doi.org/10.1021/bi00425a009.,Non-OADS,/arxiv_data1/oa_pdf/26/94/psb-8-e24012.PMC3906143.pdf
Biochem J 2007; 401:287- 97; PMID:16928193; http://dx.doi.org/10.1042/BJ20061092.,OADS,/arxiv_data1/oa_pdf/26/94/psb-8-e24012.PMC3906143.pdf
Plant Physiol  2005; 138:778-89; PMID:15908590; http://dx.doi.org/10.1104/pp.105.063388.27.,Non-OADS,/arxiv_data1/oa_pdf/26/94/psb-8-e24012.PMC3906143.pdf
FEBS 2008;  275:1056-68; http://dx.doi.org/10.1111/j.1742- 4658.2008.06262.x.,OADS,/arxiv_data1/oa_pdf/26/94/psb-8-e24012.PMC3906143.pdf
Plant Physiol 2006; 140:91- 101; PMID:16361516; http://dx.doi.org/10.1104/pp.105.071670.31.,Non-OADS,/arxiv_data1/oa_pdf/26/94/psb-8-e24012.PMC3906143.pdf
Microbiology 2006; 152:2515- 28; PMID:16946247; http://dx.doi.org/10.1099/ mic.0.28982-0.,Non-OADS,/arxiv_data1/oa_pdf/26/94/psb-8-e24012.PMC3906143.pdf
Plant Physiol 2004; 136:2621-32; PMID:15375207; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/26/94/psb-8-e24012.PMC3906143.pdf
"Mol Plant 2013; 6:216-25; PM i d: 22907882;  http://dx.doi.org/10.1093/mp/sss071.Keywords:  nicotinamide adenine  dinucleotide (NAD), NAD biosynthesis,  NAD homeostasis, redox, pollen,  germination Submitted: 02/08/13Accepted: 02/08/13 Citation: Hashida S-N, Kawai-Yamada M, Uchimiya  H. NAD+ accumulation as a metabolic off switch  for orthodox pollen.",OADS,/arxiv_data1/oa_pdf/a6/c0/psb-8-e23937.PMC3906144.pdf
Plant Signal Behav 2013; 8: e23937; http://dx.doi.org/10.4161/psb.23937*Correspondence to: Shin-nosuke Hashida;  Email: shashida@criepi.denken.or.jpTerrestrial plant pollen is classified  into two categories based on its  metabolic status: pollen with low-metab - olism are termed “orthodox” and pollen with high-metabolism are termed “recal - citrant.” Nicotinamide adenine dinu - cleotide (NAD) is crucial for a number of metabolisms in all extant organisms.,Non-OADS,/arxiv_data1/oa_pdf/a6/c0/psb-8-e23937.PMC3906144.pdf
Protoplasma 2006; 228:73-7; PMID:16937057; http://dx.doi.org/10.1007/s00709-006-0169-z.,Non-OADS,/arxiv_data1/oa_pdf/a6/c0/psb-8-e23937.PMC3906144.pdf
Ann Bot (Lond) 1999; 83:167-73; http://dx.doi.org/10.1006/anbo.1998.0807.,OADS,/arxiv_data1/oa_pdf/a6/c0/psb-8-e23937.PMC3906144.pdf
J Exp Bot 2011; 62:5267-81; PMID:21831844; http://dx.doi.org/10.1093/jxb/err154.,OADS,/arxiv_data1/oa_pdf/a6/c0/psb-8-e23937.PMC3906144.pdf
J Exp Bot 2009; 60:3891-908; PMID:19628571; http://dx.doi.org/10.1093/jxb/erp234.,Non-OADS,/arxiv_data1/oa_pdf/a6/c0/psb-8-e23937.PMC3906144.pdf
Plant Cell Environ 1995; 18:1280; http://dx.doi.org/10.1111/j.1365-3040.1995.tb00187.x.,OADS,/arxiv_data1/oa_pdf/a6/c0/psb-8-e23937.PMC3906144.pdf
"Biochim Biophys Acta 2001; 1544:196-206; PMID:11341929; http://dx.doi.org/10.1016/S0167-4838(00)00220-X.invest substrates (e.g., Asp) and energy  (e.g., ATP) for NAD biosynthesis17 to  control the redox balance during micro - spore development to acquire desiccation tolerance, thereby expanding its outcross - ing distance for heterogamy in a fluctu - ating environment.",OADS,/arxiv_data1/oa_pdf/a6/c0/psb-8-e23937.PMC3906144.pdf
Plant Physiol 2001; 126:685- 95; PMID:11402197; http://dx.doi.org/10.1104/pp.126.2.685.,Non-OADS,/arxiv_data1/oa_pdf/a6/c0/psb-8-e23937.PMC3906144.pdf
J Exp  Bot 2010; 61:3813-25; PMID:20591898; http://dx.doi.org/10.1093/jxb/erq190.,OADS,/arxiv_data1/oa_pdf/a6/c0/psb-8-e23937.PMC3906144.pdf
Plant Physiol 2009; 150:1248-59; PMID:19429607; http://dx.doi.org/10.1104/pp.109.136242.,Non-OADS,/arxiv_data1/oa_pdf/a6/c0/psb-8-e23937.PMC3906144.pdf
Plant Cell 2008; 20:2909-25; PMID:18978034; http://dx.doi.org/10.1105/tpc.107.056341.,OADS,/arxiv_data1/oa_pdf/a6/c0/psb-8-e23937.PMC3906144.pdf
Plant J 2007; 49:694-703; PMID:17270012; http://dx.doi.org/10.1111/j.1365-313X.2006.02989.x.,OADS,/arxiv_data1/oa_pdf/a6/c0/psb-8-e23937.PMC3906144.pdf
Mol Plant 2013; 6:216-25; PMID:22907882; http://dx.doi.org/10.1093/mp/sss071.,OADS,/arxiv_data1/oa_pdf/a6/c0/psb-8-e23937.PMC3906144.pdf
Plant Cell Rep 2007; 26:373-82; PMID:17053903; http://dx.doi.org/10.1007/s00299-006-0234-2.,OADS,/arxiv_data1/oa_pdf/a6/c0/psb-8-e23937.PMC3906144.pdf
Ann Bot (Lond) 2009; 103:819-24; http://dx.doi.org/10.1093/aob/mcp019.,OADS,/arxiv_data1/oa_pdf/a6/c0/psb-8-e23937.PMC3906144.pdf
"Nat Immunol 2013; 14:364-71; PMID:23435120; http://dx.doi.org/10.1038/ni.2541Keywords:  STAT5, dendritic cells, Th2  induced response, TSLP, CD11c-Cre  Stat5fl/fl mice Submitted: 06/01/13 Revised: 06/07/13Accepted: 06/10/13 Citation: Tormo AJ, Gauchat JF.",Non-OADS,/arxiv_data1/oa_pdf/58/3f/jkst-2-e25352.PMC3906145.pdf
JAK-STAT 2013; 2:e25352; http://dx.doi.org/10.4161/jkst.25352Correspondence to: Aurélie Jeanne Tormo and Jean-François Gauchat; Email: aurelie.tormo@umontreal.ca and jf.gauchat@umontreal.caDendritic cells (DC) play a key role  in immunity by recognizing and  presenting antigens.,OADS,/arxiv_data1/oa_pdf/58/3f/jkst-2-e25352.PMC3906145.pdf
Nature 1998; 392:245-52;  PMID:9521319; http://dx.doi.org/10.1038/32588 2.,Non-OADS,/arxiv_data1/oa_pdf/58/3f/jkst-2-e25352.PMC3906145.pdf
Nat Rev Immunol  2007; 7:19-30; PMID:17170756; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/58/3f/jkst-2-e25352.PMC3906145.pdf
Immunol Rev 2010; 234:45-54; PMID:20193011; http://dx.doi.org/10.1111/j.0105- 2896.2009.00879.x 4.,Non-OADS,/arxiv_data1/oa_pdf/58/3f/jkst-2-e25352.PMC3906145.pdf
Annu Rev Immunol 2011; 29:163- 83; PMID:21219184; http://dx.doi.org/10.1146/ annurev-immunol-031210-101345 5.,Non-OADS,/arxiv_data1/oa_pdf/58/3f/jkst-2-e25352.PMC3906145.pdf
Nat Rev Immunol  2011; 11:558-65; PMID:21779033; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/58/3f/jkst-2-e25352.PMC3906145.pdf
Nat Rev Immunol 2007; 7:543- 55; PMID:17589544; http://dx.doi.org/10.1038/ nri2103 7.,Non-OADS,/arxiv_data1/oa_pdf/58/3f/jkst-2-e25352.PMC3906145.pdf
"J Exp Med 1996; 184:1953- 62; PMID:8920882; http://dx.doi.org/10.1084/ jem.184.5.1953induced by sensitization, and challenged  with the hapten 2,4-dinitrofluorobenzene DNFB, 19 in which no difference between  WT and Cre+Stat5fl/fl mice were observed.",Non-OADS,/arxiv_data1/oa_pdf/58/3f/jkst-2-e25352.PMC3906145.pdf
J Immunol 2010; 184:2638-45;  PMID:20124100; http://dx.doi.org/10.4049/jim - munol.0902960 22.,Non-OADS,/arxiv_data1/oa_pdf/58/3f/jkst-2-e25352.PMC3906145.pdf
J Exp Med 2003; 198:293-303; PMID:12874262; http://dx.doi.org/10.1084/ jem.20030107 23.,Non-OADS,/arxiv_data1/oa_pdf/58/3f/jkst-2-e25352.PMC3906145.pdf
Curr Opin Immunol 1999; 11:626-34; PMID:10631546; http://dx.doi.org/10.1016/S0952-7915(99)00028-X18.,Non-OADS,/arxiv_data1/oa_pdf/58/3f/jkst-2-e25352.PMC3906145.pdf
Nat Immunol 2013; 14:364-71; PMID:23435120; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/58/3f/jkst-2-e25352.PMC3906145.pdf
Crit  Rev Immunol 2001; 21:451-72; PMID:11942559;  http://dx.doi.org/10.1615/CritRevImmunol.v21.,Non-OADS,/arxiv_data1/oa_pdf/58/3f/jkst-2-e25352.PMC3906145.pdf
Immunology 2000; 101:442-51; PMID:11122447; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/58/3f/jkst-2-e25352.PMC3906145.pdf
Immunity 2003; 19:903-12;  PMID:14670306; http://dx.doi.org/10.1016/S1074- 7613(03)00332-7 9.,OADS,/arxiv_data1/oa_pdf/58/3f/jkst-2-e25352.PMC3906145.pdf
Mol Cell Biol 2004; 24:8037-47; PMID:15340066; http://dx.doi.org/10.1128/ MCB.24.18.8037-8047.2004 10.,Non-OADS,/arxiv_data1/oa_pdf/58/3f/jkst-2-e25352.PMC3906145.pdf
Immunity  2008; 28:509-20; PMID:18342552; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/58/3f/jkst-2-e25352.PMC3906145.pdf
Trends Immunol 2006; 27:140- 5; PMID:16406699; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/58/3f/jkst-2-e25352.PMC3906145.pdf
J Exp Med 1992; 176:1693- 702; PMID:1460426; http://dx.doi.org/10.1084/jem.176.6.1693 13.,Non-OADS,/arxiv_data1/oa_pdf/58/3f/jkst-2-e25352.PMC3906145.pdf
J Exp Med 2000; 192:671- 80; PMID:10974033; http://dx.doi.org/10.1084/ jem.192.5.671 14.,Non-OADS,/arxiv_data1/oa_pdf/58/3f/jkst-2-e25352.PMC3906145.pdf
Annu Rev Immunol 2007; 25:381-418; PMID:17378762;  http://dx.doi.org/10.1146/annurev.immu - nol.25.022106.141634 15.,Non-OADS,/arxiv_data1/oa_pdf/58/3f/jkst-2-e25352.PMC3906145.pdf
Annu Rev Immunol 2007; 25:193-219; PMID:17129180; http://dx.doi.org/10.1146/annurev.immunol.25.022106.141718 Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/58/3f/jkst-2-e25352.PMC3906145.pdf
"www.landesbioscience.com Plant Signaling & Behavior e23932-1Plant Signaling & Behavior 8:5, e23932; May 2013; © 2013 Landes Bioscience ReSeaR ch P aPeR ReSeaR ch P aPeR *Correspondence to: Pradeep Sharma; Email: neprads@gmail.com Submitted: 12/20/12; Revised: 02/08/13; Accepted: 02/08/13http://dx.doi.org/10.4161/psb.23932Citation: Pandey B, Gupta OP , Pandey DM, Sharma I, Sharma P. Identification of new microRNA and their targets in wheat using computational approach.",Non-OADS,/arxiv_data1/oa_pdf/c3/4b/psb-8-e23932.PMC3906146.pdf
"28 Till now, only 270 known mature miRNA have  been reported in wheat (https://pag.confex.com/pag/xxi/webpro - gram/Paper6335.html).",Non-OADS,/arxiv_data1/oa_pdf/c3/4b/psb-8-e23932.PMC3906146.pdf
Genetics  2004; 168:1087-96; PMID:15514080; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c3/4b/psb-8-e23932.PMC3906146.pdf
Plant Cell 2011; 23:1706-18; PMID:21622801;  http://dx.doi.org/10.1105/tpc.111.086629.3.,OADS,/arxiv_data1/oa_pdf/c3/4b/psb-8-e23932.PMC3906146.pdf
PLoS ONE 2011; 6:e26421;  PMID:22028874; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/c3/4b/psb-8-e23932.PMC3906146.pdf
Cell 2004; 116:281-97;  PMID:14744438; http://dx.doi.org/10.1016/S0092- 8674(04)00045-5.,OADS,/arxiv_data1/oa_pdf/c3/4b/psb-8-e23932.PMC3906146.pdf
Biochem Biophys Res Commun 2007; 354:585- 90; PMID:17254555; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/c3/4b/psb-8-e23932.PMC3906146.pdf
Plant J 2006; 46:243-59; PMID:16623887;  http://dx.doi.org/10.1111/j.1365-313X.2006.02697.x.,OADS,/arxiv_data1/oa_pdf/c3/4b/psb-8-e23932.PMC3906146.pdf
Plant Cell 2003;  15:2730-41; PMID:14555699; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c3/4b/psb-8-e23932.PMC3906146.pdf
Nature 2003; 425:257-63;  PMID:12931144; http://dx.doi.org/10.1038/ nature01958.,OADS,/arxiv_data1/oa_pdf/c3/4b/psb-8-e23932.PMC3906146.pdf
Annu Rev Plant Physiol Plant Mol Biol  1999; 50:97-131; PMID:15012205; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c3/4b/psb-8-e23932.PMC3906146.pdf
Nature  2002; 416:703-9; PMID:11961546; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c3/4b/psb-8-e23932.PMC3906146.pdf
Plant Cell Physiol 2004; 45:1361-70; PMID:15564519; http://dx.doi.org/10.1093/pcp/ pch201.,Non-OADS,/arxiv_data1/oa_pdf/c3/4b/psb-8-e23932.PMC3906146.pdf
J Plant Res 2008; 121:351-5;  PMID:18357413; http://dx.doi.org/10.1007/s10265-007-0139-3.,OADS,/arxiv_data1/oa_pdf/c3/4b/psb-8-e23932.PMC3906146.pdf
Plant J 2005; 43:837-48;  PMID:16146523; http://dx.doi.org/10.1111/j.1365- 313X.2005.02499.x.,OADS,/arxiv_data1/oa_pdf/c3/4b/psb-8-e23932.PMC3906146.pdf
BMC Bioinformatics 2005; 6:310; PMID:16381612;  http://dx.doi.org/10.1186/1471-2105-6-310.,OADS,/arxiv_data1/oa_pdf/c3/4b/psb-8-e23932.PMC3906146.pdf
Mol Biol Evol 2007; 24:1596-9;  PMID:17488738; http://dx.doi.org/10.1093/molbev/ msm092.21.,Non-OADS,/arxiv_data1/oa_pdf/c3/4b/psb-8-e23932.PMC3906146.pdf
Curr Biol 2005; 15:2038-43;  PMID:16303564; http://dx.doi.org/10.1016/j.cub.2005.10.016.,OADS,/arxiv_data1/oa_pdf/c3/4b/psb-8-e23932.PMC3906146.pdf
Plant Cell 2005; 17:2186-203; PMID:15994906; http://dx.doi.org/10.1105/tpc.105.033456.,OADS,/arxiv_data1/oa_pdf/c3/4b/psb-8-e23932.PMC3906146.pdf
PLoS  ONE 2007; 2:e219; PMID:17299599; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c3/4b/psb-8-e23932.PMC3906146.pdf
Plant Cell  2006; 18:2051-65; PMID:16861386; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c3/4b/psb-8-e23932.PMC3906146.pdf
FEBS Lett 2006; 580:3753-62; PMID:16780841;  http://dx.doi.org/10.1016/j.febslet.2006.05.063.,OADS,/arxiv_data1/oa_pdf/c3/4b/psb-8-e23932.PMC3906146.pdf
PLoS ONE  2012; 7:e40859; PMID:22815845; http://dx.doi.org/10.1371/journal.pone.0040859.,Non-OADS,/arxiv_data1/oa_pdf/c3/4b/psb-8-e23932.PMC3906146.pdf
RNA 2003; 9:277-9; PMID:12592000;  http://dx.doi.org/10.1261/rna.2183803.,OADS,/arxiv_data1/oa_pdf/c3/4b/psb-8-e23932.PMC3906146.pdf
Nucleic Acids Res 2003; 31:3429-31;  PMID:12824340; http://dx.doi.org/10.1093/nar/ gkg599.,OADS,/arxiv_data1/oa_pdf/c3/4b/psb-8-e23932.PMC3906146.pdf
Genomics Proteomics Bioinformatics 2010; 8:113-21;  PMID:20691396; http://dx.doi.org/10.1016/S1672- 0229(10)60012-5.,OADS,/arxiv_data1/oa_pdf/c3/4b/psb-8-e23932.PMC3906146.pdf
Bioinformatics 2005; 21:3610-4;  PMID:15994192; http://dx.doi.org/10.1093/bioinfor-matics/bti562.,OADS,/arxiv_data1/oa_pdf/c3/4b/psb-8-e23932.PMC3906146.pdf
Gene 2007; 397:26-37; PMID:17574351; http://dx.doi.org/10.1016/j.gene.2007.03.020.,OADS,/arxiv_data1/oa_pdf/c3/4b/psb-8-e23932.PMC3906146.pdf
Genomics Proteomics Bioinformatics 2011; 9:200-10;  PMID:22289476; http://dx.doi.org/10.1016/S1672- 0229(11)60023-5.,OADS,/arxiv_data1/oa_pdf/c3/4b/psb-8-e23932.PMC3906146.pdf
J Struct Funct Genomics  2010; 11:233-40; PMID:20978860; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c3/4b/psb-8-e23932.PMC3906146.pdf
Plant Cell 2006; 18:412- 21; PMID:16387831; http://dx.doi.org/10.1105/ tpc.105.038943.,OADS,/arxiv_data1/oa_pdf/c3/4b/psb-8-e23932.PMC3906146.pdf
Annu Rev Plant  Biol 2006; 57:19-53; PMID:16669754; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c3/4b/psb-8-e23932.PMC3906146.pdf
Plant Physiol 2003; 132:1382-90; PMID:12857820;  http://dx.doi.org/10.1104/pp.103.021980.,Non-OADS,/arxiv_data1/oa_pdf/c3/4b/psb-8-e23932.PMC3906146.pdf
Proc Natl Acad Sci USA  2005; 102:3691-6; PMID:15738428; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c3/4b/psb-8-e23932.PMC3906146.pdf
J Integr Plant Biol  2009; 51:1071-9; PMID:20021554; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c3/4b/psb-8-e23932.PMC3906146.pdf
T rends Plant Sci 2007; 12:301- 9; PMID:17573231; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/c3/4b/psb-8-e23932.PMC3906146.pdf
Cell 2009; 136:669-87; PMID:19239888;  http://dx.doi.org/10.1016/j.cell.2009.01.046.,OADS,/arxiv_data1/oa_pdf/c3/4b/psb-8-e23932.PMC3906146.pdf
Genome  Biol 2004; 5:R65; PMID:15345049; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c3/4b/psb-8-e23932.PMC3906146.pdf
Proc Natl Acad Sci USA 2004; 101:11511-6; PMID:15272084; http://dx.doi.org/10.1073/ pnas.0404025101.,OADS,/arxiv_data1/oa_pdf/c3/4b/psb-8-e23932.PMC3906146.pdf
Cell Res 2005; 15:336- 60; PMID:15916721; http://dx.doi.org/10.1038/ sj.cr.7290302.,OADS,/arxiv_data1/oa_pdf/c3/4b/psb-8-e23932.PMC3906146.pdf
Plant J 2006a; 46:243-59; PMID:16623887;  http://dx.doi.org/10.1111/j.1365-313X.2006.02697.x.,OADS,/arxiv_data1/oa_pdf/c3/4b/psb-8-e23932.PMC3906146.pdf
Genome Biol 2007;  8:R96; PMID:17543110; http://dx.doi.org/10.1186/gb-2007-8-6-r96.,OADS,/arxiv_data1/oa_pdf/c3/4b/psb-8-e23932.PMC3906146.pdf
BMC Plant Biol 2010; 10:123;  PMID:20573268; http://dx.doi.org/10.1186/1471- 2229-10-123.,OADS,/arxiv_data1/oa_pdf/c3/4b/psb-8-e23932.PMC3906146.pdf
Nat Genet 2006;  38(Suppl):S31-6; PMID:16736022; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c3/4b/psb-8-e23932.PMC3906146.pdf
"What should Trust in nature Shu-Nong Bai State Key Laboratory of Protein and Plant Gene Research; College of Life Sciences; Peking University; Beijing, China Keywords:  Arabidopsis, hitone deacetylation, root epidermis, kinases, HDA18 *Correspondence to: Shu-Nong Bai; Email: shunongb@pku.edu.cn Submitted: 02/08/13; Accepted: 02/08/13http://dx.doi.org/10.4161/psb.23936Citation: Bai S-N. Trust in nature.",Non-OADS,/arxiv_data1/oa_pdf/ae/64/psb-8-e23936.PMC3906147.pdf
Proc Natl Acad Sci USA  2009; 106:8073-6; PMID:19416891; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ae/64/psb-8-e23936.PMC3906147.pdf
Proc Natl Acad Sci USA 2005; 102:14469- 74; PMID:16176989; http://dx.doi.org/10.1073/ pnas.0503143102.,OADS,/arxiv_data1/oa_pdf/ae/64/psb-8-e23936.PMC3906147.pdf
"Immunity 2012; 37:209-22; PMID:22921119; http://dx.doi.org/10.1016/j.immuni.2012.05.027.Keywords:  STAT3, regulatory T   lymphocyte, graft-vs.-host disease, Foxp3,  hematopoietic stem cell transplantation Submitted: 12/31/12Revised: 04/02/13Accepted: 04/02/13 Citation: Fujino M, Li XK.",OADS,/arxiv_data1/oa_pdf/bc/52/jkst-2-e24529.PMC3906148.pdf
"JAK-STAT 2013; 2:e24529; http://dx.doi.org/10.4161/jkst.24529*Correspondence to: Xiao-Kang Li;  Email: ri-k@ncchd.go.jpRegulatory T (Treg) lymphocytes are  important mediators of the allo - geneic immune response, although the mechanisms by which they are controlled are not fully understood.",Non-OADS,/arxiv_data1/oa_pdf/bc/52/jkst-2-e24529.PMC3906148.pdf
Blood 2009; 114:3101-12;  PMID:19602708; http://dx.doi.org/10.1182/blood- 2009-05-219402 7.,Non-OADS,/arxiv_data1/oa_pdf/bc/52/jkst-2-e24529.PMC3906148.pdf
Blood 2009; 113:1365-74; PMID:18957685; http://dx.doi.org/10.1182/blood- 2008-06-162420 9.,Non-OADS,/arxiv_data1/oa_pdf/bc/52/jkst-2-e24529.PMC3906148.pdf
Nat Med 2003; 9:1144-50;  PMID:12925844; http://dx.doi.org/10.1038/nm915 11.,Non-OADS,/arxiv_data1/oa_pdf/bc/52/jkst-2-e24529.PMC3906148.pdf
PLoS Biol  2010; 8:e1000302; PMID:20126379; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bc/52/jkst-2-e24529.PMC3906148.pdf
Clin Cancer Res  2006; 12:5520-5; PMID:17000688; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/bc/52/jkst-2-e24529.PMC3906148.pdf
Semin Immunol 2006; 18:78- 88; PMID:16458015; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/bc/52/jkst-2-e24529.PMC3906148.pdf
Science 2010; 329:1667-71;  PMID:20929851; http://dx.doi.org/10.1126/sci - ence.1191996 16.,OADS,/arxiv_data1/oa_pdf/bc/52/jkst-2-e24529.PMC3906148.pdf
Nat Immunol  2009; 10:1000-7; PMID:19633673; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/bc/52/jkst-2-e24529.PMC3906148.pdf
Blood 2007; 109:4368- 75; PMID:17227828; http://dx.doi.org/10.1182/ blood-2006-11-055756 18.,Non-OADS,/arxiv_data1/oa_pdf/bc/52/jkst-2-e24529.PMC3906148.pdf
Immunity 2010; 33:313-25; PMID:20870174;  http://dx.doi.org/10.1016/j.immuni.2010.09.001(4) what are the precise mechanisms and  role of STAT3 and STAT5 in Treg lym - phocyte development and induction in acute GvHD.,Non-OADS,/arxiv_data1/oa_pdf/bc/52/jkst-2-e24529.PMC3906148.pdf
Transplantation  1994; 57:249-56; PMID:7906058; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/bc/52/jkst-2-e24529.PMC3906148.pdf
Nat Rev Immunol 2009; 9:883-9; PMID:19935807; http://dx.doi.org/10.1038/ nri2660 3.,Non-OADS,/arxiv_data1/oa_pdf/bc/52/jkst-2-e24529.PMC3906148.pdf
Methods Mol Biol 2011; 707:3-17;  PMID:21287325; http://dx.doi.org/10.1007/978-1- 61737-979-6_1 4.,Non-OADS,/arxiv_data1/oa_pdf/bc/52/jkst-2-e24529.PMC3906148.pdf
J Immunol 2009; 182:5899-903;  PMID:19414739; http://dx.doi.org/10.4049/jimmu - nol.0804388 35.,Non-OADS,/arxiv_data1/oa_pdf/bc/52/jkst-2-e24529.PMC3906148.pdf
J Immunol 2010; 184:2638-45; PMID:20124100; http://dx.doi.org/10.4049/jim - munol.0902960 36.,Non-OADS,/arxiv_data1/oa_pdf/bc/52/jkst-2-e24529.PMC3906148.pdf
J Immunol 2012; 189:3848-58; PMID:22962681;  http://dx.doi.org/10.4049/jimmunol.1200819 37.,Non-OADS,/arxiv_data1/oa_pdf/bc/52/jkst-2-e24529.PMC3906148.pdf
Blood  2011; 118:5340-3; PMID:21940820; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bc/52/jkst-2-e24529.PMC3906148.pdf
Biol Blood Marrow Transplant 2011; 17:1862-8; PMID:21745454; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/bc/52/jkst-2-e24529.PMC3906148.pdf
Transplantation 2010; 90:825-35; PMID:20697326; http://dx.doi.org/10.1097/TP.0b013e3181f24e59 28.,Non-OADS,/arxiv_data1/oa_pdf/bc/52/jkst-2-e24529.PMC3906148.pdf
Blood 2011; 118:5330-9;  PMID:21917753; http://dx.doi.org/10.1182/blood- 2011-06-363408 29.,Non-OADS,/arxiv_data1/oa_pdf/bc/52/jkst-2-e24529.PMC3906148.pdf
Nat Med 2005; 11:1314- 21; PMID:16288283; http://dx.doi.org/10.1038/ nm1325 32.,OADS,/arxiv_data1/oa_pdf/bc/52/jkst-2-e24529.PMC3906148.pdf
Int Immunol 2007; 19:695-702; PMID:17493959;  http://dx.doi.org/10.1093/intimm/dxm04519.,Non-OADS,/arxiv_data1/oa_pdf/bc/52/jkst-2-e24529.PMC3906148.pdf
Blood 2008; 112:5254- 8; PMID:18838616; http://dx.doi.org/10.1182/ blood-2008-03-147322 20.,Non-OADS,/arxiv_data1/oa_pdf/bc/52/jkst-2-e24529.PMC3906148.pdf
Blood 2009; 113:2352-62; PMID:19059877; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bc/52/jkst-2-e24529.PMC3906148.pdf
Immunity 2012; 37:209- 22; PMID:22921119; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/bc/52/jkst-2-e24529.PMC3906148.pdf
Clin Cancer Res 2011; 17:77-88; PMID:21047980; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/bc/52/jkst-2-e24529.PMC3906148.pdf
J Clin Oncol 2010; 28:e602- 4; PMID:20713858; http://dx.doi.org/10.1200/ JCO.2010.29.1682,Non-OADS,/arxiv_data1/oa_pdf/bc/52/jkst-2-e24529.PMC3906148.pdf
"5C technology 7 provides an  alternative, PCR-based technology with  *Correspondence to: Peter J Park; Email: peter_park@harvard.edu; Konrad Hochedlinger; Email: khochedlinger@helix.mgh.harvard.edu Submitted: 09/07/2013; Accepted: 09/28/2013http://dx.doi.org/10.4161/cc.27028Comment on: Apostolou E, et al.",Non-OADS,/arxiv_data1/oa_pdf/62/b6/cc-13-167.PMC3906226.pdf
"Cell Stem Cell 2013; 12:699-712; PMID:23665121; http://dx.doi.org/10.1016/j.stem.2013.04.013Rearranging the chromatin for pluripotency Francesco Ferrari1,†, Effie a postolou2,3,†, Peter J Park1,4,*, and Konrad Hochedlinger2,3,* 1Center for Biomedical i nformatics; Harvard Medical s chool; Boston, M a usa ; 2Massachusetts General Hospital Cancer Center and Center for r egenerative Medicine; Harvard  stem Cell i nstitute; Boston, M a usa ; 3Howard Hughes Medical i nstitute and d epartment of s tem Cell and r egenerative Biology; Harvard u niversity and Harvard Medical  school; Cambridge, M a usa ; 4informatics Program; Children’s Hospital and d ivision of Genetics; Brigham and Women’s Hospital; Boston, M a usa †these authors contributed equally to this work.",OADS,/arxiv_data1/oa_pdf/62/b6/cc-13-167.PMC3906226.pdf
Cell 2013; 152:1324-43;  PMID:23498940 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/62/b6/cc-13-167.PMC3906226.pdf
Cell Stem Cell 2013; 12:699- 712; PMID:23665121 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/62/b6/cc-13-167.PMC3906226.pdf
Nat Rev Genet 2013; 14:390-403; PMID:23657480 ; http://dx.doi.org/10.1038/ nrg3454 4.,OADS,/arxiv_data1/oa_pdf/62/b6/cc-13-167.PMC3906226.pdf
Cell Stem Cell 2013; 13:36-47;  PMID:23747203 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/62/b6/cc-13-167.PMC3906226.pdf
Cell Stem Cell 2013; 13:30-5; PMID:23747202 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/62/b6/cc-13-167.PMC3906226.pdf
Nature 2010; 467:430-5;  PMID:20720539 ; http://dx.doi.org/10.1038/ nature09380 7.,Non-OADS,/arxiv_data1/oa_pdf/62/b6/cc-13-167.PMC3906226.pdf
Cell 2013; 153:1281- 95; PMID:23706625 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/62/b6/cc-13-167.PMC3906226.pdf
Nature 2013; 501:227-31;  PMID:23883933 ; http://dx.doi.org/10.1038/ nature12420 Figure  1.,OADS,/arxiv_data1/oa_pdf/62/b6/cc-13-167.PMC3906226.pdf
"3,8  *Correspondence to: Nils Wiedemann; Email: Nils.Wiedemann@biochemie.uni-freiburg.de Submitted: 09/17/2013; Accepted: 09/28/2013http://dx.doi.org/10.4161/cc.27035Comment on: Qiu J, et al.",Non-OADS,/arxiv_data1/oa_pdf/32/0e/cc-13-169.PMC3906227.pdf
"Cell 2013; 154:596-608; PMID:23911324; http://dx.doi.org/10.1016/j.cell.2013.06.033Biogenesis and folding of β -barrel membrane  proteins lena- sophie Wenz1,2, Jian Qiu1,3, thomas Becker1,4, and Nils Wiedemann1,4,* 1institut für Biochemie und Molekularbiologie (ZBMZ); u niversität Freiburg; Freiburg; Germany; 2Fakultät für Biologie; u niversität Freiburg; Freiburg; Germany; 3spemann  Graduate s chool of Biology and Medicine; u niversität Freiburg; Freiburg; Germany; 4Bioss  Centre for Biological s ignalling s tudies; u niversität Freiburg; Freiburg; Germany",OADS,/arxiv_data1/oa_pdf/32/0e/cc-13-169.PMC3906227.pdf
Curr Opin Microbiol 2012; 15:189- 93; PMID:22221898 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/32/0e/cc-13-169.PMC3906227.pdf
Nat Struct Mol Biol 2004; 11:1044- 8; PMID :15523480 ; http://dx.doi.org/10.1038/ nsmb852 3.,OADS,/arxiv_data1/oa_pdf/32/0e/cc-13-169.PMC3906227.pdf
Cell 2008; 132:1011-24; PMID:18358813 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/32/0e/cc-13-169.PMC3906227.pdf
Mol Biol Evol 2010; 27:887- 95; PMID:19959601 ; http://dx.doi.org/10.1093/ molbev/msp294 5.,Non-OADS,/arxiv_data1/oa_pdf/32/0e/cc-13-169.PMC3906227.pdf
Science 2010; 328:890-2; PMID:20378773 ; http://dx.doi.org/10.1126/ science.1188919 6.,Non-OADS,/arxiv_data1/oa_pdf/32/0e/cc-13-169.PMC3906227.pdf
Cell 2013; 154:596-608;  PMID:23911324 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/32/0e/cc-13-169.PMC3906227.pdf
Nature 2013; 501:385-90; PMID:23995689; http://dx.doi.org/ 10.1038/ nature12521 8.,OADS,/arxiv_data1/oa_pdf/32/0e/cc-13-169.PMC3906227.pdf
J Cell Biol 1995; 129:25-34; PMID:7698990 ; http://dx.doi.org/10.1083/ jcb.129.1.25  Figure 1.,OADS,/arxiv_data1/oa_pdf/32/0e/cc-13-169.PMC3906227.pdf
"*Correspondence to Rahul M. Kohli; Email: rkohli@upenn.edu Submitted: 08/31/2013; Accepted: 09/28/2013http://dx.doi.org/10.4161/cc.27036Comment on: Nabel CS, et al.",Non-OADS,/arxiv_data1/oa_pdf/fc/93/cc-13-171.PMC3906228.pdf
Genome Biol 2008; 9:229;  PMID:18598372 ; http://dx.doi.org/10.1186/ gb-2008-9-6-229 2.,OADS,/arxiv_data1/oa_pdf/fc/93/cc-13-171.PMC3906228.pdf
Annu Rev Pathol 2013; 8:79- 103; PMID:22974238 ; http://dx.doi.org/10.1146/ annurev-pathol-020712-164004 3.,Non-OADS,/arxiv_data1/oa_pdf/fc/93/cc-13-171.PMC3906228.pdf
Nature 2013; 494:366-70; PMID:23389445 ; http://dx.doi.org/10.1038/ nature11881 4.,Non-OADS,/arxiv_data1/oa_pdf/fc/93/cc-13-171.PMC3906228.pdf
J Biol Chem 2010; 285:40956-64;  PMID:20929867 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/fc/93/cc-13-171.PMC3906228.pdf
J Exp Med 2010; 207:141-53;  PMID:20048284 ; http://dx.doi.org/10.1084/ jem.20092238 7.,Non-OADS,/arxiv_data1/oa_pdf/fc/93/cc-13-171.PMC3906228.pdf
Nat Chem Biol 2012; 8:751-8;  PMID :22772155 ; http://dx.doi.org/10.1038/ nchembio.1042 8.,OADS,/arxiv_data1/oa_pdf/fc/93/cc-13-171.PMC3906228.pdf
Proc Natl Acad Sci USA 2013; 110:14225-30;  PMID:23942124 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fc/93/cc-13-171.PMC3906228.pdf
"For instance, it has been reported that NCC trafficking to the plasma membrane is affected  *Correspondence to: Marek Mlodzik; Email: marek.mlodzik@mssm.edu ; Andreas Jenny; Email: andreas.jenny@einstein.yu.edu Submitted: 09/20/2013; Accepted: 09/25/2013http://dx.doi.org/10.4161/cc.27038Comment on: Serysheva E, et al.",Non-OADS,/arxiv_data1/oa_pdf/a3/ea/cc-13-173.PMC3906229.pdf
"EMBO Rep 2013; 14:718-25; PMID:23797875; http://dx.doi.org/10.1038/embor.2013.88WNKs in Wnt/ β-catenin signaling Ekatherina s erysheva1, Marek Mlodzik1,*, and a ndreas Jenny2,* 1department of d evelopmental and r egenerative Biology and Graduate s chool of Biomedical s ciences; i cahn s chool of Medicine at Mount s inai; New y ork, N y usa ;  2department of d evelopmental and Molecular Biology; d epartment of Genetics; a lbert Einstein College of Medicine; Bronx, N y usa",Non-OADS,/arxiv_data1/oa_pdf/a3/ea/cc-13-173.PMC3906229.pdf
Clevers H. Cell 2006; 127:469-80; PMID:17081971 ;  http://dx.doi.org/10.1016/j.cell.2006.10.018 2.,OADS,/arxiv_data1/oa_pdf/a3/ea/cc-13-173.PMC3906229.pdf
Cold Spring Harb Perspect Biol 2012;  4; http://dx.doi.org/10.1101/cshperspect.a007930 3.,Non-OADS,/arxiv_data1/oa_pdf/a3/ea/cc-13-173.PMC3906229.pdf
Annu Rev Physiol 2008; 70:329- 55; PMID:17961084 ; http://dx.doi.org/10.1146/ annurev.physiol.70.113006.100651 4.,Non-OADS,/arxiv_data1/oa_pdf/a3/ea/cc-13-173.PMC3906229.pdf
EMBO Rep 2013; 14:718-25;  PMID:23797875 ; http://dx.doi.org/10.1038/ embor.2013.88 6.,Non-OADS,/arxiv_data1/oa_pdf/a3/ea/cc-13-173.PMC3906229.pdf
PLoS One 2013; 8:e55301;  PMID:23383144 ; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/a3/ea/cc-13-173.PMC3906229.pdf
J Am Soc Nephrol 2010; 21:82-92; PMID:19875813 ; http://dx.doi.org/10.1681/ ASN.2008121275 8.,Non-OADS,/arxiv_data1/oa_pdf/a3/ea/cc-13-173.PMC3906229.pdf
PLoS Genet 2013; 9:e1003124;  PMID:23300475 ; http://dx.doi.org/10.1371/jour - nal.pgen.1003124Figure  1.,OADS,/arxiv_data1/oa_pdf/a3/ea/cc-13-173.PMC3906229.pdf
"8 While promising,  G47Δ-mIL12 resulted in only 10–20%  *Correspondence to: Samuel D Rabkin; Email: rabkin@helix.mgh.harvard.edu Submitted: 08/19/2013; Accepted: 09/27/2013http://dx.doi.org/10.4161/cc.27039Comment on: Cheema TA, et al.",Non-OADS,/arxiv_data1/oa_pdf/3d/99/cc-13-175.PMC3906230.pdf
Oncoimmunology 2013; 2:e24612;  PMID:23894720 ; http://dx.doi.org/10.4161/ onci.24612 2.,Non-OADS,/arxiv_data1/oa_pdf/3d/99/cc-13-175.PMC3906230.pdf
Hum Gene Ther 1999;  10:385-93;  PMID:10048391 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3d/99/cc-13-175.PMC3906230.pdf
J Surg Oncol 2013; PMID:24301265; http://dx.doi.org/10.1002/jso.23494 4.,OADS,/arxiv_data1/oa_pdf/3d/99/cc-13-175.PMC3906230.pdf
Neuro Oncol 2012; 14:132- 44; PMID:22067563 ; http://dx.doi.org/10.1093/ neuonc/nor195 5.,Non-OADS,/arxiv_data1/oa_pdf/3d/99/cc-13-175.PMC3906230.pdf
Int J Cancer 2013; 132:1249-59; PMID:23180591 ; http://dx.doi.org/10.1002/ ijc.27961 6.,Non-OADS,/arxiv_data1/oa_pdf/3d/99/cc-13-175.PMC3906230.pdf
Proc Natl Acad Sci USA 2013; 110:12006-11;  PMID:23754388 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3d/99/cc-13-175.PMC3906230.pdf
Nat Med 2009; 15:110-6;   PMID:19122659 ; http://dx.doi.org/10.1038/nm.1863 8.,Non-OADS,/arxiv_data1/oa_pdf/3d/99/cc-13-175.PMC3906230.pdf
"1 Moreover, asym - metric membrane elongation in response to defective spindle positioning acts as a  *Correspondence to: Pierre Gönczy; Email: Pierre.Gonczy@epfl.ch Submitted: 08/28/2013; Accepted: 09/28/2013http://dx.doi.org/10.4161/cc.27040Comment on: Kotak S, et al.",Non-OADS,/arxiv_data1/oa_pdf/67/19/cc-13-177.PMC3906231.pdf
"EMBO J 2013; 32:2517-29; PMID:23921553; http://dx.doi.org/10.1038/emboj.2013.172NuMA phosphorylation dictates   dynein-dependent spindle positioning sachin Kotak and Pierre Gönczy* swiss i nstitute for Experimental Cancer r esearch ( isrEC); s chool of l ife s ciences; s wiss Federal i nstitute of t echnology (EPF l); lausanne, s witzerland",Non-OADS,/arxiv_data1/oa_pdf/67/19/cc-13-177.PMC3906231.pdf
EMBO J 2013; 32:2517-29;  PMID :23921553 ; http://dx.doi.org/10.1038/ emboj.2013.172 2.,Non-OADS,/arxiv_data1/oa_pdf/67/19/cc-13-177.PMC3906231.pdf
Cell  2013; 154: 391-402;  PMID:23870127 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/67/19/cc-13-177.PMC3906231.pdf
Curr Opin Cell Biol 2013; 25:741- 48; PMID:23958212; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/67/19/cc-13-177.PMC3906231.pdf
Mol Cell Biol 2010; 30:3519- 30; PMID:20479129 ; http://dx.doi.org/10.1128/ MCB.00394-10 5.,Non-OADS,/arxiv_data1/oa_pdf/67/19/cc-13-177.PMC3906231.pdf
Nat Cell Biol 2012; 14:311 -7;  PMID:22327364 ; http://dx.doi.org/10.1038/ ncb2440 6.,OADS,/arxiv_data1/oa_pdf/67/19/cc-13-177.PMC3906231.pdf
J Cell Biol 2012; 199:97-110;  PMID:23027904 ; http://dx.doi.org/10.1083/ jcb.201203166  .,OADS,/arxiv_data1/oa_pdf/67/19/cc-13-177.PMC3906231.pdf
Mol Biol Cell 2012; 23:3380-90; PMID:22809624 ; http://dx.doi.org/10.1091/mbc.,OADS,/arxiv_data1/oa_pdf/67/19/cc-13-177.PMC3906231.pdf
Dev Cell 2010; 18:533-43; PMID:20412769 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/67/19/cc-13-177.PMC3906231.pdf
"Cell Cycle 2013; 12:3564–73;  PMID:24121663; http://dx.doi.org/10.4161/cc.26771 Francesca Cutruzzolà1, Luciana Avigliano2, and Eleonora Candi2,*; 1Sapienza University of Rome; Department of Biochemistry “A.",Non-OADS,/arxiv_data1/oa_pdf/c3/51/cc-13-179.PMC3906232.pdf
"Rossi Fanelli”; Rome, Italy;  2University of Tor Vergata; Department of Experimental Medicine and Surgery; Rome, Italy; *Email: candi@uniroma2.it; http://dx.doi.org/10.4161/cc.27301 Both cancer cells and aging cells exhibit  altered metabolic activity, which is, at least  in part, due to deregulation of the p53 fam - ily members.",Non-OADS,/arxiv_data1/oa_pdf/c3/51/cc-13-179.PMC3906232.pdf
Cell Cycle  2013 ; 12:3564 -73;  PMiD:24121663 ; http://dx.doi.org/10.4161/ cc.26771 2.,OADS,/arxiv_data1/oa_pdf/c3/51/cc-13-179.PMC3906232.pdf
Nature  2013 ; 493:542- 6; PM iD:23242140 ; http://dx.doi.org/10.1038/ nature11743 3.,Non-OADS,/arxiv_data1/oa_pdf/c3/51/cc-13-179.PMC3906232.pdf
Genes Dev 2012 ; 26:2009 -14;  PMiD:22987635 ; http://dx.doi.org/10.1101/ gad.197640.112 4.,OADS,/arxiv_data1/oa_pdf/c3/51/cc-13-179.PMC3906232.pdf
Nat Cell Biol 2013 ; 15:991-1000 ;  PMiD:23811687 ; http://dx.doi.org/10.1038/ ncb2789 5.,OADS,/arxiv_data1/oa_pdf/c3/51/cc-13-179.PMC3906232.pdf
Cell Cycle  2013 ; 12:1395 -405;  PMiD:23574722 ; http://dx.doi.org/10.4161/ cc.24478 6.,OADS,/arxiv_data1/oa_pdf/c3/51/cc-13-179.PMC3906232.pdf
Proc Natl Acad s ci U s A 2010 ;  107:7461 -6; PM iD:20351271 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c3/51/cc-13-179.PMC3906232.pdf
Proc Natl Acad s ci U s A 2010 ; 107:7455 - 60; PM iD:20378837 ; http://dx.doi.org/10.1073/ pnas.1001006107,OADS,/arxiv_data1/oa_pdf/c3/51/cc-13-179.PMC3906232.pdf
"Cell Cycle 2014; 13: 138–47;   PMID:24196447; http://dx.doi.org/10.4161/cc.26885 Luis A Rokeach *, Mehdi  Jbel, and Dominic Dulude; Department of Biochemistry and Molecular Medicine; Université de Montréal; Montréal, Québec, Canada;   *Email: luis.rokeach@umontreal.ca; http://dx.doi.org/10.4161/cc.27302 For multicellular organisms, cell death can  be as important as life itself.",Non-OADS,/arxiv_data1/oa_pdf/e7/44/cc-13-181.PMC3906233.pdf
Cell Death Differ  2005 ; 12(suppl 2 ):1463 - 7; PM iD:16247491 ; http://dx.doi.org/10.1038/ sj.cdd.4401724 2.,Non-OADS,/arxiv_data1/oa_pdf/e7/44/cc-13-181.PMC3906233.pdf
"Cell Death Differ  2012 ; 19:107- 20; PM iD:21760595 ; http://dx.doi.org/10.1038/ cdd.2011.96 3. s heibani s , et al.",OADS,/arxiv_data1/oa_pdf/e7/44/cc-13-181.PMC3906233.pdf
Cell Cycle 2014; 13; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e7/44/cc-13-181.PMC3906233.pdf
Cell Cycle  2012 ; 11:3443 -62;  PMi D:22894934 ; http://dx.doi.org/10.4161/ cc.21754 6.,OADS,/arxiv_data1/oa_pdf/e7/44/cc-13-181.PMC3906233.pdf
Dev Cell  2009 ; 17:98-109;  PMiD:19619495 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e7/44/cc-13-181.PMC3906233.pdf
Dev Cell  2009 ; 17:87-97;  PMiD:19619494 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e7/44/cc-13-181.PMC3906233.pdf
Genetics  2013 ; 194:341-61;  PMiD:23733851 ; http://dx.doi.org/10.1534/ genetics.112.149013 Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/e7/44/cc-13-181.PMC3906233.pdf
"Cell Cycle 2014; 13: 106–14;   PMID:24196443; http://dx.doi.org/10.4161/cc.26814 Pradip  Raychaudhuri ; Department of Biochemistry and Molecular Genetics (M/C 669); University of Illinois at Chicago; College of Medicine; Chicago, IL USA;   Email: pradip@uic.edu; http://dx.doi.org/10.4161/cc.27303 BRCA1, which is mutated in the familial  forms of breast and ovarian cancer, plays  important roles in genome stability through  its participation in DNA damage response  (DDR) following double-stranded breaks  (DsBs).",Non-OADS,/arxiv_data1/oa_pdf/ce/d5/cc-13-183.PMC3906234.pdf
Mol Cell  2010 ; 40:179-204;  PMi D:20965415 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ce/d5/cc-13-183.PMC3906234.pdf
Mol Cell  2012 ; 47:497-510;  PMiD:22920291 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ce/d5/cc-13-183.PMC3906234.pdf
Cell 2012 ; 150:1182 -95;  PMiD:22980979 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ce/d5/cc-13-183.PMC3906234.pdf
science  2007 ; 316:1198 -202;  PMi D:17525341 ; http://dx.doi.org/10.1126/ science.1139516 5.,Non-OADS,/arxiv_data1/oa_pdf/ce/d5/cc-13-183.PMC3906234.pdf
eMBO J 2012 ; 31:1865 -78;  PMiD:22373579 ; http://dx.doi.org/10.1038/ emboj.2012.47 6.,Non-OADS,/arxiv_data1/oa_pdf/ce/d5/cc-13-183.PMC3906234.pdf
J Biol Chem 2013 ; 288:16579 -87;  PMiD:23615962 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/ce/d5/cc-13-183.PMC3906234.pdf
Curr Biol  2007 ; 17:1972 -7;  PMiD:17980597 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ce/d5/cc-13-183.PMC3906234.pdf
"17 H3.3 is con - stitutively expressed throughout the cell cycle and in quiescence18  and is incorporated into chromatin in a DNA synthesis-inde - pendent manner.19,20 It is enriched within actively transcribed  genes,21-25 but also accumulates at pericentromeric and telo - meric heterochromatin regions.26-28 While the histone chaperone  *Correspondence to: Armelle Corpet; Email: armelle.corpet@usz.ch;  Manuel Stucki; Email: manuel.stucki@usz.ch Submitted: 07/17/2013; Revised: 10/29/2013; Accepted: 10/29/2013http://dx.doi.org/10.4161/cc.26988Dynamics of histone H3.3 deposition   in proliferating and senescent cells reveals a  DAXX-dependent targeting to PML-NBs important  for pericentromeric heterochromatin organization Armelle Corpet*, t eresa o lbrich, Myriam Gwerder, Daniel Fink, and Manuel Stucki* Departement of Gynecology; University Hospital Zürich; Schlieren, Switzerland Keywords:  chromatin dynamics, H3.3, DAXX, senescence, PML-NBs Abbreviations:  ATRX, alpha-thalassemia mental retardation X-linked; DAXX, death-domain associated protein;   HP1, heterochromatin protein 1; OIS, oncogene-induced senescence; PML, promyelocytic leukemia;   PML-NBs, PML nuclear bodies; SAHF, senescence associated heterochromatin foci oncogene-induced senescence is a permanent cell cycle arrest characterized by extensive chromatin reorganization.",Non-OADS,/arxiv_data1/oa_pdf/d4/bb/cc-13-249.PMC3906242.pdf
Exp Cell Res 1961;  25:585-621;  PMID:13905658 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d4/bb/cc-13-249.PMC3906242.pdf
Gene 2007; 397:84-93;  PMID:17544228 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d4/bb/cc-13-249.PMC3906242.pdf
Br J Cancer 2007; 96:686-91;  PMID:17311013 ; http://dx.doi.org/10.1038/ sj.bjc.6603636 4.,Non-OADS,/arxiv_data1/oa_pdf/d4/bb/cc-13-249.PMC3906242.pdf
Cell 1997; 88:593-602; PMID:9054499 ;  http://dx.doi.org/10.1016/S0092-8674(00)81902-95.,OADS,/arxiv_data1/oa_pdf/d4/bb/cc-13-249.PMC3906242.pdf
Genes Dev  2001; 15:398-403;  PMID:11230148 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d4/bb/cc-13-249.PMC3906242.pdf
Nature 2006; 444:638-42; PMID:17136094 ; http://dx.doi.org/10.1038/ nature053278.,OADS,/arxiv_data1/oa_pdf/d4/bb/cc-13-249.PMC3906242.pdf
Genes Dev 2007; 21:43-8; PMID:17210786 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d4/bb/cc-13-249.PMC3906242.pdf
Nature 2005; 436:720- 4; PMID:16079850 ; http://dx.doi.org/10.1038/ nature03890 10.,OADS,/arxiv_data1/oa_pdf/d4/bb/cc-13-249.PMC3906242.pdf
Nature 2005; 436:642-642;  PMID:16079833 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d4/bb/cc-13-249.PMC3906242.pdf
Mol Cell Biol 2005; 25:2660-72; PMID:15767672 ; http://dx.doi.org/10.1128/ MCB.25.7.2660-2672.2005 13.,Non-OADS,/arxiv_data1/oa_pdf/d4/bb/cc-13-249.PMC3906242.pdf
Nat Rev Mol Cell Biol  2012; 13:436-47;  PMID:22722606 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d4/bb/cc-13-249.PMC3906242.pdf
Nat Rev Mol Cell Biol  2010; 11:264-75;  PMID:20197778 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d4/bb/cc-13-249.PMC3906242.pdf
Cell Res  2011; 21:421-34;  PMID:21263457 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d4/bb/cc-13-249.PMC3906242.pdf
Cell 1982; 31:367-74; PMID :7159927 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d4/bb/cc-13-249.PMC3906242.pdf
Cell 2004; 116:51-61; PMID:14718166 ; http://dx.doi.org/10.1016/ S0092-8674(03)01064-X 20.,OADS,/arxiv_data1/oa_pdf/d4/bb/cc-13-249.PMC3906242.pdf
Mol Cell 2002; 9:1191- 200;  PMID:12086617 ; http://dx.doi.org/10.1016/ S1097-2765(02)00542-7 22.,OADS,/arxiv_data1/oa_pdf/d4/bb/cc-13-249.PMC3906242.pdf
Genes Dev 2005; 19:1761-6; PMID:16077006 ;  http://dx.doi.org/10.1101/gad.347705 24.,OADS,/arxiv_data1/oa_pdf/d4/bb/cc-13-249.PMC3906242.pdf
EMBO Rep 2005; 6:354- 60; PMID :15776021 ; http://dx.doi.org/10.1038/ sj.embor.7400366 26.,OADS,/arxiv_data1/oa_pdf/d4/bb/cc-13-249.PMC3906242.pdf
Genes Dev 2010; 24:1253-65;  PMID:20504901 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d4/bb/cc-13-249.PMC3906242.pdf
Cell  2010; 140:678-91;  PMID:20211137 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d4/bb/cc-13-249.PMC3906242.pdf
Genome Res 2009; 19:404- 14; PMID:19196724 ; http://dx.doi.org/10.1101/ gr.084947.108 29.,OADS,/arxiv_data1/oa_pdf/d4/bb/cc-13-249.PMC3906242.pdf
Mol Cell 2002; 9:1091-100;  PMID:12049744 ; http://dx.doi.org/10.1016/ S1097-2765(02)00526-9 30.,OADS,/arxiv_data1/oa_pdf/d4/bb/cc-13-249.PMC3906242.pdf
Mol Biosyst 2009; 5:269- 75; PMID:19225618 ; http://dx.doi.org/10.1039/ b816424j 31.,Non-OADS,/arxiv_data1/oa_pdf/d4/bb/cc-13-249.PMC3906242.pdf
Mol Cell Biol 2009; 29:758-70; PMID:19029251 ; http://dx.doi.org/10.1128/ MCB.01047-08 32.,Non-OADS,/arxiv_data1/oa_pdf/d4/bb/cc-13-249.PMC3906242.pdf
Mol Cell Biol  2011; 31:4107-18;  PMID:21807893 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d4/bb/cc-13-249.PMC3906242.pdf
Nature 2012; 482:226- 31; PMID:22286061 ; http://dx.doi.org/10.1038/ nature10833 35.,Non-OADS,/arxiv_data1/oa_pdf/d4/bb/cc-13-249.PMC3906242.pdf
Cancer Cell 2012; 22:425-37; PMID:23079654 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/d4/bb/cc-13-249.PMC3906242.pdf
Acta Neuropathol 2012; 124:439-47;  PMID:22661320 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d4/bb/cc-13-249.PMC3906242.pdf
Science 2011; 331:1199- 203; PMID :21252315 ; http://dx.doi.org/10.1126/ science.1200609 39.,Non-OADS,/arxiv_data1/oa_pdf/d4/bb/cc-13-249.PMC3906242.pdf
Science 2011; 333:425;  PMID:21719641 ; http://dx.doi.org/10.1126/ science.1207313 40.,Non-OADS,/arxiv_data1/oa_pdf/d4/bb/cc-13-249.PMC3906242.pdf
Nat Rev Genet  2013; 14:62-75;  PMID:23247436 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d4/bb/cc-13-249.PMC3906242.pdf
Nat Cell Biol 2011; 13:292-302;  PMID:21336312 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d4/bb/cc-13-249.PMC3906242.pdf
Cell  2006; 126:503-14;  PMID:16901784 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d4/bb/cc-13-249.PMC3906242.pdf
Dev Cell 2005; 8:19-30; PMID :15621527 ;  http://dx.doi.org/10.1016/j.devcel.2004.10.019 45.,OADS,/arxiv_data1/oa_pdf/d4/bb/cc-13-249.PMC3906242.pdf
Nature 1998; 393:599-601;  PMID:9634239 ; http://dx.doi.org/10.1038/31275 46.,Non-OADS,/arxiv_data1/oa_pdf/d4/bb/cc-13-249.PMC3906242.pdf
Mol Cell Biol 2007; 27:2452- 65; PMID:17242198 ; http://dx.doi.org/10.1128/ MCB.01592-06,Non-OADS,/arxiv_data1/oa_pdf/d4/bb/cc-13-249.PMC3906242.pdf
Nat Rev Mol Cell Biol 2007; 8:1006-16;  PMID:17928811 ; http://dx.doi.org/10.1038/ nrm2277 49.,OADS,/arxiv_data1/oa_pdf/d4/bb/cc-13-249.PMC3906242.pdf
Cold Spring Harb Perspect Biol 2010;  2:a000661-000661;  PMID:20452955 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d4/bb/cc-13-249.PMC3906242.pdf
J Cell Biol 2007; 176:795-805; PMID:17339380 ; http://dx.doi.org/10.1083/ jcb.200701066 53.,OADS,/arxiv_data1/oa_pdf/d4/bb/cc-13-249.PMC3906242.pdf
Nat Biotechnol 2003; 21:86-9;  PMID:12469133 ; http://dx.doi.org/10.1038/nbt765 54.,Non-OADS,/arxiv_data1/oa_pdf/d4/bb/cc-13-249.PMC3906242.pdf
Proc Natl Acad Sci U S A 1995; 92:9363- 7; PMID:7568133 ; http://dx.doi.org/10.1073/ pnas.92.20.9363 56.,OADS,/arxiv_data1/oa_pdf/d4/bb/cc-13-249.PMC3906242.pdf
Genes Dev 2009; 23:798- 803; PMID:19279323 ; http://dx.doi.org/10.1101/ gad.519709 58.,Non-OADS,/arxiv_data1/oa_pdf/d4/bb/cc-13-249.PMC3906242.pdf
EMBO J 2011; 30:480- 93; PMID:21179005 ; http://dx.doi.org/10.1038/ emboj.2010.335 59.,Non-OADS,/arxiv_data1/oa_pdf/d4/bb/cc-13-249.PMC3906242.pdf
J Cell Sci 2004; 117:3807- 20; PMID:15252119 ; http://dx.doi.org/10.1242/ jcs.01230 61.,OADS,/arxiv_data1/oa_pdf/d4/bb/cc-13-249.PMC3906242.pdf
PLoS One 2011; 6:e17036;  PMID:21347226 ; http://dx.doi.org/10.1371/jour - nal.pone.001703662.,Non-OADS,/arxiv_data1/oa_pdf/d4/bb/cc-13-249.PMC3906242.pdf
J Cell Biol 2004; 164:515- 26; PMID:14970191 ; http://dx.doi.org/10.1083/ jcb.200305142 63.,OADS,/arxiv_data1/oa_pdf/d4/bb/cc-13-249.PMC3906242.pdf
J Struct Biol 2002; 140:167-79; PMID:12490165 ;  http://dx.doi.org/10.1016/S1047-8477(02)00571-3 64.,OADS,/arxiv_data1/oa_pdf/d4/bb/cc-13-249.PMC3906242.pdf
J Cell Biol 2000; 148:283-92; PMID:10648561 ;  http://dx.doi.org/10.1083/jcb.148.2.283 65.,OADS,/arxiv_data1/oa_pdf/d4/bb/cc-13-249.PMC3906242.pdf
Nat Rev Mol Cell Biol  2004; 5:296-304;  PMID :15071554 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d4/bb/cc-13-249.PMC3906242.pdf
Nucleus 2012; 3:276-85;  PMID:22572957 ; http://dx.doi.org/10.4161/ nucl.20180 67.,OADS,/arxiv_data1/oa_pdf/d4/bb/cc-13-249.PMC3906242.pdf
Science 2010; 328:1161-4; PMID:20508129 ; http://dx.doi.org/10.1126/ science.1186777 68.,Non-OADS,/arxiv_data1/oa_pdf/d4/bb/cc-13-249.PMC3906242.pdf
Nat Struct  Mol Biol 2010; 17:1218-25; PMID:20890289 ;  http://dx.doi.org/10.1038/nsmb.1897 71.,OADS,/arxiv_data1/oa_pdf/d4/bb/cc-13-249.PMC3906242.pdf
Cancer Res  2004; 64:2371-81;  PMID:15059888 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d4/bb/cc-13-249.PMC3906242.pdf
EMBO J 2003; 22:4212-22; PMID:12912919 ; http://dx.doi.org/10.1093/emboj/ cdg417 74.,OADS,/arxiv_data1/oa_pdf/d4/bb/cc-13-249.PMC3906242.pdf
Nucleus 2013;  4:23-8;  PMID:23232545 ; http://dx.doi.org/10.4161/ nucl.23189   75.,OADS,/arxiv_data1/oa_pdf/d4/bb/cc-13-249.PMC3906242.pdf
J Biol Chem 2006; 281:559-68; PMID:16267050 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/d4/bb/cc-13-249.PMC3906242.pdf
Mol Cell 2012; 47:203-14;  PMID:22795131 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d4/bb/cc-13-249.PMC3906242.pdf
Mol Cell Biol 2007; 27:2343-58;  PMID:17242207 ; http://dx.doi.org/10.1128/ MCB.02019-06 79.,Non-OADS,/arxiv_data1/oa_pdf/d4/bb/cc-13-249.PMC3906242.pdf
Cell Cycle 2011; 10:457- 68; PMID:21248468 ; http://dx.doi.org/10.4161/ cc.10.3.14707 80.,OADS,/arxiv_data1/oa_pdf/d4/bb/cc-13-249.PMC3906242.pdf
Mol Cell 2006; 24:309-16;  PMID:17052464 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d4/bb/cc-13-249.PMC3906242.pdf
Nature 2012; 491:560- 5; PMID:23075851 ; http://dx.doi.org/10.1038/ nature11608 83.,Non-OADS,/arxiv_data1/oa_pdf/d4/bb/cc-13-249.PMC3906242.pdf
Nat Struct Mol Biol 2012; 19:1287-92;  PMID:23142979 ; http://dx.doi.org/10.1038/ nsmb.2439 84.,OADS,/arxiv_data1/oa_pdf/d4/bb/cc-13-249.PMC3906242.pdf
Genome Res 2013; 23:440-51;  PMID:23222847 ; http://dx.doi.org/10.1101/ gr.142703.112 85.,OADS,/arxiv_data1/oa_pdf/d4/bb/cc-13-249.PMC3906242.pdf
Hum Mol Genet 2011; 20:2195-203;  PMID:21421568 ; http://dx.doi.org/10.1093/hmg/ ddr107 86.,OADS,/arxiv_data1/oa_pdf/d4/bb/cc-13-249.PMC3906242.pdf
Biochem Biophys Res Commun 2005;  331:929-37;  PMID:15882967 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d4/bb/cc-13-249.PMC3906242.pdf
Genes Dev 2012; 26:433- 8; PMID:22391447 ; http://dx.doi.org/10.1101/ gad.179416.111 88.,OADS,/arxiv_data1/oa_pdf/d4/bb/cc-13-249.PMC3906242.pdf
J Cell Sci 2006; 119:2518-31;  PMID:16735446 ; http://dx.doi.org/10.1242/ jcs.02965 90.,OADS,/arxiv_data1/oa_pdf/d4/bb/cc-13-249.PMC3906242.pdf
Proc Natl Acad Sci U S A 1998; 95:7316-21;  PMID:9636146 ; http://dx.doi.org/10.1073/ pnas.95.13.7316 91.,OADS,/arxiv_data1/oa_pdf/d4/bb/cc-13-249.PMC3906242.pdf
Cell Cycle 2011; 10:308-22; PMID:21228624 ;  http://dx.doi.org/10.4161/cc.10.2.14551 92.,OADS,/arxiv_data1/oa_pdf/d4/bb/cc-13-249.PMC3906242.pdf
Nucleic Acids Res  2013; 41:4447-58;  PMID:23444137 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d4/bb/cc-13-249.PMC3906242.pdf
Genes Dev 2011; 25:41-50; PMID:21205865 ; http://dx.doi.org/10.1101/ gad.197511194.,OADS,/arxiv_data1/oa_pdf/d4/bb/cc-13-249.PMC3906242.pdf
J Cell Biol 2008; 180:315- 24; PMID:18227278 ; http://dx.doi.org/10.1083/ jcb.200706083 97.,OADS,/arxiv_data1/oa_pdf/d4/bb/cc-13-249.PMC3906242.pdf
Mol Cell Biol  2003; 23:7108-21;  PMID:14517282 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d4/bb/cc-13-249.PMC3906242.pdf
Mol Cell Biol 2007; 27:949-62; PMID:17101789 ;  http://dx.doi.org/10.1128/MCB.01639-06 102.,Non-OADS,/arxiv_data1/oa_pdf/d4/bb/cc-13-249.PMC3906242.pdf
Cell Death Differ 2009; 16:298-311;  PMID:19023333 ; http://dx.doi.org/10.1038/ cdd.2008.158 103.,Non-OADS,/arxiv_data1/oa_pdf/d4/bb/cc-13-249.PMC3906242.pdf
J Cell Biol 1998; 143:563- 75; PMID:9813080 ; http://dx.doi.org/10.1083/ jcb.143.3.563 104.,OADS,/arxiv_data1/oa_pdf/d4/bb/cc-13-249.PMC3906242.pdf
"2,5,6  In these primitive steps, O2 must be utilized through the  respiratory chain to set the cellular redox state, expressed by the  *Correspondence to: Massimo Olivotto; Email: olivotto@unifi.it Submitted: 07/09/2013; Revised: 10/31/2013; Accepted: 10/31/2013http://dx.doi.org/10.4161/cc.27031Hypoxia-resistant profile implies vulnerability   of cancer stem cells to physiological agents,   which suggests new therapeutic targets Maria Grazia Cipolleschi1,†, Ilaria Marzi1,†, Roberta Santini2, David Fredducci1, Maria Cristina Vinci2, Massimo D’Amico1,  elisabetta Rovida1, theodora Stivarou1, eugenio t orre1, persio Dello Sbarba1, Barbara Stecca2, and Massimo o livotto1,* 1Department of Biomedical, e xperimental and Clinical Sciences; University of Florence; Florence, Italy; 2Laboratory of t umor Cell Biology; Core Research Laboratory-Istituto  toscano t umori (CRL-I tt); Florence, Italy †these authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/2f/ed/cc-13-268.PMC3906243.pdf
Cell Stem Cell 2010; 7:380-90;  PMID:20804973 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/2f/ed/cc-13-268.PMC3906243.pdf
Cell Cycle 2013; 12:353-64; PMID:23287475 ; http://dx.doi.org/10.4161/ cc.23200 3.,OADS,/arxiv_data1/oa_pdf/2f/ed/cc-13-268.PMC3906243.pdf
Cell Stem Cell 2010; 7:380-90;  PMID:20804973 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/2f/ed/cc-13-268.PMC3906243.pdf
J Cell Physiol  1983; 116:149-58;  PMID:6863398 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2f/ed/cc-13-268.PMC3906243.pdf
Cell 2006; 126:663- 76; PMID:16904174 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/2f/ed/cc-13-268.PMC3906243.pdf
J Cell Physiol 1981; 108:365-73; PMID:7287825 ; http://dx.doi.org/10.1002/ jcp.1041080310 13.,Non-OADS,/arxiv_data1/oa_pdf/2f/ed/cc-13-268.PMC3906243.pdf
Science 2009; 324:1029-33;  PMID:19460998 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2f/ed/cc-13-268.PMC3906243.pdf
Stem Cells  2012; 30:1808-18;  PMID:22730244 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2f/ed/cc-13-268.PMC3906243.pdf
Nature 2013; 498:109-12;  PMID:23685455 ; http://dx.doi.org/10.1038/ nature12154 17.,Non-OADS,/arxiv_data1/oa_pdf/2f/ed/cc-13-268.PMC3906243.pdf
Biochem J 2000;  350:609-29;  PMID:10970772 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2f/ed/cc-13-268.PMC3906243.pdf
Leuk Res  1989; 13:595-8;  PMID:2761291 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2f/ed/cc-13-268.PMC3906243.pdf
Clin Biochem 2005; 38:997-1008;  PMID:16139832 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/2f/ed/cc-13-268.PMC3906243.pdf
Leukemia 2006; 20:1291-3;  PMID:16710305 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2f/ed/cc-13-268.PMC3906243.pdf
"*Correspondence to: Thomas O’Brien; Email: obrien.tom@gene.com Submitted: 10/04/2013; Accepted: 11/02/2013http://dx.doi.org/10.4161/cc.27055Chk1 inhibition in p53-deficient cell lines drives  rapid chromosome fragmentation followed   by caspase-independent cell death Christopher J Del Nagro1, Jonathan Choi1, Yang Xiao1, Linda Rangell2, Sankar Mohan3,†, Ajay p andita3,†,   Jiping Zha2,‡, peter K Jackson1,§, and t homas o ’Brien1,* 1Discovery o ncology; Genentech; San Francisco, CA; 2Department of p athology; Genentech; San Francisco, CA; 3Department of Research Diagnostics;   Genentech; San Francisco, CA Current affiliations: †oncoMDx; p alo Alto, CA USA; ‡Crown Bioscience; Jiangsu p rovince, p R, China; §Stanford University Medical Center; p alo Alto, CA USA Keywords:  Chk1, GNE-783, p53, gemcitabine, chemo-potentiation, checkpoint-bypass Activation of Checkpoint kinase 1 (Chk1) following DNA damage mediates cell cycle arrest to prevent cells with  damaged DNA from entering mitosis.",Non-OADS,/arxiv_data1/oa_pdf/04/e1/cc-13-303.PMC3906246.pdf
Science 1986; 232:1264-6; PMID:2422760 ; http://dx.doi.org/10.1126/ science.2422760 2.,OADS,/arxiv_data1/oa_pdf/04/e1/cc-13-303.PMC3906246.pdf
Proc Natl Acad Sci U S A 2001; 98:9092-7;  PMID:11481475 ; http://dx.doi.org/10.1073/ pnas.161281798 3.,OADS,/arxiv_data1/oa_pdf/04/e1/cc-13-303.PMC3906246.pdf
Cancer Res 2005; 65:6835-42;  PMID:16061666 ; http://dx.doi.org/10.1158/0008- 5472.CAN-04-2246 4.,Non-OADS,/arxiv_data1/oa_pdf/04/e1/cc-13-303.PMC3906246.pdf
Mol Cancer Ther 2013; 12:2285-95;  PMID:24038068 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/04/e1/cc-13-303.PMC3906246.pdf
Mol Cancer Ther 2008; 7:2394-404;  PMID:18723486 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/04/e1/cc-13-303.PMC3906246.pdf
Mol Cancer Ther 2011; 10:591-602; PMID:21321066 ; http://dx.doi.org/10.1158/1535- 7163.MCT-10-0928 9.,Non-OADS,/arxiv_data1/oa_pdf/04/e1/cc-13-303.PMC3906246.pdf
Cancer Res 2010; 70:4972-81; PMID:20501833 ;  http://dx.doi.org/10.1158/0008-5472.CAN-09-357311.,Non-OADS,/arxiv_data1/oa_pdf/04/e1/cc-13-303.PMC3906246.pdf
Clin Cancer Res  2007; 13:591-602;  PMID:17255282 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/04/e1/cc-13-303.PMC3906246.pdf
Mol Cancer Ther 2007; 6:1239-48;  PMID:17406032 ; http://dx.doi.org/10.1158/1535- 7163.MCT-06-0633 14.,Non-OADS,/arxiv_data1/oa_pdf/04/e1/cc-13-303.PMC3906246.pdf
Trends Mol Med 2011; 17:88-96;  PMID:21087899 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/04/e1/cc-13-303.PMC3906246.pdf
J Clin Oncol 2006;  24:1770-83;  PMID:16603719 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/04/e1/cc-13-303.PMC3906246.pdf
Nature 2005;  438:1176-80;  PMID:16222244 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/04/e1/cc-13-303.PMC3906246.pdf
Mol Cell  2004 ; 15:799-811;  PMID :15350223 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/04/e1/cc-13-303.PMC3906246.pdf
Cell 2008; 134:256-67; PMID:18662541 ;  http://dx.doi.org/10.1016/j.cell.2008.05.043 20.,OADS,/arxiv_data1/oa_pdf/04/e1/cc-13-303.PMC3906246.pdf
Curr Biol 2007; 17:316-22; PMID:17291758 ;  http://dx.doi.org/10.1016/j.cub.2006.12.037 21.,OADS,/arxiv_data1/oa_pdf/04/e1/cc-13-303.PMC3906246.pdf
Cancer Cell 2008; 14:111-22;  PMID:18656424 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/04/e1/cc-13-303.PMC3906246.pdf
Dev Cell 2007; 12:247- 60; PMID:17276342 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/04/e1/cc-13-303.PMC3906246.pdf
Proc Natl Acad Sci U S A 2009;  106 :5159-64 ;  PMID:19289837 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/04/e1/cc-13-303.PMC3906246.pdf
Proc Natl Acad Sci U S A 2006; 103:11964-9;  PMID:16873548 ; http://dx.doi.org/10.1073/ pnas.0604987103 25.,OADS,/arxiv_data1/oa_pdf/04/e1/cc-13-303.PMC3906246.pdf
DNA Repair (Amst) 2012; 11:781- 8; PMID:22889934 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/04/e1/cc-13-303.PMC3906246.pdf
Mol Cancer Ther  2013; 12:1968-80;  PMID:23873850 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/04/e1/cc-13-303.PMC3906246.pdf
Int J Cancer  2006; 119:2784-94;  PMID:17019715 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/04/e1/cc-13-303.PMC3906246.pdf
Science 1998; 282:1497- 501; PMID:9822382 ; http://dx.doi.org/10.1126/ science.282.5393.1497 31.,Non-OADS,/arxiv_data1/oa_pdf/04/e1/cc-13-303.PMC3906246.pdf
Cell Cycle 2008; 7:277-82; PMID:18235223 ;  http://dx.doi.org/10.4161/cc.7.3.5328 32.,OADS,/arxiv_data1/oa_pdf/04/e1/cc-13-303.PMC3906246.pdf
Science 1992; 257:1955- 7; PMID:1384126 ; http://dx.doi.org/10.1126/ science.1384126 33.,OADS,/arxiv_data1/oa_pdf/04/e1/cc-13-303.PMC3906246.pdf
Clin Cancer Res 2011; 17:4200- 7; PMID:21562035 ; http://dx.doi.org/10.1158/1078- 0432.CCR-10-2537 34.,Non-OADS,/arxiv_data1/oa_pdf/04/e1/cc-13-303.PMC3906246.pdf
EMBO J 2007; 26:2719-31; PMID:17491592 ;  http://dx.doi.org/10.1038/sj.emboj.7601714 35.,Non-OADS,/arxiv_data1/oa_pdf/04/e1/cc-13-303.PMC3906246.pdf
Proc Natl Acad Sci U S A 2010; 107:16090-5;  PMID:20805465 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/04/e1/cc-13-303.PMC3906246.pdf
Cell Cycle 2009; 8:1036-43; PMID:19270516 ;  http://dx.doi.org/10.4161/cc.8.7.8040 37.,Non-OADS,/arxiv_data1/oa_pdf/04/e1/cc-13-303.PMC3906246.pdf
Mol Cancer Ther 2010; 9:89-100;  PMID:20053762 ; http://dx.doi.org/10.1158/1535- 7163.MCT-09-0938 38.,Non-OADS,/arxiv_data1/oa_pdf/04/e1/cc-13-303.PMC3906246.pdf
Xenobiotica 2008; 38:995-1021;  PMID:18668437 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/04/e1/cc-13-303.PMC3906246.pdf
Cell Cycle 2011; 10:2121-8; PMID:21610326 ;  http://dx.doi.org/10.4161/cc.10.13.16398 40.,OADS,/arxiv_data1/oa_pdf/04/e1/cc-13-303.PMC3906246.pdf
Cell Cycle 2007; 6:104-10; PMID:17245119 ; http://dx.doi.org/10.4161/ cc.6.1.3699 41.,OADS,/arxiv_data1/oa_pdf/04/e1/cc-13-303.PMC3906246.pdf
Cell Cycle 2010; 9:995- 1004;  PMID:20160494 ; http://dx.doi.org/10.4161/ cc.9.5.10935 42.,OADS,/arxiv_data1/oa_pdf/04/e1/cc-13-303.PMC3906246.pdf
Mol Cancer Ther 2009; 8:45-54; PMID:19139112 ; http://dx.doi.org/10.1158/1535- 7163.MCT-08-066244.,Non-OADS,/arxiv_data1/oa_pdf/04/e1/cc-13-303.PMC3906246.pdf
Mol  Cancer Ther 2011; 10:784-94; PMID:21430130 ;  http://dx.doi.org/10.1158/1535-7163.MCT-10-0809 46.,Non-OADS,/arxiv_data1/oa_pdf/04/e1/cc-13-303.PMC3906246.pdf
Invest New Drugs 2011; 29:514-22;  PMID:20024691 ; http://dx.doi.org/10.1007/ s10637-009-9361-2 47.,Non-OADS,/arxiv_data1/oa_pdf/04/e1/cc-13-303.PMC3906246.pdf
EMBO J 2009; 28:3216-27;  PMID:19730412 ; http://dx.doi.org/10.1038/ emboj.2009.253 48.,Non-OADS,/arxiv_data1/oa_pdf/04/e1/cc-13-303.PMC3906246.pdf
Clin  Cancer Res 2010; 16:2076-84; PMID:20233881 ;  http://dx.doi.org/10.1158/1078-0432.CCR-09-3277 49.,Non-OADS,/arxiv_data1/oa_pdf/04/e1/cc-13-303.PMC3906246.pdf
Oncogene 2013; 32:577-88; PMID:22430210 ;  http://dx.doi.org/10.1038/onc.2012.84 50.,Non-OADS,/arxiv_data1/oa_pdf/04/e1/cc-13-303.PMC3906246.pdf
FEBS Lett 2005; 579:1001-7;  PMID :15710382 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/04/e1/cc-13-303.PMC3906246.pdf
Biomarkers  2008; 13:579-96;  PMID:18671143 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/04/e1/cc-13-303.PMC3906246.pdf
Mol Cancer Ther 2009; 8:2992-3000; PMID:19887545 ;  http://dx.doi.org/10.1158/1535-7163.MCT-09-0463 53.,Non-OADS,/arxiv_data1/oa_pdf/04/e1/cc-13-303.PMC3906246.pdf
Oncol Rep 2010; 23:1183-92;  PMID:20372829 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/04/e1/cc-13-303.PMC3906246.pdf
Proc Natl Acad Sci U S A  2003; 100:7977-82;  PMID:12799470 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/04/e1/cc-13-303.PMC3906246.pdf
Cytogenet Genome Res  2011; 134:27-39;  PMID:21508638 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/04/e1/cc-13-303.PMC3906246.pdf
Science  1996; 273:494-7;  PMID:8662537 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/04/e1/cc-13-303.PMC3906246.pdf
"18 During embryonic development, blood-borne progenitor cells  of hematopoietic lineage migrate into an undeveloped thymic  *Correspondence to: Ariadne L Hager-Theodorides; Email: a.hager@aua.gr Submitted: 07/24/2013; Revised: 11/06/2013; Accepted: 11/07/2013http://dx.doi.org/10.4161/cc.27118Direct BMP2/4 signaling through BMP receptor IA  regulates fetal thymocyte progenitor homeostasis  and differentiation to CD4+CD8+   double-positive cell Ariadne L Hager- theodorides1,*, Susan e Ross2, Hemant Sahni2, Yuji Mishina3, Anna L Furmanski2, and t essa Crompton2 1Department of Animal Science and Aquaculture; Laboratory of Animal Breeding and Husbandry; Agricultural University of Athens; Athens, Greece; 2Immunobiology Unit; UCL  Institute of Child Health; London, UK; 3University of Michigan; School of Dentistry; Department of Biologic and Materials Sciences; Ann Arbor, MI USA Keywords:  BMP2/4, Noggin, BMPRIA, Alk3, Smad, thymus, DN thymocyte, DP, differentiation, T-cell development BMp2/4 signaling is required for embryogenesis and involved in thymus morphogenesis and t -lineage differentia - tion.",Non-OADS,/arxiv_data1/oa_pdf/e9/24/cc-13-324.PMC3906248.pdf
Cell Cycle 2013; 12:389- 90; PMID:23324340 ; http://dx.doi.org/10.4161/ cc.23553 3.,OADS,/arxiv_data1/oa_pdf/e9/24/cc-13-324.PMC3906248.pdf
Cell Cycle 2012; 11:1517-23; PMID:22436490 ;  http://dx.doi.org/10.4161/cc.198465.,OADS,/arxiv_data1/oa_pdf/e9/24/cc-13-324.PMC3906248.pdf
Cell Cycle 2012; 11:26-32;  PMID :22157093 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e9/24/cc-13-324.PMC3906248.pdf
Cell Cycle 2012; 11:424-5;  PMID:22262185 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e9/24/cc-13-324.PMC3906248.pdf
Trends Immunol 2003; 24:197-206;  PMID:12697452 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e9/24/cc-13-324.PMC3906248.pdf
J Exp Med 2002; 196:163- 71; PMID:12119341 ; http://dx.doi.org/10.1084/ jem.20020276 11.,Non-OADS,/arxiv_data1/oa_pdf/e9/24/cc-13-324.PMC3906248.pdf
Blood 2003; 102:3947-53; PMID:12920023 ;  http://dx.doi.org/10.1182/blood-2003-05-1657,Non-OADS,/arxiv_data1/oa_pdf/e9/24/cc-13-324.PMC3906248.pdf
Immunology 2007; 121:94-104;  PMID:17425602 ;  http://dx.doi.org/10.1111/j.1365-2567.2007.02541.x 13.,Non-OADS,/arxiv_data1/oa_pdf/e9/24/cc-13-324.PMC3906248.pdf
Cell Cycle  2009; 8:4119-26;  PMID:19923894 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e9/24/cc-13-324.PMC3906248.pdf
Blood 2012; 119:1861-71; PMID:22210872 ;  http://dx.doi.org/10.1182/blood-2011-07-370650 15.,Non-OADS,/arxiv_data1/oa_pdf/e9/24/cc-13-324.PMC3906248.pdf
Immunology 2011; 134:349-59;  PMID:21978004 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e9/24/cc-13-324.PMC3906248.pdf
Eur J Immunol 2012; 42:749-59; PMID:22144105 ; http://dx.doi.org/10.1002/ eji.201141702 17.,Non-OADS,/arxiv_data1/oa_pdf/e9/24/cc-13-324.PMC3906248.pdf
Dev Biol 2010; 339:141- 54; PMID:20043899 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e9/24/cc-13-324.PMC3906248.pdf
Immunol Rev 2010;  238:12-22;  PMID:20969581 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e9/24/cc-13-324.PMC3906248.pdf
Nat Immunol 2008; 9:1091- 4; PMID :18800157 ; http://dx.doi.org/10.1038/ ni1008-1091 22.,Non-OADS,/arxiv_data1/oa_pdf/e9/24/cc-13-324.PMC3906248.pdf
"Genesis 2002; 32:69-72;  PMID:11857780 ; http://dx.doi.org/10.1002/ gene.10038 23. de Boer J, Williams A, Skavdis G, Harker N, Coles  M, Tolaini M, Norton T, Williams K, Roderick K, Potocnik AJ, et al.",OADS,/arxiv_data1/oa_pdf/e9/24/cc-13-324.PMC3906248.pdf
Eur J Immunol 2003; 33:314-25; PMID:12548562 ;  http://dx.doi.org/10.1002/immu.200310005 24.,Non-OADS,/arxiv_data1/oa_pdf/e9/24/cc-13-324.PMC3906248.pdf
Mol Biol Cell 2000; 11:1023-35; PMID:10712517 ;  http://dx.doi.org/10.1091/mbc.11.3.102325.,OADS,/arxiv_data1/oa_pdf/e9/24/cc-13-324.PMC3906248.pdf
Cell Cycle 2010; 9:4144-52; PMID:20935514 ; http://dx.doi.org/10.4161/ cc.9.20.13453 26.,Non-OADS,/arxiv_data1/oa_pdf/e9/24/cc-13-324.PMC3906248.pdf
J Immunol  2009; 183:3023-32;  PMID:19667090 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e9/24/cc-13-324.PMC3906248.pdf
Cell Cycle 2010; 9:784-93; PMID:20139728 ;  http://dx.doi.org/10.4161/cc.9.4.10673,OADS,/arxiv_data1/oa_pdf/e9/24/cc-13-324.PMC3906248.pdf
"http://informahealthcare.com/dre ISSN 0963-8288 print/ISSN 1464-5165 online Disabil Rehabil, 2014; 36(1): 32–38 !2014 Informa UK Ltd. DOI: 10.3109/09638288.2013.776645 RESEARCH PAPER From dictatorship to a reluctant democracy: stroke therapists talking about self-management Meriel Norris and Cherry Kilbride Centre for Research in Rehabilitation, School of Health Sciences and Social Care, Brunel University, London, UK Abstract Purpose : Self-management is being increasingly promoted within chronic conditions including stroke.",Non-OADS,/arxiv_data1/oa_pdf/28/75/DRE-36-32.PMC3906249.pdf
"http://informahealthcare.com/dre ISSN 0963-8288 print/ISSN 1464-5165 online Disabil Rehabil, 2014; 36(1): 23–31 !2014 Informa UK Ltd. DOI: 10.3109/09638288.2013.775360 RESEARCH PAPER The Neurological Impairment Scale: reliability and validity as a predictor of functional outcome in neurorehabilitation Lynne Turner-Stokes1,2, Aung Thu2, Heather Williams2, Rebecca Casey2, Hilary Rose2, and Richard J. Siegert1,3 1School of Medicine, Department of Palliative Care Policy and Rehabilitation, King’s College London, London, UK,2Regional Rehabilitation Unit, Northwick Park Hospital, London, UK, and3School of Public Health and Psychosocial Studies and School of Rehabilitation and Occupational Studies, AUT University, Auckland, New Zealand Abstract Purpose : To examine the construct validity and inter-rater reliability of the Neurological Impairment Scale (NIS) and compare ratings by medical and multidisciplinary teams in a mixedneurorehabilitation sample.",Non-OADS,/arxiv_data1/oa_pdf/53/4e/DRE-36-23.PMC3906250.pdf
The full NIS together with detailedinstructions for rating is available through the UKROC website (http://www.csi.kcl.ac.uk/ukroc).,Non-OADS,/arxiv_data1/oa_pdf/53/4e/DRE-36-23.PMC3906250.pdf
"Copies of the Neurological Impairment Scale are available free of charge from the corresponding author, or downloaded from our website http://www.csi.kcl.ac.uk/NIS.html.",Non-OADS,/arxiv_data1/oa_pdf/53/4e/DRE-36-23.PMC3906250.pdf
"A follow-up on this Special Focus is planned for the end of this year, with a series of commentaries discussing  *Correspondence to: Ronald Ellis; Email: rellis@landesbioscience.com Submitted: 7/22/12; Accepted: 7/22/12http://dx.doi.org/10.4161/hv.26188Letter from the Editor ronald Ellis1,* and Eva M. r iedmann2 1senior Vice President r &d and Chief t echnology o fficer; n asVax, Ltd.; n ess Ziona, i srael; 2Acquisitions Editor; Landes Bioscience; Vienna, Austria",Non-OADS,/arxiv_data1/oa_pdf/b5/76/hvi-9-1609.PMC3906254.pdf
sci Transl  Med  2013 ; 5:91ra82 ; PM iD:23803704; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f9/34/hvi-9-1611.PMC3906255.pdf
J infect Dis 2013 ; 208:385-93;  PMiD:23785124 ; http://dx.doi.org/10.1093/infdis/ jit192 Modified DC immunotherapy against melanoma Modified dendritic cells (D cs) that can recog - nize cancer-associated protein fragments have shown promise in a small clinical trial studying melanoma.,Non-OADS,/arxiv_data1/oa_pdf/f9/34/hvi-9-1611.PMC3906255.pdf
"J clin i nvest 2013 ; 123:3135 - 45; PMi D:23934126 ; http://dx.doi.org/10.1172/ Jci67544 New study looks at clinical severity of human H7N9 infections According to a new report in The Lancet,4  the H7N9 avian influenza virus, first identi - fied in humans earlier this year, kills 36% of  infected people admitted to hospitals in  china.",Non-OADS,/arxiv_data1/oa_pdf/f9/34/hvi-9-1611.PMC3906255.pdf
lancet  2013 ; 382:138-45; PMi D:23803487 ;  http://dx.doi.org/10.1016/ s0140-6736(13)61207-6 5. riedmann  eM.,OADS,/arxiv_data1/oa_pdf/f9/34/hvi-9-1611.PMC3906255.pdf
"Hum Vaccin immunother  2013 ;  9:1187 -90; http://dx.doi.org/10.4161/hv.25576 Prevnar vaccines are valuable for healthcare systems Pfizer’s Prevnar vaccines have been very suc - cessful and, as shown by two recent studies, have been a boon for healthcare systems.",Non-OADS,/arxiv_data1/oa_pdf/f9/34/hvi-9-1611.PMC3906255.pdf
N e ngl J Med 2013 ; 369:155- 63; PM iD:23841730 ; http://dx.doi.org/10.1056/ NeJMoa1209165 7.,OADS,/arxiv_data1/oa_pdf/f9/34/hvi-9-1611.PMC3906255.pdf
BMc i nfect Dis 2013 ;  13:229; PM iD:23687999 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f9/34/hvi-9-1611.PMC3906255.pdf
J clin i nvest 2013 ; 123:3353 -62;  http://dx.doi.org/10.1172/J ci66634,OADS,/arxiv_data1/oa_pdf/f9/34/hvi-9-1611.PMC3906255.pdf
"for more information, please visit: http://novadigm.net/",Non-OADS,/arxiv_data1/oa_pdf/c8/6c/hvi-9-1615.PMC3906256.pdf
" ReseaR ch PaPeR www.landesbioscience.com human Vaccines & Immunotherapeutics 1617human Vaccines & Immunotherapeutics 9:8, 1617–1625; a ugust 2013; © 2013 Landes BioscienceReseaR ch PaPeR *Correspondence to: Christopher Clarke; Email: christopher.j.clarke@gsk.com Submitted: 01/24/13; Revised: 04/11/13; Accepted: 04/19/13http://dx.doi.org/10.4161/hv.24831Introduction Globally, rotavirus (RV) is a leading cause of severe gastroen - teritis (GE) among infants and young children resulting in sub - stantial morbidity and mortality.1 It is estimated that prior to  the introduction of RV vaccines, RV was associated with nearly  453,000 deaths and over two million hospitalizations worldwide among children below 5 y of age.",Non-OADS,/arxiv_data1/oa_pdf/4e/c4/hvi-9-1617.PMC3906257.pdf
Emerg Infect Dis 2003; 9:565- 72; PMID:12737740; http://dx.doi.org/10.3201/ eid0905.020562 2.,Non-OADS,/arxiv_data1/oa_pdf/4e/c4/hvi-9-1617.PMC3906257.pdf
Lancet Infect Dis 2012; 12:136-41; PMID:22030330; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4e/c4/hvi-9-1617.PMC3906257.pdf
"Accessed November 21, 2012 from: http://www.who.",Non-OADS,/arxiv_data1/oa_pdf/4e/c4/hvi-9-1617.PMC3906257.pdf
N Engl J Med 2006; 354:23- 33; PMID:16394299; http://dx.doi.org/10.1056/ NEJMoa052664 6.,OADS,/arxiv_data1/oa_pdf/4e/c4/hvi-9-1617.PMC3906257.pdf
N Engl J Med 2006; 354:11-22; PMID:16394298;  http://dx.doi.org/10.1056/NEJMoa052434 7.,OADS,/arxiv_data1/oa_pdf/4e/c4/hvi-9-1617.PMC3906257.pdf
N Engl J Med  2010; 362:289-98; PMID:20107214; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4e/c4/hvi-9-1617.PMC3906257.pdf
Lancet 2007; 370:1757-63;  PMID:18037080; http://dx.doi.org/10.1016/S0140- 6736(07)61744-9 9.,OADS,/arxiv_data1/oa_pdf/4e/c4/hvi-9-1617.PMC3906257.pdf
Vaccine  2009; 27:5936-41; PMID:19679216; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4e/c4/hvi-9-1617.PMC3906257.pdf
Lancet 2010; 376:615- 23; PMID:20692031; http://dx.doi.org/10.1016/ S0140-6736(10)60755-6 11.,Non-OADS,/arxiv_data1/oa_pdf/4e/c4/hvi-9-1617.PMC3906257.pdf
Eur J Pediatr 2010; 169:1379-86;  PMID:20559656; http://dx.doi.org/10.1007/s00431- 010-1242-3 13.,Non-OADS,/arxiv_data1/oa_pdf/4e/c4/hvi-9-1617.PMC3906257.pdf
"Accessed November 21, 2012 from: http://www.ncirs.",Non-OADS,/arxiv_data1/oa_pdf/4e/c4/hvi-9-1617.PMC3906257.pdf
J Paediatr Child Health 2006; 42:521-7;  PMID:16925538; http://dx.doi.org/10.1111/j.1440-1754.2006.00915.x 19.,Non-OADS,/arxiv_data1/oa_pdf/4e/c4/hvi-9-1617.PMC3906257.pdf
"Accessed November 21, 2012 from:  http://immunise.health.gov.au/internet/immunise/ publishing.nsf/Content/Handbook-rotavirus.",Non-OADS,/arxiv_data1/oa_pdf/4e/c4/hvi-9-1617.PMC3906257.pdf
Pediatr Infect Dis J 2011;  30(Suppl):S25-9; PMID:21183837; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4e/c4/hvi-9-1617.PMC3906257.pdf
Pediatr Infect Dis J 2009; 28:948-53; PMID:19859013; http://dx.doi.org/10.1097/ INF .0b013e3181a6ad6e 23.,OADS,/arxiv_data1/oa_pdf/4e/c4/hvi-9-1617.PMC3906257.pdf
J Infect Dis 2010; 201:1617-24;  PMID:20402596; http://dx.doi.org/10.1086/652403 24.,OADS,/arxiv_data1/oa_pdf/4e/c4/hvi-9-1617.PMC3906257.pdf
J Infect 2004; 49:13-6; PMID:15194242;  http://dx.doi.org/10.1016/j.jinf.2004.02.006 30.,OADS,/arxiv_data1/oa_pdf/4e/c4/hvi-9-1617.PMC3906257.pdf
"Human Vaccines & Immunotherapeutics 9:8, 1638–1642; August 2013; © 2013 Landes Bioscience SHort report 1638 Human Vaccines & Immunotherapeutics Volume 9 Issue 8*Correspondence to: Yan-Ping Li; Email: lyp898@163.com Submitted: 12/19/12; Revised: 05/09/13; Accepted: 05/17/13http://dx.doi.org/10.4161/hv.25076Rotavirus (RV) is the most common cause of severe gastroenteri - tis (GE) among infants and young children worldwide.",Non-OADS,/arxiv_data1/oa_pdf/89/bd/hvi-9-1638.PMC3906260.pdf
Emerg Infect Dis 2004; 10:988-95; PMID:15207047;  http://dx.doi.org/10.3201/eid1006.030519 2.,Non-OADS,/arxiv_data1/oa_pdf/89/bd/hvi-9-1638.PMC3906260.pdf
J Infect Dis 2005; 192(Suppl 1):S94-9;  PMID:16088812; http://dx.doi.org/10.1086/431505 3.,OADS,/arxiv_data1/oa_pdf/89/bd/hvi-9-1638.PMC3906260.pdf
Vaccine 2008; 26:3236- 41; PMID:18472196; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/89/bd/hvi-9-1638.PMC3906260.pdf
Vaccine 2012; 30:1244-54; PMID:22212128;  http://dx.doi.org/10.1016/j.vaccine.2011.12.092 6.,Non-OADS,/arxiv_data1/oa_pdf/89/bd/hvi-9-1638.PMC3906260.pdf
Vaccine 2012; 30:6940-5; PMID:22705174;  http://dx.doi.org/10.1016/j.vaccine.2012.05.084 8.,Non-OADS,/arxiv_data1/oa_pdf/89/bd/hvi-9-1638.PMC3906260.pdf
Lancet  2008; 371:1181-9; PMID:18395579; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/89/bd/hvi-9-1638.PMC3906260.pdf
Lancet 2007; 370:1757-63;  PMID:18037080; http://dx.doi.org/10.1016/S0140-6736(07)61744-9 10.,OADS,/arxiv_data1/oa_pdf/89/bd/hvi-9-1638.PMC3906260.pdf
Vaccine  2012; 30:4552-7; PMID:22497874; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/89/bd/hvi-9-1638.PMC3906260.pdf
N Engl J Med 2010; 362:289-98; PMID:20107214; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/89/bd/hvi-9-1638.PMC3906260.pdf
Vaccine 2011; 29:6335- 41; PMID:21640780; http://dx.doi.org/10.1016/j.vac- cine.2011.05.017 13.,Non-OADS,/arxiv_data1/oa_pdf/89/bd/hvi-9-1638.PMC3906260.pdf
Gastroenterology 2009; 137:1970-5; PMID:19632228;  http://dx.doi.org/10.1053/j.gastro.2009.07.046 14.,Non-OADS,/arxiv_data1/oa_pdf/89/bd/hvi-9-1638.PMC3906260.pdf
"J Infect Dis 2010; 201:363-9; PMID:20047501;  http://dx.doi.org/10.1086/649843 15. de Palma O, Cruz L, Ramos H, de Baires A, Villatoro N, Pastor D, et al.",OADS,/arxiv_data1/oa_pdf/89/bd/hvi-9-1638.PMC3906260.pdf
N Engl  J Med 2010; 362:299-305; PMID:20107215; http://dx.doi.org/10.1056/NEJMoa0905211,OADS,/arxiv_data1/oa_pdf/89/bd/hvi-9-1638.PMC3906260.pdf
Vaccine 2011; 29:2029-36;  PMID:21256876; http://dx.doi.org/10.1016/j.vac-cine.2011.01.018 25.,Non-OADS,/arxiv_data1/oa_pdf/89/bd/hvi-9-1638.PMC3906260.pdf
Hum Vaccin Immunother 2012; 8:806- 12; PMID:22699440; http://dx.doi.org/10.4161/ hv.1985321.,Non-OADS,/arxiv_data1/oa_pdf/89/bd/hvi-9-1638.PMC3906260.pdf
Pediatr Infect Dis J 2011; 30(Suppl):S6-10;  PMID:21048524; http://dx.doi.org/10.1097/ INF .0b013e3181fefa05 23.,Non-OADS,/arxiv_data1/oa_pdf/89/bd/hvi-9-1638.PMC3906260.pdf
Available at:  http://www.who.int/vaccines-documents/DocsPDF/ www9541.pdf.,Non-OADS,/arxiv_data1/oa_pdf/89/bd/hvi-9-1638.PMC3906260.pdf
Pediatr Infect Dis  J 2010; 29:673-5; PMID:20300045; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/89/bd/hvi-9-1638.PMC3906260.pdf
PLoS Med 2011; 8:e1001024; PMID:21526228; http://dx.doi.org/10.1371/journal.pmed.1001024 19.,Non-OADS,/arxiv_data1/oa_pdf/89/bd/hvi-9-1638.PMC3906260.pdf
Int J Infect Dis 2011; 15:e206-10; PMID:21193339;  http://dx.doi.org/10.1016/j.ijid.2010.11.007 20.,OADS,/arxiv_data1/oa_pdf/89/bd/hvi-9-1638.PMC3906260.pdf
Pediatr  Infect Dis J 2011; 30(Suppl):S11-5; PMID:21183834;  http://dx.doi.org/10.1097/INF .0b013e3181fefb32,Non-OADS,/arxiv_data1/oa_pdf/89/bd/hvi-9-1638.PMC3906260.pdf
" Short report www.landesbioscience.com human Vaccines & Immunotherapeutics 1679human Vaccines & Immunotherapeutics 9:8, 1679–1684; August 2013; © 2013 Landes BioscienceShort report *Correspondence to: Yong Poovorawan; Email: Yong.P@chula.ac.th Submitted: 12/23/12; Revised: 04/18/13; Accepted: 04/27/13http://dx.doi.org/10.4161/hv.24844Introduction Vaccination is a well-established, safe and effective method of  conferring long-term protection against hepatitis B viral infec - tions, liver cirrhosis and hepatocellular carcinoma (HCC) world - wide.1 Vaccination has resulted in a substantial decline in the  hepatitis B virus (HBV)-related disease burden, prevalence of chronic HBV infections and HBV-related HCC among chil - dren and adolescents worldwide.",Non-OADS,/arxiv_data1/oa_pdf/d4/a3/hvi-9-1679.PMC3906265.pdf
Available at: http://www.who.int/wer.,Non-OADS,/arxiv_data1/oa_pdf/d4/a3/hvi-9-1679.PMC3906265.pdf
Vaccine 2007; 25:2817-22; PMID:17276552;  http://dx.doi.org/10.1016/j.vaccine.2006.12.021 3.,Non-OADS,/arxiv_data1/oa_pdf/d4/a3/hvi-9-1679.PMC3906265.pdf
Ann Intern Med  2001; 135:796-800; PMID:11694104; http://dx.doi.org/10.7326/0003-4819-135-9-200111060-00009 5.,Non-OADS,/arxiv_data1/oa_pdf/d4/a3/hvi-9-1679.PMC3906265.pdf
N Engl J Med 1997; 336:1855-9; PMID:9197213;  http://dx.doi.org/10.1056/NEJM199706263362602 6.,Non-OADS,/arxiv_data1/oa_pdf/d4/a3/hvi-9-1679.PMC3906265.pdf
T rop  Med Int Health 2006; 11:1496-502; PMID:17002723;  http://dx.doi.org/10.1111/j.1365-3156.2006.01709.x 7.,Non-OADS,/arxiv_data1/oa_pdf/d4/a3/hvi-9-1679.PMC3906265.pdf
Vaccine  2003; 21:1310-6; PMID:12615425; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d4/a3/hvi-9-1679.PMC3906265.pdf
Vaccine 2010; 28:730-6; PMID:19892043; http://dx.doi.org/10.1016/j.vaccine.2009.10.074 9.,Non-OADS,/arxiv_data1/oa_pdf/d4/a3/hvi-9-1679.PMC3906265.pdf
Hum Vaccin  Immunother 2012; 8:896-904; PMID:22777097;  http://dx.doi.org/10.4161/hv.1998910.,Non-OADS,/arxiv_data1/oa_pdf/d4/a3/hvi-9-1679.PMC3906265.pdf
J Med Virol 2012; 84:1177-85; PMID:22711345; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d4/a3/hvi-9-1679.PMC3906265.pdf
J Viral Hepat 2011; 18:369- 75; PMID:20384962; http://dx.doi.org/10.1111/ j.1365-2893.2010.01312.x 12.,Non-OADS,/arxiv_data1/oa_pdf/d4/a3/hvi-9-1679.PMC3906265.pdf
Pediatr Infect Dis J 1992; 11:816-21; PMID:1408478;  http://dx.doi.org/10.1097/00006454-199210000-00002 13.,OADS,/arxiv_data1/oa_pdf/d4/a3/hvi-9-1679.PMC3906265.pdf
Arch Dis Child Fetal Neonatal Ed 1997; 77:F47-51; PMID:9279183;  http://dx.doi.org/10.1136/fn.77.1.F47 14.,Non-OADS,/arxiv_data1/oa_pdf/d4/a3/hvi-9-1679.PMC3906265.pdf
Viral Immunol  2009; 22:125-30; PMID:19326999; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d4/a3/hvi-9-1679.PMC3906265.pdf
Pediatr  Infect Dis J 2008; 27:881-5; PMID:18756185; http://dx.doi.org/10.1097/INF .0b013e31817702ba 16.,OADS,/arxiv_data1/oa_pdf/d4/a3/hvi-9-1679.PMC3906265.pdf
Vaccine 2007; 25:6958-64; PMID:17714836;  http://dx.doi.org/10.1016/j.vaccine.2007.06.059 17.,Non-OADS,/arxiv_data1/oa_pdf/d4/a3/hvi-9-1679.PMC3906265.pdf
Hepatology 2004; 40:1415- 20; PMID:15565627; http://dx.doi.org/10.1002/hep.20490 19.,Non-OADS,/arxiv_data1/oa_pdf/d4/a3/hvi-9-1679.PMC3906265.pdf
J Infect Dis 2001; 184:905-8;  PMID:11509998; http://dx.doi.org/10.1086/323396 20.,OADS,/arxiv_data1/oa_pdf/d4/a3/hvi-9-1679.PMC3906265.pdf
Vaccine 2005; 23:4158-66; PMID:15964484; http://dx.doi.org/10.1016/j.vac- cine.2005.03.017 22.,Non-OADS,/arxiv_data1/oa_pdf/d4/a3/hvi-9-1679.PMC3906265.pdf
Pediatr Infect Dis  J 2005; 24:786-92; PMID:16148845; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d4/a3/hvi-9-1679.PMC3906265.pdf
J Infect Dis 2006; 193:1528-35; PMID:16652281;  http://dx.doi.org/10.1086/503433 26.,Non-OADS,/arxiv_data1/oa_pdf/d4/a3/hvi-9-1679.PMC3906265.pdf
" Commentary www.landesbioscience.com Human Vaccines & Immunotherapeutics 1701Human Vaccines & Immunotherapeutics 9:8, 1701–1705; a ugust 2013; © 2013 Landes BioscienceCommentary Keywords:  enterovirus 71, hand-foot- mouth diseases (HFMD), inactivated  whole-virus vaccine, immunogenicity, protective effect, standard Submitted: 04/23/13Accepted: 05/06/13http://dx.doi.org/10.4161/hv.24949 *Correspondence to: Jun-Zhi Wang;   Email: wangjz@nicpbp.org.cnThe prevalence of diseases caused  by EV71 infection has become a  serious public health problem in the Western Pacific region.",Non-OADS,/arxiv_data1/oa_pdf/de/80/hvi-9-1701.PMC3906269.pdf
Vaccine 2011;  29:4829-38; PMID:21550375; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/de/80/hvi-9-1701.PMC3906269.pdf
Microbes Infect 2006; 8:1671-8;  PMID:16815726; http://dx.doi.org/10.1016/j.micinf.2006.01.021 10.,OADS,/arxiv_data1/oa_pdf/de/80/hvi-9-1701.PMC3906269.pdf
J Virol 2007; 81:9386- 95; PMID:17567701; http://dx.doi.org/10.1128/ JVI.02856-06 11.,Non-OADS,/arxiv_data1/oa_pdf/de/80/hvi-9-1701.PMC3906269.pdf
Vaccine  2008; 26:1855-62; PMID:18329759; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/de/80/hvi-9-1701.PMC3906269.pdf
Vaccine  2001; 20:895-904; PMID:11738755; http://dx.doi.org/10.1016/S0264-410X(01)00385-1 13.,Non-OADS,/arxiv_data1/oa_pdf/de/80/hvi-9-1701.PMC3906269.pdf
Vaccine 2010; 28:6951-7; PMID:20797455;  http://dx.doi.org/10.1016/j.vaccine.2010.08.052 14.,Non-OADS,/arxiv_data1/oa_pdf/de/80/hvi-9-1701.PMC3906269.pdf
Genet Vaccines Ther 2007; 5:6;  PMID:17445254; http://dx.doi.org/10.1186/1479- 0556-5-6 15.,Non-OADS,/arxiv_data1/oa_pdf/de/80/hvi-9-1701.PMC3906269.pdf
Microbes Infect 2007; 9:1299- 306; PMID:17890123; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/de/80/hvi-9-1701.PMC3906269.pdf
Vaccine  2010; 28:7444-51; PMID:20831911; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/de/80/hvi-9-1701.PMC3906269.pdf
Hum Vaccin Immunother 2012; 8;  PMID:22992566; http://dx.doi.org/10.4161/ hv.21739 18.,Non-OADS,/arxiv_data1/oa_pdf/de/80/hvi-9-1701.PMC3906269.pdf
Vaccine 2012; 30:3295-303;  PMID:22426327; http://dx.doi.org/10.1016/j.vac - cine.2012.03.010 19.,Non-OADS,/arxiv_data1/oa_pdf/de/80/hvi-9-1701.PMC3906269.pdf
Vaccine 2011; 29:9668-74; PMID:22015395; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/de/80/hvi-9-1701.PMC3906269.pdf
J Infect Dis  1974; 129:304-9; PMID:4361245; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/de/80/hvi-9-1701.PMC3906269.pdf
Hum Vaccin  2010; 6:1028-37; PMID:21150270; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/de/80/hvi-9-1701.PMC3906269.pdf
PLoS One  2013; 8:e54451; PMID:23372725; http://dx.doi.org/10.1371/journal.pone.0054451 5.,Non-OADS,/arxiv_data1/oa_pdf/de/80/hvi-9-1701.PMC3906269.pdf
Vaccine 2011; 29:6269-75;  PMID:21722686; http://dx.doi.org/10.1016/j.vac - cine.2011.06.044 6.,Non-OADS,/arxiv_data1/oa_pdf/de/80/hvi-9-1701.PMC3906269.pdf
Hum Vaccin Immunother 2013; 9; PMID:23291952;  http://dx.doi.org/10.4161/hv.22699 50.,Non-OADS,/arxiv_data1/oa_pdf/de/80/hvi-9-1701.PMC3906269.pdf
PLoS One 2012; 7:e46043; PMID:23029378;  http://dx.doi.org/10.1371/journal.pone.0046043 52.,Non-OADS,/arxiv_data1/oa_pdf/de/80/hvi-9-1701.PMC3906269.pdf
PLoS One 2011; 6:e25662; PMID:21980521; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/de/80/hvi-9-1701.PMC3906269.pdf
Int J Infect Dis 2010; 14:e739- 43; PMID:20400350; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/de/80/hvi-9-1701.PMC3906269.pdf
PLoS Negl Trop Dis 2012; 6:e1737;  PMID:22953003; http://dx.doi.org/10.1371/jour - nal.pntd.0001737 56.,OADS,/arxiv_data1/oa_pdf/de/80/hvi-9-1701.PMC3906269.pdf
Vaccine 2010; 28:3516-21;  PMID:20304038; http://dx.doi.org/10.1016/j.vac - cine.2010.03.00332.,Non-OADS,/arxiv_data1/oa_pdf/de/80/hvi-9-1701.PMC3906269.pdf
Pediatr Infect Dis J 2012; 31:1158- 65; PMID:22926209; http://dx.doi.org/10.1097/ INF.0b013e31826eba74 33.,OADS,/arxiv_data1/oa_pdf/de/80/hvi-9-1701.PMC3906269.pdf
http://wb.yunnan.cn/html/2013/duch - eng_0312/64349.html 35.,Non-OADS,/arxiv_data1/oa_pdf/de/80/hvi-9-1701.PMC3906269.pdf
2013.  http://en.cnbg.com.cn/html/news/2013/0326/768.,Non-OADS,/arxiv_data1/oa_pdf/de/80/hvi-9-1701.PMC3906269.pdf
Vaccine 2012; 30:703-11; PMID:22142585; http://dx.doi.org/10.1016/j.vaccine.2011.11.087 37.,Non-OADS,/arxiv_data1/oa_pdf/de/80/hvi-9-1701.PMC3906269.pdf
Vaccine 2002; 20:2485-93; PMID:12057603; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/de/80/hvi-9-1701.PMC3906269.pdf
Clin Dev  Immunol 2012; 2012:831282; PMID:23008736;  http://dx.doi.org/10.1155/2012/831282 39.,Non-OADS,/arxiv_data1/oa_pdf/de/80/hvi-9-1701.PMC3906269.pdf
PLoS One 2012; 7:e34834; PMID:22529942; http://dx.doi.org/10.1371/journal.pone.0034834 40.,Non-OADS,/arxiv_data1/oa_pdf/de/80/hvi-9-1701.PMC3906269.pdf
Vaccine  2004; 22:3858-64; PMID:15364432; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/de/80/hvi-9-1701.PMC3906269.pdf
Vaccine  2007; 25:19-24; PMID:16919374; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/de/80/hvi-9-1701.PMC3906269.pdf
Vaccine 2013; 31:2471-6;  PMID:23541623; http://dx.doi.org/10.1016/j.vac - cine.2013.03.015 43.,Non-OADS,/arxiv_data1/oa_pdf/de/80/hvi-9-1701.PMC3906269.pdf
http://prsinfo.clinicaltrial.gov/ct2/show/nct01376479?term=inviragen+%28si ngapore%29+pte+ltd.&rank=1 2013.20.,Non-OADS,/arxiv_data1/oa_pdf/de/80/hvi-9-1701.PMC3906269.pdf
J  Virol Methods 2011; 176:60-8; PMID:21704080;  http://dx.doi.org/10.1016/j.jviromet.2011.06.001 21.,OADS,/arxiv_data1/oa_pdf/de/80/hvi-9-1701.PMC3906269.pdf
Hum Vaccin Immunother 2012; 8:668- 74; PMID:22634437; http://dx.doi.org/10.4161/ hv.19521 25.,Non-OADS,/arxiv_data1/oa_pdf/de/80/hvi-9-1701.PMC3906269.pdf
Virology 2012; 432:417-26; PMID:22819834; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/de/80/hvi-9-1701.PMC3906269.pdf
J Clin Immunol 2012; 32:1048-58; PMID:22585051; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/de/80/hvi-9-1701.PMC3906269.pdf
"Resea Rch  Pa P e R www.landesbioscience.com  h uman Vaccines & Immunotherapeutics  1741h uman Vaccines & Immunotherapeutics 9:8, 1741–1751;  august 2013; © 2013 Landes Bioscienc eResea Rch  Pa P e R *Correspondence to: Rosalind Rowland; Email: rosrowland@yahoo.co.uk Submitted: 02/04/13; Revised: 04/17/13; Accepted: 05/10/13http://dx.doi.org/10.4161/hv.24998Introduction The accurate interpretation of biochemical and hematological  blood analyses are an important aspect of clinical trials of pre - ventive vaccines, both for trial inclusion decisions and post-inter - vention safety evaluation.",Non-OADS,/arxiv_data1/oa_pdf/45/4e/hvi-9-1741.PMC3906276.pdf
PLoS One 2007; 2:e1052; PMID:17957238; http://dx.doi.org/10.1371/journal.pone.0001052 29.,Non-OADS,/arxiv_data1/oa_pdf/45/4e/hvi-9-1741.PMC3906276.pdf
Vaccine 2006; 24:3026-34; PMID:16488059; http://dx.doi.org/10.1016/j.vac-cine.2005.10.058 30.,Non-OADS,/arxiv_data1/oa_pdf/45/4e/hvi-9-1741.PMC3906276.pdf
Infect Immun 2006; 74:2706-16; PMID:16622207; http://dx.doi.org/10.1128/IAI.74.5.2706-2716.2006 31.,Non-OADS,/arxiv_data1/oa_pdf/45/4e/hvi-9-1741.PMC3906276.pdf
Vaccine 2006; 24:2850-9; PMID:16434127; http://dx.doi.org/10.1016/j.vaccine.2005.12.041 32.,Non-OADS,/arxiv_data1/oa_pdf/45/4e/hvi-9-1741.PMC3906276.pdf
Infect Immun 2006; 74:5933-42; PMID:16988273; http://dx.doi.org/10.1128/IAI.00590-06 33.,Non-OADS,/arxiv_data1/oa_pdf/45/4e/hvi-9-1741.PMC3906276.pdf
Vaccine 2005; 23:857-64; PMID:15603885; http://dx.doi.org/10.1016/j.vaccine.2004.08.020 35.,Non-OADS,/arxiv_data1/oa_pdf/45/4e/hvi-9-1741.PMC3906276.pdf
Nat Med 2004; 10:1240-4; PMID:15502839; http://dx.doi.org/10.1038/nm1128 36.,OADS,/arxiv_data1/oa_pdf/45/4e/hvi-9-1741.PMC3906276.pdf
Vaccine 2003; 21:1995-2002; PMID:12706689; http://dx.doi.org/10.1016/S0264-410X(02)00771-5 37.,Non-OADS,/arxiv_data1/oa_pdf/45/4e/hvi-9-1741.PMC3906276.pdf
Nat Med 2003; 9:729-35; PMID:12766765; http://dx.doi.org/10.1038/nm881 38.,Non-OADS,/arxiv_data1/oa_pdf/45/4e/hvi-9-1741.PMC3906276.pdf
"http://www.west-gard.com/biodatabase1.htm, 2012.14.",Non-OADS,/arxiv_data1/oa_pdf/45/4e/hvi-9-1741.PMC3906276.pdf
J Infect Dis 2012; 205:772-81; PMID:22275401; http://dx.doi.org/10.1093/infdis/jir850 15.,OADS,/arxiv_data1/oa_pdf/45/4e/hvi-9-1741.PMC3906276.pdf
PLoS One 2012; 7:e31208; PMID:22363582; http://dx.doi.org/10.1371/journal.pone.0031208 16.,Non-OADS,/arxiv_data1/oa_pdf/45/4e/hvi-9-1741.PMC3906276.pdf
J Infect Dis 2012; 205:1035-42; PMID:22396610; http://dx.doi.org/10.1093/infdis/jis012 17.,OADS,/arxiv_data1/oa_pdf/45/4e/hvi-9-1741.PMC3906276.pdf
Clin Infect Dis 2012; 55:19-25; PMID:22441650; http://dx.doi.org/10.1093/cid/cis327 18.,Non-OADS,/arxiv_data1/oa_pdf/45/4e/hvi-9-1741.PMC3906276.pdf
Sci T ransl Med 2012; 4:ra1; PMID:22218690; http://dx.doi.org/10.1126/scitranslmed.3003155 19.,Non-OADS,/arxiv_data1/oa_pdf/45/4e/hvi-9-1741.PMC3906276.pdf
Vaccine 2012; 30:5616-24; PMID:22789508; http://dx.doi.org/10.1016/j.vaccine.2012.06.084 20.,Non-OADS,/arxiv_data1/oa_pdf/45/4e/hvi-9-1741.PMC3906276.pdf
Mol Ther 2011; 19:2269-76; PMID:21862998; http://dx.doi.org/10.1038/mt.2011.176 21.,Non-OADS,/arxiv_data1/oa_pdf/45/4e/hvi-9-1741.PMC3906276.pdf
Clin Infect Dis 2011; 52:1-7; PMID:21148512; http://dx.doi.org/10.1093/cid/ciq015 22.,Non-OADS,/arxiv_data1/oa_pdf/45/4e/hvi-9-1741.PMC3906276.pdf
PLoS One 2011; 6:e22271; PMID:21799809; http://dx.doi.org/10.1371/journal.pone.0022271 23.,Non-OADS,/arxiv_data1/oa_pdf/45/4e/hvi-9-1741.PMC3906276.pdf
Vaccine 2011; 29:7514-22; PMID:21501642; http://dx.doi.org/10.1016/j.vaccine.2011.03.083 24.,Non-OADS,/arxiv_data1/oa_pdf/45/4e/hvi-9-1741.PMC3906276.pdf
PLoS One 2009; 4:e5934; PMID:19529780; http://dx.doi.org/10.1371/journal.pone.0005934 25.,Non-OADS,/arxiv_data1/oa_pdf/45/4e/hvi-9-1741.PMC3906276.pdf
Am J Respir Crit Care Med 2009; 179:724-33; PMID:19151191; http://dx.doi.org/10.1164/rccm.200809-1486OC 26.,Non-OADS,/arxiv_data1/oa_pdf/45/4e/hvi-9-1741.PMC3906276.pdf
PLoS One 2008; 3:e1493; PMID:18231580; http://dx.doi.org/10.1371/journal.pone.0001493References 1.,OADS,/arxiv_data1/oa_pdf/45/4e/hvi-9-1741.PMC3906276.pdf
Ann Clin Biochem 2008; 45:467-75; PMID:18753418; http://dx.doi.org/10.1258/acb.2008.008028 3.,Non-OADS,/arxiv_data1/oa_pdf/45/4e/hvi-9-1741.PMC3906276.pdf
Liver Int 2006; 26:445-50; PMID:16629648; http://dx.doi.org/10.1111/j.1478-3231.2006.01197.x 5.,Non-OADS,/arxiv_data1/oa_pdf/45/4e/hvi-9-1741.PMC3906276.pdf
J Clin Pathol 1996; 49:664-6; PMID:8881919; http://dx.doi.org/10.1136/jcp.49.8.664 6.,Non-OADS,/arxiv_data1/oa_pdf/45/4e/hvi-9-1741.PMC3906276.pdf
Vaccine 2012; 30:6163-74; PMID:22871351; http://dx.doi.org/10.1016/j.vaccine.2012.07.065 8.,Non-OADS,/arxiv_data1/oa_pdf/45/4e/hvi-9-1741.PMC3906276.pdf
PLoS Negl T rop Dis 2012; 6:e1704; PMID:22802974; http://dx.doi.org/10.1371/journal.pntd.0001704 9.,OADS,/arxiv_data1/oa_pdf/45/4e/hvi-9-1741.PMC3906276.pdf
T rials in Vaccinology 2012; 1:27-35; http://dx.doi.org/10.1016/j.trivac.2012.07.001 12.,OADS,/arxiv_data1/oa_pdf/45/4e/hvi-9-1741.PMC3906276.pdf
Hum Vaccin Immunother 2012; 9:50-62; PMID:23143773; http://dx.doi.org/10.4161/hv.22464 13.,Non-OADS,/arxiv_data1/oa_pdf/45/4e/hvi-9-1741.PMC3906276.pdf
Vaccine 2013; 31:1026-33; PMID:23266342; http://dx.doi.org/10.1016/j.vaccine.2012.12.042,Non-OADS,/arxiv_data1/oa_pdf/45/4e/hvi-9-1741.PMC3906276.pdf
Ann Intern Med 2002; 137:1-10; PMID:12093239; http://dx.doi.org/10.7326/0003-4819-137-1-200207020-00006 58.,Non-OADS,/arxiv_data1/oa_pdf/45/4e/hvi-9-1741.PMC3906276.pdf
"http://www.transfusionguidelines.org.uk/index.aspx?Publication=WB&Section=5&PageID=3702&AZLetter=H, 2013.",Non-OADS,/arxiv_data1/oa_pdf/45/4e/hvi-9-1741.PMC3906276.pdf
Crit Rev Clin Lab Sci 1989; 27:409-37; PMID:2679660; http://dx.doi.org/10.3109/10408368909106595 63.,Non-OADS,/arxiv_data1/oa_pdf/45/4e/hvi-9-1741.PMC3906276.pdf
http://www.metoffice.,Non-OADS,/arxiv_data1/oa_pdf/45/4e/hvi-9-1741.PMC3906276.pdf
Clin Biochem 2009; 42:813-8; PMID:19232334; http://dx.doi.org/10.1016/j.clinbiochem.2009.01.024 49.,OADS,/arxiv_data1/oa_pdf/45/4e/hvi-9-1741.PMC3906276.pdf
J Clin Pathol 2003; 56:385-8; PMID:12719461; http://dx.doi.org/10.1136/jcp.56.5.385 50.,Non-OADS,/arxiv_data1/oa_pdf/45/4e/hvi-9-1741.PMC3906276.pdf
J Clin Pathol 1980; 33:380-5; PMID:7400337; http://dx.doi.org/10.1136/jcp.33.4.380 51.,Non-OADS,/arxiv_data1/oa_pdf/45/4e/hvi-9-1741.PMC3906276.pdf
Vaccine 2007; 25:5717-24; PMID:17493712; http://dx.doi.org/10.1016/j.vac-cine.2007.02.067 52.,Non-OADS,/arxiv_data1/oa_pdf/45/4e/hvi-9-1741.PMC3906276.pdf
Int J Epidemiol 2008; 37(Suppl 1):i16-22; PMID:18381388; http://dx.doi.org/10.1093/ije/dym280 53.,OADS,/arxiv_data1/oa_pdf/45/4e/hvi-9-1741.PMC3906276.pdf
Ann Clin Biochem 2012; 49:94-6; PMID:22067093; http://dx.doi.org/10.1258/acb.2011.011122 55.,Non-OADS,/arxiv_data1/oa_pdf/45/4e/hvi-9-1741.PMC3906276.pdf
Clin  Chim Acta 2003; 334:5-23; PMID:12867273; http://dx.doi.org/10.1016/S0009-8981(03)00133-5 56.,OADS,/arxiv_data1/oa_pdf/45/4e/hvi-9-1741.PMC3906276.pdf
J Nutr Health Aging 2012; 16:412-6; PMID:22499467; http://dx.doi.org/10.1007/s12603-011-0355-3 40.,Non-OADS,/arxiv_data1/oa_pdf/45/4e/hvi-9-1741.PMC3906276.pdf
Am J Gastroenterol 2005; 100:2201-4; PMID:16181369; http://dx.doi.org/10.1111/j.1572-0241.2005.41822.x 42.,Non-OADS,/arxiv_data1/oa_pdf/45/4e/hvi-9-1741.PMC3906276.pdf
"Factors associated with serum alanine transaminase activity in healthy subjects: consequences for the definition of normal values, for selection of blood donors, and for patients with chronic hepatitis C. Hepatology 1998; 27:1213-9; PMID:9581673; http://dx.doi.org/10.1002/hep.510270505 43.",Non-OADS,/arxiv_data1/oa_pdf/45/4e/hvi-9-1741.PMC3906276.pdf
N Engl J  Med 2002; 346:1221-31; PMID:11961152; http://dx.doi.org/10.1056/NEJMra011775 44.,Non-OADS,/arxiv_data1/oa_pdf/45/4e/hvi-9-1741.PMC3906276.pdf
N Engl J Med 2006; 354:2473-83; PMID:16760447; http://dx.doi.org/10.1056/NEJMra054415 47.,Non-OADS,/arxiv_data1/oa_pdf/45/4e/hvi-9-1741.PMC3906276.pdf
Clin Ther 2011; 33:717-25; PMID:21704236; http://dx.doi.org/10.1016/j.clinthera.2011.05.004,OADS,/arxiv_data1/oa_pdf/45/4e/hvi-9-1741.PMC3906276.pdf
"Correspondence to: Kristen A Feemster; Email: feemster@email.chop.edu Submitted: 08/05/13; Accepted: 08/05/13http://dx.doi.org/10.4161/hv.26217Overview Special Focus Vaccine Acceptance Kristen A  Feemster Children’s Hospital of Philadelphia; University of Pennsylvania Perelman s chool of Medicine; Philadelphia, PA U sA",Non-OADS,/arxiv_data1/oa_pdf/bb/68/hvi-9-1752.PMC3906277.pdf
Health  Aff (Millwood) 2011; 30:1021-8; PMID:21653952 ;  http://dx.doi.org/10.1377/hlthaff.2011.0382 2.,Non-OADS,/arxiv_data1/oa_pdf/bb/68/hvi-9-1752.PMC3906277.pdf
Health Aff  (Millwood) 2011; 30:1010-20;  PMID:21653951 ;  http://dx.doi.org/10.1377/hlthaff.2011.0381 3.,Non-OADS,/arxiv_data1/oa_pdf/bb/68/hvi-9-1752.PMC3906277.pdf
Soc Sci Med 2007; 65:1751- 64; PMID:17644230 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/bb/68/hvi-9-1752.PMC3906277.pdf
Hum Vaccin Immunother 2013; 9:1755-62;  PMID:23744504 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/bb/68/hvi-9-1752.PMC3906277.pdf
Hum Vaccin  Immunother 2013; 9:1774-8;  PMID:23733039 ;  http://dx.doi.org/10.4161/hv.24961 8.,Non-OADS,/arxiv_data1/oa_pdf/bb/68/hvi-9-1752.PMC3906277.pdf
Hum Vaccin  Immunother 2013; 9:1782-9; http://dx.doi.org/10.4161/hv.25959 10.,Non-OADS,/arxiv_data1/oa_pdf/bb/68/hvi-9-1752.PMC3906277.pdf
Hum Vaccin Immunother  2013; 9:1795-801;  PMID:23811786 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/bb/68/hvi-9-1752.PMC3906277.pdf
Hum Vaccin Immunother 2013 ; 9:1815-8 ;  PMID:23807359 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/bb/68/hvi-9-1752.PMC3906277.pdf
"(Supplementary video, Supplemental digital content 1, http://links.lww.com/WNR/A267 ).",Non-OADS,/arxiv_data1/oa_pdf/f3/5b/wnr-25-177.PMC3906289.pdf
"The genome of AIV contains eight gene segments; polymerase basic 2 (PB2, seg - ment 1), hemagglutinin (HA, segment 4), nucleoprotein (NP, segment 5) and Avian influenza virus NS1 A small protein with diverse and versatile functions E M abdelwhab*, Jutta Veits, and t homas C Mettenleiter Friedrich-Loeffler- institut; Federal r esearch i nstitute for a nimal Health; i nstitute of Molecular Biology; i nsel r iems, Germany Keywords:  avian influenza virus, H5N1, H9N2, NS1 Abbreviations:  2'-5' OAS, 2'-5' oligoadenylate synthetase-RNase; AIV, avian influenza virus; AP1, activator protein 1; CEF,  chicken embryo fibroblasts; CSPF30, the cleavage and polyadenylation specificity factor 30; DIVA, differentiating between  infected and vaccinated animals; ED, effector domain; eIF4GI, eukaryotic translation initiation factor 4GI; HA, hemagglutinin;  HP, highly pathogenic; IFN, interferon; IRF-3, interferon regulatory factor-3; M, matrix; MDCK, madin darby canine kidney;  NA, neuraminidase; NF κB, nuclear factor kappa B; NLS, nuclear localization signal; NoLS, nucleolus localization signal; NP,  nucleoprotein; NS, non-structure; P13K, Phosphatidylinositol 3-kinase; PA, polymerase acidic; PABP, poly(A)-binding protein; PB,  polymerase basic; PDZ, postsynaptic density protein 95, drosophila disc large tumor suppressor, and zonula occludens 1 protein;  PKR, protein kinase R; RBD, RNA binding domain; RIG-I, retinoic-acid inducible gene I; TNF- α, tumor necrosis factor alpha *Correspondence to: E M Abdelwhab; Email: sayed.abdel-whab@fli.bund.de Submitted: 08/31/13; Accepted: 09/03/13http://dx.doi.org/10.4161/viru.26360Comment on: Munir et al.",Non-OADS,/arxiv_data1/oa_pdf/c8/ca/viru-4-583.PMC3906290.pdf
"Virulence 2013; 4:612-23; PMID:23959028; http://dx.doi.org/10.4161/viru.26055neuraminidase (NA, segment 6) encode  only one protein, whereas the PB1 (seg - ment 2), polymerase acidic (PA, segment 3), the matrix (M, segment 7), and NS (segment 8) encode two proteins PB1 and PB1-F2, PA and PA-X, M1 and M2, and NS1 and NS2, respectively.",Non-OADS,/arxiv_data1/oa_pdf/c8/ca/viru-4-583.PMC3906290.pdf
Virology 2013; 444:12- 20; PMID:23849789; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/c8/ca/viru-4-583.PMC3906290.pdf
Avian Pathol 2011; 40:613-28; PMID:22107096; http://dx.doi.org/10.1080/0307945 7.2011.621410 16.,Non-OADS,/arxiv_data1/oa_pdf/c8/ca/viru-4-583.PMC3906290.pdf
J Gen Virol 2012; 93:1649-57; PMID:22592261;  http://dx.doi.org/10.1099/vir.0.042895-0 17.,Non-OADS,/arxiv_data1/oa_pdf/c8/ca/viru-4-583.PMC3906290.pdf
Virus Genes 2007; 34:37-45;  PMID:16927114; http://dx.doi.org/10.1007/s11262- 006-0007-6 18.,Non-OADS,/arxiv_data1/oa_pdf/c8/ca/viru-4-583.PMC3906290.pdf
Avian Dis 2007; 51(Suppl):279-84;  PMID:17494567; http://dx.doi.org/10.1637/7551- 033106R.1 19.,Non-OADS,/arxiv_data1/oa_pdf/c8/ca/viru-4-583.PMC3906290.pdf
Virus Genes 2005; 31:329-35;  PMID:16175338; http://dx.doi.org/10.1007/s11262- 005-3251-2 20.,Non-OADS,/arxiv_data1/oa_pdf/c8/ca/viru-4-583.PMC3906290.pdf
Virus Res 1998; 55:143-56;  PMID:9725667; http://dx.doi.org/10.1016/S0168-1702(98)00038-0 22.,OADS,/arxiv_data1/oa_pdf/c8/ca/viru-4-583.PMC3906290.pdf
Virus Res 1998; 54:59-69; PMID:9660072; http://dx.doi.org/10.1016/S0168-1702(98)00011-2 23.,OADS,/arxiv_data1/oa_pdf/c8/ca/viru-4-583.PMC3906290.pdf
Virus Genes  2007; 34:157-68; PMID:17171546; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c8/ca/viru-4-583.PMC3906290.pdf
Virus  Res 1989; 14:257-69; PMID:2483012; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c8/ca/viru-4-583.PMC3906290.pdf
Vet Microbiol  2010; 140:237-45; PMID:19782482; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c8/ca/viru-4-583.PMC3906290.pdf
Avilable online at: http://www.who.int/influen- za/human_animal_interface/EN_GIP_20130604Cum ulativeNumberH5N1cases.pdf (Accessed 26.08.2013).,OADS,/arxiv_data1/oa_pdf/c8/ca/viru-4-583.PMC3906290.pdf
Proc Natl Acad Sci U S  A 1999; 96:9363-7; PMID:10430948; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c8/ca/viru-4-583.PMC3906290.pdf
Virology 2000; 278:36-41; PMID:11112478; http://dx.doi.org/10.1006/viro.2000.0585 7.,Non-OADS,/arxiv_data1/oa_pdf/c8/ca/viru-4-583.PMC3906290.pdf
PLoS  One 2009; 4:e5788; PMID:19517011; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c8/ca/viru-4-583.PMC3906290.pdf
Virology 2002; 292:16-23; PMID:11878904;  http://dx.doi.org/10.1006/viro.2001.1207 12.,Non-OADS,/arxiv_data1/oa_pdf/c8/ca/viru-4-583.PMC3906290.pdf
Virol  J 2010; 7:233; PMID:20843374; http://dx.doi.org/10.1186/1743-422X-7-233 13.,Non-OADS,/arxiv_data1/oa_pdf/c8/ca/viru-4-583.PMC3906290.pdf
"Emerg Infect Dis 2008; 14:1731- 5; PMID:18976556; http://dx.doi.org/10.3201/ eid1411.080555to control apoptosis of the cells has been  described.46,64-66 In late stages of the viral  replication-cycle, the NS1 protein may be indirectly involved in morphogenesis of the virus particles through binding the Staufen protein.",Non-OADS,/arxiv_data1/oa_pdf/c8/ca/viru-4-583.PMC3906290.pdf
J Virol 2009; 83:9901-10; PMID:19625397;  http://dx.doi.org/10.1128/JVI.00608-09 55.,Non-OADS,/arxiv_data1/oa_pdf/c8/ca/viru-4-583.PMC3906290.pdf
J Virol 2000; 74:6203-6; PMID:10846107; http://dx.doi.org/10.1128/JVI.74.13.6203-6206.2000 57.,Non-OADS,/arxiv_data1/oa_pdf/c8/ca/viru-4-583.PMC3906290.pdf
PLoS Pathog 2012; 8:e1003059;  PMID:23209422; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/c8/ca/viru-4-583.PMC3906290.pdf
Cell Host Microbe 2009; 5:439-49; PMID:19454348; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/c8/ca/viru-4-583.PMC3906290.pdf
Proc Natl Acad Sci U S A  2006; 103:7100-5; PMID:16627618; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c8/ca/viru-4-583.PMC3906290.pdf
J Biol Chem  2000; 275:8307-14; PMID:10722660; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c8/ca/viru-4-583.PMC3906290.pdf
J Gen Virol  2009; 90:2124-33; PMID:19420157; http://dx.doi.org/10.1099/vir.0.011270-0 63.,Non-OADS,/arxiv_data1/oa_pdf/c8/ca/viru-4-583.PMC3906290.pdf
J Virol 2007; 81:12730-9; PMID:17881440;  http://dx.doi.org/10.1128/JVI.01427-07 65.,Non-OADS,/arxiv_data1/oa_pdf/c8/ca/viru-4-583.PMC3906290.pdf
J Biol Chem 2008; 283:5719-27;  PMID:18165234; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/c8/ca/viru-4-583.PMC3906290.pdf
J Biol Chem  2008; 283:1372-80; PMID:18029356; http://dx.doi.org/10.1074/jbc.M70886220040.,OADS,/arxiv_data1/oa_pdf/c8/ca/viru-4-583.PMC3906290.pdf
Avian Dis 2010;  54(Suppl):532-7; PMID:20521690; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c8/ca/viru-4-583.PMC3906290.pdf
Antiviral  Res 2008; 79:166-78; PMID:18547656; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c8/ca/viru-4-583.PMC3906290.pdf
Bioessays 2011; 33:180-8; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c8/ca/viru-4-583.PMC3906290.pdf
J Virol 2010; 84:10708- 18; PMID:20686040; http://dx.doi.org/10.1128/ JVI.00610-10 46.,Non-OADS,/arxiv_data1/oa_pdf/c8/ca/viru-4-583.PMC3906290.pdf
J Virol 2013; 87:4861-71; PMID:23408626; http://dx.doi.org/10.1128/ JVI.02608-12 47.,Non-OADS,/arxiv_data1/oa_pdf/c8/ca/viru-4-583.PMC3906290.pdf
PLoS One 2013; 8:e63270;  PMID:23646204; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/c8/ca/viru-4-583.PMC3906290.pdf
Vet Microbiol  2009; 138:85-91; PMID:19342184; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c8/ca/viru-4-583.PMC3906290.pdf
Mol Immunol 2013; 56:358- 68; PMID:23911391; http://dx.doi.org/10.1016/j.molimm.2013.05.236 50.,Non-OADS,/arxiv_data1/oa_pdf/c8/ca/viru-4-583.PMC3906290.pdf
J Virol 2012; 86:10370-6; PMID:22787231; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c8/ca/viru-4-583.PMC3906290.pdf
Virology 2007; 363:236-43; PMID:17320139;  http://dx.doi.org/10.1016/j.virol.2007.01.038 53.,Non-OADS,/arxiv_data1/oa_pdf/c8/ca/viru-4-583.PMC3906290.pdf
PLoS Pathog  2008; 4:e1000072; PMID:18497857; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c8/ca/viru-4-583.PMC3906290.pdf
Acta Biochim Biophys  Sin (Shanghai) 2007; 39:155-62; PMID:17342253;  http://dx.doi.org/10.1111/j.1745-7270.2007.00263.x 29.,OADS,/arxiv_data1/oa_pdf/c8/ca/viru-4-583.PMC3906290.pdf
J Infect Dis  2010; 202:1338-46; PMID:20854176; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c8/ca/viru-4-583.PMC3906290.pdf
J Gen Virol 2010; 91:2907-17; PMID:20826615; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c8/ca/viru-4-583.PMC3906290.pdf
Virol J 2011; 8:13; PMID:21226922; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c8/ca/viru-4-583.PMC3906290.pdf
J Gen Virol 2012; 93:998- 1006; PMID:22323532; http://dx.doi.org/10.1099/ vir.0.039701-0 35.,Non-OADS,/arxiv_data1/oa_pdf/c8/ca/viru-4-583.PMC3906290.pdf
J Virol 2013; 87:5362-71; PMID:23468508; http://dx.doi.org/10.1128/ JVI.02969-12 36.,Non-OADS,/arxiv_data1/oa_pdf/c8/ca/viru-4-583.PMC3906290.pdf
J Virol 2011; 85:7048- 58; PMID:21593152; http://dx.doi.org/10.1128/ JVI.00417-11 37.,Non-OADS,/arxiv_data1/oa_pdf/c8/ca/viru-4-583.PMC3906290.pdf
J  Virol 2008; 82:220-8; PMID:17942562; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c8/ca/viru-4-583.PMC3906290.pdf
J Virol 2010; 84:11323- 35; PMID:20739516; http://dx.doi.org/10.1128/ JVI.01034-10 39.,Non-OADS,/arxiv_data1/oa_pdf/c8/ca/viru-4-583.PMC3906290.pdf
J Virol 2010; 84:2122-33; PMID:20007264;  http://dx.doi.org/10.1128/JVI.01668-09,Non-OADS,/arxiv_data1/oa_pdf/c8/ca/viru-4-583.PMC3906290.pdf
PLoS Pathog 2012; 8:e1002668;  PMID:22577360; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/c8/ca/viru-4-583.PMC3906290.pdf
Arch Biochem Biophys 2010;  494:198-204; PMID:19995550; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c8/ca/viru-4-583.PMC3906290.pdf
BMC Complement Altern Med 2010; 10:69;  PMID:21078173; http://dx.doi.org/10.1186/1472-6882-10-69 85.,OADS,/arxiv_data1/oa_pdf/c8/ca/viru-4-583.PMC3906290.pdf
J Virol  2000; 74:6592-9; PMID:10864673; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c8/ca/viru-4-583.PMC3906290.pdf
J Virol 2010; 84:11858- 65; PMID:20844052; http://dx.doi.org/10.1128/ JVI.01011-10 87.,OADS,/arxiv_data1/oa_pdf/c8/ca/viru-4-583.PMC3906290.pdf
RNA 1999; 5:195-205; PMID:10024172; http://dx.doi.org/10.1017/S1355838299981621 88.,OADS,/arxiv_data1/oa_pdf/c8/ca/viru-4-583.PMC3906290.pdf
PLoS One  2009; 4:e5984; PMID:19543385; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c8/ca/viru-4-583.PMC3906290.pdf
Avian Dis 2010; 54(Suppl):278-86; PMID:20521645; http://dx.doi.org/10.1637/8644-020409-Reg.1 79.,Non-OADS,/arxiv_data1/oa_pdf/c8/ca/viru-4-583.PMC3906290.pdf
Vet Microbiol  2011; 147:283-91; PMID:20673616; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c8/ca/viru-4-583.PMC3906290.pdf
Vaccine 2008; 26:3580- 6; PMID:18539366; http://dx.doi.org/10.1016/j.vac-cine.2008.05.001 81.,Non-OADS,/arxiv_data1/oa_pdf/c8/ca/viru-4-583.PMC3906290.pdf
Vaccine 2010; 28:2388-96;  PMID:20064474; http://dx.doi.org/10.1016/j.vac- cine.2009.12.07467.,Non-OADS,/arxiv_data1/oa_pdf/c8/ca/viru-4-583.PMC3906290.pdf
Nucleic Acids Res 1999; 27:2241-7; PMID:10325410;  http://dx.doi.org/10.1093/nar/27.11.2241 69.,OADS,/arxiv_data1/oa_pdf/c8/ca/viru-4-583.PMC3906290.pdf
J Virol 2006; 80:11009- 18; PMID:16943300; http://dx.doi.org/10.1128/JVI.00787-06 70.,Non-OADS,/arxiv_data1/oa_pdf/c8/ca/viru-4-583.PMC3906290.pdf
Equine Vet J  2009; 41:87-92; PMID:19301588; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c8/ca/viru-4-583.PMC3906290.pdf
J Virol 2004; 78:13037- 45; PMID:15542655; http://dx.doi.org/10.1128/ JVI.78.23.13037-13045.2004 72.,Non-OADS,/arxiv_data1/oa_pdf/c8/ca/viru-4-583.PMC3906290.pdf
J Gen Virol  2005; 86:2817-21; PMID:16186237; http://dx.doi.org/10.1099/vir.0.80991-0 73.,Non-OADS,/arxiv_data1/oa_pdf/c8/ca/viru-4-583.PMC3906290.pdf
J Virol 2009; 83:1742- 53; PMID:19073731; http://dx.doi.org/10.1128/ JVI.01920-08 74.,Non-OADS,/arxiv_data1/oa_pdf/c8/ca/viru-4-583.PMC3906290.pdf
PLoS One 2011; 6:e18577;  PMID:21490925; http://dx.doi.org/10.1371/journal.pone.0018577,Non-OADS,/arxiv_data1/oa_pdf/c8/ca/viru-4-583.PMC3906290.pdf
"John K Crane department of Medicine; d ivision of i nfectious d iseases; University at Buffalo; Buffalo, NY US a Keywords:  envelope stress response, degP , rotavirus, enteroaggregative Correspondence to: John K Crane; Email: jcrane@buffalo.edu Submitted: 08/19/13; Accepted: 09/16/13http://dx.doi.org/10.4161/viru.26504Comment on: Medeiros P , et al.",Non-OADS,/arxiv_data1/oa_pdf/ab/98/viru-4-589.PMC3906291.pdf
"Virulence 2013; 4:624-33; PMID:23958904; http://dx.doi.org/10.4161/viru.26120the heat-labile toxin LT, there is a theoreti - cal rationale for the use of zinc, based on  zinc’s ability to inhibit the cyclic AMP-stimulated potassium channel located in the basolateral aspect of intestinal cells.",Non-OADS,/arxiv_data1/oa_pdf/ab/98/viru-4-589.PMC3906291.pdf
MBio 2012; 3:e00171- 12; PMID:22851657; http://dx.doi.org/10.1128/ mBio.00171-12 4.,Non-OADS,/arxiv_data1/oa_pdf/ab/98/viru-4-589.PMC3906291.pdf
J Infect Dis  2005; 191:1072-7; PMID:15747242; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ab/98/viru-4-589.PMC3906291.pdf
Infect Immun 2007; 75:5974-84;  PMID:17875638; http://dx.doi.org/10.1128/ IAI.00750-07 9.,Non-OADS,/arxiv_data1/oa_pdf/ab/98/viru-4-589.PMC3906291.pdf
BMC Microbiol 2012; 12:123;  PMID:22727253; http://dx.doi.org/10.1186/1471- 2180-12-123 10.,Non-OADS,/arxiv_data1/oa_pdf/ab/98/viru-4-589.PMC3906291.pdf
Infect Immun 2012; 80:3077-85; PMID:22710873;  http://dx.doi.org/10.1128/IAI.00081-12 11.,Non-OADS,/arxiv_data1/oa_pdf/ab/98/viru-4-589.PMC3906291.pdf
Infect Immun 2008; 76:1465- 75; PMID:18227171; http://dx.doi.org/10.1128/ IAI.01265-07 12.,Non-OADS,/arxiv_data1/oa_pdf/ab/98/viru-4-589.PMC3906291.pdf
FEMS Microbiol Lett 2012; 326:2-11;  PMID:22092948; http://dx.doi.org/10.1111/j.1574- 6968.2011.02406.x 13.,OADS,/arxiv_data1/oa_pdf/ab/98/viru-4-589.PMC3906291.pdf
Sci News 2013; 183:21-7; http://dx.doi.org/10.1002/scin.5591831217 14.,Non-OADS,/arxiv_data1/oa_pdf/ab/98/viru-4-589.PMC3906291.pdf
J Appl Microbiol 2013; Forthcoming;  PMID:23869938; http://dx.doi.org/10.1111/ jam.12307 15.,Non-OADS,/arxiv_data1/oa_pdf/ab/98/viru-4-589.PMC3906291.pdf
Appl Environ Microbiol  2011; 77:2325-31; PMID:21296935; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ab/98/viru-4-589.PMC3906291.pdf
Int J Pediatr  2010; 2010:671587; PMID:20592753; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ab/98/viru-4-589.PMC3906291.pdf
BMC Infect Dis 2011; 11:122;  PMID:21569418; http://dx.doi.org/10.1186/1471- 2334-11-122 2.,Non-OADS,/arxiv_data1/oa_pdf/ab/98/viru-4-589.PMC3906291.pdf
"Arch Surg 2007; 142:624-31, discussion 631;  PMID:17638799; http://dx.doi.org/10.1001/arch - surg.142.7.62419.",Non-OADS,/arxiv_data1/oa_pdf/ab/98/viru-4-589.PMC3906291.pdf
Curr Opin Infect  Dis 2006; 19:467-74; PMID:16940871; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ab/98/viru-4-589.PMC3906291.pdf
Clin  Microbiol Rev 2010; 23:529-49; PMID:20610822;  http://dx.doi.org/10.1128/CMR.00082-0917.,Non-OADS,/arxiv_data1/oa_pdf/ab/98/viru-4-589.PMC3906291.pdf
J Pediatr 2005; 146:54- 61; PMID:15644823; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ab/98/viru-4-589.PMC3906291.pdf
N Engl J Med 2011; 365:1763-70; PMID:22029753;  http://dx.doi.org/10.1056/NEJMoa1106482,OADS,/arxiv_data1/oa_pdf/ab/98/viru-4-589.PMC3906291.pdf
"7-11 Risk factors for CDI include (advanced) age, antibiotic treat - ment, and hospitalization, and for that reason it has long been  Correspondence to: Wiep Klaas Smits; Email: w.k.smits@lumc.nl Submitted: 08/01/13; Revised 08/27/13; Accepted: 08/28/13http://dx.doi.org/10.4161/viru.26297Clostridium difficile  infections (CDI) have emerged as a  major cause of healthcare associated disease, and recent  epidemiological evidence also suggests an important role in  community-acquired diarrhea.",Non-OADS,/arxiv_data1/oa_pdf/f5/97/viru-4-592.PMC3906292.pdf
Am J Dis Child 1935;  49:390-402; http://dx.doi.org/10.1001/archpe-di.1935.01970020105010 2.,Non-OADS,/arxiv_data1/oa_pdf/f5/97/viru-4-592.PMC3906292.pdf
N Engl  J Med 1978; 298:531-4; PMID:625309; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f5/97/viru-4-592.PMC3906292.pdf
Clin  Infect Dis 2008; 46(Suppl 1):S4-11; PMID:18177220; http://dx.doi.org/10.1086/521865 4.,Non-OADS,/arxiv_data1/oa_pdf/f5/97/viru-4-592.PMC3906292.pdf
Nat Rev Microbiol 2009; 7:526-36; PMID:19528959; http://dx.doi.org/10.1038/nrmi- cro2164 5.,Non-OADS,/arxiv_data1/oa_pdf/f5/97/viru-4-592.PMC3906292.pdf
N Engl J Med 2005; 353:2433- 41; PMID:16322603; http://dx.doi.org/10.1056/ NEJMoa051590,OADS,/arxiv_data1/oa_pdf/f5/97/viru-4-592.PMC3906292.pdf
PLoS Pathog 2010; 6:e1001061;  PMID:20808849; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/f5/97/viru-4-592.PMC3906292.pdf
FEMS Microbiol Lett 2000;  186:307-12; PMID:10802189; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f5/97/viru-4-592.PMC3906292.pdf
Protein Expr Purif 2010; 74:42- 8; PMID:20433927; http://dx.doi.org/10.1016/j.pep.2010.04.014 38.,OADS,/arxiv_data1/oa_pdf/f5/97/viru-4-592.PMC3906292.pdf
J Bacteriol 2007; 189:7290- 301; PMID:17693517; http://dx.doi.org/10.1128/ JB.00731-07 39.,Non-OADS,/arxiv_data1/oa_pdf/f5/97/viru-4-592.PMC3906292.pdf
J Infect Dis 2006; 193:1143-50; PMID:16544255; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f5/97/viru-4-592.PMC3906292.pdf
J Biol Chem 2011; 286:29356-65; PMID:21705797; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/f5/97/viru-4-592.PMC3906292.pdf
PLoS Pathog 2009; 5:e1000626;  PMID:19834554; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/f5/97/viru-4-592.PMC3906292.pdf
J  Med Microbiol 2005; 54:181-5; PMID:15673514;  http://dx.doi.org/10.1099/jmm.0.45804-0 45.,Non-OADS,/arxiv_data1/oa_pdf/f5/97/viru-4-592.PMC3906292.pdf
Emerg Infect Dis 2011; 17:976-82; PMID:21749757;  http://dx.doi.org/10.3201/eid1706.101483 46.,Non-OADS,/arxiv_data1/oa_pdf/f5/97/viru-4-592.PMC3906292.pdf
Future Microbiol 2011; 6:121- 3; PMID:21366410; http://dx.doi.org/10.2217/ fmb.10.169 22.,Non-OADS,/arxiv_data1/oa_pdf/f5/97/viru-4-592.PMC3906292.pdf
Gut Microbes 2010;  1:58-64; PMID:20664812; http://dx.doi.org/10.4161/ gmic.1.1.10768 23.,Non-OADS,/arxiv_data1/oa_pdf/f5/97/viru-4-592.PMC3906292.pdf
Nature  2010; 467:711-3; PMID:20844489; http://dx.doi.org/10.1038/nature09397 24.,Non-OADS,/arxiv_data1/oa_pdf/f5/97/viru-4-592.PMC3906292.pdf
Emerg Infect Dis 2013; 19:790- 2; PMID:23697508; http://dx.doi.org/10.3201/eid1905.121062 25.,Non-OADS,/arxiv_data1/oa_pdf/f5/97/viru-4-592.PMC3906292.pdf
J Med Microbiol 2008; 57:685-9; PMID:18480323; http://dx.doi.org/10.1099/ jmm.0.47775-0 26.,Non-OADS,/arxiv_data1/oa_pdf/f5/97/viru-4-592.PMC3906292.pdf
Mol Microbiol 2007; 64:1274-88;  PMID:17542920; http://dx.doi.org/10.1111/j.1365- 2958.2007.05739.x 27.,Non-OADS,/arxiv_data1/oa_pdf/f5/97/viru-4-592.PMC3906292.pdf
J Clin Microbiol  2007; 45:215-21; PMID:17035492; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f5/97/viru-4-592.PMC3906292.pdf
Lancet 2005; 366:1079-84; PMID:16182895;  http://dx.doi.org/10.1016/S0140-6736(05)67420-X 30.,Non-OADS,/arxiv_data1/oa_pdf/f5/97/viru-4-592.PMC3906292.pdf
J Bacteriol 2010; 192:4904- 11; PMID:20675495; http://dx.doi.org/10.1128/ JB.00445-10 31.,Non-OADS,/arxiv_data1/oa_pdf/f5/97/viru-4-592.PMC3906292.pdf
Microbiology 2011; 157:1343- 53; PMID:21330434; http://dx.doi.org/10.1099/ mic.0.046243-0 32.,Non-OADS,/arxiv_data1/oa_pdf/f5/97/viru-4-592.PMC3906292.pdf
Appl Environ Microbiol 2012; 78:4683-90; PMID:22522680;  http://dx.doi.org/10.1128/AEM.00249-12 33.,OADS,/arxiv_data1/oa_pdf/f5/97/viru-4-592.PMC3906292.pdf
PLoS One 2012; 7:e43247;  PMID:22912837; http://dx.doi.org/10.1371/journal.pone.0043247 34.,Non-OADS,/arxiv_data1/oa_pdf/f5/97/viru-4-592.PMC3906292.pdf
Mol Microbiol  2012; 84:66-76; PMID:22372854; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f5/97/viru-4-592.PMC3906292.pdf
CMAJ 2005; 173:1037-42; PMID:16179431;  http://dx.doi.org/10.1503/cmaj.050978 10.,OADS,/arxiv_data1/oa_pdf/f5/97/viru-4-592.PMC3906292.pdf
Infect Control  Hosp Epidemiol 2005; 26:273-80; PMID:15796280;  http://dx.doi.org/10.1086/502539 11.,Non-OADS,/arxiv_data1/oa_pdf/f5/97/viru-4-592.PMC3906292.pdf
Gastroenterology 2009; 136:1913-24; PMID:19457419; http://dx.doi.org/10.1053/j.,Non-OADS,/arxiv_data1/oa_pdf/f5/97/viru-4-592.PMC3906292.pdf
Clin  Microbiol Rev 2010; 23:529-49; PMID:20610822;  http://dx.doi.org/10.1128/CMR.00082-09 13.,Non-OADS,/arxiv_data1/oa_pdf/f5/97/viru-4-592.PMC3906292.pdf
Gut Microbes 2010; 1:234-42; PMID:21327030;  http://dx.doi.org/10.4161/gmic.1.4.12706 14.,Non-OADS,/arxiv_data1/oa_pdf/f5/97/viru-4-592.PMC3906292.pdf
Clin Infect Dis 2008; 47:1162-70;  PMID:18808358; http://dx.doi.org/10.1086/592257 15.,Non-OADS,/arxiv_data1/oa_pdf/f5/97/viru-4-592.PMC3906292.pdf
Clin Microbiol Infect  2012; 18:635-45; PMID:22536816; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f5/97/viru-4-592.PMC3906292.pdf
Vet Microbiol 2011; 153:205-17;  PMID:21530110; http://dx.doi.org/10.1016/j.vet - mic.2011.03.020 17.,OADS,/arxiv_data1/oa_pdf/f5/97/viru-4-592.PMC3906292.pdf
J Clin Microbiol  2010; 48:3744-9; PMID:20686080; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f5/97/viru-4-592.PMC3906292.pdf
Nat Genet 2013; 45:109-13; PMID:23222960; http://dx.doi.org/10.1038/ng.2478 19.,OADS,/arxiv_data1/oa_pdf/f5/97/viru-4-592.PMC3906292.pdf
J Med Microbiol 2008; 57:784- 9; PMID:18480338; http://dx.doi.org/10.1099/ jmm.0.47738-0 75.,Non-OADS,/arxiv_data1/oa_pdf/f5/97/viru-4-592.PMC3906292.pdf
Emerg Infect  Dis 2010; 16:675-7; PMID:20350385; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f5/97/viru-4-592.PMC3906292.pdf
Methods Mol Biol  2010; 646:149-62; PMID:20597008; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f5/97/viru-4-592.PMC3906292.pdf
Genome  Biol 2009; 10:R102; PMID:19781061; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f5/97/viru-4-592.PMC3906292.pdf
PLoS One 2012; 7:e31559; PMID:22396735; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/f5/97/viru-4-592.PMC3906292.pdf
J Infect Dis 2013; 207:675-86; PMID:23204167;  http://dx.doi.org/10.1093/infdis/jis734 80.,OADS,/arxiv_data1/oa_pdf/f5/97/viru-4-592.PMC3906292.pdf
J Med  Microbiol 2012; 61:49-56; PMID:21903827; http://dx.doi.org/10.1099/jmm.0.036194-0 81.,Non-OADS,/arxiv_data1/oa_pdf/f5/97/viru-4-592.PMC3906292.pdf
Lancet  2011; 377:1407; PMID:21515161; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f5/97/viru-4-592.PMC3906292.pdf
J Med Microbiol 2013; 62:1486- 9; PMID:23558137; http://dx.doi.org/10.1099/ jmm.0.057968-0 83.,Non-OADS,/arxiv_data1/oa_pdf/f5/97/viru-4-592.PMC3906292.pdf
Gut  Microbes 2012; 3:121-34; PMID:22555464; http://dx.doi.org/10.4161/gmic.19399 84.,Non-OADS,/arxiv_data1/oa_pdf/f5/97/viru-4-592.PMC3906292.pdf
Int J Med Microbiol 2010; 300:387-95; PMID:20547099; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f5/97/viru-4-592.PMC3906292.pdf
J Med Microbiol 2013; 62:1444-52; PMID:23722432; http://dx.doi.org/10.1099/ jmm.0.058719-0 86.,Non-OADS,/arxiv_data1/oa_pdf/f5/97/viru-4-592.PMC3906292.pdf
J Med Microbiol  2013; 62:1386-93; PMID:23518658; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f5/97/viru-4-592.PMC3906292.pdf
Infect Immun 2009; 77:3661- 9; PMID:19564382; http://dx.doi.org/10.1128/ IAI.00558-09 63.,Non-OADS,/arxiv_data1/oa_pdf/f5/97/viru-4-592.PMC3906292.pdf
Nat Genet  2006; 38:779-86; PMID:16804543; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f5/97/viru-4-592.PMC3906292.pdf
J Bacteriol 2006; 188:7297- 305; PMID:17015669; http://dx.doi.org/10.1128/ JB.00664-06 65.,Non-OADS,/arxiv_data1/oa_pdf/f5/97/viru-4-592.PMC3906292.pdf
J Antimicrob Chemother 2012; 67:2788-92;  PMID:22865382; http://dx.doi.org/10.1093/jac/ dks302 66.,OADS,/arxiv_data1/oa_pdf/f5/97/viru-4-592.PMC3906292.pdf
J Antimicrob Chemother 2008; 62:1046-52; PMID:18693234; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f5/97/viru-4-592.PMC3906292.pdf
J Antimicrob Chemother  2011; 66:2227-34; PMID:21771851; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f5/97/viru-4-592.PMC3906292.pdf
J Antimicrob  Chemother 2013; 68:1951-61; PMID:23620467;  http://dx.doi.org/10.1093/jac/dkt129 69.,Non-OADS,/arxiv_data1/oa_pdf/f5/97/viru-4-592.PMC3906292.pdf
Clin Infect Dis 2008;  46(Suppl 1):S19-31; PMID:18177218; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f5/97/viru-4-592.PMC3906292.pdf
Clin Infect Dis 2011; 53:860- 9; PMID:21914851; http://dx.doi.org/10.1093/cid/ cir549 71.,Non-OADS,/arxiv_data1/oa_pdf/f5/97/viru-4-592.PMC3906292.pdf
Antimicrob Agents  Chemother 2009; 53:5155-62; PMID:19805572; http://dx.doi.org/10.1128/AAC.00532-09 72.,Non-OADS,/arxiv_data1/oa_pdf/f5/97/viru-4-592.PMC3906292.pdf
J Med Microbiol 2013; 62:741-7; PMID:23429695;  http://dx.doi.org/10.1099/jmm.0.056218-0 73.,Non-OADS,/arxiv_data1/oa_pdf/f5/97/viru-4-592.PMC3906292.pdf
Antimicrob Resist Infect Control 2013; 2:14; PMID:23566553; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f5/97/viru-4-592.PMC3906292.pdf
Infect Genet Evol  2012; 12:1577-85; PMID:22705462; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f5/97/viru-4-592.PMC3906292.pdf
Infect Immun 2011; 79:636-43; PMID:21098099; http://dx.doi.org/10.1128/IAI.00954-10 51.,Non-OADS,/arxiv_data1/oa_pdf/f5/97/viru-4-592.PMC3906292.pdf
J Clin Microbiol  2006; 44:353-8; PMID:16455883; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f5/97/viru-4-592.PMC3906292.pdf
Nat Rev Microbiol 2005; 3:969-78; PMID:16261177;  http://dx.doi.org/10.1038/nrmicro1288 54.,OADS,/arxiv_data1/oa_pdf/f5/97/viru-4-592.PMC3906292.pdf
Infect Immun 2012; 80:2704-11; PMID:22615253; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f5/97/viru-4-592.PMC3906292.pdf
J Bacteriol 2009; 191:7296-305; PMID:19783633;  http://dx.doi.org/10.1128/JB.00882-09 57.,Non-OADS,/arxiv_data1/oa_pdf/f5/97/viru-4-592.PMC3906292.pdf
PLoS  One 2012; 7:e48608; PMID:23119071; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f5/97/viru-4-592.PMC3906292.pdf
J Clin  Microbiol 2008; 46:1530-3; PMID:18287318; http://dx.doi.org/10.1128/JCM.01964-07 59.,Non-OADS,/arxiv_data1/oa_pdf/f5/97/viru-4-592.PMC3906292.pdf
PLoS One  2011; 6:e24894; PMID:21949780; http://dx.doi.org/10.1371/journal.pone.0024894 60.,Non-OADS,/arxiv_data1/oa_pdf/f5/97/viru-4-592.PMC3906292.pdf
Anaerobe 2010; 16:618-22; PMID:20950700; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f5/97/viru-4-592.PMC3906292.pdf
PLoS One 2012; 7:e32381; PMID:22384234; http://dx.doi.org/10.1371/journal.pone.0032381,Non-OADS,/arxiv_data1/oa_pdf/f5/97/viru-4-592.PMC3906292.pdf
14 G. mellonella  larvae  *Correspondence to: Kevin Kavanagh; Email: kevin.kavanagh@nuim.ie Submitted: 06/11/13; Revised: 07/24/13; Accepted: 07/25/13http://dx.doi.org/10.4161/viru.25906The insect immune response demonstrates a number of  structural and functional similarities to the innate immune system of mammals.,Non-OADS,/arxiv_data1/oa_pdf/e2/79/viru-4-597.PMC3906293.pdf
Immunol Lett 1998; 62:59-66; PMID:9698099; http://dx.doi.org/10.1016/S0165-2478(98)00023-6 3.,Non-OADS,/arxiv_data1/oa_pdf/e2/79/viru-4-597.PMC3906293.pdf
Dev Biol  2001; 230:243-57; PMID:11161576; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e2/79/viru-4-597.PMC3906293.pdf
Amer J Biochem  Mol Biol 2012; 2:82-105; http://dx.doi.org/10.3923/ ajbmb.2012.82.105 6.,Non-OADS,/arxiv_data1/oa_pdf/e2/79/viru-4-597.PMC3906293.pdf
FEMS Microbiol Rev 2004; 28:101-12;  PMID:14975532; http://dx.doi.org/10.1016/j.fem- sre.2003.09.002 7.,OADS,/arxiv_data1/oa_pdf/e2/79/viru-4-597.PMC3906293.pdf
Immunol Invest  2011; 40:676-91; PMID:21985301; http://dx.doi.org /10.3109/08820139.2011.587218 9.,Non-OADS,/arxiv_data1/oa_pdf/e2/79/viru-4-597.PMC3906293.pdf
FEMS Immunol Med Microbiol 2002; 34:153-7;  PMID:12381467; http://dx.doi.org/10.1111/j.1574- 695X.2002.tb00617.x 11.,Non-OADS,/arxiv_data1/oa_pdf/e2/79/viru-4-597.PMC3906293.pdf
J Bacteriol 2006; 188:7686-8; PMID:16936013;  http://dx.doi.org/10.1128/JB.00700-06 12.,Non-OADS,/arxiv_data1/oa_pdf/e2/79/viru-4-597.PMC3906293.pdf
Annu Rev Immunol  2007; 25:697-743; PMID:17201680; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e2/79/viru-4-597.PMC3906293.pdf
FEMS Microbiol Lett 2006; 263:1-9;  PMID:16958844; http://dx.doi.org/10.1111/j.1574-6968.2006.00388.x 14.,OADS,/arxiv_data1/oa_pdf/e2/79/viru-4-597.PMC3906293.pdf
Curr Opin  Microbiol 2006; 9:346-51; PMID:16814595; http://dx.doi.org/10.1016/j.mib.2006.06.00415.,OADS,/arxiv_data1/oa_pdf/e2/79/viru-4-597.PMC3906293.pdf
J Bacteriol 2000; 182:3843- 5; PMID:10851003; http://dx.doi.org/10.1128/ JB.182.13.3843-3845.2000 18.,Non-OADS,/arxiv_data1/oa_pdf/e2/79/viru-4-597.PMC3906293.pdf
J Med Microbiol 2011; 60:661- 9; PMID:21233296; http://dx.doi.org/10.1099/jmm.0.026658-0 19.,Non-OADS,/arxiv_data1/oa_pdf/e2/79/viru-4-597.PMC3906293.pdf
Appl Environ Microbiol 2010; 76:310-7; PMID:19897755;  http://dx.doi.org/10.1128/AEM.01301-09 20.,Non-OADS,/arxiv_data1/oa_pdf/e2/79/viru-4-597.PMC3906293.pdf
Microbiology 2010; 156:3456- 68; PMID:20688820; http://dx.doi.org/10.1099/ mic.0.040782-0 21.,Non-OADS,/arxiv_data1/oa_pdf/e2/79/viru-4-597.PMC3906293.pdf
Infect Immun  2008; 76:1267-75; PMID:18195031; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e2/79/viru-4-597.PMC3906293.pdf
Microbiology 2009; 155:1516-22; PMID:19383703;  http://dx.doi.org/10.1099/mic.0.026823-0 23.,Non-OADS,/arxiv_data1/oa_pdf/e2/79/viru-4-597.PMC3906293.pdf
Mycopathologia 2004; 158:73-9;  PMID:15487324; http://dx.doi.org/10.1023/ B:MYCO.0000038434.55764.16 24.,Non-OADS,/arxiv_data1/oa_pdf/e2/79/viru-4-597.PMC3906293.pdf
Infect Immun 2005; 73:3842-50; PMID:15972469; http://dx.doi.org/10.1128/ IAI.73.7.3842-3850.2005 25.,Non-OADS,/arxiv_data1/oa_pdf/e2/79/viru-4-597.PMC3906293.pdf
Microbes Infect 2007; 9:729- 34; PMID:17400503; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e2/79/viru-4-597.PMC3906293.pdf
Lancet Infect Dis 2007; 7:42-55;  PMID:17182343; http://dx.doi.org/10.1016/S1473- 3099(06)70686-7 27.,Non-OADS,/arxiv_data1/oa_pdf/e2/79/viru-4-597.PMC3906293.pdf
Biometals 2009; 22:461-7; PMID:19082779; http://dx.doi.org/10.1007/s10534- 008-9182-328.,Non-OADS,/arxiv_data1/oa_pdf/e2/79/viru-4-597.PMC3906293.pdf
Antimicrob Agents Chemother 2004; 48:774- 9; PMID:14982763; http://dx.doi.org/10.1128/AAC.48.3.774-779.2004 30.,Non-OADS,/arxiv_data1/oa_pdf/e2/79/viru-4-597.PMC3906293.pdf
Drug Discov Today Dis  Models 2007; 4:105-10; http://dx.doi.org/10.1016/j.ddmod.2007.06.007 31.,OADS,/arxiv_data1/oa_pdf/e2/79/viru-4-597.PMC3906293.pdf
Virulence 2013; 4:324- 32; PMID:23348912; http://dx.doi.org/10.4161/ viru.23629 32.,Non-OADS,/arxiv_data1/oa_pdf/e2/79/viru-4-597.PMC3906293.pdf
T rends  Genet 1993; 9:178-83; PMID:8337755; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e2/79/viru-4-597.PMC3906293.pdf
Insect Biochem Mol Biol 2002;  32:1295-309; PMID:12225920; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e2/79/viru-4-597.PMC3906293.pdf
Microbes Infect 2003; 5:1389- 95; PMID:14670452; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e2/79/viru-4-597.PMC3906293.pdf
J Insect Physiol 2000; 46:1129-35; PMID:10817839; http://dx.doi.org/10.1016/S0022- 1910(99)00223-1 38.,OADS,/arxiv_data1/oa_pdf/e2/79/viru-4-597.PMC3906293.pdf
T rends Biochem Sci 1990; 15:69-72; PMID:2186518; http://dx.doi.org/10.1016/0968- 0004(90)90179-F 39.,OADS,/arxiv_data1/oa_pdf/e2/79/viru-4-597.PMC3906293.pdf
J Invertebr Pathol 2011; 108:126-30; PMID:21843526; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/e2/79/viru-4-597.PMC3906293.pdf
Nature  1997; 388:394-7; PMID:9237759; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e2/79/viru-4-597.PMC3906293.pdf
J Biochem Mol Biol 2011; 158:90-8;  http://dx.doi.org/10.1016/j.cbpb.2010.10.001 68.,OADS,/arxiv_data1/oa_pdf/e2/79/viru-4-597.PMC3906293.pdf
Science 2004; 303:1532-5;  PMID:15001782; http://dx.doi.org/10.1126/sci- ence.1092385 69.,OADS,/arxiv_data1/oa_pdf/e2/79/viru-4-597.PMC3906293.pdf
J  Innate Immun 2009; 1:194-201; PMID:20375577;  http://dx.doi.org/10.1159/000206974 71.,Non-OADS,/arxiv_data1/oa_pdf/e2/79/viru-4-597.PMC3906293.pdf
J Magn Magn Mater  2001; 225:218-25; http://dx.doi.org/10.1016/S0304- 8853(00)01261-0 72.,Non-OADS,/arxiv_data1/oa_pdf/e2/79/viru-4-597.PMC3906293.pdf
Mycopathologia  2006; 161:377-84; PMID:16761185; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e2/79/viru-4-597.PMC3906293.pdf
Gene Expr Patterns 2002; 2:311- 7; PMID:12617819; http://dx.doi.org/10.1016/ S1567-133X(02)00020-056.,OADS,/arxiv_data1/oa_pdf/e2/79/viru-4-597.PMC3906293.pdf
Microbes Infect 2000; 2:257- 72; PMID:10758402; http://dx.doi.org/10.1016/ S1286-4579(00)00302-6 58.,OADS,/arxiv_data1/oa_pdf/e2/79/viru-4-597.PMC3906293.pdf
J Exp Med  1986; 163:981-97; PMID:3950549; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e2/79/viru-4-597.PMC3906293.pdf
Eur J Immunol 1997; 27:2426- 35; PMID:9341789; http://dx.doi.org/10.1002/eji.1830270942 60.,Non-OADS,/arxiv_data1/oa_pdf/e2/79/viru-4-597.PMC3906293.pdf
Dev Comp Immunol 2003; 27:189-96;  PMID:12590970; http://dx.doi.org/10.1016/S0145- 305X(02)00099-X 62.,Non-OADS,/arxiv_data1/oa_pdf/e2/79/viru-4-597.PMC3906293.pdf
Infect Immun 2004; 72:3373- 82; PMID:15155643; http://dx.doi.org/10.1128/ IAI.72.6.3373-3382.2004 63.,Non-OADS,/arxiv_data1/oa_pdf/e2/79/viru-4-597.PMC3906293.pdf
Microbes Infect 2007; 9:47-54; PMID:17196420; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e2/79/viru-4-597.PMC3906293.pdf
J Med Microbiol  2010; 59:625-33; PMID:20203215; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e2/79/viru-4-597.PMC3906293.pdf
Microbiology 2011; 157:1481- 8; PMID:21349977; http://dx.doi.org/10.1099/ mic.0.043786-042.,Non-OADS,/arxiv_data1/oa_pdf/e2/79/viru-4-597.PMC3906293.pdf
Bioessays 2001; 23:344-51;  PMID:11268040; http://dx.doi.org/10.1002/ bies.1049 46.,OADS,/arxiv_data1/oa_pdf/e2/79/viru-4-597.PMC3906293.pdf
J Clin Invest 1990; 86:1381-6; PMID:2243118;  http://dx.doi.org/10.1172/JCI114851 48.,Non-OADS,/arxiv_data1/oa_pdf/e2/79/viru-4-597.PMC3906293.pdf
Mol Cell Endocrinol 2013; 368:85- 98; PMID:22546548; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e2/79/viru-4-597.PMC3906293.pdf
Nat Rev Immunol 2006; 6:173-82;  PMID:16498448; http://dx.doi.org/10.1038/nri1785 51.,Non-OADS,/arxiv_data1/oa_pdf/e2/79/viru-4-597.PMC3906293.pdf
Curr Opin Immunol 2002; 14:420-31;  PMID:12088675; http://dx.doi.org/10.1016/S0952- 7915(02)00365-5 52.,OADS,/arxiv_data1/oa_pdf/e2/79/viru-4-597.PMC3906293.pdf
Nature 1998; 392:245-52;  PMID:9521319; http://dx.doi.org/10.1038/32588 54.,Non-OADS,/arxiv_data1/oa_pdf/e2/79/viru-4-597.PMC3906293.pdf
J Exp Med  1996; 183:1865-78; PMID:8666943; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e2/79/viru-4-597.PMC3906293.pdf
"Virulence 4:7, 638–640; October 1, 2013; © 2013 Landes Bioscience 638 Virulence Volume 4 Issue 7 Aut OphA gIc punctum Keywords:  C. elegans , neurons, host– pathogen interactions Submitted: 07/23/2013Accepted: 07/23/13http://dx.doi.org/10.4161/viru.25858 Correspondence to: Alejandro Aballay;   Email: a.aballay@duke.eduTell us about your early days.",Non-OADS,/arxiv_data1/oa_pdf/37/45/viru-4-638.PMC3906298.pdf
Artwork is by Julie n ewdoll (http://www.brushwithscience.com).,Non-OADS,/arxiv_data1/oa_pdf/37/45/viru-4-638.PMC3906298.pdf
"tomasz Jarzembowski1,*, Agnieszka d aca2, Jacek Witkowski3, Bolesław rutkowski4, Justyna Gołębiewska4,   and Alicja d ębska-Ślizień4 1department of Microbiology; Medical University of Gdansk; Gdansk, Poland; 2department of Pathology and e xperimental r heumatology; Medical University of Gdansk;  Gdansk, Poland; 3department of Pathophysiology; Medical University of Gdansk; Gdansk, Poland; 4department of Nephrology, t ransplantology and i nternal Medicine;  Medical University of Gdansk; Gdansk, Poland Keywords:  RTx, CMV, ASA gene, enterococci *Correspondence to: Tomasz Jarzembowski; Email: tjarzembowski@gumed.edu.pl Submitted: 08/23/13; Accepted: 08/29/13http://dx.doi.org/10.4161/viru.26315enterococcal binding substance (EBS).",Non-OADS,/arxiv_data1/oa_pdf/77/07/viru-4-641.PMC3906299.pdf
Clin T ransplant  2006; 20:401-9; PMID:16842513; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/77/07/viru-4-641.PMC3906299.pdf
T ransplant Proc 2011; 43:2985- 90; PMID:21996206; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/77/07/viru-4-641.PMC3906299.pdf
T ransplant Proc 2010; 42:280- 1; PMID:20172330; http://dx.doi.org/10.1016/j.transproceed.2009.11.029 5.,OADS,/arxiv_data1/oa_pdf/77/07/viru-4-641.PMC3906299.pdf
Kidney  Int 2010; 78:774-81; PMID:20720526; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/77/07/viru-4-641.PMC3906299.pdf
Infect Immun 2004; 72:2445-8; PMID:15039379;  http://dx.doi.org/10.1128/IAI.72.4.2445-2448.2004 7.,Non-OADS,/arxiv_data1/oa_pdf/77/07/viru-4-641.PMC3906299.pdf
Infect Dis Clin North Am  2003; 17:367-94; PMID:12848475; http://dx.doi.org/10.1016/S0891-5520(03)00008-48.,Non-OADS,/arxiv_data1/oa_pdf/77/07/viru-4-641.PMC3906299.pdf
Infect  Immun 2002; 70:4344-52; PMID:12117944; http://dx.doi.org/10.1128/IAI.70.8.4344-4352.2002 10.,Non-OADS,/arxiv_data1/oa_pdf/77/07/viru-4-641.PMC3906299.pdf
J Virol 2004; 78:10378-89; PMID:15367604; http://dx.doi.org/10.1128/ JVI.78.19.10378-10389.2004 11.,Non-OADS,/arxiv_data1/oa_pdf/77/07/viru-4-641.PMC3906299.pdf
T ransplant Proc 2012; 44:706-9; PMID:22483473; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/77/07/viru-4-641.PMC3906299.pdf
T ransfusion 2001; 41:1249-57;  PMID:11606824; http://dx.doi.org/10.1046/j.1537- 2995.2001.41101249.x 14.,Non-OADS,/arxiv_data1/oa_pdf/77/07/viru-4-641.PMC3906299.pdf
"Nephrol Dial T ransplant 2007; 22(Suppl 8):viii72,  viii82; PMID:17890268; http://dx.doi.org/10.1093/ ndt/gfm648 15.",Non-OADS,/arxiv_data1/oa_pdf/77/07/viru-4-641.PMC3906299.pdf
Apollo Medicine  2008; 5:333-7; http://dx.doi.org/10.1016/S0976- 0016(11)60161-0 17.,Non-OADS,/arxiv_data1/oa_pdf/77/07/viru-4-641.PMC3906299.pdf
Blood 2011; 118:6783-92;  PMID:22031867; http://dx.doi.org/10.1182/blood- 2011-02-337956 18.,Non-OADS,/arxiv_data1/oa_pdf/77/07/viru-4-641.PMC3906299.pdf
Infect Immun  2000; 68:4900-6; PMID:10948103; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/77/07/viru-4-641.PMC3906299.pdf
Biochim Biophys Acta 2011; 1812:1272-80;  PMID:21241798; http://dx.doi.org/10.1016/j.bba- dis.2011.01.006 20.,OADS,/arxiv_data1/oa_pdf/77/07/viru-4-641.PMC3906299.pdf
Dis Mon  1995; 41:693-765; PMID:7587886; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/77/07/viru-4-641.PMC3906299.pdf
Nephrol Dial T ransplant 2012; 27:3746-51; PMID:23114901; http://dx.doi.org/10.1093/ndt/ gfs352 23.,Non-OADS,/arxiv_data1/oa_pdf/77/07/viru-4-641.PMC3906299.pdf
J Med Microbiol 2004; 53:13- 20; PMID:14663100; http://dx.doi.org/10.1099/ jmm.0.05353-0 24.,Non-OADS,/arxiv_data1/oa_pdf/77/07/viru-4-641.PMC3906299.pdf
J Oral Microbiol 2012; 4:10855; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/77/07/viru-4-641.PMC3906299.pdf
Anal Biochem 2009; 390:109-14; PMID:19393610;  http://dx.doi.org/10.1016/j.ab.2009.04.026 28.,OADS,/arxiv_data1/oa_pdf/77/07/viru-4-641.PMC3906299.pdf
"36,37 Since it is likely that the virus so  formed arises from free amino acids of Relationship between plasma l-lysine  concentrations and levels of HIV-1 RNA evgeny Vlad Butorov the Municipal Center of hi V/AidS Prophylaxis; Surgut, r ussian Federation Keywords:  HIV, plasma l-lysine, viral load Correspondence to: Evgeny Vlad Butorov; Email: butorov888@gmail.com Submitted: 08/24/13; Accepted: 09/03/13http://dx.doi.org/10.4161/viru.26361the cell, knowledge of the changes of free  amino acids in the host cell and tissue, and its modification by infection, should be of interest.",Non-OADS,/arxiv_data1/oa_pdf/0a/58/viru-4-646.PMC3906300.pdf
AIDS 1992; 6:815-9; PMID:1418777; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0a/58/viru-4-646.PMC3906300.pdf
J Acquir Immune Defic  Syndr Hum Retrovirol 1998; 18:80-5; PMID:9593462;  http://dx.doi.org/10.1097/00042560-199805010- 00012 8.,Non-OADS,/arxiv_data1/oa_pdf/0a/58/viru-4-646.PMC3906300.pdf
"Biol Chem Hoppe Seyler 1989; 370:101- 8; PMID:2784973; http://dx.doi.org/10.1515/ bchm3.1989.370.1.101Acknowledgments The author thanks the laboratory staff of  the Municipal Center of HIV/AIDS pro - phylaxis (Surgut, Russian Federation) for their technical support and for their per - formance of routine hematological analy - ses and HIV-1 RNA viral loads.",Non-OADS,/arxiv_data1/oa_pdf/0a/58/viru-4-646.PMC3906300.pdf
N Engl J Med 1992; 327:329-37; PMID:1620172;  http://dx.doi.org/10.1056/NEJM199207303270506Figure 2.,OADS,/arxiv_data1/oa_pdf/0a/58/viru-4-646.PMC3906300.pdf
Annu Rev Microbiol  1984; 38:91-109; PMID:6093688; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0a/58/viru-4-646.PMC3906300.pdf
Nat Chem Biol 2012;  8:23-4; http://dx.doi.org/10.1038/nchembio.743;  PMID:22173355 43.,OADS,/arxiv_data1/oa_pdf/0a/58/viru-4-646.PMC3906300.pdf
Biochem J 2000; 351:1-12;  PMID:10998343; http://dx.doi.org/10.1042/0264- 6021:3510001 44.,Non-OADS,/arxiv_data1/oa_pdf/0a/58/viru-4-646.PMC3906300.pdf
Nat Chem Biol 2012;  8:65-71; http://dx.doi.org/10.1038/nchembio.710;  PMID:22082910 48.,OADS,/arxiv_data1/oa_pdf/0a/58/viru-4-646.PMC3906300.pdf
J Biol Chem 2004; 279:3588- 95; PMID:14602716; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/0a/58/viru-4-646.PMC3906300.pdf
Nucleic Acids  Res 2000; 28:4783-9; PMID:11095691; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0a/58/viru-4-646.PMC3906300.pdf
J Virol 2003; 77:9817-22; PMID:12941890; http://dx.doi.org/10.1128/JVI.77.18.9817-9822.200328.,Non-OADS,/arxiv_data1/oa_pdf/0a/58/viru-4-646.PMC3906300.pdf
Int J Mol Med 2009; 23:495- 9; PMID:19288025; http://dx.doi.org/10.3892/ ijmm_00000156 30.,OADS,/arxiv_data1/oa_pdf/0a/58/viru-4-646.PMC3906300.pdf
J Clin Gastroenterol  1984; 6:453-60; PMID:6501833; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0a/58/viru-4-646.PMC3906300.pdf
Curr Opin Clin Nutr Metab  Care 1999; 2:47-53; PMID:10453330; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0a/58/viru-4-646.PMC3906300.pdf
BMC Cancer 2010; 10:690; PMID:21176209; http://dx.doi.org/10.1186/1471-2407-10-690 37.,Non-OADS,/arxiv_data1/oa_pdf/0a/58/viru-4-646.PMC3906300.pdf
Annu Rev Biochem  1987; 56:317-32; PMID:3113326; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0a/58/viru-4-646.PMC3906300.pdf
Virology  1966; 30:355-67; PMID:4288415; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0a/58/viru-4-646.PMC3906300.pdf
Ann Intern  Med 1967; 67:744-79; PMID:4964043; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0a/58/viru-4-646.PMC3906300.pdf
Am Rev Respir  Dis 1990; 141:902-8; PMID:2327654; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0a/58/viru-4-646.PMC3906300.pdf
Annu Rev Nutr  1990; 10:107-32; PMID:2200459; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0a/58/viru-4-646.PMC3906300.pdf
Biochem Med 1984; 32:181-8; PMID:6391476;  http://dx.doi.org/10.1016/0006-2944(84)90071-1 21.,OADS,/arxiv_data1/oa_pdf/0a/58/viru-4-646.PMC3906300.pdf
Metabolism 1972; 21:67- 76; PMID:4621526; http://dx.doi.org/10.1016/0026- 0495(72)90021-2 23.,Non-OADS,/arxiv_data1/oa_pdf/0a/58/viru-4-646.PMC3906300.pdf
J Gen Virol 1978; 39:281- 92; PMID:650177; http://dx.doi.org/10.1099/0022- 1317-39-2-281 24.,Non-OADS,/arxiv_data1/oa_pdf/0a/58/viru-4-646.PMC3906300.pdf
J Gen  Virol 1968; 3:143-6; PMID:4300565; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0a/58/viru-4-646.PMC3906300.pdf
J Gen Virol 1968; 3:9-17;  PMID:4300568; http://dx.doi.org/10.1099/0022- 1317-3-1-9,Non-OADS,/arxiv_data1/oa_pdf/0a/58/viru-4-646.PMC3906300.pdf
"Lurie Children’s h ospital of Chicago; Chicago, i L USA; 2Feinberg School of Medicine; Northwestern University; Chicago, i L USA Current affiliations: †rush University Medical Center; r ush Medical College; Chicago, i L USA; ‡Seattle Biomedical r esearch i nstitute; University of Washington; Seattle, WA USA;  §CVS-Caremark; Northbrook, i L USA Keywords:  Staphylococcus aureus , epidemiology, pregnancy, molecular epidemiology, infections in obs and gyn *Correspondence to: Latania K Logan; Email: latania_logan@rush.edu Submitted: 06/04/13; Revised: 09/06/13; Accepted: 09/09/13http://dx.doi.org/10.4161/viru.26435the last decade, with rates as high as 996  per 100 000 patients in certain high risk  areas and patient populations.5 Recent data suggests that infants born  to mothers who are S.  aureus  colonized are  more likely to become colonized as neo - nates, but not necessarily infected, and this transmission is most often horizontal rather than vertical in nature.",Non-OADS,/arxiv_data1/oa_pdf/b2/bd/viru-4-654.PMC3906301.pdf
N Engl J Med  2003; 348:1342-7; PMID:12672861; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b2/bd/viru-4-654.PMC3906301.pdf
Antimicrob Agents  Chemother 2004; 48:285-96; PMID:14693553;  http://dx.doi.org/10.1128/AAC.48.1.285-296.2004 17.,Non-OADS,/arxiv_data1/oa_pdf/b2/bd/viru-4-654.PMC3906301.pdf
J Clin Microbiol 2005;  43:2380-3; PMID:15872270; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b2/bd/viru-4-654.PMC3906301.pdf
J Clin Microbiol  2009; 47:2097-105; PMID:19458176; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b2/bd/viru-4-654.PMC3906301.pdf
FEMS  Microbiol Lett 1999; 170:97-103; PMID:9919657;  http://dx.doi.org/10.1111/j.1574-6968.1999.,OADS,/arxiv_data1/oa_pdf/b2/bd/viru-4-654.PMC3906301.pdf
J Antimicrob Chemother 2008; 61:73-7; PMID:17989100; http://dx.doi.org/10.1093/ jac/dkm422 10.,Non-OADS,/arxiv_data1/oa_pdf/b2/bd/viru-4-654.PMC3906301.pdf
Nat Med 2012; 18:816-9; PMID:22522561;  http://dx.doi.org/10.1038/nm.2692 11.,OADS,/arxiv_data1/oa_pdf/b2/bd/viru-4-654.PMC3906301.pdf
Microbiology  2003; 149:643-54; PMID:12634333; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b2/bd/viru-4-654.PMC3906301.pdf
J Clin Microbiol 2002; 40:3970- 5; PMID:12409360; http://dx.doi.org/10.1128/ JCM.40.11.3970-3975.2002References 1.,OADS,/arxiv_data1/oa_pdf/b2/bd/viru-4-654.PMC3906301.pdf
Pediatrics  2012; 129:e1252-9; PMID:22473373; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b2/bd/viru-4-654.PMC3906301.pdf
Infect Dis  Obstet Gynecol 2007; 2007:70876; http://dx.doi.org/10.1155/2007/70876; PMID:18273405 5.,Non-OADS,/arxiv_data1/oa_pdf/b2/bd/viru-4-654.PMC3906301.pdf
Clin Infect Dis 2010; 50:979-87; PMID:20192731;  http://dx.doi.org/10.1086/651076 6.,Non-OADS,/arxiv_data1/oa_pdf/b2/bd/viru-4-654.PMC3906301.pdf
J Pediatr Infect Dis Soc 2012; 1:7- 15; http://dx.doi.org/10.1093/jpids/pis001 Figure 1.  relationship analysis of Staphylococcus aureus  isolates.,OADS,/arxiv_data1/oa_pdf/b2/bd/viru-4-654.PMC3906301.pdf
Antimicrob Agents Chemother 2001; 45:1955- 63; PMID:11408208; http://dx.doi.org/10.1128/ AAC.45.7.1955-1963.200120.,Non-OADS,/arxiv_data1/oa_pdf/b2/bd/viru-4-654.PMC3906301.pdf
Antimicrob Agents Chemother 2000; 44:1549- 55; PMID:10817707; http://dx.doi.org/10.1128/ AAC.44.6.1549-1555.200018.,Non-OADS,/arxiv_data1/oa_pdf/b2/bd/viru-4-654.PMC3906301.pdf
Lancet 2006; 367:731-9;  PMID:16517273; http://dx.doi.org/10.1016/S0140-6736(06)68231-7Table 2.,Non-OADS,/arxiv_data1/oa_pdf/b2/bd/viru-4-654.PMC3906301.pdf
"Antibodies to watch in 2013 Mid-year update Janice M. r eichert Editor-in- chief, mAbs; Landes Bioscience; Austin, t X UsA *Correspondence to: Janice M. Reichert; Email: janice.reichert@landesbioscience.com Submitted: 05/05/13; Accepted: 05/05/13http://dx.doi.org/10.4161/mabs.24990the transitions of antibody therapeutics to late-stage clinical development, regulatory review and the market are  proceeding at a rapid pace in 2013. s ince late 2012, two monoclonal antibody (mAb) therapeutics (itolizumab, trastuzumab  emtansine) received their first approvals, first marketing applications for three mAbs (vedolizumab, ramucirumab,  obinutuzumab) were submitted to regulatory agencies, and five mAbs (brodalumab, MABp1, moxetumomab pasudotox,  tildrakizumab, rilotumumab) entered their first Phase 3 studies.",Non-OADS,/arxiv_data1/oa_pdf/c7/db/mabs-5-513.PMC3906304.pdf
MAbs 2013; 5:1-4;  PMID:23254906; http://dx.doi.org/10.4161/mabs.22976 2.,OADS,/arxiv_data1/oa_pdf/c7/db/mabs-5-513.PMC3906304.pdf
MAbs 2012; 4:1-3;  PMID:22327425; http://dx.doi.org/10.4161/mabs.4.1.18719 3.,Non-OADS,/arxiv_data1/oa_pdf/c7/db/mabs-5-513.PMC3906304.pdf
MAbs 2011; 3:76-99; PMID:21051951; http://dx.doi.org/10.4161/mabs.3.1.13895 4.,Non-OADS,/arxiv_data1/oa_pdf/c7/db/mabs-5-513.PMC3906304.pdf
MAbs 2010; 2:84-100; PMID:20065640; http://dx.doi.org/10.4161/mabs.2.1.10677 5.,Non-OADS,/arxiv_data1/oa_pdf/c7/db/mabs-5-513.PMC3906304.pdf
Nat Rev Drug  Discov 2013; 12:329-32; PMID:23629491; http://dx.doi.org/10.1038/nrd4009,Non-OADS,/arxiv_data1/oa_pdf/c7/db/mabs-5-513.PMC3906304.pdf
"Do not distribute.mAbs 5:4, 518–522; July/August 2013; © 2013 Landes Bioscience Short Communi CAtion 518 mA bs  V olume 5 i ssue 4*Correspondence to: Etienne Weiss; Email: eweiss@unistra.fr Submitted: 04/08/13; Revised: 05/17/13; Accepted: 05/18/13http://dx.doi.org/10.4161/mabs.25084When antibodies specific for endogenous cellular proteins are  introduced into intact mammalian cells, it becomes possible to study the functional activity of these proteins in their natural environment.",Non-OADS,/arxiv_data1/oa_pdf/f2/7e/mabs-5-518.PMC3906305.pdf
Biochem Biophys Res Commun 1985; 130:257-63; PMID:4040753; http://dx.doi.org/10.1016/0006-291X(85)90410-3 3.,OADS,/arxiv_data1/oa_pdf/f2/7e/mabs-5-518.PMC3906305.pdf
Eur J Immunol 2008; 38:3178-90; PMID:18991292; http://dx.doi.org/10.1002/eji.200838678 5.,Non-OADS,/arxiv_data1/oa_pdf/f2/7e/mabs-5-518.PMC3906305.pdf
Bioconjug Chem 2012; 23:2025-31; PMID:22989361; http://dx.doi.org/10.1021/bc300030d 6.,OADS,/arxiv_data1/oa_pdf/f2/7e/mabs-5-518.PMC3906305.pdf
Mol Ther 2004; 9:964-9; PMID:15194063; http://dx.doi.org/10.1016/j.ymthe.2004.03.007 7.,OADS,/arxiv_data1/oa_pdf/f2/7e/mabs-5-518.PMC3906305.pdf
MAbs 2011; 3:3-16; PMID:21099369; http://dx.doi.org/10.4161/mabs.3.1.141108.,Non-OADS,/arxiv_data1/oa_pdf/f2/7e/mabs-5-518.PMC3906305.pdf
Mol Cancer Ther 2007; 6:1728-35; PMID:17575104; http://dx.doi.org/10.1158/1535-7163.MCT-06-0808 9.,Non-OADS,/arxiv_data1/oa_pdf/f2/7e/mabs-5-518.PMC3906305.pdf
Cytometry 1991; 12:64-7; PMID:1999124; http://dx.doi.org/10.1002/cyto.990120109 10.,Non-OADS,/arxiv_data1/oa_pdf/f2/7e/mabs-5-518.PMC3906305.pdf
J Immunol Methods 1994; 170:255-9; PMID:8158003; http://dx.doi.org/10.1016/0022-1759(94)90400-6 11.,Non-OADS,/arxiv_data1/oa_pdf/f2/7e/mabs-5-518.PMC3906305.pdf
J Immunol Methods 2000; 242:115-26; PMID:10986394; http://dx.doi.org/10.1016/S0022-1759(00)00242-8 12.,Non-OADS,/arxiv_data1/oa_pdf/f2/7e/mabs-5-518.PMC3906305.pdf
FEBS J 2010; 277:3072-8; PMID:20608972; http://dx.doi.org/10.1111/j.1742-4658.2010.07733.x 14.,OADS,/arxiv_data1/oa_pdf/f2/7e/mabs-5-518.PMC3906305.pdf
Cytometry A 2008; 73A:1128-40; PMID:18773464; http://dx.doi.org/10.1002/cyto.a.20635 15.,Non-OADS,/arxiv_data1/oa_pdf/f2/7e/mabs-5-518.PMC3906305.pdf
Exp Cell Res 1996; 226:208-13; PMID:8660957; http://dx.doi.org/10.1006/excr.1996.0220 17.,OADS,/arxiv_data1/oa_pdf/f2/7e/mabs-5-518.PMC3906305.pdf
J Biol Chem 2003; 278:25207-17; PMID:12676962; http://dx.doi.org/10.1074/jbc.M300070200 18.,OADS,/arxiv_data1/oa_pdf/f2/7e/mabs-5-518.PMC3906305.pdf
Cell Mol Life Sci 2008; 65:3789-808; PMID:18726183; http://dx.doi.org/10.1007/s00018-008-8305-x 19.,OADS,/arxiv_data1/oa_pdf/f2/7e/mabs-5-518.PMC3906305.pdf
J Gen Virol 2003; 84:2099-104; PMID:12867640; http://dx.doi.org/10.1099/vir.0.18961-0 20.,Non-OADS,/arxiv_data1/oa_pdf/f2/7e/mabs-5-518.PMC3906305.pdf
Histochem Cell Biol 2011; 135:263-80; PMID:21347609; http://dx.doi.org/10.1007/s00418-011-0793-3,Non-OADS,/arxiv_data1/oa_pdf/f2/7e/mabs-5-518.PMC3906305.pdf
Powers; Email: david.powers@abbvie.com Submitted: 04/02/13; Revised: 05/08/13; Accepted: 05/08/13http://dx.doi.org/10.4161/mabs.24979Introduction Protein engineering has proven successful at dramatically alter - ing the function and utility of many proteins across multiple spe - cies and protein classes.,Non-OADS,/arxiv_data1/oa_pdf/37/bb/mabs-5-523.PMC3906306.pdf
Nat Rev Immunol 2006; 6:343-57; PMID:16622479;  http://dx.doi.org/10.1038/nri1837 2.,Non-OADS,/arxiv_data1/oa_pdf/37/bb/mabs-5-523.PMC3906306.pdf
Curr Opin Immunol 2008; 20:460-70; PMID:18656541; http://dx.doi.org/10.1016/j.coi.2008.06.012 3.,OADS,/arxiv_data1/oa_pdf/37/bb/mabs-5-523.PMC3906306.pdf
Nat Rev Genet 2010; 11:31-46; PMID:19997069; http://dx.doi.org/10.1038/nrg2626 4.,OADS,/arxiv_data1/oa_pdf/37/bb/mabs-5-523.PMC3906306.pdf
T rends Biotechnol 2011; 29:435-42; PMID:21561674; http://dx.doi.org/10.1016/j.tibtech.2011.04.003 5.,OADS,/arxiv_data1/oa_pdf/37/bb/mabs-5-523.PMC3906306.pdf
Curr Cancer Drug Targets 2010; 10:80-95; PMID:20088790; http://dx.doi.org/10.2174/156800910790980241 7.,Non-OADS,/arxiv_data1/oa_pdf/37/bb/mabs-5-523.PMC3906306.pdf
J Immunol Methods 2007; 327:40-52; PMID:17719061; http://dx.doi.org/10.1016/j.jim.2007.07.007 8.,Non-OADS,/arxiv_data1/oa_pdf/37/bb/mabs-5-523.PMC3906306.pdf
Nat Biotechnol 2007; 25:1171-6; PMID:17891135; http://dx.doi.org/10.1038/nbt1336 10.,Non-OADS,/arxiv_data1/oa_pdf/37/bb/mabs-5-523.PMC3906306.pdf
Cancer Cell 2005; 7:301-11; PMID:15837620; http://dx.doi.org/10.1016/j.ccr.2005.03.003 12.,Non-OADS,/arxiv_data1/oa_pdf/37/bb/mabs-5-523.PMC3906306.pdf
J Exp Med 1998; 187:479-85; PMID:9463398; http://dx.doi.org/10.1084/jem.187.4.479 13.,Non-OADS,/arxiv_data1/oa_pdf/37/bb/mabs-5-523.PMC3906306.pdf
J Mol Biol 1998; 280:1-9; PMID:9653027; http://dx.doi.org/10.1006/jmbi.1998.1843 14.,Non-OADS,/arxiv_data1/oa_pdf/37/bb/mabs-5-523.PMC3906306.pdf
Science 1989; 244:1081-5; PMID:2471267; http://dx.doi.org/10.1126/sci-ence.2471267 15.,OADS,/arxiv_data1/oa_pdf/37/bb/mabs-5-523.PMC3906306.pdf
Sci T ransl Med 2009; 1:12ra23; PMID:20161664; http://dx.doi.org/10.1126/scitranslmed.3000540 16.,OADS,/arxiv_data1/oa_pdf/37/bb/mabs-5-523.PMC3906306.pdf
MAbs 2011; 3:17-20; PMID:21099370; http://dx.doi.org/10.4161/mabs.3.1.14169 17.,Non-OADS,/arxiv_data1/oa_pdf/37/bb/mabs-5-523.PMC3906306.pdf
Nat Biotechnol 2010; 28:965-9; PMID:20802495; http://dx.doi.org/10.1038/nbt.1673 20.,Non-OADS,/arxiv_data1/oa_pdf/37/bb/mabs-5-523.PMC3906306.pdf
Science 2009; 324:807-10; PMID:19423829; http://dx.doi.org/10.1126/sci-ence.1170020 21.,OADS,/arxiv_data1/oa_pdf/37/bb/mabs-5-523.PMC3906306.pdf
Nucleic Acids Res 2010; 38:e110; PMID:20144949; http://dx.doi.org/10.1093/nar/gkq052 22.,OADS,/arxiv_data1/oa_pdf/37/bb/mabs-5-523.PMC3906306.pdf
Nucleic Acids Res 2010; 38:e193; PMID:20846958; http://dx.doi.org/10.1093/nar/gkq789 23.,OADS,/arxiv_data1/oa_pdf/37/bb/mabs-5-523.PMC3906306.pdf
Anal Biochem 2012; 421:622-31; PMID:22178910; http://dx.doi.org/10.1016/j.ab.2011.11.005 24.,OADS,/arxiv_data1/oa_pdf/37/bb/mabs-5-523.PMC3906306.pdf
Mol Biosyst 2010; 6:1782-90; PMID:20714644; http://dx.doi.org/10.1039/c0mb00061b 25.,OADS,/arxiv_data1/oa_pdf/37/bb/mabs-5-523.PMC3906306.pdf
Nat Methods 2010; 7:741-6; PMID:20711194; http://dx.doi.org/10.1038/nmeth.1492,OADS,/arxiv_data1/oa_pdf/37/bb/mabs-5-523.PMC3906306.pdf
J Mol Biol  1983; 168:595-617; PMID:6193280; http://dx.doi.org/10.1016/S0022-2836(83)80304-0 33.,OADS,/arxiv_data1/oa_pdf/37/bb/mabs-5-523.PMC3906306.pdf
Science 1987; 238:791-3; PMID:3118465; http://dx.doi.org/10.1126/science.3118465 34.,Non-OADS,/arxiv_data1/oa_pdf/37/bb/mabs-5-523.PMC3906306.pdf
J Immunol 2012; 189:4470-7; PMID:23018459; http://dx.doi.org/10.4049/jimmunol.1201813 30.,Non-OADS,/arxiv_data1/oa_pdf/37/bb/mabs-5-523.PMC3906306.pdf
MAbs 2010; 2:256-65; PMID:20400861; http://dx.doi.org/10.4161/mabs.2.3.11641 31.,OADS,/arxiv_data1/oa_pdf/37/bb/mabs-5-523.PMC3906306.pdf
Nat Biotechnol 2012; 30:543-8; PMID:22634563; http://dx.doi.org/10.1038/nbt.2214 28.,Non-OADS,/arxiv_data1/oa_pdf/37/bb/mabs-5-523.PMC3906306.pdf
Biochem Biophys Res Commun 2012; 428:395-400; PMID:23103372; http://dx.doi.org/10.1016/j.bbrc.2012.10.066,OADS,/arxiv_data1/oa_pdf/37/bb/mabs-5-523.PMC3906306.pdf
"Do not distribute.www.landesbioscience.com  mAbs  595mA bs 5:4, 595–607; July/August 2013; © 2013 Landes Bioscience Repo Rt Repo Rt *Correspondence to: Wendy R. Gion; Email: wendy.gion@abbvie.com Submitted: 04/05/13; Revised: 05/21/13; Accepted: 05/23/13http://dx.doi.org/10.4161/mabs.25161Introduction The emerging success of monoclonal antibodies (mAbs) as thera- peutic agents for a wide range of human diseases in the past decade has heightened both medical and commercial interests in further exploiting these molecules in the clinic.",Non-OADS,/arxiv_data1/oa_pdf/e1/05/mabs-5-595.PMC3906313.pdf
"In order to improve signal peptide 2 processing from mature light chain, VBase (http://vbase.mrc-cpe.cam.ac.uk/) was surveyed and a range of  native human kappa light chain signal peptides chosen.",OADS,/arxiv_data1/oa_pdf/e1/05/mabs-5-595.PMC3906313.pdf
"To improve pro - cessing of light chain and produce antibody identical to that generated by conventional techniques, we tested a limited selec - tion of other native human V kappa light chain signal pep - tides (http://vbase.mrc-cpe.cam.ac.uk/) in place of the original light chain signal peptide in the PablonHL+ construct.",Non-OADS,/arxiv_data1/oa_pdf/e1/05/mabs-5-595.PMC3906313.pdf
"T ranscr 2011; 2:1, 9-14; http://dx.doi.org/10.4161/trns.2.1.13511 26.",OADS,/arxiv_data1/oa_pdf/e1/05/mabs-5-595.PMC3906313.pdf
Nucleic Acids Res 2001; 29:3327-34; PMID:11504870; http://dx.doi.org/10.1093/nar/29.16.3327 28.  v on Heijne G. The signal peptide.,OADS,/arxiv_data1/oa_pdf/e1/05/mabs-5-595.PMC3906313.pdf
J Membr Biol  1990; 115:195-201; PMID:2197415; http://dx.doi.org/10.1007/BF01868635 29.,Non-OADS,/arxiv_data1/oa_pdf/e1/05/mabs-5-595.PMC3906313.pdf
EMBO J 2000; 19:5019-26; PMID:10990465; http://dx.doi.org/10.1093/emboj/19.18.5019 30.,Non-OADS,/arxiv_data1/oa_pdf/e1/05/mabs-5-595.PMC3906313.pdf
Nucleic Acids Res 2002; 30:E9; PMID:11788735; http://dx.doi.org/10.1093/nar/30.2.e9 32.,OADS,/arxiv_data1/oa_pdf/e1/05/mabs-5-595.PMC3906313.pdf
Methods Enzymol 1990; 185:537-66; PMID:1974323; http://dx.doi.org/10.1016/0076-6879(90)85044-O 36.,OADS,/arxiv_data1/oa_pdf/e1/05/mabs-5-595.PMC3906313.pdf
Biotechnol Prog 2009; 25:735-44; PMID:19363814; http://dx.doi.org/10.1002/btpr.182 14.,Non-OADS,/arxiv_data1/oa_pdf/e1/05/mabs-5-595.PMC3906313.pdf
IUBMB Life 2005; 57:469-76; PMID:16081367; http://dx.doi.org/10.1080/15216540500163343 15.,OADS,/arxiv_data1/oa_pdf/e1/05/mabs-5-595.PMC3906313.pdf
Annu Rev Biochem 2000; 69:447-96; PMID:10966466; http://dx.doi.org/10.1146/annurev.biochem.69.1.447 16.,Non-OADS,/arxiv_data1/oa_pdf/e1/05/mabs-5-595.PMC3906313.pdf
Gene 1999; 231:1-13; PMID:10231563; http://dx.doi.org/10.1016/S0378-1119(99)00103-1 18.,OADS,/arxiv_data1/oa_pdf/e1/05/mabs-5-595.PMC3906313.pdf
J Biol Chem 2005; 280:2714-20; PMID:15557319; http://dx.doi.org/10.1074/jbc.M412313200 19.,OADS,/arxiv_data1/oa_pdf/e1/05/mabs-5-595.PMC3906313.pdf
T rends Biotechnol 2006; 24:137-42; PMID:16460822; http://dx.doi.org/10.1016/j.tibtech.2006.01.007 20.,OADS,/arxiv_data1/oa_pdf/e1/05/mabs-5-595.PMC3906313.pdf
J Biotechnol 2004; 107:95-105; PMID:14711493; http://dx.doi.org/10.1016/j.jbiotec.2003.09.015 22.,OADS,/arxiv_data1/oa_pdf/e1/05/mabs-5-595.PMC3906313.pdf
Biotechnol Prog 2005; 21:106-11; PMID:15903247; http://dx.doi.org/10.1021/bp0498241 23.,Non-OADS,/arxiv_data1/oa_pdf/e1/05/mabs-5-595.PMC3906313.pdf
Biotechnol Prog 2000; 16:736-43; PMID:11027164; http://dx.doi.org/10.1021/bp000107q 24.,OADS,/arxiv_data1/oa_pdf/e1/05/mabs-5-595.PMC3906313.pdf
Genes Dev 1989; 3:49-59; PMID:2523329; http://dx.doi.org/10.1101/gad.3.1.49References 1.,OADS,/arxiv_data1/oa_pdf/e1/05/mabs-5-595.PMC3906313.pdf
Nat Biotechnol 2004; 22:1393-8; PMID:15529164; http://dx.doi.org/10.1038/nbt1026 2.,OADS,/arxiv_data1/oa_pdf/e1/05/mabs-5-595.PMC3906313.pdf
Appl Microbiol Biotechnol 2005; 68:283-91; PMID:15834715; http://dx.doi.org/10.1007/s00253-005-1980-8 3.,Non-OADS,/arxiv_data1/oa_pdf/e1/05/mabs-5-595.PMC3906313.pdf
Mol Biotechnol 2000; 16:151-60; PMID:11131974; http://dx.doi.org/10.1385/MB:16:2:151 4.,Non-OADS,/arxiv_data1/oa_pdf/e1/05/mabs-5-595.PMC3906313.pdf
Curr Opin Biotechnol 2004; 15:456-62; PMID:15464378; http://dx.doi.org/10.1016/j.copbio.2004.08.002 5.,OADS,/arxiv_data1/oa_pdf/e1/05/mabs-5-595.PMC3906313.pdf
Cell 1984; 36:403-11; PMID:6319021; http://dx.doi.org/10.1016/0092-8674(84)90233-2 6.,OADS,/arxiv_data1/oa_pdf/e1/05/mabs-5-595.PMC3906313.pdf
Biotechnol Bioeng 2007; 96:337-48; PMID:17001634; http://dx.doi.org/10.1002/bit.21119 7.,Non-OADS,/arxiv_data1/oa_pdf/e1/05/mabs-5-595.PMC3906313.pdf
Biotechnol Prog 2000; 16:710-5; PMID:11027161; http://dx.doi.org/10.1021/bp000114e 8.,OADS,/arxiv_data1/oa_pdf/e1/05/mabs-5-595.PMC3906313.pdf
J Biotechnol 2007; 128:716-25; PMID:17324483; http://dx.doi.org/10.1016/j.jbiotec.2006.12.016 9.,OADS,/arxiv_data1/oa_pdf/e1/05/mabs-5-595.PMC3906313.pdf
Biochem Biophys Res Commun 1996; 229:295-8; PMID:8954121; http://dx.doi.org/10.1006/bbrc.1996.1795 10.,Non-OADS,/arxiv_data1/oa_pdf/e1/05/mabs-5-595.PMC3906313.pdf
J Immunol Methods 2007; 318:113-24; PMID:17161420; http://dx.doi.org/10.1016/j.jim.2006.10.010 11.,Non-OADS,/arxiv_data1/oa_pdf/e1/05/mabs-5-595.PMC3906313.pdf
Nat Biotechnol 2005; 23:584-90; PMID:15834403; http://dx.doi.org/10.1038/nbt1087 12.,OADS,/arxiv_data1/oa_pdf/e1/05/mabs-5-595.PMC3906313.pdf
Plant Signal Behav 2013; 8: e24354; http://dx.doi.org/10.4161/psb.24354Introduction Tobacco is a model plant which belongs to solanaceae family  and is being used also a bioreactor to introduce more genes to the plant to produce therapeutic proteins.,Non-OADS,/arxiv_data1/oa_pdf/70/d8/psb-8-e24354.PMC3906319.pdf
Infect Immun 2005; 73:8266- 74; PMID:16299323; http://dx.doi.org/10.1128/ IAI.73.12.8266-8274.2005 2.,Non-OADS,/arxiv_data1/oa_pdf/70/d8/psb-8-e24354.PMC3906319.pdf
Plant  Cell Rep 1993; 12:408-13; http://dx.doi.org/10.1007/ BF00234702 4.,OADS,/arxiv_data1/oa_pdf/70/d8/psb-8-e24354.PMC3906319.pdf
Ann Bot (Lond) 2000; 86:237-44; http://dx.doi.org/10.1006/anbo.2000.1192 8.,OADS,/arxiv_data1/oa_pdf/70/d8/psb-8-e24354.PMC3906319.pdf
Resonance 2001; 6:39-47; http://dx.doi.org/10.1007/ BF02839082 9.,Non-OADS,/arxiv_data1/oa_pdf/70/d8/psb-8-e24354.PMC3906319.pdf
Plant Biotechnol Rep 2007; 1:101-7; http://dx.doi.org/10.1007/s11816-007-0015-6 11.,Non-OADS,/arxiv_data1/oa_pdf/70/d8/psb-8-e24354.PMC3906319.pdf
"Stolarz A, Macewicz J, Lorz H. Direct somatic embryo-genesis and plant regeneration from leaf explants of  Nicotiana tabacum L. J Plant Physiol 1991; 137:347- 57; http://dx.doi.org/10.1016/S0176-1617(11)80144- 6 12.",OADS,/arxiv_data1/oa_pdf/70/d8/psb-8-e24354.PMC3906319.pdf
Plant Cell Rep 1993;  12:154-9; http://dx.doi.org/10.1007/BF00239097 13.,OADS,/arxiv_data1/oa_pdf/70/d8/psb-8-e24354.PMC3906319.pdf
Plant Cell Tissue Organ  Cult 1993; 33:105-19; http://dx.doi.org/10.1007/ BF0198322314.,Non-OADS,/arxiv_data1/oa_pdf/70/d8/psb-8-e24354.PMC3906319.pdf
Planta 1965; 65:102-4; http://dx.doi.org/10.1007/ BF00385183 19.,Non-OADS,/arxiv_data1/oa_pdf/70/d8/psb-8-e24354.PMC3906319.pdf
Plant Sci 1999; 141:51-8; http://dx.doi.org/10.1016/S0168-9452(98)00228-3 20.,OADS,/arxiv_data1/oa_pdf/70/d8/psb-8-e24354.PMC3906319.pdf
Plant Cell Rep 1988; 7:583-6; http://dx.doi.org/10.1007/ BF00272763 21.,OADS,/arxiv_data1/oa_pdf/70/d8/psb-8-e24354.PMC3906319.pdf
Planta 1992; 188:439-56; http://dx.doi.org/10.1007/BF00192812 22.,Non-OADS,/arxiv_data1/oa_pdf/70/d8/psb-8-e24354.PMC3906319.pdf
Biotechnology  1987; 5:726-30; http://dx.doi.org/10.1038/nbt0787- 726 23.,Non-OADS,/arxiv_data1/oa_pdf/70/d8/psb-8-e24354.PMC3906319.pdf
Plant Cell Rep 1991; 10:90-3;  http://dx.doi.org/10.1007/BF00236464 24.,OADS,/arxiv_data1/oa_pdf/70/d8/psb-8-e24354.PMC3906319.pdf
Plant Cell  Rep 1993; 12:621-4; http://dx.doi.org/10.1007/ BF00232811 25.,OADS,/arxiv_data1/oa_pdf/70/d8/psb-8-e24354.PMC3906319.pdf
Plant Cell Rep 1994;  13:344-8; http://dx.doi.org/10.1007/BF00232634 26.,OADS,/arxiv_data1/oa_pdf/70/d8/psb-8-e24354.PMC3906319.pdf
Plant Cell Rep 1994; 13:256-61; http://dx.doi.org/10.1007/BF0023331527.,OADS,/arxiv_data1/oa_pdf/70/d8/psb-8-e24354.PMC3906319.pdf
Plant Cell Rep 1993; 13:18-31; http://dx.doi.org/10.1007/BF00232310 28.,OADS,/arxiv_data1/oa_pdf/70/d8/psb-8-e24354.PMC3906319.pdf
Plant Cell Rep 1995; 14:267-72; http://dx.doi.org/10.1007/BF00232026 29.,OADS,/arxiv_data1/oa_pdf/70/d8/psb-8-e24354.PMC3906319.pdf
Plant  Cell Rep 2001; 20:712-20; http://dx.doi.org/10.1007/ s002990100382 30.,OADS,/arxiv_data1/oa_pdf/70/d8/psb-8-e24354.PMC3906319.pdf
Plant  Mol Biol 1987; 8:291-8; http://dx.doi.org/10.1007/BF00021308 32.,OADS,/arxiv_data1/oa_pdf/70/d8/psb-8-e24354.PMC3906319.pdf
Plant Physiol 1988; 88:570-3; PMID:16666350; http://dx.doi.org/10.1104/ pp.88.3.570 33.,Non-OADS,/arxiv_data1/oa_pdf/70/d8/psb-8-e24354.PMC3906319.pdf
Plant Cell Rep 1990;  9:276-9; http://dx.doi.org/10.1007/BF00232301 34.,OADS,/arxiv_data1/oa_pdf/70/d8/psb-8-e24354.PMC3906319.pdf
Proc Natl Acad Sci USA 1986; 83:379- 83; PMID:16593648; http://dx.doi.org/10.1073/ pnas.83.2.379 35.,OADS,/arxiv_data1/oa_pdf/70/d8/psb-8-e24354.PMC3906319.pdf
Mol Gen Genet 1988; 213:1-8; http://dx.doi.org/10.1007/BF00333390 36.,Non-OADS,/arxiv_data1/oa_pdf/70/d8/psb-8-e24354.PMC3906319.pdf
Plant Cell Rep 2000; 19:229-34;  http://dx.doi.org/10.1007/s00299005000439.,OADS,/arxiv_data1/oa_pdf/70/d8/psb-8-e24354.PMC3906319.pdf
Plant Cell Rep 2003; 22:38-45;  PMID:12827433; http://dx.doi.org/10.1007/s00299- 003-0648-z 40.,OADS,/arxiv_data1/oa_pdf/70/d8/psb-8-e24354.PMC3906319.pdf
Bio-Tech 1995; 13:481-5; http://dx.doi.org/10.1038/ nbt0595-48143.,Non-OADS,/arxiv_data1/oa_pdf/70/d8/psb-8-e24354.PMC3906319.pdf
Physiol Plant 1962; 15:473-97; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/70/d8/psb-8-e24354.PMC3906319.pdf
"Our analyses so far have used a single fluidic channel, whereas multiple channels will scale throughput  *Correspondence to: Paul D Soloway; Email: soloway@cornell.edu Submitted: 08/02/2013; Accepted: 08/05/2013http://dx.doi.org/10.4161/cc.26694Comment on: Murphy PJ, et al.",OADS,/arxiv_data1/oa_pdf/ea/86/cc-12-3451.PMC3906324.pdf
Genome Res 2012; 22:1128- 38; PMID:22466170 ; http://dx.doi.org/10.1101/ gr.133728.111 2.,OADS,/arxiv_data1/oa_pdf/ea/86/cc-12-3451.PMC3906324.pdf
Cell 2012; 151:181-93;  PMID:23021224 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ea/86/cc-12-3451.PMC3906324.pdf
Nat Methods 2010; 7:615-8; PMID:20622861 ; http://dx.doi.org/10.1038/ nmeth.1478 4.,OADS,/arxiv_data1/oa_pdf/ea/86/cc-12-3451.PMC3906324.pdf
Anal Chem 2010; 82:2480- 7; PMID:20184350 ; http://dx.doi.org/10.1021/ ac9028642 5.,OADS,/arxiv_data1/oa_pdf/ea/86/cc-12-3451.PMC3906324.pdf
Proc Natl Acad Sci U S A 2012;  109:8477-82;  PMID:22586076 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ea/86/cc-12-3451.PMC3906324.pdf
Proc Natl Acad Sci U S A 2013; 110:7772-7;  PMID:23610441 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ea/86/cc-12-3451.PMC3906324.pdf
PLoS One 2013; 8:e53880; PMID:23326524 ; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/ea/86/cc-12-3451.PMC3906324.pdf
Lab Chip 2012; 12:4848-54;  PMID:23018789 ; http://dx.doi.org/10.1039/ c2lc40955kFigure  1.,OADS,/arxiv_data1/oa_pdf/ea/86/cc-12-3451.PMC3906324.pdf
"Collectively, the recent discoveries  demonstrating that the pro-apoptotic BH3-only proteins either inhibit or induce autophagy by either stabilizing or inac - tivating the Beclin1-Bcl-2/Bcl- XL/Mcl-1  *Correspondence to: Yohannes Tesfaigzi; Email: ytesfaigzi@lrri.org Submitted: 07/21/2013; Accepted: 08/05/2013http://dx.doi.org/10.4161/cc.26696Comment on: Contreras AU, et al.",Non-OADS,/arxiv_data1/oa_pdf/0e/13/cc-12-3453.PMC3906325.pdf
"J Cell Biol 2013; 201:427-37; PMID:23629966; http://dx.doi.org/10.1083/jcb.201205064BH3-only proteins, Bmf and Bim, in autophagy Monica d elgado and y ohannes t esfaigzi* Chronic o bstructive Pulmonary d isease Program; l ovelace r espiratory r esearch i nstitute; a lbuquerque, NM usa",Non-OADS,/arxiv_data1/oa_pdf/0e/13/cc-12-3453.PMC3906325.pdf
J Exp Med 2008; 205:641-55;  PMID:18299399 ; http://dx.doi.org/10.1084/ jem.20071658 2.,Non-OADS,/arxiv_data1/oa_pdf/0e/13/cc-12-3453.PMC3906325.pdf
Science 2001; 293:1829- 32; PMID:11546872 ; http://dx.doi.org/10.1126/ science.1062257 3.,OADS,/arxiv_data1/oa_pdf/0e/13/cc-12-3453.PMC3906325.pdf
Cell Death Differ 2006; 13:129-40; PMID :15947789 ; http://dx.doi.org/10.1038/ sj.cdd.4401686 4.,Non-OADS,/arxiv_data1/oa_pdf/0e/13/cc-12-3453.PMC3906325.pdf
Proc Natl Acad Sci U S A 2003; 100:2432- 7; PMID:12591950 ; http://dx.doi.org/10.1073/ pnas.0438011100 5.,OADS,/arxiv_data1/oa_pdf/0e/13/cc-12-3453.PMC3906325.pdf
